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SUMMARY
An investigation into the mechanisms involved in ulceration of the stomach and small 
bowel was conducted. Wistar rats were dosed with a selection of NSAIDs, diclofenac, 
fenbufen, indomethacin, nabumetone, naproxen and piroxicam, at varying concentrations 
over different periods of time (one to twenty-eight days) and the corresponding effects 
on the stomach and small bowel were investigated. NSAID-induced ulceration o f the rat 
small bowel, caused only by indomethacin or diclofenac, was found to be associated with 
bacteria.
The bacteria associated with rat small bowel ulcers were investigated via scanning 
electron microscopy. Attempts at identification were conducted via the use of the 
antibiotics, amoxycillin, cloxacillin, erythromycin, metronidazole, nalidixic acid and 
neomycin sulphate, in vivo, and via antibiotic susceptibility tests in vitro. Numerous 
bacteria were isolated but the only ones positively identified were Proteus spp. and 
Escherichia coli.
The effects o f indomethacin on a cellular level, within the small bowel mucosa of rats, 
were examined via immunohistochemistry in order to try and determine the role of 
cytokines in ulcer formation. The concentration o f TNF-a was found to be highest 
within the Peyer's patches associated with ulcers and lowest within the unulcerated 
regions, between ulcers, in small bowel tissue taken from rats dosed with indomethacin 
ID 6o. The activity of TNF-a within normal control rat small bowel tissue was 
approximately midway between the two extremes observed within the ulcerated tissue. 
TNF-a activity in the small bowel tissue of animals treated with indomethacin ID 3o, a 
non-ulcerogenic dose, was approximately half that observed within the control tissue. 
Concentrations o f IL -la  were found to be highest within the small bowel tissue taken 
from rats dosed with indomethacin ID30, and lowest within the ulcerated small bowel 
tissue. IL -la  activity within the normal control tissue was approximately half that 
observed within indomethacin ID30 tissue and twice that observed in the ulcerated small 
bowel tissue.
xiv
The concentrations o f serum haptoglobin and serum myoglobin within the systemic 
circulation of rats treated with the selected NSAIDs were investigated in order to 
ascertain their usefulness as in vivo protein markers o f the presence and severity of small 
bowel ulceration.
Helicobacter pylori-positive and Helicobacter pylori-negative human gastric mucosa 
samples, from patients attending The Royal National Hospital o f Rheumatic Diseases in 
Bath, were examined via immunohistochemistry. The activity of the o f cytokines TNF- 
a , IL -la and IL-8 were found to be elevated within the infected gastric mucosa tissue.
xv
1.0 INTRODUCTION
1 1 PHYSIOLOGY AND PATHOLOGY OF THE STOMACH AND SMALL BOWEL
1.1.1 Stomach
The stomach has a number o f characteristics which enable it to perform various functions 
(see fig. 1.1.1). The main receptacle of the stomach consists o f the fundus and the body 
which are between them able to expand and accommodate an increase in volume o f up to
1.5 litres without an equivalent increase in intragastric pressure. The contractions o f the 
fundus and body are usually weak so most o f the gastric contents here remain relatively 
unmixed for long periods. In the antrum, however, the contractions are vigorous, 
fulfilling the dual role o f thoroughly mixing the antral chyme with gastric juice and 
emptying, in small bursts, the contents o f the stomach into the duodenal bulb.
The gastric mucosa is comprised o f many deep glands which in the body and the fundus 
contain parietal (or oxyntic) cells, which secrete hydrochloric acid and intrinsic factor, 
and chief (or zymogen) cells which secrete pepsinogens. Several o f these glands open 
onto a common chamber called the gastric pit. In the antral region o f the stomach the 
glands contain G cells which release gastrin, a hormone which stimulates gastric acid and 












Fig. 1.1.1 The Major Anatomical Divisions o f the Stomach
1
1.1.2 The Gastroduodenal Junction
The gastric antrum and the initial part o f the duodenum (duodenal bulb or cap) are 
separated by the pylorus. Although the pylorus is not strictly a true anatomical sphincter 
it functions physiologically as such in many respects. The circular smooth muscle of the 
pylorus forms two ring-like thickenings that are followed by a connective tissue ring that 
separates the pylorus from the duodenum. The pylorus is densely innervated by vagal 
and sympathetic nerve fibres. The sympathetic postganglionic fibres release 
norepinephrine which acts on a-adrenergic receptors causing the sphincter to constrict 
even more. The vagal fibres have both excitatory and inhibitory effects on the smooth 
muscle of the pylorus. Cholinergic vagal fibres stimulate the sphincter to constrict and 
the inhibitory vagal fibres release another transmitter, vasoactive intestinal polypeptide 
(VTP), which causes it to relax. In addition to this other substances, cholecystokinin, 
gastrin, gastric inhibitory peptide and secretin cause the pylorus to constrict. It is not 
known if all these hormones are physiological regulators for the pylorus, however, 
cholecystokinin constricts the pyloric sphincter at concentrations which activate gall­
bladder constriction.
This junction has two functions, it regulates the emptying o f the stomach, so that the 
gastric contents pass through to the duodenum at a rate that the duodenum can process 
the chyme, as too rapid emptying can lead to duodenal ulcers. It also prevents 
regurgitation o f the duodenal contents back into the stomach as although the gastric 
mucosa is highly resistant to acid it may be damaged by bile. [Ganong, 1987; Kutchai, 
1993b],
1.1.3 The Small Bowel
The small bowel, particularly the duodenum and jejunum, is the site of most digestion 
and absorption. It is approximately five metres long, is the largest segment o f the 
gastrointestinal tract and accounts for 75 per cent o f the total length in humans (the 
chyme takes between two to four hours to traverse the entire length). About nine litres 
of fluid pass through the small bowel per day, two via fluid intake through the stomach 
and the rest is made up of gastrointestinal secretions.
2
1.1.3.1 The Duodenum
The duodenal bulb is the first part of the duodenum and is regularly in contact with the 
acidic gastric contents which have been emptied from the stomach through the pylorus. 
As a result this is a common site of peptic ulceration. The duodenum is approximately 
25 cm long, is the region without any mesentery, and easily distinguished from the rest of 
the small bowel histologically. The villi o f the distal duodenum may be leaf or finger 
shaped and range in height from 0.5 to 0.8 mm. [Ganong, 1987; Madara & Trier, 1987a; 
Kutchai, 1993c].
1.1.3.2 The Jejunum
At the ligament o f Treitz the duodenum becomes the jejunum which accounts for 
approximately 40 per cent o f the remainder of the small bowel although there is no sharp 
dividing line between it and the ileum. The villi in the human proximal jejunum are 
similar to those found in the distal duodenum, [Ganong, 1987; Madara & Trier, 1987a; 
Kutchai, 1993c].
1.1.3.3 The Ileum
The ileum is the longest part o f the small bowel, accounting for almost 60 per cent of the 
entire length, and in this region the human villi are finger shaped, rarely exceeding 0.5 
mm in height. The distal ileum is the site o f reabsorption o f bile acids and here the 
epithelial cells actively take up bile acids against a large concentration gradient. As a 
result the pH in the distal ileum tends to be higher than the rest of the small bowel 
[Borgstrom et al., 1957] which is usually at a pH of 7.0. The terminal ileum is separated 
from the caecum, the first part o f the colon, by the ileocaecal sphincter. [Ganong, 1987; 
Madara & Trier, 1987a; Kutchai, 1993c],
1.1.4 The General Structure o f the Gastrointestinal Tract Wall
The gastrointestinal mucosa is made up o f three distinct layers. The deepest is a 
continuous thin sheet o f contractile smooth muscle, ten cells thick, called the muscularis 
mucosa which separates the mucosa from the submucosa. Its precise role is unclear but 
it is thought to contribute to intestinal function as its contractions may facilitate the
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emptying o f crypt luminal contents by causing luminal compression. In addition, it is 
possible that the contractions also contribute to villi movement thus affecting the 
unstirred layer adjacent to the absorptive epithelium.
The middle mucosal layer, called the lamina propria, is the continuous connective tissue 
space which forms the connective tissue core of the villi and surrounds the crypt 
epithelium. The lamina propria, which supports the epithelial cells, has a number of 
important functions the main one being that it contains the blood vessels which nourish 
the epithelium. The most abundant cell types present are the mononuclear cells which 
are necessary for an immunological response, such as plasma cells, lymphocytes and 
macrophages, and as a consequence the lamina propria has important immunological 
functions both in healthy and disease states. The blood and lymph vessels o f the lamina 
propria also transport the material which is absorbed by the epithelium.
The third layer o f the intestinal mucosa consists o f a continuous sheet of epithelial cells, 
one cell thick, which lines the villi and the crypts and as a result is in direct contact with 
the contents o f the lumen. The epithelium is separated from the lamina propria by a thin 
continuous basement membrane which is in two parts, the basal lamina (which is in direct 
contact with the basal surface o f the epithelium) and a deeper layer of reticular fibres and 
glycoprotein connective tissue (which adheres to the lamina propria). The crypt 
epithelium consists o f many different cell types. Mucus-secreting goblet cells, a variety 
of endocrine cells, occasionally a caveolated (or tuft) cell, Paneth cells (in most 
mammals) containing large secretory granules and many undifferentiated cells which are 
actively proliferating. The epithelium covering the villi is also made up o f mucus- 
secreting goblet cells, rare caveolated cells and a few endocrine cells. However, in 
addition to these there are large numbers of absorptive cells (or enterocytes). In the 
ileum there occurs a specialised epithelial cell, the M cell (which covers the top o f Peyer's 
patches) and the occasional cup cell. There are 20 to 40 villi per square mm of mucosa 
and the free edges o f the cells o f their epithelium are divided into minute microvilli which 
form a brush border.
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Underlying the mucosa is the submucosa, another layer o f connective tissue, which 
contains a network of nerve cells, called the submucous plexus, as well as blood and 
lymphatic vessels that penetrate up into the mucosa and down into the muscularis 
externa. The muscularis externa is made up of two layers o f muscle, a relatively thick 
inner layer of circular muscle and a thinner outer layer of longitudinal muscle, between 
which lies another network of nerve cells known as the myenteric plexus.
The outermost covering, called the adventitia (in the mesentery free region o f the 
duodenum) or serosa, consists mainly o f a thin layer of cells and connective tissue which 
do not form an integral part of the small bowel. These thin sheets o f connective tissue 
anchor the jejunum and the ileum, via the mesentery, to the posterior body wall, thus 
supporting the gastrointestinal tract within the abdominal cavity. [Ganong, 1987; 
Madara & Trier, 1987a; Kutchai, 1993c; Vander et al., 1994; Telford & Bridgman, 
1995],
1.2 MECHANISMS OF DAMAGE TO THE STOMACH AND SMALL BOWEL
1.2.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Although NSAIDs have now been in use for almost 100 years some of their modes of 
action are still not clearly understood. The first evidence that a NSAID could cause 
damage to the stomach was reported by Douthwaite and Lintott [1938], who observed, 
via gastroscopy, the damage caused by aspirin, which by this time had been commercially 
synthesised for at least 40 years [Dreser, 1899]. NSAIDs are now believed to cause this 
damage in a variety of ways, some of which are interconnected.
1.2.1.1 Ion Trapping
Some of the damage caused to the gastric mucosa by NSAIDs is probably due to a 
direct, topical effect as they pass through the stomach. Weak organic acids are unable to 
dissociate in the low pH of the stomach and most NSAIDs are weak acids with pKa 
values less than 5. Usually such compounds will be 99 per cent ionised in an 
environment that is two pH units above that o f its pKa value but at other times they 
remain un-ionised. Thus in the stomach, with a pH of 1 to 2, they are un-ionised and in
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this form they are able to pass easily though the lipid bilayer that makes up the gastric 
epithelial cell walls. However, once these weak acids are inside the epithelial cells, 
where the pH is maintained at between 7.0 and 7.4, they become ionised. The ionised 
drugs are now trapped inside the cell as they are unable to pass easily back across the 
phospholipid membrane. This phenomenon of'ion trapping' [Martin, 1963] means that 
water soluble NSAIDs can, temporarily, become highly concentrated within the gastric 
epithelial cells [Brune et a l, 1979, 1980] causing damage as a result. The high 
intracellular concentrations of acidic NSAIDs may cause a direct acid damaging effect 
[Schoen & Vender, 1989] especially if they are water soluble [Garner, 1978], Although 
this high concentration of NSAID is probably short-lived the resulting inhibition of 
cyclooxygenase (COX) may possibly last for many hours.
1.2.1.2 Re-exposure Due To Enterohepatic Recirculation
The 'ion trapping' mechanism explains some of the damage caused to the gastric mucosa, 
particularly by water soluble NSAIDs such as aspirin and diclofenac, but does not 
explain the damage caused to the small bowel which is usually maintained at a neutral 
pH. The topical damage here is due, in part, to enterohepatic circulation as some 
NSAIDs and/or their metabolites, once they have been conjugated in the liver, are 
excreted in the bile. Hydrolysis of these biliary excreted conjugates by bacterial (3- 
glucuronidase and sulphatase result in the small bowel being repeatedly exposed to the 
active drug enabling some o f it to be reabsorbed [Kent et a l, 1969; Rainsford, 1983; 
Simon & Gorbach 1986, 1987; Rainsford, 1989; Bjamason & MacPherson, 1989], 
Evidence supporting this proposed mechanism comes from animal experiments whereby 
damage to the gastrointestinal mucosa caused by indomethacin can either be greatly 
reduced upon fasting, which decreases bile flow; or prevented by bile duct ligation 
[Brodie et a l, 1970],
1.2.1.3 Inhibition of Cyclooxygenase (COX)
COX is the first dedicated enzyme in prostaglandin synthesis (see fig. 1.2.1.3a) and the 
inhibition of this enzyme as being the means by which NSAIDs exerted their 
antiinflammatory activity was first proposed by Vane [1971], Evidence supporting that 




















Figure 1.2.1.3a Conversion o f Arachidonic Acid to Prostaglandins and Thromboxanes







tract was later provided by experiments that showed that a variety of prostaglandins and 
their analogues could prevent the damage caused by NSAIDs, if given concomitantly 
[Robert, 1974; Robert, 1975; Fang et a l, 1975], Also drugs, such as prednisolone, 
which were known to inhibit the formation o f arachidonic acid from membrane 
phospholipid via the enzyme phospholipase A2 [Gryglewski et a., 1975], were also 
shown to cause ulceration to the gastrointestinal tract, similar to that found with 
indomethacin [Lancaster & Robert, 1978], Thus it was confirmed that prostaglandins 
conferred a cytoprotective effect [Robert, 1976, 1979] on the gastrointestinal tract but 
inhibition of their synthesis does not fully explain all mechanisms involved in NSAID- 
induced damage.
Flower and Vane [1972] proposed that there may be more than one form of COX and 
that different tissues might contain their own variant of the enzyme. Evidence 
supporting this theory has been provided by the finding that prostaglandin synthesis 
could be inhibited by sodium salicylate at inflammatory sites without affecting 
prostaglandin synthesis in the gastrointestinal tract [Whittle et al. 1980]. Conclusive 
evidence was provided by the characterisation o f an isozyme of COX [Xie, et al., 1991] 
which was different from the one already identified [Yokoyama & Tanabe, 1989] and as 
a result Vane [1992] has revised his original hypothesis. These two isozymes, which 
have been designated COX-1 and COX-2, operate in different ways (see fig. 1.2.1.3b).
The COX-1 enzyme is the constitutive form which is responsible for the physiological 
synthesis o f prostaglandins in the gut, kidney, blood platelets [Funk et al., 1991] and 
other tissues [Simmons et al., 1991], It is inhibition of this enzyme by NSAIDs which is 
responsible for the damage they cause to the gastrointestinal tract and the older NSAIDs 
(indomethacin, naproxen and diclofenac) are more selective for COX-1 than COX-2 
[Meade, et a l, 1993; Mitchell et a l, 1993]. COX-2 is the inducible form which appears 
to be the major enzyme responsible for inflammatory prostaglandin synthesis and its 
expression is found to be greatly increased at sites o f inflammation [Vane et a l,  1994], 
In fact, activity o f COX-2 is induced by many factors including serum [Simmons, et a l, 
1991], lipopolysaccharide (LPS) [O'Sullivan et a l, 1992a; 1992b] and inflammatory 
cytokines such as Interleukin-1 [Lyons-Giordano et al., 1992]. One of the newer
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NSAIDs, nabumetone, appears to have a higher selectivity for the COX-2 enzyme 
[Meade, et al., 1993], which may be one o f the reasons why it causes very little damage 
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Figure 1.2.1 3b Vane's Revised Hypothesis o f the Mechanism of Action of NSAIDs
1.2.1.4 Production o f Leukotrienes
It has been suggested that when NSAIDs inhibit COX, the result is that more 
leukotrienes are formed as 5-lipoxygenase, the first dedicated enzyme in leukotriene 
synthesis, channels the surplus arachidonic acid down this pathway (see fig. 1.2.1.a) 
[Rainsford, 1987; Bjamason et al., 1989], Leukotrienes have been implicated in the 
pathogenesis o f NSAID-induced damage to the gastrointestinal tract [Rainsford, 1987; 
Pihan et al., 1988; Asako et al., 1992; Vaananan et al., 1992] and elevated levels o f 
leukotriene B4 (LTB4), probably the most important inflammatory leukotriene in man 
[Lewis & Keft, 1995], have been found in gastric biopsies taken from patients taking
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NSAIDs long-term [Hudson et a l, 1991], Leukotrienes stimulate the synthesis of the 
proinflammatory cytokine IL-1 [Hwang, 1989] and LTB4 is itself a chemoattractant for 
neutrophils in humans [Goetzl & Pickett, 1980; Bray et a l, 1981; Palmblad et a l, 1981; 
Grisham & Granger, 1988], The presence of LTB4 also rapidly increases the cell surface 
expression o f the adhesion glycoprotein CD11/CD18 in activated neutrophils 
[Zimmerman & McIntyre, 1988; Harlan & Liu, 1992] thus stimulating the adherence of 
neutrophils to the vascular endothelium [Dahlen et a l, 1981; To et a l, 1990; Asako et 
a l, 1992], LTB4, however, is not thought to be chemotactic for rat neutrophils [Kreisle 
et a l, 1985], NSAID-induced damage of the gastrointestinal tract has been ameliorated 
by administering either anti-LTB4 [Wallace et a l, 1992] or an LTB4 receptor agonist 
[Asako et a l, 1992; Wallace & Granger, 1992; Jacobson, 1995] and also by the direct 
inhibition o f leukotriene synthesis [Samuelson, 1980; Batt, 1992; Musser & Kreft, 1992; 
Vaananan et a l,  1992], however, this protection may have been due to a non-specific 
action such as free radical scavenging [Rainsford, 1987; Pihan et a l, 1988; Vaananan et 
a l, 1992],
1.2.1.5 Adherence and Activation of Neutrophils
Damage to the gastrointestinal tract as a result o f neutrophil adherence could occur in 
one o f two ways [Wallace & Granger, 1992]. The signals which cause neutrophils to 
adhere may also be the ones which activate them, resulting in the release o f oxygen 
derived free radicals and proteases, thus causing injury to the surrounding cells of the 
epithelium or endothelium. Although all cells possess numerous antioxidant enzymes 
and scavengers with which to protect themselves from these injurious agents, the rate of 
production o f reactive oxygen metabolites (ROMS) may overwhelm the capacity o f the 
antioxidant defences [Grisham & Granger, 1988] and the imbalance between 
prooxidative and antioxidative processes, termed 'oxidative stress' [Sies, 1985], results in 
substantial damage to surrounding tissues. Evidence that free radicals, released from 
neutrophils after NSAID administration, contribute to gastrointestinal mucosa damage 
has been shown in rats [Del Soldato et a l, 1985; Pihan et a l, 1987; Vaananan et a l, 
1991], The other way in which neutrophil adherence could result in damage to the 
gastrointestinal tract is by their obstructing the capillaries in the gastrointestinal mucosa, 
thus reducing the mucosal blood flow and compromising the defences o f the mucosa
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accordingly. NSAIDs are known to reduce gastric blood flow [Ashley et a l, 1985; 
Kitahora & Guth, 1987; Gana et a l, 1987] and this has been shown to occur after the 
appearance of white thrombi in the gastric microcirculation [Kitahora et a l, 1987], It 
has also been demonstrated that NSAID-induced damage to the gastrointestinal tract is 
significantly reduced in rats which have been depleted of neutrophils, either by 
methotrexate or anti-neutrophil serum, prior to NSAID administration [Wallace et a l, 
1990; Lee et a l,  1992], Similarly prevention of neutrophil adherence to the endothelium 
by an antiserum directed against the neutrophil adhesion glycoprotein CD 18 also reduces 
indomethacin-induced ulceration [Vedder e/a/., 1988; Wallace et a l, 1991],
1.2.1.6 NSAID Uncoupling o f Mitochondrial Oxidative Phosphorylation
The uncoupling o f oxidative phosphorylation has been implicated as having a role in 
NSAID-induced damage of the gastrointestinal tract. Earlier experiments show that 
NSAIDs (salicylate and acetylsalicylate) can act as uncouplers o f oxidative 
phosphorylation [Brody, 1956; Penniall, 1958; Packer et a l, 1959; Jeffrey & Smith, 
1959; Whitehouse, 1964; Smith & Dawkins, 1971; Tokumitsu et a l, 1977; Kawai et a l, 
1985] and that in vitro they can also inhibit a wide range o f cellular enzymes such as 
dehydrogenases [Smith & Dawkins, 1971]. The uncoupling o f mitochondrial oxidative 
phosphorylation and inhibition of mitochondrial dehydrogenases by salicylate are 
consistent with it having a role in the mitochondrial injury seen in Reye's syndrome 
[Martens & Lee, 1984],
As a result it has been proposed that NSAIDs, such as indomethacin, cause the 
uncoupling o f mitochondrial oxidative phosphorylation through a topical action as they 
pass through the gastrointestinal tract, thus disrupting the energy metabolism of the 
mitochondria in the epithelial cells. Recently, ingestion of NSAIDs has been shown, in 
vivo, to increase the activity o f specific mitochondrial and brush border marker enzymes 
in rats, which is consistent with the uncoupling o f oxidative phosphorylation, prior to any 
visible signs o f macroscopic damage to the gastrointestinal mucosa [Bjamason & 
Hayllar, 1996]. These events have been mirrored by visible changes in mitochondria 
viewed via electron microscopy [Bjamason & Hayllar, 1996], In vitro experiments on 
isolated coupled rat liver mitochondrial preparations have also shown that all acidic
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NSAIDs uncouple mitochondrial oxidative phosphorylation to a similar degree and that 
their uncoupling potency is correlated to pKa value [Mahmud et a l, 1996a, 1996b]. 
These in vitro effects on mitochondrial respiration were found to occur with the NSAID 
concentrations (pM) at a level easily achievable within the intestinal epithelium 
[Bjamason & Hayllar, 1996], and experimental animals with bile duct ligation showed 
that unmetabolised indomethacin within the gastrointestinal lumen was necessary for the 
uncoupling to occur [Bjamason & Hayllar, 1996].
Therefore the pathogenesis of NSAID-induced gastrointestinal damage may be due to 
uncoupling of mitochondrial oxidative phosphorylation [Hayllar et al., 1991; 
Somasundaram et al., 1992; Somasundaram et al., 1995; Mahmud et al., 1996a] which 
depletes the epithelial cells o f ATP [Whitehouse, 1964; Mehlman et a l, 1972; Tokumitsu 
et a l, 1977; Kawai et al., 1985] resulting in a disruption of epithelial cell junctions 
[Meza et al., 1980; Madara & Dharmsathaphom, 1985; Madara et al., 1986, 1987], The 
corresponding increase in mucosal permeability [Bjamason et a l, 1993] thus renders the 
gastrointestinal mucosa exposed to luminal aggressive factors [Somasundaram et al.,
1995], It has therefore been concluded that NSAIDs cause biochemical cell damage, 
which is quite distinct and severe, resulting in increased intestinal permeability which may 
in itself be the central mechanism for an inflammatory tissue reaction [Bjamason & 
Peters, 1996],
1.2.1.7 Inhibition of Glycolysis and Tricarboxylic Acid Cycle
It has also been proposed that NSAIDs cause damage to the gastrointestinal tract by 
inhibiting glycolysis and the tricarboxylic acid cycle. This suggestion has been a result o f  
in vitro experiments which show that NSAIDs affect glycolysis and also inhibit a wide 
range o f cellular enzymes such as dehydrogenases [Smith & Dawkins, 1971] as well as 
uncoupling oxidative phosphorylation at a number o f sites [Smith & Dawkins, 1971; 
Mehlman et a l, 1971; Glarborg-Jorgensen et a l, 1976a; Spenney & Brown, 1977; 
Tokumitsu et al., 1977; Martens & Lee, 1984; Rainsford, 1989]. (Mitochondrial 
dehydrogenases are important enzymes in the tricarboxylic acid cycle.) This hypothesis 
is supported by the fact that a glucose-citrate formulation o f indomethacin prevents 
NSAID-induced gastrointestinal damage in the rat [Rainsford & Whitehouse, 1980].
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The mechanism is uncertain but it is thought that NSAIDs may be competitive inhibitors 
of specific enzymes involved in glycolysis or in the tricarboxylic acid cycle thus causing a 
reduction in ATP production [Glarborg-Jorgensen et a l , 1976a, 1976b; Rainsford & 
Whitehouse, 1980; Rainsford, 1989] resulting in cell death. An alternative explanation of 
these findings is that citrate, a potent inactivator of phosphofructokinase, the rate- 
limiting enzyme o f glycolysis, may funnel glucose into the hexose monophosphate 
pathway and thus provide increased reduction power to combat the oxygen free radicals 
formed as a result o f NSAID metabolism [Bjamason et a l, 1992a]. Thus the 
concomitant administration of glucose and citrate is thought to provide the epithelial 
cells of the gastrointestinal tract with the substrates required for the relevant pathways 
which have been disrupted by the NSAID and as a result prevent the disruption of 
intercellular junctions [Bjamason et a l, 1992a],
1.2 .2 Bacteria o f the Upper Gastrointestinal Tract
Initially, due to the hostile environment, the stomach and small bowel were assumed to 
be sterile [Gorbach et a l, 1967], The stomach because it is bathed in hydrochloric acid 
at a pH of 1-2, and the small bowel similarly so as the duodenum is regularly flushed 
with acid (when the stomach empties) and because the jejunum and ileum are regularly in 
contact with bile salts. As a result the general dogma had been that these environs were 
free o f any colonising bacteria but this was proved to be untrue and the gastrointestinal 
tract, o f any one individual, is now known to host more than 400 bacterial species, some 
of them pathogens [Simon & Gorbach, 1986, 1987],
The microflora o f the stomach is mostly gram-positive and aerobic (commonly 
streptococci, staphylococci and lactobacilli) [Gorbach et a l, 1967] whereas the distal 
ileum predominantly contains anaerobes such as Bacteroides, Bifidobacterium, 
Fusobacterium (which are gram-negative) and Clostridium (which is gram-positive) 
[Gorbach et a l, 1967; Draser et a l, 1969; Drasar & Shiner, 1969; Simon & Gorbach, 
1984], Stretching between these two extremes, the sparsely populated stomach and the 
more densely populated distal ileum, the rest of the small bowel contains a mixture of 




Helicobacter pylori is a gram-negative bacterium with a curved, spiral or gull-wing 
shape. It is 2.5 to 3 .5 pm long, 0.5 to 1.0 pm in diameter and has a periodicity of 1.0 to
2.0 pm. The surfaces o f this bacterium are smooth and one to six flagellae (which are 
sheathed and contain a terminal bulb) emerge from one of its rounded ends. The 
flagellae, which are thought to be sheathed in order to protect them from the acidic 
environment, are necessary for motility but are not a prerequisite for attachment to 
gastric cells [Eaton et al., 1989, 1991]. Initially, owing to its close similarity to 
Campylobacter jejuni, it was called Campylobacter pylori but it has since been 
reclassified and now is universally known as Helicobacter pylori. [Dubois, 1995],
Helicobacter pylori, a type I carcinogen [Logan, 1994], colonises the non-acid secreting 
mucosa o f the stomach and is seldom found in the area where parietal cells are 
numerous. As a result it is found in the gastric antrum, cardia, corpus and attached to 
the gastric epithelial cells o f the duodenum. (The tissue specific binding of Helicobacter 
pylori has been demonstrated in vitro since binding o f the bacteria is significantly 
increased in human gastric cells as opposed to non-gastric ones [Nilius et al., 1993; 
Smoot et al, 1993].) Helicobacter pylori multiplies rapidly within the stomach but not in 
the lumen because it prefers to live within the pH range 4 to 7 [Dubois, 1995],
Helicobacter pylori was first linked to gastritis and gastric and duodenal ulceration by 
Marshall and Warren [1983, 1984] but almost 15 years later the mechanisms involved are 
still not truly understood. Initially it was thought that the bacterium's potent urease, 
which it uses to convert urea into ammonia [Cover et al., 1991; el Nujumi et al., 1992], 
thus making its environment more habitable [Perez-Perez et al. 1992; Segal et al., 1996]; 
was responsible for all the inflammation seen. Although ammonia generated by the 
urease has been shown to be a potent cytotoxin for many cell lines in vitro [Xu et al., 
1990; Megraund et al., 1992], particularly gastric ones [Smoot et al., 1990; Segal et al.,
1996], and in vivo [Eaton et al., 1991] this is not now thought to be the major culprit.
There are known to be two broad types of the bacterium, classified as type 1 and type 2, 
and it is the type I bacteria which have been found to be the most virulent strains [Xiang
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et al., 1995], Type 1 possess a larger DNA region [Segal, 1997] which contain the 
genes, vac A and cagA, that enable these bacteria to produce vacuolating cytotoxin and 
cytotoxin-associated protein, respectively. It is the type I strains that are implicated in 
the pathogenesis of duodenitis, duodenal ulcers and gastric cancer [Covacci et al., 1993; 
Xiang et al., 1995; Weel et al., 1996] although not all humans infected with these strains 
go on to develop a duodenal ulcer.
Helicobacter pylori-positive patients with duodenal ulcer have been found to have higher 
fasting serum gastrin levels than those who only have gastritis and they in turn have 
fasting serum gastrin levels higher than the negative controls [Haruma et al., 1995], 
Gastric acid secretion is higher in patients with duodenal ulcer than those without [Blair 
et a l,  1987; Feldman et al., 1988] and it has been suggested that Helicobacter pylori 
infection increases gastric acid secretion through hypergastrinaemia [Levi et a l,  1989a] 
owing to the trophic effects on parietal cells [Johnson, 1976], However, recent studies 
have reported that although eradication of Helicobacter pylori consistently lowers serum 
gastrin levels [Marshall et al., 1988; Levi et al., 1989b; Graham et a l ,  1990] this has had 
no corresponding effect on basal or maximal acid output [Montbriand et al., 1989] or on 
intragastric pH [McColl etal., 1991],
Studies on the regulation of gastrin secretion show that gastrin G cells are under constant 
restraint by somatostatin D cells in the antral mucosa [Saflfouri et a l ,  1980; Schubert et 
a l,  1988] and the presence of high gastric acid secretion increases somatostatin release 
resulting in reduced gastrin secretion. It has been proposed that the modification o f the 
gastric surface pH via neutralisation o f gastric acid by ammonia [Levi et al., 1989b], 
produced through the urease activity of Helicobacter pylori, results in lower antral 
somatostatin concentration [Kaneko et a l,  1992], Thus enhanced gastrin synthesis and 
release occur as a result o f the inhibition of somatostatin synthesis in spite o f the low 
intraluminal pH [Queiroz et a l,  1993].
More than 95 per cent of patients with duodenal ulcer and more than 80 per cent of 
patients with gastric ulcer are infected with Helicobacter pylori [Peterson, 1991; 
Graham, 1991; Veldhuyzen van Zanten et a l,  1994] but only 15 to 20 per cent o f those
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infected will develop an ulcer during their lifetime [Sipponen et al., 1989] so 
Helicobacter pylori does not appear to be the sole causative agent. Other factors which 
increase the risk of Helicobacter pylori-positive subjects developing an ulcer include 
cigarette smoking [van Deventer et al., 1989] and the taking of NSAIDs [Jones et al., 
1991], However, in the majority of cases, Helicobacter pylori infection, once diagnosed, 
can be easily eradicated by a combination of two antibiotics, amoxycillin [Adamek et al.,
1993] and metronidazole [Rautelin et al., 1992], in conjunction with an antimicrobial 
agent such as bismuth (which disrupts the integrity o f bacterial cell walls [van 
Caekenberghe & Breyssens, 1987]) [Walsh & Peterson, 1995],
1.2.2.2 Bacteria o f the Rat Small Bowel
Bacteria have been shown to be mediators in NSAID-induced damage to the 
gastrointestinal mucosa in the rat small bowel [Kent et al., 1969], After administration 
of NSAIDs the numbers o f bacteria in the rat small bowel are seen to increase along with 
the formation o f ulcers [Kent et al., 1969; Yamada et al., 1993], This ulceration is 
prevented or reduced by concomitant or pre-treatment with various antibiotics [Kent et 
al,  1969; Fang et al., 1977; Yamada et al., 1993; Collins et a l,  1995], A similar result 
has been obtained using germ-free rats [Robert & Asano, 1977] which, when mono­
contaminated with Escherichia coli, developed ulcers in the small bowel although these 
were less severe than those found in germ-free rats contaminated with the normal 
microflora o f rat small bowel [Robert & Asano, 1977], These results suggest that it is 
the antimicrobial action o f the antibiotics which attenuate the formation o f NSAID- 
induced ulceration. However, some researchers believe it is a direct effect of the 
antibiotics themselves on the cells of the gastrointestinal mucosa which is cytoprotective 
[Satoh, et a l,  1983] as some antibiotics have been found to control the production of IL- 
2 in vitro [Braquet & Rola-Pleszczynski, 1987], Metronidazole has been reported as 
being an immunosuppressant [Grove et a l,  1977] possibly by acting as an inhibitor of 
leucocyte-endothelial cell adhesion [Arndt et a l ,  1994] or as a scavenger for free radicals 
[Akamatsu et a l ,  1990].
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1.2.3 Contributory Mechanisms of Ulcerogenesis
Although the mechanisms associated with the following environmental factors were not 
investigated during the course of this research project, they are believed to exacerbate 
the damage caused by other pathogens such as NSAIDs and Helicobacter pylori.
1.2.3.1 Smoking
Cigarette smoking has long been implicated as having a role in ulcer formation as people 
who smoke are at a greater risk of developing an ulcer than non smokers [Friedman et 
al., 1974; Piper et a l,  1982; Kato et al., 1992] and these ulcers are more likely to be in 
the stomach rather than in the duodenum [Friedman et al., 1974], In addition, ulcers 
take longer to heal in patients who smoke [Doll et al., 1958; Chujoh & Nakazawa, 1981; 
Korman et el., 1981, 1982; Massarrat & Eisenmann, 1981] and are also more likely to 
recur [Sontag et a l,  1984; Korman et a l,  1983], Inhalation of cigarette smoke alone, 
however, does not appear to cause gastrointestinal ulceration [Toon et al., 1983] so it 
would appear that cigarette smoking mediates mucosal damage which is being caused by 
some other noxious agent. Various studies have shown that cigarette smoking not only 
mediates mucosal damage it also attenuates mucosal protection.
1.2.3.11 Smoking as a Mediator of Mucosal Damage
The major cause of gastric ulceration is thought to be excessive levels o f gastric acid 
secretion [Koelz et a l,  1986] and smokers are found to have increased basal and peak 
gastric acid output [Steigmann et al., 1954; Piper & Raine, 1959; Murthy et al., 1977; 
Sontag et al., 1984; Parente et a l,  1985; Whitfield & Hobsley, 1987; Lanas & 
Hirschowitz, 1992], Cigarette smoking also enhances the rate of nocturnal secretion of 
acid [Weir, 1988] and reverses the inhibition of nocturnal acid secretion produced by FL 
receptor antagonists [Boyd et a l,  1983].
Pepsin is an aggressive factor to the gastrointestinal mucosa [Shay, 1961] and smokers 
have been found to have significantly higher basal, vagally stimulated and maximal levels 
of pepsin with or without duodenal ulcer [Lanas & Hirschowitz, 1992], It has also been 
reported that after administration of histamine or pentagastrin to patients with peptic
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ulcer, pepsin secretion was higher in smokers than non smokers [Walker & Taylor, 
1979],
Reflux of bile salts into the stomach causes damage to the gastric mucosa [Rhodes et a l,  
1969] and long term smokers have been shown to have an increased susceptibility to 
duodenogastric reflux [Dippy et al., 1973; Read & Grech, 1973; Muller-Lissner, 1986],
Helicobacter pylori are known mediators of gastrointestinal ulceration and cigarette 
smoking increases the risk of infection [Bateson, 1993]. It has also been found that 
nicotine increases the activity of the vacuolating toxin associated with the more virulent 
strains of Helicobacter pylori [Cover et al., 1992].
Oxygen-derived free radicals are known to mediate damage to the gastrointestinal 
mucosa and levels of neutrophils actively producing these free radicals are found to be 
higher in the blood of smokers [Kalra et a l,  1991],
Patients taking NSAIDs are at risk o f developing gastrointestinal ulcers and cigarette 
smoking increases the risk of bleeding in the upper gastrointestinal tract o f these patients 
by 40 per cent [Rodriguez & Jick, 1994],
1.2.3.1.2 Smoking as an Attenuator o f Mucosal Defence
The integrity of the gastrointestinal mucosa is dependent on the cytoprotective effect o f  
prostaglandins and their production is reduced in smokers [Balint & Varro, 1986; 
Quimby et al., 1986; Hudson et a l,  1990; Cryer et al., 1992]. Prostaglandins enhance 
the mucosal defence systems, by inhibiting the secretion of gastric acid [Weir, 1988], 
stimulating the output o f bicarbonate [Bolten & Cohen, 1978; Kauffman et a l ,  1980] 
and mucus [Soli et al., 1989; Bickel & Kauffman, 1981; McQueen et a l,  1983], and, in 
addition to their protective properties on a cellular level [Tamawski et al., 1988], help to 
maintain the mucosal blood flow [Main & Whittle, 1973; Gerber & Neis, 1982; Silen, 
1987; Whittle & Vane, 1987], Prostaglandins also inhibit free radical production and 
enzyme release by neutrophils [Gryglewski et al., 1987; Kainoh et al., 1990] and also 
stabilise mucosal mast cells [Bickel & Kauffman, 1981; McQueen e ta l ,  1983].
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Cigarette smoking decreases the gastrointestinal blood flow [Fletcher et a l,  1985; 
Kawano et a l,  1989a, 1989b], which is believed to compromise the defences of the 
mucosa, and blood flow is also known to be reduced at sites o f ulceration [Ashley et al.,
1985], Blood flow correlates well with rates of bicarbonate secretion [Nagata & Guth, 
1983] which is itself elevated in response to histamine. Histamine is released during 
injury to the gastrointestinal mucosa [Fromm, 1987], which occurs continuously as a 
result o f food and other trauma [Soli et al., 1989], and the ability of the blood to provide 
a buffer to the mucosa and thus protect the damaged area from the low intraluminal pH 
is decreased by the reduction in blood flow.
Epidermal growth factor (EGF) is secreted into the saliva and as a result enters the 
stomach [Gregory et al., 1979], It has been reported to have to have a cytoprotective 
effect [Endoh & Leung, 1994], one of which is its ability to inhibit gastric acid secretion 
[Elder et a l,  1975]. Smoking one cigarette every 30 minutes has been found to lower 
basal-salivary EGF secretion in healthy human subjects [Konturek et al., 1989] and this 
has been linked to an increased risk o f gastric ulceration [Ohmura et a l,  1987; Jones et 
al,  1992],
It has been proposed that the development of a gastrointestinal ulcer depends on the 
balance between protective and aggressive factors which results in an ulcer when the 
balance is tipped in favour of the aggressors [Shay, 1961], Thus it would appear that 
although inhalation o f cigarette smoke alone does not directly lead to gastrointestinal 
ulceration, coupled with any of the aggressive factors it is able to tip the balance towards 
ulcer formation.
1 .2 .3.2 Alcohol
Alcohol has been implicated as being a risk factor for gastric ulceration and patients 
taking NSAIDs who are heavy drinkers of alcohol have an increased risk o f upper 
gastrointestinal bleeding [Carson et a l,  1987]. Topical application o f 60 per cent (v/v) 
ethanol to the gastric mucosa of rats has been shown to induce an immediate leakage of 
macromolecules, such as albumin, out o f capillaries and the postcapillary venules into the 
interstitial space [Szabo et a l,  1985; Kalia et a l,  1997], This leakage occurs primarily in
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regions of the gastric mucosa where there has been an accompanying decrease in blood 
flow [Szabo et a l,  1985; Kalia et al., 1997] and is indicative of damage to the 
endothelium [Szabo et al., 1985; Kalia et al., 1997], Studies of these areas, on a cellular 
level, show that whereas no circulating or adherent leucocytes are visible in the 
microcvasculature o f the control gastric mucosa, shortly after ethanol administration a 
number of adherent leucocytes begin to appear on the edge of the area of blood flow 
stasis [Kalia et a l ,  1997], It has been proposed that a close association exists between 
reduction in blood flow and damage to the gastrointestinal mucosa [Ashley, et a l ,  1985; 
Pihan et a l ,  1986; Bou-Abboud et al., 1988] and that some areas o f the mucosa are 
more susceptible to ischaemia and its related injury than others [Piasecki, 1991], This 
would explain the fact that although noxious substances such as ethanol bathe the entire 
area o f the gastric mucosa to a similar extent, lesions only occur at a few focal points.
Studies have demonstrated that a change in blood flow occurs prior to ulcer formation 
[Szabo et a l ,  1985; Pihan et al., 1986; Bou-Abboud et al., 1988;] and evidence exists 
that the areas o f gastric ulceration are linked closely to the microvasculature [Anthony et 
al,  1995, 1996], One hypothesis is that certain regions of the gastric mucosa may be 
more susceptible to ulceration than others owing to the presence o f end arteries 
[Piasecki, 1991]. Studies that have shown that there is a link between vascular stasis and 
mucosal necrosis [Szabo et a l ,  1985; Pihan et a l,  1986; Bou-Abboud et a l ,  1988;] are 
supported by reports detailing neutrophils as being mediators in the formation o f ethanol- 
induced ulcers [Kvietys et a l ,  1989, 1990;]. Thus it would appear that the initial 
damage to the endothelium caused by the topical effect o f the ethanol [Pihan et a l,
1986], visible as gaps between the endothelial cells when viewed via electron microscopy 
[Kalia et a l,  1997]; is exacerbated by the neutrophil response [Grisham & Granger, 
1988] and the resultant tissue damage [Weiss, 1989; Kvietys e ta l ,  1990].
1 .2 .3.3 Stress
Controversy surrounds the subject of stress ulcers [Konturek et a l ,  1990], first described 
60 years ago [Selye, 1936], as some researchers disagree with the premise that emotional 
stress can lead to ulceration o f the gastrointestinal mucosa owing to a lack o f evidence 
supporting this theory [Piper et a l,  1978, 1981; Thomas & Piper, 1980], Although
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emotional stress alone is unlikely to result in gastrointestinal ulceration it is thought by 
some that, in conjunction with other risk factors, emotional stress may mediate damage 
to the gastric mucosa [Spicer et al., 1944; Weiner et a l,  1957; Brodie & Hanson, 1960; 
Desiderato et a l,  1974; Peters & Richardson, 1983; Walker et a l,  1988], It has been 
suggested that people experiencing acute emotional stress are likely to smoke more 
cigarettes and have an increased alcohol consumption than unstressed individuals who 
share the habit and these two practices have been implicated as exposing patients to a 
higher risk of gastrointestinal ulceration [Friedman et a l , 1974; Cummings et a l ,  1983; 
Ostensen et a l,  1985; Ganz, 1987]. There is also a possibility that chronic emotional 
stress in humans may have an effect on the vagus nerve, resulting in its chronic 
stimulation which is known to lead to an increase in parietal cell density and chief cell 
density with an associated rise in gastric acid secretion and hyperpepsinogenaemia [Pearl 
etal., 1965, 1966; Thirlby & Feldman, 1984],
Physiological stress, however, as a result of trauma through bums [Czaja et a l ,  1974], 
shock, sepsis [Moody et al, 1976] or serious injury [Lucas et a l,  1972] particularly to 
the head [Watts & Clark, 1969; Norton et a l,  1970], is accepted as being a cause of 
damage to the gastrointestinal mucosa [Stremple et a l ,  1973, Robert & Kauffman, 
1983], Even so, most patients exposed to severe physiological stress do not go on to 
develop erosions or ulcers to the gastrointestinal mucosa and in one study only 59 cases 
o f gastric erosions were found out of 2,600 post mortems carried out [Moody et a l,  
1976], Patients who do present with upper gastrointestinal bleeding after head injury or 
neurosurgery are therefore unusual [Watts & Clark, 1969; Norton et a l,  1970] and in 
this group the erosive gastritis is associated with hypersecretion of gastric acid.
Experiments with animals indicate that acute stress inhibits gastric epithelial proliferation 
rates [Kim et a l,  1967; Lahtihaiju & Rytomaa, 1967; Imondi et a l,  1968; Ludwig & 
Lipkin 1969; Willems & Lehy, 1975; Takeuchi & Johnson, 1979; Kuwayama & 
Eastwood, 1985] and increases the rate of surface cell loss in the fundus whereas it has 
no effect on epithelial proliferation in the antrum [Kuwayama & Eastwood, 1985], This 
finding correlates with the fact that ulcers induced by physiological stress tend to appear 
in the mucosa of the fundus rather than the antral mucosa [Kuwayama & Eastwood,
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1985], The gastric epithelium needs to be constantly replaced, as epithelial cells 
regularly slough off naturally and the mechanics of ingestion continually cause damage to 
the gastric mucosa [Eastwood, 1977]. Consequently any reduction in the replacement 
rate of worn out or damaged epithelial cells leaves the gastric mucosa with an area 
susceptible to attack from acid in the gastric lumen. Restraint stress in animals also 
causes a reduction in blood flow [Guth, 1972] within the fiindic mucosa which probably 
is responsible for the reduced rate o f proliferation in this region.
1.3 CYTOKINES AND THEIR ROLE IN THE INFLAMMATORY PROCESS
Cytokines are a family o f small host-derived proteins or glycoproteins produced by cells 
involved in the host's immune response to injury, invasion, infection and inflammation 
[Tracey & Cerami, 1993]. They act locally as messengers between cells and are 
mediators in the regulation o f the immune response [Kroemer & Martinez, 1991] 
controlling the production and effect o f other cytokines (see fig. 1.3).
1.3.1 Tumour Necrosis Factor a  (TNF-a)
TNF-a is the major cytokine involved in the host response to bacterial invasion [Fong et 
al., 1989], responding to the bacterium itself as well as to various bacterial toxins, 
including endotoxins, such as lipopolysaccharide, a large molecule in the outer cell walls 
of gram-negative bacteria; and exotoxins produced by gram-positive bacteria such as 
Staphlococci and Streptococci [Dinarello, 1991], Production o f TNF-a initiates the 
inflammatory cytokine cascade [Fong et a l,  1989; Tracey & Cerami, 1993] by 
stimulating neighbouring leucocytes and endothelial cells to synthesise and secrete IL-1. 
Production o f TNF-a can also be stimulated by itself and by other cytokines such as IL- 
1, IL-2 and granulocyte-macrophage-colony stimulating factor (GM-CSF) [Tracey, 
1994], TNF-a is a potent stimulator o f various immune responses but in the presence of 
IL-1 these responses are more than doubled as TNF-a and IL-1 together amplify their 
effects synergistically [Elias et a l ,  1987; Mandrup-Poulsen, et a l,  1987; Okusawa et a l  
1988], (This synergism appears to be caused by second messenger molecules rather than 
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Figure 1.3 Interrelationship o f  Cytokines Studied During this Research
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[Holtmann & Wallach, 1987; Wallach et a l , 1989].) These mediators in turn stimulate 
surrounding tissue cells, such as the gastric epithelial cells and gastric endothelial cells, to 
secrete IL-8 , a potent chemoattractant for neutrophils which causes migration of 
neutrophils to the infected area and primes them to release their destructive contents 
against the invading organisms.
Human TNF-a is produced principally by macrophages and monocytes but is also made 
by other cells including basophils, eosinophils, natural killer cells, mast cells, B cells and 
T cells [Gordon & Galli, 1991, 1994; Galli, 1993; Tracey & Cerami, 1993; Tracey,
1994], Initially TNF-a is synthesised as a large precursor molecule, 233 amino acids 
long [Wang et a l ,  1985; Spies et a l,  1986; Davis et a l,  1987; Muller et a l,  1987], that 
is cleaved by proteases into the smaller active form, 17 kilodaltons in size and made up 
of 157 amino acids, which is secreted outside the cell and is the biologically active form 
[Tracey & Cerami, 1993], There is, however, an intermediate membrane associated 
form, 26 kilodaltons in size, which is also biologically active [Kriegler et a l,  1988; Jue et 
a l,  1990; Perez et a l,  1990], TNF-a causes fever [Dinarello, 1986; Dinarello et al,  
1986a, 1986b], anorexia, shock [Okusawa et a l,  1988], hypotension and capillary 
leakage as well as increasing skeletal muscle degradation and lipolysis [Dewhirst et al,  
1985; Krane et a l ,  1985; Warren et a l,  1987; Starnes et a l,  1988; Spriggs, et a l,  1988; 
Bauer et a l,  1989],
1.3.2 Interleukin 1 (IL-1)
There are two forms o f IL-1, IL-1 a  and IL-1 (3, which are the products of different genes 
and as a result have differing amino acid sequences. Nevertheless, despite these 
differences, their three dimensional structure is similar enabling them to act through the 
same receptors and as a result share the same biological activities [Dinarello, 1991], 
Even so IL-1 a  has a greater affinity for the Type I receptor, which is found on most 
cells, and IL-lp has a greater affinity for the Type II receptor, found primarily on 
neutrophils, monocytes, bone marrow cells and B lymphocytes [Dinarello & Wolff, 
1993]. Both proteins are rapidly synthesised, primarily by monocytes and macrophages, 
in response to other cytokines such as TNF-a [Dinarello et a l,  1986b; Dinarello & 
Wolff, 1993], granulocyte-macrophage-colony stimulating factor (GM-CSF) [Sisson &
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Dinarello, 1988], macrophage-colony stimulating factor (M-CSF) [Dinarello, 1991] and 
to microbial toxins, inflammatory agents, products of activated lymphocytes, 
complement and clotting factor [Dinarello, 1991], Synthesis o f IL-1 is not restricted to 
leucocytes, however, and it is found in nearly all tissue [Dinarello, 1991; Dayer & 
Fenner, 1992] including epithelial cells and endothelial cells which also secrete IL-1 in 
response to extracellular TNF-a [Libby et a l,  1986; Nawroth et a l,  1986; Tracey & 
Cerami, 1993],
Initially both human forms of the cytokine are synthesised as a large precursor molecule 
with a molecular weight of around 31 kilodaltons but after enzyme cleavage the mature 
proteins are about 17.5 kilodaltons in size [Dinarello & Wolff, 1993], IL-a being made 
up of 159 amino acids and IL-1 (3 made up of 153 amino acids. The IL-a precursor is 
active prior to cleavage [Howard et a l,  1991] and several common enzymes are able to 
cleave it into smaller and more active forms. Conversely IL-ip must be cleaved for it to 
have optimum biological activity and only one protease, IL-1 (3-converting enzyme (ICE), 
appears to be highly specific in cleaving the 31 kilodalton IL-1 (3 precursor leaving it in its
17.5 kilodalton active form [Kostura et a l,  1989; Schmidt & Tocci, 1990; Cerretti et a l ,  
1992; Thomberry et a l,  1992]. During the first 24 hours of activation, after stimulation 
with bacterial toxins, most IL-1 a  (80 per cent) remains within the monocyte/macrophage 
[Lasfargues et a l,  1987; Howard et a l, 1991], either free within the cytosol [Lasfargues 
et a l ,  1987] or bound to the inner membrane of the cell, although extracellular 
concentrations of EL-l a  are detectable within 6 hours [Lonnemann et a l,  1989], These 
extracellular levels gradually increase until they exceed cell-associated levels after 48 
hours [Lonnemann et a l, 1989], Conversely the majority of IL-1 p is secreted into the 
extracellular space, via mechanisms such as exocytosis from vesicles, active transport by 
multi-drug resistant proteins or by the death of the cell itself [Dinarello & Wolff, 1993], 
reaching its maximal levels after about 12 hours [Lonnemann et a l,  1989], EL-1 is a 
stimulus for its own gene expression and synthesis in blood mononuclear cells, 
fibroblasts, endothelial and smooth muscle cells [Dinarello et a l,  1987; Warner et a l ,  
1987a, 1987b] although steady state levels are slower to increase [Schindler et a l , 
1990], Endothelial cells exposed to IL-1 produce DL-8, [van Damme, 1994] a potent
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chemoattractant for neutrophils, and also produce adhesion molecules which mediate 
neutrophil adhesion [Dejana et a l ,  1987],
IL-1 a  and EL-lp both induce fever, sleep, shock and anorexia [Dinarello & Wolff, 1993] 
and a single intravenous injection decreases mean arterial pressure, lowers systemic 
vascular resistance and induces leucopenia and thrombocytopenia [Okusawa et al., 1988; 
Fischer et a l,  1991], EL-1 also stimulates T cells and B cells [Neta et a l,  1988],
1.3.3 Interleukin 4 (IL-4)
IL-4 is a type 2 cytokine which means that its role is an antiinflammatory one and thus it 
is able to down regulate the cellular immune response to infection by inhibiting many of 
the leucocyte responses [Danzer, et a l,  1994; D'Andrea et a l,  1995], EL-4 is thought to 
contribute to the balance between the production of EL-1 and EL-1 receptor antagonist 
(EL-Ira) by increasing the formation o f EL-Ira [Kam et a l,  1995] as well as by 
decreasing the production o f EL-1 itself [Hart et al,  1989; Vannier et a l,  1992]. (The 
protective effect o f IL-lra is thought to be its ability to neutralise the synergistic effect 
between IL-1 and TNF-a as IL-1 alone is not very toxic [Waage & Espevik, 1988].) 
This balance is important for whereas small amounts of IL-1 may be necessary to 
maintain the host's immune defences, large amounts in the presence of TNF-a can be 
lethal [Waage & Espevik, 1988; Fong et a l,  1989; Waage et a l,  1989; Munoz et a l,  
1991; Cannon et a l,  1992], IL-4 is also thought to inhibit the synthesis o f TNF-a [Fan 
et a l,  1995] and interferon-y (EFN-y), both type 1 cytokines [Vercelli et a l,  1990; Erard 
et a l,  1993; Danzer, et a l,  1994], and to enhance the production o f EL-10, another type 
2 cytokine [Danzer, et a l,  1994; D'Andrea e/ al,  1995].
EL-4 is mainly synthesised by activated T cells [Poo et a l ,  1988], but is also produced by 
mast cells and basophils [Piccinni et a l,  1991, Brunner et a l,  1993]. It has a wide range 
of biological activity on leucocytes, such as macrophages, natural killer cells, B cells and 
T cells, and also on fibroblasts and endothelial cells [Banchereau & Rybak, 1994], 
Initially human IL-4 is synthesised as a precursor molecule, 153 amino acids long 
[Yokota et a l,  1986], that is cleaved by proteases into the smaller biologically active 
form, 20 kilodaltons in size and made up of 129 amino acids, which is secreted outside 
the cell [Banchereau & Rybak, 1994],
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1.3.4. Interleukin 8 (IL-8)
IL- 8  belongs to a group o f cytokines called the Chemokines. These are a group of 
cytokines which are related in sequence and structure. They are all about 8-10 
kilodaltons in size and fall into two groups depending on whether the first two o f the 
four cysteine residues, common to all chemokines and involved in the tertiary structure, 
are adjacent (C-C) or separated (C-X-C) by another amino acid [Oppehheim et al., 1991; 
Schall, 1991]. Chemokines selectively attract and stimulate distinct leucocyte 
populations unlike other inflammatory agents such as leukotrienes which are less specific 
chemoattractants for leucocytes. EL- 8  belongs to the C-X-C subgroup and is a potent 
chemoattractant for neutrophils, directing their migration [Schroder et al., 1987; 
Yoshimura et a l, 1987a; van Damme et al., 1988] to sites of infection and inflammation 
and also inducing their adhesion to endothelial cells [Carveth et al., 1989] and activation 
by degranulation [Walz et a l,  1987],
IL- 8  is synthesised and released by a number o f leucocytes including monocytes 
[Matsushima et al., 1988], macrophages [Walz et a l,  1987; Yoshimura et al, 1987b], T 
cells [Gregory et a l,  1988] and neutrophils [Strieter et a l,  1990], However, EL- 8  is also 
produced by cells which play an important role in the mediation of inflammation, 
immunity and wound healing [Miller & Krangel, 1992] such as fibroblasts [van Damme 
et a l,  1989a, Larsen et a l,  1989a; Schroder et a l, 1990], endothelial cells [Strieter et 
al,  1989] and gastric epithelial cells [Crabtree et a l,  1994]. These cells produce EL- 8  
after stimulation by EL-1 or TNF-a [van Damme, 1994] although synthesis can be 
directly induced in fibroblasts by viruses [van Damme et a l, 1989a]. Initially IL- 8  is 
synthesised as a precursor molecule, 99 amino acids long, that is cleaved by proteases 
into smaller forms, the 8  kilodaltons size, made up o f 72 amino acids, being the most 
biologically active [Lindley et a l,  1988, Gimbrone et a l,  1989]. From its three 
dimensional structure, natural IL- 8  appears to occur as a doublet [van Damme et a l ,  
1989b] held together by hydrogen bonds.
Rats do not synthesise EL- 8  but they do have an equivalent (C-X-C) chemokine protein 
which is called Cytokine-Induced Neutrophil Chemoattractant (CINC) and as the name 
suggests operates in a parallel fashion. It is also released from similar cells, in the same
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manner as IL-8 , after stimulation by IL-1 and TNF-a. [Nakagawa et al, 1993, Zagorski 
& De Larco, 1993; Blackwell et a l,  1994; Harada et a l,  1994; Koike et a l,  1994; Wu et 
al,  1994; Aihara 1995],
1.4 NSAIDS USED DURING THIS PROJECT
Almost 300,000 prescriptions for NSAIDs are written each year per million inhabitants 
of the Western world [Walt et a l,  1986] and total sales o f NSAIDs are in the region of 
£4 billion annually [Gamer, 1992] making this group o f drugs the most successful ever 
developed [Bjamason et a l,  1992b]. Although these drugs are very efficacious they 
have an unfortunate side effect in that they are known to have a detrimental effect on the 
mucosa o f the gastrointestinal tract. Initially the problem was thought to be mainly 
restricted to the stomach but during the past 2 0  years it has become increasingly evident 
that, during long-term use, they have a more deleterious and serious effect in the 
duodenum [Hawkey, 1990] and the rest o f small bowel [Sturges & Krone, 1973; 
Schwartz, 1981], Lesions here are difficult to quantify, they fail to show up during X- 
ray procedures [Collins et a l,  1994] and conventional endoscopes cannot reach far 
enough into the small bowel to visualise them, however, anaemia, accompanied by blood 
and protein loss in the faeces [Collins & Du Toit, 1987] (a consequence of small bowel 
permeability due to long-term use of NSAIDs [Bjamason et a l, 1987]) would appear to 
indicate that there is a significant problem. The unfortunate idiosyncrasy o f NSAID- 
induced ulcers is that they are usually 'silent' ones [Jorde & Burhol, 1987], Whether this 
is a result of the drug itself masking the pain or the fact that these ulcers are in 
themselves asymptomatic is unknown, but what is known is that the presence of such an 
ulcer is usually only realised when it manifests itself on haemorrhage or perforation [Day, 
1983; Langman et a l,  1985; Madhok et a l ,  1986; Deakin, 1988], a catastrophic event 
often leading to sudden death [Armstrong & Blower, 1987; Allison et a l,  1992].
Enteroscopes are few (and costly) and the procedure o f enteroscopy is in itself time 
consuming and not without risk to the patient [Morris et a l,  1991; 1992]. As a result 
there has been an increase in research into finding a means of diagnosing the presence o f 
such ulcers, via simple diagnostic blood tests, and an attempt to learn more about the 
mechanisms of NSAID-induced gastroenteropathy. The six NSAID drugs selected for
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this project have been chosen because they are a cross section of such drugs on the 
market today. Indomethacin, which incidentally is banned in the United States of 
America [Spangler, 1993], is the mostly widely prescribed NSAID for rheumatoid 
arthritis in the United Kingdom (despite its being one of the oldest drugs of its type and 
being the most hazardous) as it is still the most effective in alleviating pain and 
inflammation. Diclofenac, which is also quite an old drug, is the most widely prescribed 
NSAID in Europe [Spangler, 1993] although it too is known to cause serious damage to 
the gastrointestinal tract (less severe than that found with indomethacin). Piroxicam and 
naproxen are newer than those described above (second generation NSAIDs) and as a 
result are less damaging to the gastrointestinal mucosa. Fenbufen and nabumetone are 
pro drugs (the latest generation of NSAIDs) which are inactive until they have been 
metabolised by the liver, thus enabling them to pass through the stomach into the small 
bowel without causing any damage to the gastric mucosa.
1.4.1 Diclofenac (Voltarol)
v  NH
c , N i v c l
Diclofenac sodium (sodium-[o[(2,6-dichlorophenyl)-amino]-phenyl]-acetate) belongs to 
a class o f NSAIDs called Acetic Acids. Diclofenac has analgesic and antipyretic activity, 
is rapidly absorbed in the stomach (reaching its peak plasma concentration in man after 
two hours), and has a half-life o f two hours. Diclofenac sodium is a weak acid with a 
pKa o f 3.9. [Riess eta l ., 1978; Wallis & Simkin, 1983; Brune & Lanz, 1985],
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1.4.2 Fenbufen (Lederfen)
C -C H COOH
Fenbufen (y-oxol(l,l'-biphenyl)-4 butanoic acid) is a pro-drug which belongs to a class 
of NSAIDs called Propionates. Fenbufen, a weak inhibitor o f cyclooxygenase, is 
absorbed from the gastrointestinal tract and is converted by the liver into five 
metabolites, the most active being [l,l'-Biphenyl]-4-acetic acid (BPAA), which is a 
potent inhibitor of cyclooxygenase activity. Fenbufen has analgesic and antipyretic 
activity, is rapidly absorbed (reaching its peak plasma concentration in man after two 
hours (BPAA eight hours)), and has a half-life of 11 hours (BPAA 12 hours). Fenbufen 







Indomethacin (l-(p-chlorobenzoyl)-5-methoxy-2-methyl-indole-3-acetic acid), an indole 
derivative, belongs to a class of NSAIDs called Acetic Acids. It is the most toxic of the 
NSAIDs, but also the most effective, and is a potent inhibitor of cyclooxygenase activity. 
Indomethacin has analgesic and antipyretic activity, is rapidly absorbed in the stomach 
(reaching its peak plasma concentration in man after two hours), and has a half-life of 
two hours. Indomethacin is a weak acid with a pKa o f 4.5. [Yesair et a l ,  1970; Brune 




Nabumetone, a nonacidic pro-drug, belongs to a class of NSAIDs called 
Naphthylalkanones. Nabumetone, because it is nonacidic, cannot dissociate in the 
stomach and as a result 'ion-trapping' does not occur thus preventing damage to the 
gastric mucosa. Following absorption in the small bowel, Nabumetone, a weak inhibitor 
of cyclooxygenase, is converted by the liver to its active metabolite, 6 -methoxy-2 - 
napthylacetic acid (6 MNA), which is a potent inhibitor of cyclooxygenase activity. 
Nabumetone is well absorbed (with 6 MNA reaching peak plasma concentration in man 
after 1 to 4 hours) and has a half-life o f 24 hours. [Blower, 1992; Fleischmann, 1992; 
Hyneck 1992; Melarange e ta l ,  1992].
1.4.5 Naproxen (Anaprox, Naprosyn)
c h 3
H,CO
Naproxen [(+)-6-Methoxy-a-methyl-2-naphthalene-acetic acid] belongs to a class of 
NSAIDs called Propionates. Naproxen has analgesic and antipyretic activity and is 
rapidly absorbed in gastrointestinal tract although absorption through the stomach can be 
delayed if taken in conjunction with antacids. Naproxen, which is highly albumin bound, 
reaches its peak plasma concentration in man after two hours and has a half-life of 13 
hours. Naproxen is a weak acid with a pKa of 4.2. [Ansell et a l,  1975; Wallis & 




Piroxicam belongs to a class of NSAIDs called Oxicams which are members o f a series 
of 4-(N-aryl) carboxamides of 4-hydroxy-1,2-benzothiazine 1,1-dioxide. Its chemical 
structure is unique as almost all other NSAIDs are basically carboxylic acids. Piroxicam 
has analgesic and antipyretic activity, is rapidly absorbed in the stomach (reaching 80% 
of its peak plasma concentration in one hour) and has a half-life o f 45 hours which is 
long in comparison with most other NSAIDs. Unlike many NSAIDs Piroxicam is a 
selective reversible inhibitor o f the cyclooxygenase step in the metabolism of arachidonic 
acid. Piroxicam is a weak acid with a pKa o f 6.3. [Carty et al., 1980; Brune & Lanz, 
1985; Verbeeck et al., 1986],
1.5 SCOPE OF THE WORK
The aim of the project was to investigate the mechanisms involved in ulceration o f the 
stomach and small bowel caused by Helicobacter pylori and NSAIDs. During this 
research a selection o f NSAIDs were used in order to compare the damage, if any, they 
caused to both the stomach and the small bowel. Indomethacin and diclofenac are 
known to cause ulceration throughout the gastrointestinal tract in man whereas 
nabumetone does not, thus a comparison between the different pharmacokinetic 
properties and actions of these drugs may possibly explain the ulcerative process and this 
was investigated. The rat was to be used as a model for NSAID-induced ulceration in 
man even though significant metabolic, inflammatory and behavioural differences were 
known to exist between the two species; for example drug metabolism, chemotactic 
factors and gut flora (due to coprophagy). Its suitability for this role was to be 
ascertained accordingly. In addition it was planned to investigate a potential non-
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invasive diagnostic 'test' for small bowel damage by screening in vivo protein markers in 
the systemic circulation.
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2.0 MATERIALS AND METHODS - NSAIDS AND ULCER FORMATION
2.1 PRODUCTION OF SMALL BOWEL ULCERS
2.1.1 Materials
2.1.1.1 Drugs and Reagents
2.1.1.1.1 NSAIDs
Diclofenac Sodium {D-6899}, Fenbufen {F-8755}, Indomethacin {1-7378}, Piroxicam 
{P-5654} and Naproxen [(s)-6-methoxy-a-methyl-2-naphthaleneacetic acid free acid] 
{M-4015} were purchased from Sigma. Nabumetone {BRL 14777} was a gift from 
SmithKline Beecham Pharmaceuticals in West Sussex. Tween-80
(Polyoxyethylenesorbitan Monooleate) {P-l754} was purchased from Sigma.
2.1.1.1 . 2  Antibiotics
Cloxacillin Sodium Monohydrate {C-9393}, Erythromycin Ethylsuccinate {E-8755}, 
Nalidixic Acid Sodium {N-4382} and Neomycin Sulphate {N-1876} were purchased 
from Sigma. Amoxycillin and Metronidazole were purchased, on prescription from 
Boots the Chemists, Bath or supplied by the Pharmacy at The Royal United Hospital, 
Bath.
2 .1.1.2 Animals
Male Wistar rats, either the University o f Bath Strain or from Interfauna, maintained on a 
12 hour light/12 hour dark cycle and weighing between 135 and 450 g were used in this 
study. Most rats weighed 250 g when dosed and calculations were made during the 
antibiotic studies so that when the rat was given its first dose of NSAID it weighed 
approximately 250 g. (One study, however, did compare the effect that size may have 
on the response to a particular dose of indomethacin.) Rats which were starved before 
dosing had food withdrawn 2 1  hours prior to the administration of the drug and were 
kept without food until 3 hours after. At all other times the rats were allowed free 




2.1.2.1 Small Bowel Ulcers
2.1.2.1.1 Drug Preparation - NSAIDs
All the NSAIDs were dissolved/suspended in 10% Tween-80 (100% Tween-80 diluted 
1:9 with distilled water). The drugs were weighed out into glass bottles, diluted to the 
required concentration with 10% Tween-80, vortex mixed then placed in a sonicator 
(Dawe 'Sonicleaner') for 30 minutes, after which time they were vortex mixed again. 
The drugs were dissolved/suspended in 10% Tween-80 so that the volume administered 
to the animal would be less than 1.0 ml. The drugs were vortex mixed again prior to 
administration to the animals, and between each animal dosed, if the drug was in 
suspension. All drugs were used within 24 hours o f preparation.
2.1.2.1.2 Drug Preparation - Antibiotics
All the antibiotics were weighed into a glass bottle, dissolved/suspended in distilled water 
of the required volume and vortex mixed. The antibiotics were dissolved/suspended in 
distilled water so that the volume administered to the animal would be less than 1 . 0  ml. 
The antibiotics were vortex mixed again prior to administration to the animals, and 
between each animal dosed, if the drug was in suspension. All antibiotics were used 
within 30 min of preparation.
2.1.2.13 Dosing - Acute Oral Administration o f NSAIDs
Groups o f rats (3-6) were dosed once, orally, with one of the six drugs (diclofenac, 
fenbufen, indomethacin, nabumetone, naproxen, piroxicam) selected for the study and 
then killed 48 hours later. The doses ranged from the ID2 5 value o f each drug to five 
times this amount (ID125). The ID25 value being the dose calculated to bring about a 
25% reduction in carrageenan-induced oedema volume in the rat [Spangler, 1993] (see 
table 2.1.2.1.3) which is an assay for antiinflammatory drugs [Winter et al., 1962].
The ID 125 value for each drug was used initially on both starved and fed animals. In the 
event that ulcers were not produced, it was deemed unnecessary to dose with the ID25 
value, thus conserving animals. As a result, animals were only dosed with the ID 125 value
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of diclofenac (11.5 mg/kg), fenbufen (50.0 mg/kg), nabumetone (79.0 mg/kg), naproxen 
(5.0 mg/kg) and piroxicam (7.0 mg/kg). Indomethacin ID125 (12.5 mg/kg) caused severe 
ulceration so a range of doses was used in order to determine the level at which small 
bowel ulceration commenced and to find a dose which would reproducibly produce 
moderate ulceration in the small bowel. As a consequence rats were dosed with ED 37.5, 







Determine ID2 5 
Value mg/kg pKa
Diclofenac 2.3 0.3-10 3.9






Nabumetone 15.8 3.0-30.0 —
Naproxen 1 . 0 — 4.2
Piroxicam 1.4 0.3-3.0 6.3
ID25 is the dose calculated to produce 25% reduction in oedema volume
Table 2.1.2.1.3 Activity o f NSAIDs in Inhibiting Carrageenan-Induced Oedema in the
Rat Following Oral Administration
NB. Multiples of the ED2 5 values of the drugs used in this project do not refer to their 
ability to reduce carrageenan-induced oedema volume in the rat by the equivalent 
amount, i.e. diclofenac ED50 does not reduce carrageenan-induced oedema volume by 
50%. These values have been used by SKB solely as a simple means o f comparing 
concentrations of drugs of equivalent efficacy.
In addition to the treated animals, rats were dosed with 10% Tween-80 (2.0 ml/kg) as 
vehicle a control and distilled water (2.0 ml/kg) as a control. Drugs were administered
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to the animals using a three inch straight (16G) oral gavage needle (International Market 
Supply [IMS]).
2.1.2.1.4 Chronic Oral Administration of NSAIDs - Short Term
Groups of rats (3-6) were dosed once, orally, daily for seven days with one of the six 
drugs selected for the study, then killed 72 hours after the final dose. Initially the rats 
were dosed with the ED25 values o f the drugs diclofenac (2.3 mg/kg), fenbufen (10.0 
mg/kg), indomethacin (2.5 mg/kg) nabumetone (15.8 mg/kg), naproxen (1.0 mg/kg) and 
piroxicam (1.4 mg/kg). The procedure was repeated using the ID125 value of all the 
drugs except for indomethacin ID 125 which was omitted owing to the severity of 
ulceration found after a single dose. The animals dosed with diclofenac ID125 (11.5 
mg/kg), however, had to be killed on the fifth day after they had only received four doses 
as the rats began to lose weight. Chronic dosing was repeated using the ID75, ID 100 and 
ID 112.5 values of diclofenac (6.9, 9.2 and 10.35 mg/kg, respectively).
2.1.2.1.5 Chronic Oral Administration of NSAIDs - Long Term
Groups of four rats were dosed orally, once daily, for 21 days, over a four week period, 
with the ID125 values of fenbufen (50.0 mg/kg), nabumetone (79.0 mg/kg), naproxen (5.0 
mg/kg) and piroxicam (7.0 mg/kg). These animals were killed on the 29th day of the 
experiment. Owing to the severity o f ulceration found after dosing with indomethacin, 
acutely, and diclofenac, chronically (after five days) it was decided not to use these two 
drugs for this particular experiment.
2.1.2.1 . 6  Pre-Treatment With Antibiotics - Individually
Groups of rats (3-6) were dosed orally, once daily, for three days with one of the six 
antibiotics selected, amoxycillin (50 mg/kg), cloxacillin (100 mg/kg), erythromycin (100 
mg/kg), metronidazole ( 1 0 0  mg/kg), nalidixic acid ( 2 0 0  mg/kg) and neomycin sulphate 
(100 mg/kg). The rats were then given an acute dose o f indomethacin 24 hours after the 
final dose of antibiotic and then killed 48 hours after the dose o f indomethacin. (The 
doses administered were calculated as being equivalent to an approximation of the mg/kg 
value recommended for humans in the British National Formulary.)
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2.1.2.1.7 Pre-Treatment With Antibiotics - Combined
Two of the antibiotics were also administered together, metronidazole (100 mg/kg) and 
amoxycillin (50 mg/kg) as these two antibiotics are commonly used together in clinical 
practice to treat various conditions affecting the human gastrointestinal tract. Groups of 
rats (3-6) were dosed orally, once, daily, for three days with the antibiotic mixture. The 
rats were then given an acute dose of indomethacin (either ID 6o, ID65 or ID 7o) 24 hours 
after the final dose of the antibiotic mixture and then killed 48 hours after the dose of 
indomethacin. This experiment was repeated with the dose of indomethacin being 
administered 8  and 15 days after the three daily doses o f the antibiotic mixture.
Finally a group of rats (12) were treated simultaneously. Three were dosed with the 
antibiotic mixture for the three days prior to 15 days before the dose of indomethacin, 
while the other nine were dosed with distilled water only. A week later a different group 
of three rats were dosed with the antibiotic mixture for three days while the remaining 
nine rats were given distilled water only. A week later another group of three rats were 
given the antibiotic mixture for three days and the remainder received distilled water 
only. All 1 2  rats were given a single dose o f indomethacin (ID 6o) 24 hours later. The 
animals were killed by cervical dislocation 48 hours after the dose of indomethacin.
2.1.2.1 . 8  Number of Animals Per Experimental Group
Owing to the variation in drug response found within Wistar rats over a prolonged 
period of time it was necessary to compare as many drugs as possible on animals which 
would react in a similar manner. In addition it was only practicable to handle nine 
animals at a time as on the occasions that twelve animals were killed on the same day the 
workload was very high and difficult to achieve within the hours that the animal house 
remained open. Consequently only three animals per group were used and often it was 
difficult to find nine animals o f equivalent weight (250 g) on any one day. In the event 
that the results were inconclusive the experiment was repeated in order to increase the 
numbers within the group. On the majority o f occasions the results were such that a 
repetition of the experiment was considered unnecessary. As a comparison between 
drug regimes at an instant in time these results are deemed to be valid although there are
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often only three rats per group. (Similar experiments on groups equally small have been 
conducted in the past [Kent et al., 1969].)
2.1.2.2 Sample Collection and Preparation - Blood
Blood was collected from an anaesthetised rat (Halothane) via cardiac puncture using a 
needle (0.8 x 16) and syringe (both 2.0 and 10.0 ml). For haptoglobin assays it is 
essential that there is no free haemoglobin in the serum. In order to achieve this the first 
2 . 0  ml of blood (which usually enters the syringe freely under cardiac pressure) was 
collected separately into glass LP3 tubes {L.I.P.} using the 2.0 ml syringe as this helped 
to prevent haemolysis. The remaining blood was then collected into 10 ml glass Z10 
tubes {L.I.P.}. The blood was left to clot for a minimum of 20 min at 4°C then spun at 
2500 rpm for 15 min in a centrifuge (Jouan B311) at 4°C. Using a glass pasteur pipette 
the serum was aliquoted into eppendorfs (for haptoglobin or myoglobin assays) and 5.0 
ml glass Z5 tubes {L.I.P.} (for stock purposes) then stored at -20°C before analysis.
2.1.2.3 Sample Collection and Preparation - Urine
Urine was collected into an eppendorf from a rat, recently killed by cervical dislocation, 
using a needle (0.8 x 16) and 1.0 ml syringe to drain the bladder. The recovery rate of 
urine from the animals was very poor as often the animals would urinate during the 
process o f anaesthesia.
2.1.2.4 Removal of Small Bowel and Mapping of Ulcers.
The stomach and small bowel of each rat were removed and placed in physiological 
saline (0.9% NaCl (w/v) in distilled water) at 4°C and kept on ice. The stomach was 
opened along the greater curvature, washed with physiological saline at 4°C and 
inspected for signs o f ulceration. The small bowel was flushed with physiological saline 
at 4°C using a 1 0  ml syringe. Once the small bowel was cleared of gut debris, it was cut 
into 15 cm strips, which were opened along the anti-mesenteric side and laid out onto an 
acetate cooled to 4°C (which was itself laid out on a glass plate cooled on the underside 
by ice) to expose the luminal surface. Any macroscopic lesions observed were mapped
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onto a clear acetate for analysis at a later date. (The rat small bowel was usually 10 mm 
in width.)
2.1.2.5 Calculation of Extent o f Small Bowel Ulceration
i. Densitometer
The acetates onto which the small bowel ulcers had been mapped were scanned using an 
Imaging Densitometer {Model GS-670, Bio-Rad}. The computer file for each individual 
scan was greater than the space available on a 3 ! /2  inch floppy disc (1.44 MB), so it was 
decided that the ulcer maps on the acetates should be reduced in size by photocopying 
them. However, when using the software package on the Imaging Densitometer, a 
discrepancy was found between the actual area o f ulceration and that calculated by the 
computer. The problem was that the computer software analysed the density o f each 
individual area. Consequently an area of ulceration mapped using one type o f indelible 
marker gave the same value as a smaller area o f ulceration which had been marked with a 
thicker pen. The lines bordering the segments were also of varying thickness which 
affected the overall calculation. (Even when the same pen had been used there was a 
difference as during the mapping process the ink lines drawn by the pen became thinner.)
ii. Graph Paper
The acetates onto which the small bowel ulcers had been mapped were photocopied. 
The photocopied small bowel ulcer maps were then divided into ten equal segments with 
a ruler and pencil. The photocopy was then overlaid with an acetate onto which a sheet 
of graph paper (10 mm2) had been photocopied. The area o f ulceration, in square 
millimetres, for each section was calculated visually and then this value divided by the 
length of the segment in centimetres. (This converted the overall area of ulceration for 
each segment into a percentage figure to enable it to be compared with other animals as 
the lengths o f the small bowels varied between animals.)
The percentage areas of ulceration were all calculated using this method since although it 
was time consuming it was the most accurate. The mean percentage areas were plotted
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for each segment and total ulceration was calculated by summing these values and 
dividing by ten.
iii. Visilog
The acetates onto which the small bowel ulcers had been mapped were photocopied. 
The photocopied small bowel ulcer maps were divided into ten equal segments, with a 
ruler and pencil, which were then cut out, without the bordering lines, and stuck on a 
piece o f A4 paper adjacent to each other,. The segments were then reduced in size, 
twice, using a photocopier. The reduced sections were scanned on an Imaging 
Densitometer and stored on a 3 Vz inch floppy disc (1.44 MB). The scans were then 
evaluated using an 'Image Processing Package' {Visilog 4, Noesis}.
The procedure of reducing the photocopies o f the acetates followed by cutting and 
pasting ten equal segments onto another piece of paper plus the scanning process turned 
out to be very time consuming. In addition to this the calculation of the area of 
ulceration using the computer analysis software was inaccurate compared to calculating 
it by eye. Consequently it was decided not to use this method for calculating the 
percentage areas of ulceration.
2.1.2.6 Measurement o f pH of Small Bowel Contents
The small bowels o f control rats (250 g) were removed and laid out on a glass plate 
cooled on the underside by ice. Starting from the stomach end, a small cut was made 
every 2  cm, along the entire length of the intact small bowel, into which a piece of 
Universal Indicator paper (pH 1-11, Whatman) was inserted. Once this procedure had 
been completed the Universal Indicator papers which had been inserted first were 
withdrawn in chronological order. A note was made o f the pH of the small bowel 
contents found at each point along the small bowel.
2 .1.2.7 Statistical Analysis
Results are expressed as the mean (± SEM). The significance of the differences in the 
mean values within groups was assessed by Student's t-test and between groups by the
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nonparametric Mann-Whitney test using the statistical software, Minitab for Windows
10.1 {Minitab Inc.}. The significance o f the differences in the mean values between 
groups > 2 was assessed by one way analysis of variance (ANOVA) using the statistical 
function of Excel 5 for Windows {Microsoft Corporation}. Differences were considered 
statistically significant when p < 0.05. Regression analysis was conducted using the 
statistical function of Excel 5 for Windows {Microsoft Corporation}.
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Aluminium Test Tube Caps {TA003A, Oxoid}
Anaerobic Gas Generating Kits {BR038B, Oxoid}
Anaerobic Jar {HP011A, Oxoid}
Antimicrobial Susceptibility Discs and Disc Dispenser {Oxoid} 
API 20 g kit {Bio Merieux}
AtmosBag (ethylene oxide treated) {A-3283, Sigma} 
McCartney Bottles {Richardsons}
Oxy-Trap {All Tech Associates Inc.}
Pyrex Rimless Test Tubes (150 mm x 16 mm)
Sterile Polystyrene Petri-Dishes (9 cm) {Bibby Sterilin Ltd.} 
Tubing, Tygon B-44-4X {Fisons}
2.2.1.2 Culture Media
Brain Heart Infusion Medium {CM225, Oxoid}
Cooked Meat Medium {CM81, Oxoid}
Desoxycholate Citrate Agar {CM35, Oxoid}
Fastidious Anaerobic Agar {Lab90, Lab M}
Horse Blood (defibrinated) {HB034, T.C.S.}
Lab-Lemco Powder {Lab M}
McConkey 3 Agar {CM7, Oxoid}
Nutrient Agar {CM3, Oxoid}
Thioglycollate Medium {CM23, Oxoid} 1 
Tryptone Soya Agar {CM131, Oxoid}
Tryptone Soya Medium {CM129, Oxoid}
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2.2.2 Methods
2.2.2.1 Preparation of Growth Media
All broths and agar plates were prepared and stored as recommended by 'The Oxoid 
Manual' [1982],
2.2.2.2. Dissection of Small Bowel
The rat, which had been dosed once with indomethacin ID75 (7.5 mg/kg), was killed (48 
hours later) by cervical dislocation and the body then soaked in a mixture o f 70% (v/v) 
ethanol/1.0% (v/v) cetrimide in distilled water to ensure that the animal was sterile on the 
outside. The body was then placed on a sterile dissection tray in a 'Class 3' Laminar 
Flow Cabinet {'Microflow' Pathfinder, Inter Med} and the small bowel dissected 
aseptically. (Sterile physiological saline at 37°C was poured into the peritoneal cavity so 
that the small bowel did not become dehydrated while it was being cut free of the 
mesentery, as otherwise the temperature inside the laminar flow cabinet caused the small 
bowel to dry out very quickly.)
2.2.2.2.1 Tissue Scrapings
The small bowel was cut into short sections (10 cm) and flushed clean of gut debris using 
sterile physiological saline, at 37°C, and a sterile 10 ml syringe. The section of small 
bowel was then opened aseptically along the anti-mesenteric side and, using a sterile 
(flamed) loop, scrapings were taken from the ulcer base and from the normal intact 
mucosa. The scrapings were placed in bottles containing either Tryptone Soya broth or 
Thioglycollate broth (both preheated to 37°C) and then incubated at 37°C for 48 hours. 
In order to obtain individual colonies aliquots o f the bottle contents were then streaked 
out onto nutrient agar or McConkey 3 agar and incubated as before. Bacteria from 
individual colonies were stained using Gram's staining procedure and the gram-negative 
bacteria were further typed using an api 20 e  kit. Bacteria from distinct individual 
colonies, which could not be identified using the api 20 e  kit, were cultured in Tryptone 
Soya broth or Thioglycollate broth and then frozen in liquid nitrogen and stored for 
identification at a later date.
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2.2.2.2.2 Complete Ulcers Excised Aerobically
After dissection the small bowel was supported, by laying it across sterile cocktail sticks, 
while short sections (10 cm) were cut off and flushed clean of gut debris using sterile 
physiological saline and a sterile 10 ml syringe. The sections of small bowel were then 
opened aseptically along the anti-mesenteric side and any ulcer found cut from the 
surrounding tissue. Individual ulcers, which had been excised in this manner, were cut in 
half and one half placed in Brain Heart Infusion broth and the other half in Cooked Meat 
broth (both broths preheated to 37°C) for the culture of aerobic and anaerobic bacteria, 
respectively. Gloves which had been tested for sterility prior to commencement o f the 
dissection were checked similarly after the procedure had been completed. The bottles 
containing the broth were then incubated at 37°C and after 4 hours the broth had become 
turbid. At this time some of the samples were frozen in liquid nitrogen while others were 
streaked out onto Blood Agar, Desoxycholate Citrate Agar and Tryptone Soya Agar 
plates then left overnight in the incubator room at 37°C, half in anaerobic jars. The 
plates which had been incubated aerobically contained many colonies but the plates 
which had been incubated anaerobically did not, so the anaerobic jars were returned to 
the incubator for a further 48 hours. Bacteria from individual colonies which had been 
grown aerobically were stained using Gram's staining procedure and the gram-negative 
bacteria further analysed using an api 20 e kit. As before, bacteria which could not be 
identified were cultured in Cooked Meat broth or Brain Heart Infusion broth and then 
aliquots stored in liquid nitrogen. This procedure was repeated with the slower growing 
bacteria which had been incubated anaerobically.
2.2.2.2.3 Complete Ulcers Excised Anaerobically
The abdomen o f the rat was opened aseptically as before and the small bowel cut free of 
the mesentery without cutting through the small bowel itself. The small bowel was 
clamped at both the stomach and the caecum ends and then the small bowel was cut free 
of the rat on the stomach and caecum sides o f the clamps, keeping the contents under 
anaerobic conditions. The small bowel was then immersed in sterile physiological saline, 
at 37°C, in a sterile plastic beaker and placed inside a sterile AtmosBag along with 
bottles containing either Cooked Meat broth or Brain Heart Infusion broth, which had
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been preheated to 37°C. An anaerobic jar, filled with Petri dishes containing Fastidious 
Anaerobic Agar {Lab 90, Lab M}, was also placed inside along with small bottles of 
sterile physiological saline and a sterile 10 ml syringe. The bag was sealed and then filled 
with nitrogen. Under pressure the bag was opened slightly so that oxygenated air, which 
had still been trapped inside the AtmosBag, could be bled from the system. Once this 
was done the AtmosBag was resealed and the small bowel opened, flushed clean of gut 
debris and the ulcers excised as before. The ulcers were halved and one half was added 
to Brain Heart Infusion broth and the remaining half placed in Cooked Meat broth. 
Individual ulcers were also wiped across the surface of the Fastidious Anaerobic Agar. 
Once the lids were in place on the Petri dishes, the AtmosBag was opened and the Petri 
dishes placed inside an anaerobic jar. The bottles of broth and the plates in the anaerobic 
jar were then incubated as before at 37°C. Analysis of the cultures was performed as 
described above.
2.2.2.3 Preparation for Antibiotic Susceptibility Test
Samples, mixtures and isolates, which had previously been cultured from rat small bowel 
ulcers and stored in liquid nitrogen were grown up in Cooked Meat broth and Brain 
Heart Infusion broth at 37°C.
Nutrient agar plates were dried, lids off, upside down on a shelf in the incubator room 
for 30 min and during this time the Oxoid antibiotic disc holders were loaded into the 
dispensers. Once the plates were dry they were placed on the bench. A sterile Pasteur 
pipette was held loosely between the first two fingers while the top was taken off the 
bottle of medium by unscrewing the top using the small finger against the hand. 
Approximately 1.0 ml of medium was aliquoted onto the plate while keeping the lid of  
the Petri dish above it so as to prevent any airborne microbes from falling into the dish. 
The medium was then spread over the entire surface o f the agar by tilting the dish and 
gently rocking. After all the dishes had been treated in this manner, the excess liquid was 
pipetted off the surface of the agar. Once the surface o f the agar had dried the antibiotic 
discs were placed on the agar and the plates incubated overnight at 37°C, half aerobically 
and half anaerobically in anaerobic jars.
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The diameter o f the zones o f growth inhibition were measured and a note made of any 
colonies of resistant populations of bacteria or of any hazy areas. The diameter of the 
Oxoid disk (6 mm) was subtracted from the overall diameter of circle o f inhibition, and 
the resulting figure divided by two to give the radius of inhibition.
2.2.2.4 API 20 g  Kit
The api 20 g  kit {Bio Merieux} is an identification system for Enterobacteria and other 
non-fastidious gram-negative rods. The system uses 23 miniaturised biochemical tests 






Calcium Chloride, Magnesium Chloride, di-Sodium Hydrogen Orthophosphate 
Dihydrate, Sodium Dihydrogen Orthophosphate Dihydrate and Sucrose were purchased 
from BDH. Glutaraldehyde, Osmium Tetroxide, Paraformaldehyde and Sodium 
Cacodylate were purchased from Agar Scientific Ltd.
2.3.1.2 Solvents
Acetone and Ethanol were purchased from BDH.
2.3.2 Methods
2.3.2.1 Scanning Electron Microscopy (SEM)
2.3.2.1.1 Sample Collection and Preparation
2.3.2.1.1.1 Control and Experimental Rat Small Bowel Tissue
Control rats were killed by cervical dislocation. The experimental tissue included that 
from rats which had been dosed once, orally, either with nabumetone ID125 (79.0 mg/kg) 
or indomethacin ID 75 (7.5 mg/kg) and from rats which had been pretreated for three days 
with antibiotics (metronidazole 100 mg/kg/amoxycillin 50 mg/kg) prior to the 
indomethacin challenge (indomethacin ID75). These animals were killed 48 hours after 
NSAID administration by cervical dislocation. The tissue from animals with diclofenac- 
induced ulcers came from rats which had been dosed once, orally, for four days with 
diclofenac LD112.5 (10.35 mg/kg) which were killed 48 hours after the final dose by 
cervical dislocation.
2.3.2.1.1.2 Dissection of Rat Small Bowel
The small bowel was dissected out aseptically, as previously described, and cut into short 
sections (10 cm) then flushed clean o f gut debris using sterile physiological saline, at 
37°C, and a sterile 10 ml syringe. The section of small bowel was then opened 
aseptically along the anti-mesenteric side and discrete ulcers, surrounded by a small area
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of intact mucosa, excised. These were placed in small glass jars containing 2 ml of 
fixative (2% (v/v) glutaraldehyde in 0.05 M Sorensen's phosphate buffer, pH 7.4) which 
had been pre-cooled to 4°C, capped and then stored overnight in a refrigerator at 4°C
2.3.2.1.1.3 Human Small Bowel
Samples were obtained from patients (referred by their general practitioner as presenting 
with upper gastrointestinal discomfort) who were undergoing upper gastrointestinal 
endoscopy at The Royal National Hospital for Rheumatic Diseases, Bath. The samples, 
taken from the upper duodenum, were placed in small glass jars containing 2 ml of 
fixative (2% (v/v) glutaraldehyde in 0.05 M Sorensen's phosphate buffer, pH 7.4) which 
had been pre-cooled to 4°C, capped and then stored overnight in a refrigerator at 4°C.
2.3.2.1.2 Scanning Electron Microscopy Processing
After overnight fixation the samples were prepared for SEM using the OTOTO method 
as described by Kelley et al. [1973] which is a modification o f the OTO method first 
described by Seligman et al. [1966], See Appendix 1.
The samples were then processed via the 'general-purpose critical-point drying method' 
(see Appendix 2), mounted on SEM stubs with carbon dag {Agar Scientific Ltd.} and 
stored with silica gel in a dessicator until required. Prior to viewing the samples were 
adhered to a 25 mm aluminium planchette (three samples per planchette) with carbon 
dag then coated with gold {Edwards 150B Gold Sputter Coater}. The samples were 
viewed with a JM 6310 or a T-330 Scanning Electron Microscope {Jeol}.
2.3.2.2. Transmission Electron Microscopy (TEM)
2.3.2.2.1 Sample Collection and Preparation
2.3.2.2.1.1 Control and Experimental Rat Small Bowel Tissue
Rats which had been dosed once, orally, with the fD6o value of an NSAID (either 
diclofenac (5.52 mg/kg), indomethacin (6.0 mg/kg), nabumetone (37.92 mg/kg), 
naproxen (5.0 mg/kg) or piroxicam (3.36 mg/kg)) were killed 48 hours later by cervical 
dislocation. The control tissue came from rats which had either been dosed with distilled
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water (2.0 ml/kg) or 10 per cent (v/v) Tween-80 (2.0 ml/kg) prior to cervical dislocation 
48 hours.
2.3 .2.2.1.2 Dissection of Rat Small Bowel
2.3.2.2.1.2.1 Method One
The small bowel was dissected out, as aseptically as possible, in a fume cupboard (using 
sterile apparatus and instruments) and cut into short sections (10 cm) which were then 
flushed clean o f gut debris with fixative, at 4°C, using a sterile 10 ml syringe. The 
section of small bowel was then opened aseptically along the anti-mesenteric side and 
small pieces of tissue excised. (Samples o f ulcerated and non ulcerated small bowel were 
taken from the animals which had been dosed with indomethacin.) Samples o f all the 
experimental and control tissue were placed in small glass jars containing 2 ml o f fixative, 
which had been pre-cooled to 4°C, capped and then stored on ice at 4°C.
2.3.2.2.1.2.2 Method Two
The small bowel was dissected out, as aseptically as possible, in a fume cupboard (using 
sterile apparatus and instruments). Small pieces (2.0 cm) containing ulcers were cut 
from the distal end of the small bowel and placed in a glass Petri dish containing fixative 
at 4°C. (The location of ulcers was determined by white nodules on the surface o f the 
serosa.) The small bowel was cut open using a razor blade and cleaned of gut debris by 
gently moving it about in the fixative. Very thin sections of small bowel tissue were 
excised by cutting across the tissue with two razor blades, which had been taped together 
with a thin piece o f card between them. (Samples o f ulcerated and non ulcerated small 
bowel were taken from the animals which had been dosed with indomethacin.) Samples 
of all the experimental and control tissues were placed in small glass jars containing 2 ml 
of fixative, which had been pre-cooled to 4°C, capped and then stored on ice at 4°C.
2.3.2.2.2 Transmission Electron Microscopy - Processing
It had been reported that damaged mitochondria had been seen in the unulcerated areas 
of ulcerated rat small bowel tissue taken from animals dosed with indomethacin 
[Bjamason et a l, 1993], As a result various combinations of recognised methods of
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fixation and tissue preparation were tried, in conjunction with different resins, in an 
attempt to improve the visualisation of cristae within the mitochondria of rat small bowel 
tissue in order to try and verify this observation. On receiving advice from an expert in 
electron microscopy [Nunn, 1995] all samples recorded in this thesis were processed as 
described in Appendix 3.1. Although there was a distinct improvement in the visual 
quality of the sections from the blocks prepared via this particular process and it was 
possible to study the cristae within the mitochondria sufficiently to determine any initial 
damage which might be occurring; it was thought that the visual acuity could be further 
improved.
Finally it was decided that the tissue would have to be fixed by the perfusion method (see 
Appendix 3.2) and after this step the tissue was processed as for the previous samples. 
This time half the samples were embedded in Spurr's resin and the remainder in 
Quetol/NSA/MNA/ resin. During sectioning a definite improvement was found (with 
tissue that had been embedded in either of the two resins) as these blocks were easier to 
cut. The semi-thin sections, when viewed via light microscopy, were also o f a higher 
quality than that seen previously suggesting that the tissue had been correctly fixed and 
that there was improved infiltration of the resin as a result. Unfortunately at this point all 
work in the laboratory had to cease as it was decided that insufficient time was available 
for any more practical work.
2.3.2.2.3 Transmission Electron Microscopy - Sectioning
2.3.2.2.3.1 Preparation of Glass Knives.
The glass knives were prepared immediately prior to use. Wearing washed gloves 
(powder free), a strip o f ultramicrotome glass {Agar Scientific Ltd.} was first cleaned 
well with neat liquid detergent and a little warm water. The glass strip was then dried 
with a paper towel and stored in a dust free environment. The knives were cut on a LKB 
Knifemaker {7801 A, LKB Produkter AB} during which time care was taken not to get 
finger prints on the glass strip. In order to cut the glass strip, it was first scored and then 
a straight clean fracture was obtained, along the score line, by applying equal pressure 
either side of it. The glass strip was first cut in half, so that it was of a more manageable 
size, then cut into squares. The squares were then cut into two equal halves, producing
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two 45° knives, each half having one cutting edge. The knives were assessed visually for 
suitability and any substandard ones discarded. The selected knives were placed on a 
Multiplate {2208, LKB Produkter AB} to warm and then plastic troughs {LKB truf, 
Leica UK Ltd.} were attached to them with molten dental wax {Agar Scientific Ltd.}. 
The knives were stored in a glass knife storage box {Taab Laboratories Equipment Ltd.} 
until required for sectioning (dust particles can cause nicks in the cutting edge). At all 
times care was taken when handling the knives not to touch the cutting edge. (During 
thin sectioning a glass knife can only be used for a short period of time before it is 
necessary to replace it.)
2.3.2.2.3.2 Preparation and Trimming of the Block Face.
The resin block containing the sample was first pressed out o f the mould or, if it had 
been set in a gelatin capsule, the gelatin was removed from the block with a Personna 
'Super' single edged razor blade {Agar Scientific Ltd.}. The block was then inspected 
and mounted in the chuck in a manner which would place the sample in the best possible 
orientation. The block was trimmed into a trapezoidal (truncated pyramid) shape using a 
double-edged stainless steel teflon-coated razor blade {Electron Microscopy Sciences.} 
(If the sample had been embedded in LR White, a Personna 'Super' razor blade was used 
for trimming.) Once a flat top had been obtained the chuck was fitted into the 
ultramicrotome {OMU3, Reichert (Leica)}, and the top o f the block fine trimmed with a 
glass knife.
2.3.2.2.3.3 Thin Sectioning
The block was carefully placed in the chuck (if it had been removed after trimming) and 
then the chuck was clamped tightly in the ultramicrotome. The knife, with plastic trough 
attached, was positioned in the knife holder and then moved by hand so that the block 
face was close to the knife but not touching.
The knife edge was aligned with the block face so that the top and bottom of the block 
was parallel with the knife itself. To do this the microtome lighting was switched to 
'background mode' and when the knife was correctly positioned a band o f bright light, 
seen on the block face, was of a constant width as the block passed down in front o f the
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knife. The knife was then carefully moved closer to the block by hand then by using the 
circular adjuster (which has an adjusting bolt in the top) until a thin narrow bright light 
with a 'rainbow effect' was seen. The plastic trough attached to the knife was filled with 
sterile distilled water using a 20 ml syringe which was fitted with a 0.22 pm filter. The 
trough was slightly overfilled at first and the excess water removed, using a needle and 
syringe, till an almost flat meniscus was obtained which gave a silver reflection when 
viewed through the binocular microscope o f the microtome. (An almost flat meniscus 
causes optimal wetting of the knife edge.)
The knife was moved closer to the block by turning the handle and using the fine 
adjustment control, to the left o f the microtome, until the knife started to cut sections off 
the block. This continued until the sections started to be cut evenly. Initially semi-thin 
sections of 5 pm thickness were cut which were lifted off the surface of the water with 
the flattened end o f a cocktail stick. These semi-thin sections were then floated off onto 
a microscope slide which already had a pool o f sterile water on it. The microscope slide 
was placed on a multiplate, covered by a watch glass until it dried. The semi-thin 
sections were then stained with 1.0 % (v/v) toluidine blue/1.0 % (v/v) borax in distilled 
water for one minute, rinsed with distilled water and dried again. Once dry the semi-thin 
sections were mounted in XAM. The semi-thin sections were then studied under a light 
microscope {Carl Zeiss Jena} to ensure that the sample was orientated correctly as a 
transverse section through the wall o f the small bowel was required.
A new knife was then fitted and, once the block and the sample were correctly aligned, 
the ultramicrotome was switched to 'automatic mode', which meant that the knife was 
advanced towards the block by a thermal advance system until thin sections were cut. 
The thickness o f these sections could be estimated by the colour they appeared to be 
when viewed on the surface o f the water through the binocular microscope attached to 
the microtome (see table below). The estimated thickness o f these thin sections is 




Grey < 60 nm
Silver 60 - 90 nm
Gold 90 - 150 nm
Purple 150 - 190 nm
Blue 190 - 240 nm
Table 2.3.2.2.3.3 Interference colour index and section thickness scale.
Ultrathin sections of 100 nm are recommended for TEM and these appear gold on the 
surface o f the water.) Unsuitable sections were removed from the surface o f the water 
using an eyelash which had been attached to the end o f a cocktail stick with dental wax. 
Ideally the gold sections formed a ribbon across the surface o f the water so that as many 
thin sections as possible could be picked up at one time on the grid. The sections needed 
to be stretched prior to picking them up on the grid as they were compressed during the 
cutting process. This was achieved by warming them gently with a heated pen.
The sections were collected onto a metal grid (nickel, copper or gold) by holding the 
grid with forceps at an angle to the surface o f the meniscus so that when it was removed 
from the water the sections were left adhering to it. The underside of the grid was dried 
with filter paper then left to dry completely. The thin sections were then stored in a grid 
box {Agar Scientific Ltd.} until required for staining and viewing. On some occasions it 
was necessary to use a diamond knife {DDK Delaware, Agar Scientific Ltd.} to cut thin 
sections because the tissue was too hard to be cut with a glass knife successfully.
2.3.2.2.4 Staining
2.3.2.2.4.1 Uranyl Acetate Solution
If the sample had not already been block stained with uranyl acetate during processing, 
the sections were first stained with uranyl acetate solution. The concentration, 
composition and length of staining time varied depending on the method of lead citrate 
staining which was to be used. (See Appendix 4a for details.)
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2.3.2.2.4.2 Lead Citrate Solutions
A number of different lead citrate solutions were tried in an attempt to improve the 
degree of contrast within the ultrathin sections, when viewed via TEM.
2.3.2.2.4.2.1 Reynolds' Lead Citrate Solution (Modified)
This method of staining was first described by Reynolds [1963], (See Appendix 4b for 
protocol.) However, when viewing the sections of rat small bowel on the Transmission 
Electron Microscope {JM 1200EX, Jeol}, the tissue was found to be inadequately 
stained with poor contrast.
2.3.2.2.4.2.2 Double Lead Stain
This double lead stain technique was developed by Daddow [1983] in order to enhance 
the contrast o f tissue which had been embedded in Spurr's resin [Spurr, 1969], (See 
Appendix 4c for protocol.)
Tissue may be poorly stained due to a variety o f reasons one o f which is that the tissue 
itself may be difficult to stain. Long-term fixation in glutaraldehyde and the addition of 
sucrose to the fixatives can also be a reason. (The osmolarity o f the small bowel tissue 
was such that sucrose had to be added to the fixatives so that they would be of a similar 
osmolarity.) The double lead stain, especially the abbreviated method [Daddow, 1986], 
should have overcome some of the problems encountered with respect to poorly 
contrasting sections.
2.3.2.2.4.2.3 SynapTek Grid Stick
The SynapTek Grid Stick {Electron Microscopy Sciences} was another variation on the 
uranyl acetate/lead citrate method of staining sections. The staining procedure was 
carried out according to the data sheet.
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Cryostat Tubes {Coming, BDH}
Dialysis Tubing (Size 1) {Medicell International Ltd.}
Glass Racks {E/98, R.A. Lamb}
Glass Troughs {E/105 & E/106, R.A. Lamb}
Incubator/Steriliser (MINO/3 0/S S/IS) {SS20, GENLAB}
'Pen for Immunocytochemistry1 {S2002, DAKO}
Plastic Slide Box { E32.6, R. A. Lamb}
Polyacetal Rack {E99, R.A. Lamb}
Polypropylene Graduated Disposable Pasteur Pipettes (1 and 3 ml) {S.L.S.} 
Polypropylene LP3 Tubes {30882, L.I.P.}
Polypropylene Caps for LP3 Tubes {30965, L.I.P.}
Polystyrene LP3 Tubes {30908, L.I.P.}
Polystyrene Z5 Tubes {71050 Z5/WSC, L.I.P.}
Prestige Stainless Steel Automatic Pressure Cooker {860/7223, Argos}
Pre-Washed Microscope Slides (Twin Frosted One End) {HV Skan Ltd.}
Stainless Steel Swing Handle Rack {E/102, R.A. Lamb}




Aluminium Potassium Sulphate 12-Hydrate {10009}, Ammonium Sulphate {10033}, 
Calcium Chloride 2-hydrate {10070}, Chloral Hydrate {27668}, Haematoxylin 
(monohydrate) {34037}, Hydrogen Peroxide {10128}, Tris[hydroxymethyl]methylamine 
{10315} and XAM neutral medium improved white Gurr {36119} from BDH. 
Hydrochloric Acid (S.G.1.18), Potassium Dihydrogen Orthophosphate, di-Sodium 
Hydrogen Orthophosphate, Sodium Chloride and Sodium Hydroxide from Fisons.
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Gill2 Hematoxylin {Shandon, Life Sciences International}
3-Aminopropyltriethoxysilane (APES) {A-3648}, Bacterial Lipopolysaccharide (LPS) 
{L-8274}, Bovine Serum Albumin {A-7284}, A-Chymotrypsin Type II From Bovine 
Pancreas {C-4129}, 3,3'-Diaminobenzidine (DAB) Tetrahydrochloride Tablets {D- 
5905}, Poly-L-Lysine {P-8920}, Sodium Azide {S-2002}, Sodium Citrate Dihydrate 
ACS Reagent {S-46410} from Sigma, Sodium Iodate {21,591-0, Aldrich}.
RPMI 1640 Medium and Foetal Calf Serum from GIBCO.
Eosin Yellow {S/115.3} and OCT (Tissue Tek){C/101.25} from R.A. Lamb 
Sodium Hyperchlorite {Coventry Chemicals Ltd.}
Sta-On {Surgipath}
3.1.1.3 Solvents
Buffered Formalin Concentrate {Western Solvents Ltd.}
Citroclear CC500 {HD Supplies}
Ethanol {HaymanLtd.}
Industrial Methylated Spirits 99 {Tennants}
Isopentane (2-Methylbutane) {10361, BDH}
Acetone and Methanol (both HPLC Grade) {Fisons}
Xylene {BDH}
3.1.1.4 Primary Antibodies - Rat Studies
Polyclonal Rabbit Anti-Mouse LL-a {EP-110, Genzyme}
Monoclonal Hamster Anti-Mouse IL-P {1997-01, Genzyme}
Monoclonal Mouse Anti-Human IL-4 {1842-01, Genzyme}
Polyclonal Rabbit Anti-Mouse TNF-a {IP-400, Genzyme}
Polyclonal Rabbit Anti-Mouse TNF-a {Gift from Dr. S.L. Kunkel, University of 
Michigan, USA.}
3.1.1.5 Primary Antibodies - Human Studies
Polyclonal Rabbit Anti-Human IL-la {80-3054-01, Genzyme}
Monoclonal Mouse Anti-Human IL-8 {MCA1109, Serotec}
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Polyclonal Rabbit Anti-Human IL-8 {80-3718-01, Genzyme}
Monoclonal Mouse Anti-Human IL-8 {Gift from Dr. Ivan Lindley, SANDOZ, Vienna, 
Austria.}
Polyclonal Rabbit Anti-Human TNF-a {IP-300, Genzyme}
3.1.1.6 Secondary Antibodies
Biotinylated Swine Anti-Rabbit Immunoglobulins {E353, DAKO}
Biotinylated F(ab') 2  Fragment o f Rabbit Anti-Mouse {E413, DAKO}
Biotinylated Rabbit F(ab') 2  Fragment Rabbit Anti-Syrian Hamster {307-066-003} and 
Biotinylated Rabbit Anti-Syrian Hamster IgG {307-065-003} from Jackson 
ImmunoResearch.
3.1.1.7 Recombinant Proteins - Rat Studies
Recombinant Mouse IL-la {1920-01, Genzyme}
Recombinant Mouse TNF-a {TNF-M, Genzyme}
Rat Interleukin-4 {Gift from Serotec}
3.1.1.8 Recombinant Proteins - Human Studies
Recombinant Human IL -la {Gift from Glaxo}
Recombinant Human TNF-a {Gift from Bayer}
3.1.1.9 Control Serums
Normal Swine Serum {X0901}, Normal Rabbit Serum{X0902} and Normal Rabbit 
Immunoglobulin Fraction {X0903} were purchased from DAKO.
Normal Rabbit Serum {R-4505, Sigma}
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3.2 Methods
3.2.1 Sample Collection and Preparation.
3.2.1.1 Positive Control Tissues
Positive control tissues were collected so that they could be used during the 
immunhistochemistry procedure. The specimens are processed identically to the 
experimental tissue but must contain the target protein. It is advantageous, although not 
necessary, to have the control tissue stain marginally positive so as to monitor not only 
for the presence of the antigen but also any possible loss of sensitivity. This loss might 
not be apparent if only intensely staining controls are used [Boenisch 1989],
3.2.1.1.1 Rat Lung
Rat lung was incubated with bacterial lipopolysaccharide (LPS), 10 pg/ml, in RPMI 
1640 medium containing 10% foetal calf serum for 1, 2 and 4 hours at 37°C. After 
incubation the tissue was either placed in 10% neutral phosphate buffered formalin or 
snap frozen. Sections taken from the formalin-fixed paraffin-embedded activated lung 
tissue, which had been incubated for one hour with LPS, were found to have sufficient 
TNF-a and IL-la activity for binding of the rabbit anti-mouse TNF-a and the rabbit 
anti-mouse IL-la so this was the control tissue used for these two antibodies.
3.2.1.1.2 Rat Spleen
Initially a rat spleen was dissected out o f the animal, placed in 10% neutral buffered 
saline and then embedded in paraffin wax. However, when sections of this tissue were 
used for immunhistochemistry the activity of TNF-a was so low that no visible binding 
o f the polyclonal rabbit anti-mouse TNF-a was detected. Therefore it was decided to 
activate the spleen with bacterial lipopolysaccharide (LPS) [Zuckerman et al., 1991], 
Initially rat spleen was incubated with LPS, 10 |ig/ml, in RPMI 1640 medium containing 
10% foetal calf serum for 1, 2 and 4 hours at 37°C. After incubation the tissue was 
either placed in 10% neutral phosphate buffered formalin or snap frozen in 
isopentane/liquid nitrogen. Although sections from the formalin-fixed paraffin-embedded 
tissue displayed positive binding for the rabbit anti-mouse TNF-a and the rabbit anti-
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mouse IL-la it was not as suitable as the lung tissue. In the literature spleen was 
reported as being an organ which could be induced to synthesise an abundance o f IL-1P 
[Koenig et al., 1990], however no such activity was found initially. Further research of  
the literature revealed that levels of IL-1 (3 did not start to rise until six hours after initial 
stimulation with LPS and reached peak levels after approximately 19 hours [Lonnemann 
et al., 1989], As a result rat spleen was incubated as before but this time for six hours 
and 19 hours.
3.2.1.1.3 Human Tonsil
Human tonsil tissue was collected, within minutes o f its removal from the patient, from 
the operating theatres of the Royal United Hospital, Bath. The tissue was rapidly cut 
into small segments which were either fixed in 10% neutral phosphate buffered formalin 
or snap frozen in isopentane/liquid nitrogen. At the time a note was made as to the 
suitability o f the tissue collected for control tissue purposes as the tonsil tissue needed to 
be 'reactive' but not too infected. Tonsil tissue was selected for this purpose as it has 
been shown that tonsil tissue produces 19 different cytokines [Andersson et al,. 1994],
3.2.1.2 Experimental Tissues
3.2.1.2.1 Rat Small Bowel
Groups o f rats (3-6) were dosed once with either indomethacin, fD6o (ulcer causing 
dose) or ED30 (non ulcer causing dose), 10% Tween-80 (vehicle) or with water (control). 
48 hours later they were killed by cervical dislocation and samples were taken for 
immunohistochemistry.
3.2.1.2.2 Human Gastric Mucosa
Samples of gastric mucosa (5 per patient) were obtained from patients (referred by their 
general practitioner as presenting with upper abdominal discomfort) who were 
undergoing upper gastrointestinal endoscopy at The Royal National Hospital for 
Rheumatic Diseases, Bath. Immediately after excision two samples were placed in 
plastic universals containing 10% neutral phosphate buffered formalin and two were snap 
frozen in isopentane/liquid nitrogen. The fifth sample was placed in the medium of a
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'CLO Test' (for Campylobacter-like organisms), containing urea and a pH-sensitive dye 
[Marshall et a l, 1987], to see if the sample was positive for Helicobacter pylori. At 
endoscopy a note was made as whether the patient was Helicobacter pylori-positive and 
whether or not they had ulcers or were suffering from gastritis.
3.2.1.3 Formalin-Fixed Paraffin-Embedded Tissue
3.2.1.3.1 Histopathology Laboratory, Royal United Hospital, Bath.
Samples were placed in plastic containers (universals or Sterilin 50 ml pots) containing 
10% neutral phosphate buffered formalin. (It is imperative for immunohistochemistry 
that the samples be embedded as soon as possible, recommended fixation time being 
between 6-24 hours.) After fixation the samples were processed overnight on an 
enclosed processor {Shandon Hypercenter 2} and embedded in paraffin wax {Histoplast, 
Life Sciences International} which is a blend of paraffin waxes that has a melting point at 
56°C (see table 3.2.1.3.1).
Programme For Shandon Hypercenter 2
PROGRAMME ROUTINE
Reagent. % TMP VAC TIME DRAIN
1. Formalin 10% 40 N 2.15 1
2 . Alcohol 70% 37 N 0.25 1
3. Alcohol 95% A N 0.25 1
4. Alcohol 100% A N 0.25 1
5. Alcohol 100% A N 1.00 1
6 . Alcohol 100% A N 1.00 1
7. Alcohol 100% A N 1.00 1
8 . Xylene A N 1.00 1
9. Xylene A N 1.00 1
10 . Xylene A N 1.30 1
11 . Wax 62 Y 1.30 2
12 . Wax 62 Y 2.30 2
Total Time 14 Hrs 36 Mins
Table 3.2.1.3.1 Processing Procedure for Formalin-Fixed Paraffin Embedded Tissue
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3.2.1.3.2 Bath Clinic, Bath.
Samples were placed in plastic universals containing 10% neutral phosphate buffered 
formalin. After fixation the samples were processed overnight and embedded in 
plasticised paraffin wax {Life Sciences International} at a temperature of 65°C.
3.2.1.4 Samples frozen in isopentane/liquid nitrogen
3.2.1.41 Rat Lung, Rat Spleen, Human Gastric Mucosa and Human Tonsil
A 50 ml plastic beaker containing approximately 30 ml o f isopentane was lowered into a 
thermos flask, using a wooden test tube holder, containing liquid nitrogen. Once the 
isopentane had frozen solid it was removed from the liquid nitrogen and allowed to 
partially thaw. The samples were dropped into the isopentane and once frozen were 
placed into cryostat tubes and then dropped directly into the liquid nitrogen. The 
samples were then stored in a freezer at -70°C. Some samples were surrounded by OCT 
(Tissue Tek) and wrapped in aluminium foil before being dropped into the isopentane 
and then these packets were dropped into the liquid nitrogen. These samples were then 
placed into airtight polythene bags and also stored at -70°C.
3.2.1.4.2 Rat Small Bowel
Samples of rat small bowel were cut down the antimesenteric side and laid out carefully 
onto benchcoat. The small bowel samples and the benchcoat were then dropped into 
isopentane at the correct temperature. These samples, which had been frozen flat, were 
carefully removed from the benchcoat and then put into cryostat tubes and dropped into 
liquid nitrogen. (After being frozen in the isopentane an attempt was made to freeze 
some o f these frozen samples in OCT (Tissue Tek) but the problem was that the small 
bowel samples defrosted too quickly and could not be frozen flat using the OCT.) The 
samples were then stored in a freezer at -70°C.
3.2.2 Preparation of Glass Slides for Sections Cut on Cryostat
Glass slides were first placed in a plastic slide rack and then cleaned in acid alcohol (1% 
(v/v) concentrated HC1 in 70% (v/v) ethanol) for 10 min. The glass slides were then 
washed well in distilled water.
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3.2.2.1 Poly-L-Lysine
The poly-L-lysine (1 g/1) was diluted 1:10 with deionized water prior to coating the glass 
slides. Cleaned glass slides in a plastic rack were placed in the poly-L-lysine solution, 
held in a 1 litre polypropylene beaker, for 5 min. The slides were then drained and either 
dried for one hour in an oven at 60°C or at room temperature overnight.
3.2.2.2 'Sta-On'
A 5% solution (50 ml/1) of'Sta-On' {Surgipath} was used for precoating the glass slides. 
Cleaned glass slides in a plastic rack were placed in the 'Sta-On' solution for 30 minutes 
then drained and left to dry at room temperature.
3.2.3 Sectioning
3.2.3.1 Formalin-Fixed Paraffin-Embedded Tissue
3.2.3.1.1 Histopathology Laboratory, Royal United Hospital, Bath.
The sections were cut, at a thickness of 4 pm, on a Leitz Rotary Microtome and floated 
off into a water bath, at 43°C, containing a tissue section adhesive {'Sta-On', Surgipath, 
10 ml/1}. (Initially glass slides pre-coated with 2% (v/v) APES were used but owing to a 
problem with the sections washing off the slides during the immunhistochemical 
procedure it was decided to switch to 'Sta-On'). The sections were then picked up on 
glass slides, which had been acid/alcohol washed, and dried for between 24 and 48 hours 
in an oven at 37°C. A section from each block was H & E stained to ensure that the 
tissue was correctly orientated and that the sections were of a high enough quality for 
immunohistochemistry
3.2.3.1.2 Bath Clinic, Bath
Initially the sections were cut, at a thickness o f 4 pm, on a Leitz Sledge Microtome and 
floated off into a water bath at 55°C containing 'Sta-On', 10 ml/1, a tissue section 
adhesive. The sections were then picked up on glass slides, which had been acid/alcohol 
washed, and dried for 1 hour at 70°C. This method o f preparing tissue sections is 
suitable for routine light microscopy but not for sections which are required for
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immunohistochemistry. Once this mistake had been realised the sections were cut and 
dried at temperatures as close as possible to those recommended by the Royal United 
Hospital.
3.2.3.2 Frozen Tissue
3 .2.3 .2.1 Cryostat, School of Pharmacy and Pharmacology, University of Bath.
Some OCT (Tissue Tek) was placed on the cooled chuck in the cryostat and allowed to 
freeze. The tissue was then placed on this frozen OCT, surrounded by more OCT, 
orientated into the correct position and held in place until the OCT froze around it. The 
sections were cut, at a thickness o f 6 pm, on a cryostat {Bright Instrument Company 
Ltd.} at a temperature of -12 to -15°C and picked up onto precoated glass slides which 
were themselves at room temperature.
Problems were encountered when trying to cut sections o f 6 pm thickness on this 
cryostat as the knife was not sharp enough to cut the tissue cleanly and the sections were 
tom. An attempt was made to use these sections for immunhistochemical staining but 
the antibodies became trapped under the sections where the tissue was ripped.
There was also an additional problem with cutting human tonsil tissue on this cryostat as 
it was in regular use by other members o f the department who had not been vaccinated 
against Hepatitis B. Therefore it was decided to seek permission to cut the sections on 
the cryostat in the Histopathology Laboratory at the RUH.
3.2.3.2.2 Cryostat, Histopathology Laboratory, RUH, Bath.
Some OCT (Tissue Tek) was placed on the cooled chuck in the cryostat and allowed to 
freeze. The tissue was then placed on this frozen OCT, surrounded by more OCT, 
orientated into the correct position and held in place until the OCT froze around it.
The sections were cut, at a thickness o f 5pm, on a cryostat {1720, Leitz} at a 
temperature of -20°C and picked up onto precoated glass slides which were themselves 
at room temperature (3 sections/slide). The first few sections from each sample were H
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& E stained to ensure that the tissue was correctly orientated and that the sections were 
of a high enough quality for immunohistochemistry. During sectioning the slides were 
stored in a rack inside the cryostat until sufficient sections had been cut. The sections 
were then air dried ( by placing the slide rack in front o f a fume cupboard which had the 
front closed down) for 30 minutes at room temperature. The sections were then stored 
at -70°C in one of three ways (detailed in chronological order).
(i) The sections were placed in a large plastic slide holder with some silica gel, wrapped 
in aluminium foil and sealed with masking tape.
(ii) The sections were placed in small plastic slide holders, (5 sections/holder), sealed 
with masking tape and then placed into airtight polythene bags with silica gel.
(iii) The sections were placed in cardboard slide holders, wrapped well in aluminium foil, 
sealed with masking tape and then placed into airtight polythene bags with silica gel.
The final method of storage was found to be the most suitable and only enough slides for 
an experiment were sealed up in each individual packet.
3.2.4 Antibodies
3.2.4.1 Commercially Available Antibodies
The antibodies which had been purchased were stored on arrival at the temperature 
recommended by the data sheet. Prior to use 10 pi aliquots were pipetted aseptically 
into sterile 0.5 ml eppendorfs which were then frozen upright in a plastic rack. (The 
antibodies were aliquoted to prevent a freeze/thaw cycle which would destroy the 
antibody.) The frozen aliquots were placed in suitable containers which were then sealed 
inside airtight polythene bags in order to prevent the small aliquots from dehydrating 
whilst stored in the freezer. Most o f the antibodies were stored at -20°C however the 
monoclonal hamster anti-mouse EL-ip was stored at -70°C as recommended. The 
biotinylated F(ab')2 fragment rabbit anti-syrian hamster IgG secondary antibody had to be 
mixed 1:1 with sterile glycerol before it was stored in the freezer at -20°C.
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3.2.4.2 Donated Antibodies
3.2.4.2.1 Polyclonal Rabbit Anti-Mouse TNF-a
3.2.4.2.1.1 Hyperimmune Serum
This antibody, which was a gift from Dr Kunkel, was stored as a hyperimmune serum in 
aliquots o f varying sizes. Prior to use, for immunhistochemistry, 10 pi aliquots were 
pipetted aseptically into sterile 0.5 ml eppendorfs which were then frozen upright in a 
plastic rack. (The antibodies were aliquoted to prevent a freeze/thaw cycle which would 
destroy the antibody.) The frozen aliquots were placed in suitable containers which were 
then sealed inside airtight polythene bags in order to prevent the small aliquots from 
dehydrating whilst stored in the freezer.
3.2.4.2.1.2 Rabbit Gamma-Globulin (RyG) Preparation
The polyclonal rabbit anti-mouse TNF-a had been supplied as a neat hyperimmune 
serum. In order to improve the binding o f this antibody it was decided that it should be 
further purified. The method o f ammonium sulphate precipitation used was a 
modification of that described by Hudson & Hay [1989], (The ammonium sulphate 
precipitate of whole rat serum is not strictly y-globulin but is serum depleted mainly of 
albumin.)
3.2.4.2.1.2.1 Antiserum Fractionation
Hyperimmune rabbit serum (1.5 ml) was placed, with a small flea, in a Beckman 
centrifuge tube, which was held over a magnetic stirrer by a clamp fixed to a retort stand. 
To this 1.5 ml of saturated ammonium sulphate solution (in 0.2 M Tris, pH 8.0) was 
added dropwise, with constant stirring, to 50% saturation. The resultant mixture was 
left stirring at room temperature for 30 minutes. The mixture was then spun at 6000 rpm 
in a Beckman J2-MC centrifuge, using the 20.1 rotor, for 20 min at 25°C. (The outer 
holes o f the rotor were at a radius o f 115 cm which meant that the mixture was spun at 
approximately 3000g as required.) The supernatant was pipetted off and stored at 4°C 
and the precipitate was redissolved in 1.5 ml of 0.2 M Tris-HCl, pH 8.0. To this 1.5 ml 
o f saturated ammonium sulphate solution (in 0.2 M Tris, pH 8.0) was added dropwise, 
with constant stirring, to 50% saturation. The resultant mixture was left stirring at room
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temperature for 30 minutes and then spun as before. The supernatant was pipetted off 
and stored at 4°C and the precipitate was redissolved in 1.5 ml of 0.02 M phosphate 
buffer, pH 7.4. The solution was then loaded into dialysis tubing and the Beckman tube 
rinsed with a small amount of phosphate buffer which was also loaded into the dialysis 
tubing. The tubing was knotted and the solution inside dialysed at 4°C against 2.0 litres 
of phosphate buffer pH 7.4., twice for 2 hrs, overnight and then 4 hours in phosphate 
buffer which had been made up with Milli-Q water.
A precipitate had formed during dialysis so the RyG was spun as before. The 
supernatant was then diluted 1:19 with phosphate buffer and read at 280 nm in a 0.8 ml 
quartz cuvette on a spectrophotometer (UV/VIS, Lambda 3, Perkin-Elmer). (At 280 nm 
an Optical Density o f 1.0 (in a 1.0 cm cuvette) = RyG cone o f 0.74 mg/ml.) The two 
original supernatants were discarded when it was known that a good yield o f RyG had 
been obtained. In the event that the concentration of protein had been very low, the two 
original supernatants would have been combined and the whole process repeated using 
the combined supernatants.
This procedure was repeated at a later date with 250 pi of hyperimmune serum and 
although the yield was slightly down (more dilute due to the smaller quantity being used) 
it was very successful. Initially the RyG of the hyperimmune serum was stored in 50 pi 
aliquots at -20°C however, after 6 months, the antibody was found to have lost its 
activity. As a result it was decided to store subsequent batches of RyG at 4°C with 0.1% 
(w/v) sodium azide.
3.2.4.2.1.2.2. Control Rat Serum Fractionation
The above purification method was repeated using 1.5 ml o f frozen serum from a Male 
Wistar Rat, University of Bath Strain.
3.2.4.2.2 Monoclonal Mouse Anti-Human IL-8
This was stored, as delivered, with 0.1% (w/v) sodium azide at 4°C.
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3.2.5 Preparation of Dialysis Tubing
Approximately 30 cm of dialysis tubing was placed in a glass beaker with 500 ml of 
Milli-Q water (containing a few mg of EDTA) and boiled for 10 min. The dialysis tubing 
was then washed well with Milli-Q water, and stored at 4°C in Milli-Q water with 
sodium azide (0.05% w/v) until required for use.
3.2.6 Haematoxylin and Eosin Staining 
See Appendix 5
3.2.7 Procedures for Immunohistochemistry
The technique chosen for the immunohistochemistry procedure was that which uses the 
Avidin-Biotin-Peroxidase Complex (ABC) which was developed by Hsu et a l  [1981] for 
use with formalin-fixed paraffin-embedded tissue. The binding of this complex to the 
biotinylated secondary antibody results in a higher staining intensity, owing to 
amplification o f the original signal, as a large amount o f peroxidase is attached to each 
primary antigen site. The peroxidase is then developed by DAB (3,3'-Diaminobenzidine 
Tetrahydrochloride). This peroxidase staining method was selected, rather than one 
which utilised alkaline phosphatase, because it enabled the stained sections to be stored 
over a long period of time without fear of the staining in the tissue fading. (Staining with 
alkaline phosphatase only remains visible for a few weeks.) The problem with using a 
peroxidase staining method is that the tissue sections have to be blocked with 2.5% (v/v) 
Hydrogen Peroxide/Methanol, to quench any endogenous peroxidase activity, and there 
is a risk that some antigens may be destroyed by this procedure.
3.2.7.1 Formalin Fixed Paraffin Embedded Tissue
3.2.7.1.1 Monoclonal Antibodies 
Protocol - See Appendix 6
During the immunhistochemical procedure negative control sections are processed at the 
same time. These sections o f positive control tissue and experimental tissue are subject 
to the same procedure as the other sections except that they are incubated with buffer
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only when the other sections are being incubated with the primary antibody. These 
control sections are to ensure that there is no non-specific staining present and should 
always be free of staining after the procedure is completed. Should any staining be found 
in these sections it may be due to either (or all) of the following.
In order to find out which o f the steps in the process is responsible it is necessary to run 
the immunhistochemcal procedure, using sections o f positive control tissue without using 
a primary antibody and omitting each one of the subsequent staining steps in turn, 
replacing it with buffer.
i. Endogenous Peroxidase Activity
Staining obtained when both the secondary antibody and the ABComplex have been 
replaced with buffer means that the DAB is binding to the endogenous peroxidases in the 
tissue and the Hydrogen Peroxidase/Methanol blocking step needs to be extended in time 
or the concentration o f hydrogen peroxidase increased.
ii. Endogenous Biotin
Staining obtained when the secondary antibody has been replaced with buffer is 
indicative of the ABComplex binding to endogenous biotin in the tissue.
iii. Non-Specific Binding o f Secondary Antibody
Should the above both give a negative result then the non-specific staining must be due 
to the secondary antibody. This can be overcome by using the F(ab' ) 2  fragment of the 
biotinylated antibody instead.
3.2.7.1.2 Polyclonal Antibodies 
Protocol - See Appendix 7
During the immunhistochemical procedure negative control sections are processed at the 
same time as described above. In addition to these, sections of positive control tissue 
and experimental tissue are processed using control serum (from the same animal that the
71
primary antibody had been raised in), at the same concentration but instead of the 
primary antiserum. (When using the IgG fraction o f the antiserum the equivalent fraction 
is used from the control serum.) This is to ensure that all visible staining is due to the 
antibody binding to the protein under investigation only.
3.2.7.1.3 Antigen Retrieval
3.2.7.1.3.1 Protease (Trypsin)
Distilled water (300 ml) and tris buffered HC1, pH 7.8, (300 ml) were placed in glass 
pots then warmed in an oven at 37°C. Once warm the glass pot containing tris buffered 
HC1 was placed on a magnetic stirrer (heater on very low) with a flea. To this calcium 
chloride (0.3 mg) and a-chymotrypsin (0.3 mg) were added. Once these reagents had 
dissolved sodium hydroxide (3%) was added until the solution was at a pH of 7.8. The 
trypsin solution was then returned to the oven until required for use.
After deparaffinisation and blocking with methanol the sections were washed and then 
placed in warm distilled water for 5 minutes at 37°C. Next the sections were placed in 
the trypsin solution and returned to the oven for 15 minutes at 37°C. The sections were 
then washed well with water and placed in a glass pot containing tris buffered saline, pH 
7.6, followed by blocking with serum which had come from the animal in which the 
secondary antibody had been raised. The protocol for immunohistochemistry then 
proceeded as before.
3.2.7.1.3.2. Microwaving
The technique used was based on that described by King [1994], After deparaffinisation 
and blocking with methanol the sections, in a polyacetyl rack, were washed well and then 
placed in a polypropylene container (measuring 140 mmx 90 mm x 80 mm) with 600 ml 
of 0.01M HC1 sodium citrate buffer, pH 6.0. The height of the liquid in the container 
was marked, with an indelible pen, and then the container was placed into a microwave 
oven (Blomberg 850 w). The container and sections were heated on full power for a 
total of 40 minutes in 4 x 10 minute bursts. After each 10 minute period the level of 
liquid in the container was topped up with distilled water to the level marked initially.
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(The container with the sections was itself placed in a larger polypropylene box so that if 
the buffer boiled over it would be contained.) The sections were then left for 20 minutes 
to cool to room temperature and then transferred into a glass pot containing tris buffered 
saline, pH 7.6. The protocol for immunohistochemistry then proceeded as before with 
the serum blocking step.
3 .2.7.1.3 .3. Pressure Cooking
The technique used was based on that described by Auld [1994], After deparaffinisation 
and blocking with methanol the sections, in a stainless steel rack, were washed well with 
water. During these procedures 3.0 litres o f 0.01M HC1 sodium citrate buffer, pH 6.0, 
were brought to the boil in a stainless steel pressure cooker, BUT NOT under pressure. 
The sections were carefully lowered into the boiling buffer, the pressure cooker lid 
closed, and then, after full pressure had been obtained, boiled for 2 minutes. The 
pressure cooker was cooled rapidly by quenching in a sink of cold running tap water. 
Once cooled the sections were washed well in water and then transferred to a glass pot 
containing tris buffered saline, pH 7.6. The immunhistochemistry protocol was then 
followed as before.
N.B. Stainless steel apparatus had to be used during pressure cooking so that the buffer 
was not contaminated with aluminium ions.
3.2.7.2 Frozen Sections - Protocol
3.2.7.2.1 Monoclonal and Polyclonal Antibodies
Sections were removed from the freezer and left to come to room temperature, still 
wrapped up, for 30 minutes to 1 hour. The sections were fixed in acetone at room 
temperature for 10 minutes and then left to air dry for 10 minutes. The sections were 
then blocked in 2.5% (v/v) hydrogen peroxide in methanol for 15 minutes followed by 
rinsing in distilled water. The sections were placed in a glass pot o f tris buffered saline, 
pH 7.6 for 5 minutes and then the procedure for immunohistochemistry proceeded as 
normal with the serum blocking step.
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Initially the sections were blocked in 0.6% (v/v) hydrogen peroxide in methanol for 20 
minutes, as recommended by DAKO, however background staining was found in the 
negative control section due to the DAB binding to the endogenous peroxidase in the 
tissue. An experiment without using a primary antibody was conducted to see what the 
minimum length of time was required for blocking. It was found that for most frozen 
tissue blocking in 2.5% (v/v) hydrogen peroxide in methanol for 15 minutes was 
sufficient.
3.2.7.2.2 Antigen Retrieval - Saponin
The method used was that described by Andersson et al. [1994],
3.2.8 Protein Blotting
The protein blotting technique used was an adaptation of two methods previously 
described by Renart et al. [1979] and Bowen et al. [1979], (See Appendix 8 for 
protocol.)
3.2.9 Neutralisation of Mouse IL-la and Mouse TNF-a
The neutralisation procedure was necessary in the case of the polyclonal rabbit anti­
mouse EL-la and the polyclonal rabbit anti-mouse TNF-a as these antisera were not 
specific for the respective rat cytokines. Although the Genzyme polyclonal rabbit anti­
mouse EL-la had been reported as crossreacting with rat EL-la [Diamond & Pesek, 
1991; Perretti et al, 1991, Merrick et al., 1992, Merrill et al., 1993; Teti et al., 1993] as 
had the Genzyme polyclonal rabbit anti-mouse TNF-a [Diamond & Pesek, 1991; Merrill 
et a l, 1993; Teti et al., 1993] and the donated polyclonal rabbit anti-mouse TNF-a 
[Osborn et a l ,  1989] it was still necessary to confirm this with the sections o f rat tissue 
being used for immunohistochemistry.
3.2.9.1 LP3 Tubes
Recombinant protein, o f varying concentration, in 100 jil o f tris buffered saline (pH 7.6), 
was added to LP3 tubes with 100 pi of double strength working antibody dilution. The 
solutions were mixed then left to stand for one hour. The mixtures were then added to
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sections of control tissue, at the primary antibody incubation step, and the protocol for 
immunohistochemistry followed as before.
3.2.9 2 ELISA Plate
Recombinant protein, of varying concentration, in 100 pi of coating buffer (0.05 M 
sodium carbonate buffer, pH 9.6), was added to a 96-well ELISA plate, sealed with a 
transparent lid and left overnight at 4°C (or 2 hours at 37°C). The following morning 
the coating buffer was aspirated from the wells and the wells were rinsed twice with tris 
buffered saline (pH 7.6). A 200 pi aliquot of tris buffered saline (pH 7.6) containing the 
antiserum (working dilution) was added to each o f the wells and left for 1 hour at 37°C. 
The contents o f each well were then added to sections o f control tissue (one well per 
section), at the primary antibody incubation step, and the protocol for 
immunhistochemistry followed as before.
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4 .1 . 1 . 1  Apparatus
4.1.1.1.1 Radial Immunodiffusion (RID)
Haptoglobin Kit RID Method { Hycor Biomedical Inc., 883145, Bio-Stat}
4.1.1.1.2 Immunoelectrophoresis 
Agarose 15 'Electran' {44302, BDH}
Gel Bond-Agarose Support Medium (102 mm x 0.2 mm x 16.5 m) {Flowgen}
Gel Levelling Platform
Glass Gel Support Plates




Barbitone (Diethylbarbituric Acid) {27282}, Barbitone Sodium {27283}and 
Polyethylene Glycol (PEG) 6000 {44271} were purchased from BDH. Brilliant Blue R 
(Coomassie Brilliant Blue R-250) {B-0149, Sigma}
4.1.1.3 Solvents
Glacial Acetic Acid {A/0360/PB17, Fisons} and Methanol {BDH}
4.1.1.4 Antibodies
Polyclonal Goat Anti-Human Haptoglobin {ORER 04/05, Behring}
Polyclonal Rabbit Anti-Human Haptoglobin {A0030, DAKO}
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4.1.1.5 Standard and Control Serums
Human Standard Serum Protein Calibrator {X0908, DAKO}
Human Standard Serum Protein High Control {X0940, Gift from DAKO}
Normal Control Rat Serum {R-7648, Sigma}
Normal Control Rat Serum {X0912, Gift from DAKO}
4.1.2 Methods
4.1.2.1 Radial Immunodiffusion (RID) Test
Initially an RID Test kit from Hycor Biomedical Inc. {Bio-Stat Diagnostics} was tried, 
which is based on the technique described by Feinberg [1957], The tests were carried 
out according to the data sheet but the anti-human haptoglobin did not recognise the rat 
protein. (This kit would have been too expensive even if the anti-human haptoglobin had 
recognised the rat protein as only six samples could be assayed per kit.)
4.1.2.2 Rocket Immunoelectrophoresis
This method is based on the 'Laurell Rocket Technique' as described by Laurell [1966, 
1972], See Appendix 9 for protocol.
4.1.2.2.1. Polyclonal Goat Anti-Human Haptoglobin
Initially the Polyclonal Goat Anti-Human Haptoglobin Antibody from Behring was tried. 
This antibody did not cross react with the rat haptoglobin protein and the only sign of 
any reaction was a minute circular band around the well in which the rat serum had been 
aliquoted. The test serum used had come from rats which had been chronically dosed as 
long as possible with indomethacin so that the level o f haptoglobin in the serum should 
have been very high.
4.1.2.2.2 Polyclonal Rabbit Anti-Human Haptoglobin
After an exhaustive literature search a paper was found [Persson et al., 1992] which 
cited an anti-human haptoglobin antibody which would cross react with the equivalent 
rat protein [Fries & Lindstrom 1986], The company which had supplied it was
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Dakopatts in Denmark. The company was contacted and details were received back 
including the information that the antibody was available from DAKO, UK.
4.2 MYOGLOBIN - HPLC
4.2.1 Materials
4.2.1.1 Reagents
Horse Heart Cytochrome C {C-2506}, Horse Heart Myoglobin {M-1882}, Horse 
Skeletal Muscle Myoglobin {M-0630}and Rat Heart Cytochrome C {C-7892} from 
Sigma.
4.2.1.2 Solvents
Acetonitrile (Methylcyanide) HPLC Grade {UNI648, BDH or A/0627/17, Fisons}and 
Trifluoroacetic Acid HPLC Grade {30,203-1, Aldrich}
4.2.2 Methods
The two methods employed were an adaptation o f that described by Hanson et al. 
[1992]. Myoglobin was assayed in rat serum and rat urine by reverse phase HPLC with 
U.V. and visible light detection using equine heart and equine muscle myoglobin as 
standards. The 15 cm stainless steel analytical column was packed with Chrompack P 
300 RP material which is a rigid macroporous polystyrene divinylbenzene polymer with a 
particle size of 8  pm and a pore size o f 300A. The two mobile phases A and B were as 
follows, mobile phase A consisted o f 0.1% (v/v) trifluoroacetic acid in acetonitrile 95:5 
filtered distilled water and mobile phase B was 0.1% (v/v) trifluoroacetic acid in filtered 
water only. The mobile phase and glass distilled water were filtered through a 0.45 pm 
nylon filter {Sigma} using a glass filtering system {SPC 29, Hario} and vacuum-pump 
{Geryk, Alley Compressors Ltd.}. The equipment was operated at room temperature 
throughout.
The standards were made up in filtered distilled water as the myoglobin would not 
readily dissolve in the mobile phase (and even in water the highest concentration of 
myoglobin used, lOOpg/ml, did not go into solution quickly). Initially the serum (rat and
78
human) samples were diluted 1:9 with filtered distilled water and diluted 1:9 with the 
relevant mobile phase. However it was found that the myoglobin in the standards and 
the serum samples quickly deteriorated when diluted with the mobile phase. 
(Trifluoroacetic acid at a concentration of 0.1% (v/v) in both the water and the organic 
solvent results in a low pH (2) and many proteins are susceptible to unfolding in such 
aqueous organic solutions at acidic pH, particularly during prolonged exposure [Hanson 
et al. 1992]). Thus all standard and serum dilutions were in filtered water.
4.2.2 .1  Isocratic System
Standards and rat serum samples, diluted 1:9 with filtered distilled water, were assayed 
using LDC components {Milton Roy, LDC Division }. The mobile phase was pumped 
to the column at a constant flow using a Model III Constametric pump and the samples 
were injected onto the column through a lOOjul loop by injecting 250pl of the standard or 
sample into the system via an Hamilton Syringe. The eluted products were then detected 
using a SpectroMonitor III variable wavelength U.V. spectrophotometer and the 
chromatograms were produced on a chart recorder {Servogor Z10, BBC Goerz}. The 
mobile phase was made up and degassed by standing the bottle that contained it in a 
sonicator {Ultratech} for 10 minutes. (This degassing process had to be repeated on a 
regular basis.) The method recommended for the column by Chrompack utilised a 
gradient which was not possible on the isocratic system so two ratios of the mobile 
phases, A and B, were tried as a compromise. The ratio 50:50 was unsuccessful (the 
elution time of the myoglobin peak was too rapid) so the ratio utilised was 40:60, A:B, 
at a flow rate o f 1.5 ml/min, as being the closest to the gradient conditions for the elution 
of myoglobin. The wavelength recommended was 220 nm, but at this wavelength the 
base line was very unstable and no individual peaks were obtained as proteins were seen 
to be eluting very close together so that the peaks overlapped. 3.0 ml o f the highest 
myoglobin standard ( 1 0 0  pg/ml) was placed in a cuvette, scanned on a 
spectrophotometer {SP6-500 U.V., Pye Unicam Ltd.} and a second peak was observed 
at a wavelength o f 405 nm. Using this wavelength on the detector a flat baseline was 
achieved with a narrow peak eluting at around 1 0  minutes with the 1 0 0  jig/ml standard.
79
During the course of this work it was found that levels of myoglobin in rat serum were 
very low so it was decide to collect urine for analysis instead as it was reported that 
myoglobin levels in urine were generally higher [Powell et al. 1884], In addition to this 
urine samples are 'cleaner' than serum samples which meant that higher concentrations of 
sample could be passed through the column without the risk of it becoming blocked.
4.2.2.2 Gradient System
Standards and samples were assayed on a gradient system as recommended by 
Chrompack for the column. The mobile phase was pumped to the column at constant 
flow via a Constametric CM 4000 tertiary pump and programmable multiple solvent 
delivery system {Milton Roy LDC Division}. The mobile phase was degassed prior to 
use and subsequently maintained degassed by constant purging with helium {BOC}. 
Samples were injected onto the column through a 100 pi loop from a rotating Promis 
programmable autosampler {Milton Roy} and the eluted products detected using a 
SpectroMonitor, SM3100 variable wavelength U.V. spectrophotometer (U.V. range 
190-350 nm) Chromatograms were produced and collected using a Thermochrome 737 
computer system. Initially a few rat and human urine samples were run on the above 
system but owing to the scarcity of rat urine samples, as a consequence o f a lack of 
success in urine collection, serum samples had to be used. However, when using a 100 
pi loop, with the serum sample diluted 1:9 with filtered distilled water, the myoglobin 
peak was undetectable. As a result neat serum was used but the protein tended to block 
the column. In order to try and facilitate analysis, the serum was filtered using a 
micropartition system {MPS-1, Amicon} but this filtered out all the protein which had 
been seen to be eluting from the column.
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5.0 RESULTS AND DISCUSSION - NSAIDS AND ULCER FORMATION
5.1 RESULTS - NSAIDS AND ULCER FORMATION
5.1.1 Production of Small Bowel Ulcers
5 .1 . 1 . 1  Acute Oral Administration of NSAIDs
5.1.1.11 Animals Allowed Free Access to Food
Animals (n = 3-6) dosed with the DD125 value of diclofenac (11.5 mg/kg), fenbufen (50.0 
mg/kg), nabumetone (79.0 mg/kg), naproxen (5.0 mg/kg) and piroxicam (7.0 mg/kg) did 
not have any macroscopic sign of gastric or small bowel ulceration. All of the animals (n 
= 3), however, which had been dosed with piroxicam had dilated blood vessels coming 
from the mesentery (see photo. 5.1.1a) and two o f the animals had very small stomachs 
(half the normal size) which were empty. There was also a blockage in the midileum of 
one o f these rats which was 26 cm in length and the area involved was inflamed. 
Samples of this area of small bowel were taken for histological examination via light 
microscopy. This revealed chronic inflammation around the artery and the vein although 
the walls o f these blood vessels appeared to be normal. The mucosa of the small bowel 
also appeared normal although the fat cells in the mesentery contained more cells than 
they would under normal conditions, some of which were lymphocytes and mast cells.
The animals (n = 4) given indomethacin ID 125 (12.5 mg/kg) exhibited ulcers in their small 
bowel which varied in severity from one animal which had only two discrete ulcers on 
the mesenteric side (0.09% of the total area) to another animal which had multiple sharp 
longitudinal ulceration (13.15% of the total area) accompanied by perforations and 
adhesions to adjacent loops of intestine. These ulcers were sharply delineated from the 
non-ulcerated areas o f mucosa (see photo. 5.1.1b) and were accompanied by partial to 
complete necrosis of the muscularis externa. The longitudinal ulcers (see photo. 5.1.1c) 
were also on the mesenteric side o f the small bowel and were positioned anywhere from 
the midjejunum to the proximal ileum. (There were very few, if any, ulcers in the 
duodenum or the distal ileum of all the animals investigated and in most animals, except 
in cases of severe ulceration, the ulcers were on the mesenteric side o f the small bowel.) 
The mean percentage area o f ulceration for the animals dosed with indomethacin ID 125 (n 
= 4) was 4.55 ±2.95%.
81
Photo. 5.1.1a
Photo. 5.1.1b Photo. 5.1.1c
Photo. 5.1.1 Samples o f Small Bowel Tissue from NSAID Treated Rats
a Dilated Mesenteric Blood Vessels in Tissue from a Rat Dosed with Piroxicam ID125 Acute (7.0 mg/kg) 
b Discrete Ulcers in Tissue from a Rat Dosed with Indomethacin ID125 Acute (12.5 mg/kg) 
c Longitudinal Ulcer in Tissue from a Rat Dosed with Indomethacin ID125 Acute (12.5 mg/kg)
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Samples o f these ulcerated areas o f small bowel were taken for histological examination 
via light microscopy. The longitudinal ulcers and the discrete ulcers were located along 
the mesentery and were full o f bacteria. The discrete ulcers were usually severe, 
invading the muscle layer, and were associated with Peyer's patches. In these instances 
the necrotic tissue surrounded the Peyer's patch and often the top of the lymphoid follicle 
was itself necrotic. These Peyer's patches were enlarged, owing to the increase in 
antigenic activity, and they were full o f plasma cells, lymphocytes and other mononuclear 
cells involved in the inflammatory response, such as neutrophils. Neutrophils were also 
visible on the edge of the necrotic tissue, as were macrophages. The lamina propria 
within the ulcerated regions was full o f inflammatory cells, such as macrophages, 
eosinophils and mast cells. In other sections o f small bowel there was some necrotic 
tissue immediately above the Peyer's patches, probably just involving the M cell and 
some o f the surrounding epithelial cells, whereas the villi tissue adjacent to the Peyer's 
patch appeared normal. These were erosions and in these instances the Peyer's patches 
were active as they were enlarged and full o f plasma cells, lymphocytes, neutrophils and 
other mononuclear cells as was the adjacent lamina propria. In the unulcerated regions 
of small bowel tissue, from animals with ulcers, the Peyer's patches were normal in 
appearance. The lamina propria contained more inflammatory mononuclear cells than 
normal, a slight increase in eosinophils and macrophages, but otherwise the tissue 
appeared relatively normal. In tissue from animals where the discrete small bowel ulcers 
were more numerous, there was evidence o f slight necrosis at the villus tip in regions 
away from Peyer's patches. Other than a few lymphocytes in a small cluster around these 
necrotic villi tips there were very few mononuclear cells and in the locality o f these 
microscopic erosions there was no obvious evidence o f inflammation. The mesentery 
associated with the ulcerated region o f the small bowel was full o f inflammatory cells and 
the fat cells were rounded owing to the numbers o f mononuclear cells which had 
infiltrated this tissue. These cells, mostly macrophages, mast cells, lymphocytes and 
neutrophils, appeared to be migrating both to and from the small bowel tissue. The 
mesentery in the unulcerated areas of small bowel tissue, taken from the same animals, 
where the Peyer's patches appeared normal contained few inflammatory cells although 
slightly more than the control tissue. The mesentery from control animals, however, did 
not have any inflammatory cells within it and as a result the fat cells were irregular in
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shape. The muscle layers underlying the full thickness ulcers were also infiltrated with 
inflammatory cells. Small abscesses were also visible in some tissue samples along with 
the inflamed muscle and peritonitis. In areas where the small bowel had been perforated 
there was evidence of inflammation on the outside o f the bowel. The Peyer's patches and 
villous tissue in small bowel samples taken from animals which had received an acute 
dose of indomethacin ED30 were normal in appearance and there was no evidence of 
ulceration. The lamina propria, however, contained more inflammatory cells, 
lymphocytes and macrophages, than the normal control tissue. (The small bowel tissue 
from rats which had been dosed with the vehicle (10% Tween-80) was similar to that 
seen in control animals.)
Animals were also given acute doses of indomethacin at varying concentrations in order 
to determine the concentration at which ulceration commenced, and to find a dose which 
would reproducibly produce moderate ulceration in the small bowel. The doses of 
indomethacin given were the ID37.5, ID40, ID50, ff>60, ID 70 and ID75 values (3.75, 4.0,
5.0, 6 .0 , 7.0 and 7.5 mg/kg respectively). Animals given the ID37.5 (n = 3) or the ID40 (n 
= 3) dose o f indomethacin did not develop any sign of ulceration although one of the 
animals given the ID40 dose did have one small erosion in the proximal jejunum. The 
animals given the ID 50 (n = 3) dose all had erosions (one with erosions in only the 
proximal jejunum and one with erosions only in the mid ileum). The one animal which 
displayed any ulceration had six ulcers (0.17% of the total area), the bulk of them in the 
mid jejunum, with erosions in the proximal jejunum and the mid ileum.
While conducting these experiments it was thought that animals purchased from 
Interfauna were less susceptible to NSAID toxicity than the Bath University strain of 
Wistar rat. As a result experiments were conducted to compare ulceration between the 
two strains of Wistar rats. During the second course o f experiments the animals from 
Interfauna appeared to be more susceptible to ulceration than the Bath strain when using 
the ID 125 value o f indomethacin as the percentage area o f ulceration was greater in the 
Interfauna animals and there was a significant difference (p < 0.05) in the distribution of
the ulceration (see table 5.1.1.1.1.d and fig. 5.1.1.1.1.d). The animal with the most
• * 2  severe ulceration also had ulcers in the antrum of the stomach which covered 45 .0 mm
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Figure 5.1.1.1. Id Comparison Between Interfauna and Bath University Wistar Rats (Mean ± SEM)
of the stomach surface area. (The Bath strain were now a different group of animals as 
the original breeding stock had been replaced with healthier animals.) On comparing the 
animals after administration of the ED75 value o f indomethacin, however, the reverse was 
found. All o f the animals had ulcerated small bowels but in the Bath animals (n = 3) this 
was statistically more severe (p < 0.05) with an area of ulceration at 7.62 ± 2.20% 
compared to the Interfauna animals (n = 3) which had an area of ulceration at 4.65 ± 
1.91%.
Wistar Rat (Strain) Starved or Fed Prior to 
Dosing
Mean Total Percentage 
Area of Ulceration (%)
Bath University Fed 4.55 ±2.95
Bath University Starved 5.94 ±2.34
Interfauna Fed 7.36 ± 2.18
Interfauna Starved 10.63 ±4.21
Bath University NBS Fed 4.66 ± 1.56
Bath University NBS Starved 7.75 ±2.16
Table 5.1.1.1.1 .d Comparison Between Interfauna and Bath University Wistar Rats 
Given an Acute Dose of Indomethacin ID125 (12.5 mg/kg) (Mean ± SEM)
The ulceration in the small bowels o f the animals (n = 3) dosed with indomethacin ID70 
was less severe than that in the animals (n = 3) given the ED75 dose although one o f the 
animals did have two of the longitudinal ulcers in the midjejunum of approximately 1.0 to
1.5 cm in length (mean surface area 1.63 ± 0.39%). As a result it was decided to use a 
dose o f indomethacin at a concentration o f ED6o for the rest of the experiments as at this 
concentration ulceration in the small bowel was moderate.
During the course o f these experiments, however, it was obvious that there was a lot of 
variation between and within groups o f animals as to their susceptibility to NSAID 
toxicity and the resulting severity o f ulceration. As a result it was decided that, during all 
experiments, there would have to be a control group o f animals, dosed with 
indomethacin ID60, that could be used as a direct comparison between it and other drug 
regimes. Within seven groups (n = 3) o f Bath animals, given a dose o f indomethacin 
ID6o, there was in fact a statistical difference (p < 0.05) in the degree of ulceration 
between most of the groups with the total area of ulceration ranging from 0.31 ± 0.06% 
to 5.6 ± 1.62%.
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5.1.1.1.2 Animals Starved Before and After NSAID Administration
Animals (n = 3-6) dosed with the ID125 value of diclofenac (11.5 mg/kg), fenbufen (50.0 
mg/kg), nabumetone (79.0 mg/kg), naproxen (5.0 mg/kg) and piroxicam (7.0 mg/kg) did 
not display any macroscopic sign o f small bowel ulceration.
The original Bath University rats (n = 4) dosed with indomethacin ID125 (12.5 mg/kg) all 
displayed small bowel ulceration and the severity was greater in these animals than seen 
in those which had been allowed free access to food before and after dosing (see table 
5.1.1.1.1 .d and fig. 5.1.1.1.1 d). Similarly, this experiment was repeated comparing the 
Bath strain (NBS) of animals with those from Interfauna. As with the animals, in the 
parallel experiment, allowed free access to food; the percentage area of ulceration was 
greater in the Interfauna animals when compared the Bath strain (NBS) (10.63 ± 4.21% 
as opposed to 7.75 ± 2.16%) and there was a significant difference (p < 0.05) in the 
distribution of the ulceration (see table 5.1.1.1.1 d and fig. 5.1.1.1.1 .d). Two (n = 3) of 
the Interfauna animals had ulcers in the antrum of the stomach, covering a total surface 
area o f 35.5 mm2 and 23.0 mm2 respectively, although in this group the animal with the 
most stomach ulcers had the least ulceration in the small bowel. The overall ulceration 
was more severe in the animals starved before and after dosing with indomethacin ED125 
than in the equivalent strains o f Wistar rats allowed free access to food and water. 
Conversely, as with the animals allowed free access to food and water before and after 
dosing, the degree of ulceration in the animals given the ID75 dose was least in the 
Interfauna animals and whereas all the Bath animals (n = 3) had ulcers in the small bowel, 
two of the Interfauna animals (n = 3) had no sign of ulceration at all. (Total mean 
percentage area of ulceration for the Bath animals was 2.89 ± 0.97% compared to the 
Interfauna animals with a mean percentage area o f ulceration o f 0.11 ± 0.11%). There 
was also a statistical difference in the degree of ulceration (p < 0.05) with the starved 
animals given ID75 dose having fewer ulcers than the animals allowed free access to food 
and water before and after dosing (see table 5.1.1.1.2 and fig. 5.1.1.1.2).
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Figure 5.1.1.1.2 Comparison Between Interfauna and Bath University Wistar Rats Given 
an Acute Dose o f Indomethacin ID75 (7.5 mg/kg) (Mean ± SEM)
Wistar Rat (Strain) Starved or Fed Prior to 
Dosing
Mean Total Percentage 
Area o f Ulceration (%)
Bath University 2 Fed 7.62 ±2.20
Bath University 2 Starved 2.89 ±0.97
Interfauna Fed 4.65 ± 1.91
Interfauna Starved 0.11 ±0.11
Table 5.1.1.1.2
This group of animals (Interfauna/Bath University) dosed with indomethacin ID75 had all 
weighed around 325 g when dosed (the Interfauna animals had been supplied at a greater 
weight than requested so that many of them exceeded 250 g before they could be used 
experimentally). Consequently the unexpected results o f the animals dosed with 
indomethacin ID75, when compared to the animals dosed with indomethacin ID 125, 
(which was the reverse) was thought to be weight related. As a result groups o f rats 
(Bath University NBS) o f differing weights (150, 250, 350 and 450 g) were given an 
acute dose of indomethacin ID75 (n = 3) to ascertain whether the dosed weight had an
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effect on indomethacin-induced ulceration. The animals which had weighed
approximately 250 g when dosed had the least ulceration but overall there was no 
significant difference within the groups.
5.1.1.1.3 Correlation Between Indomethacin Acute ID value and Area o f Ulceration
There was a significant correlation (r = 0.57, p < 0.001) between the acute dose of 
indomethacin administered and the total percentage area o f ulceration seen in the small 
bowel of rats (n = 92) as measured by regression analysis (see fig 5.1.1.13).
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Figure 5.1.11.3 Ratio Between Acute Indomethacin Dose and Area o f Ulceration
5.1.1.2 Chronic Oral Administration o f NSAIDs
5.1.1.2.1. Short Term Dosing
Initially no ulcers were found in any o f the animals (n = 3) dosed chronically, for seven 
days, with the ID25 values o f the drugs diclofenac (2.3 mg/kg), fenbufen (10.0 mg/kg), 
indomethacin (2.5 mg/kg) nabumetone (15.8 mg/kg), naproxen (1.0 mg/kg) and 
piroxicam (1.4 mg/kg). However, when the indomethacin experiment was repeated 
using the ID25 value the chronic dosing had to be halted after 5 days because two o f the 
rats began to lose weight. The mean percentage area o f ulceration (0.25 ± 0.12%) was 
significantly higher in this group (p < 0.05) although one animal did not have any sign o f 
ulceration The initial group o f animals had been purchased from Interfauna whereas the
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second group of animals were of the Bath University strain of Wistar rats. As a result 
this experiment was repeated, comparing the two strains o f animals. On this occasion 
only one animal from each group (n = 3) displayed any form of ulceration, the Interfauna 
animal being more ulcerated than the animal from the Bath University strain (the new 
breeding stock, NBS) although this was not significant (mean percentage area of 0.01 ± 
0.01% compared to 0.22 ± 0.22).
Animals (Bath University, NBS) were treated for 7 days with indomethacin ID27.5 and 
killed on day ten. The total percentage area o f ulceration for these animals (0.08 ± 
0.02%) was greater than the ulceration found in the same strain o f Bath animal similarly 
dosed with the ID25 value o f indomethacin (0.01 ±0.01% ) although overall this was not 
significant (p = 0.6). The distribution of the ulceration, however, was significantly 
different (p < 0.05) with most of the ulcers appearing in the jejunum.
Animals (n = 3) from the original Bath University strain o f Wistar rats had been treated 
with indomethacin ID50 but only for three days as one of the animals had begun to lose 
weight after the third dose (mean percentage area 2.74 ± 1.26%). Consequently the dose 
was reduced and rats (n = 3) from the Bath University strain (again the original breeding 
stock) were dosed for 5 days with indomethacin ID37.5 . These animals also had to be 
killed early (on day 6) as one o f these animals had begun to lose weight (mean 
percentage area of ulceration 2.02 ± 0.94%). (These animals were significantly (p < 
0.05) more ulcerated than the same batch of animals dosed for 5 days with the ID25 value 
of indomethacin.) It was a consequence of the level o f ulceration found in these animals 
that the original experiment with the ID25 value o f indomethacin was repeated as the 
severity of ulceration at the ID37.5 dose had been unexpected owing to the fact that 
initially no ulceration had been seen after the initial indomethacin ID25 chronic dosing 
experiment (performed on the original batch o f Interfauna animals).
Animals (Bath University, NBS) were also treated with indomethacin ID30 chronically, 
one group for three days and one group for six days, with the animals all being killed on 
the seventh day. Only one o f the animals dosed for three days had any sign of ulceration 
and this was one small ulcer (0.03% of the small bowel area) in the midjejunum. The
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animals which had been treated with indomethacin ID?0 for six days all had ulceration of 
the small bowel, which was significantly greater than that o f the animals treated for three 
days (p < 0.05) with most o f the ulcers being located within the jejunum (0.88 ± 0.48% 
of the total surface area). Animals (Bath University, NBS) were then treated with 
indomethacin ID4o for three days and killed on day seven. In this group one o f the 
animals did not have any sign o f ulceration and o f the animals that did, the majority of 
ulcers occurred between the midjejunum and the midileum. The total area of ulceration 
(0.13 ± 0.12%) was not significantly greater however. This experiment was repeated 
using the ID45 value o f indomethacin but the experiment had to be terminated after three 
days when one of the three animals (Bath University, NBS) began to lose weight after 
only two doses. In this instance the ulceration stretched from the proximal jejunum to 
the distal ileum and there were many longer ulcers present (although nothing similar to 
the longitudinal ulceration seen with larger doses of indomethacin). The area of 
ulcerated small bowel in these animals (3.84 ± 1.68%) was significantly greater (p < 
0.05) than that seen in the animals dosed with indomethacin ID40 for three days (see fig.
5.1.1.2.1).
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Figure 5.1.1.2.1 Comparison Between Animals Dosed Chronically With Either 
Indomethacin ID40 (4.0 mg/kg) or Indomethacin ID45 (4.5 mg/kg) (Mean ± SEM)
Animals (Bath University strain) were dosed with the ID 125 value of all the drugs, except 
for indomethacin, for seven days and killed on day 10. Animals (n = 3) dosed with the 
ID 125 value o f fenbufen (50.0 mg/kg), nabumetone (79.0 mg/kg), naproxen (5.0 mg/kg) 
and piroxicam (7.0 mg/kg) did not have any sign o f gastric or small bowel ulceration.
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The animals dosed with piroxicam did have dilated blood vessels coming from the 
mesentery in all the animals but there was no sign of inflammation visible within the small 
bowel. The result obtained with piroxicam was unexpected as other researchers had 
obtained ulceration in rats using this drug under similar circumstances [Spangler, 1993], 
As a result this experiment was repeated at a later date, this time using Bath University 
Wistar rats from the new breeding stock, but as before there was no sign of ulceration. 
(The mucosal surface in some areas o f the jejunum, however, was quite fragile.)
The animals (n = 3) dosed with diclofenac ID125 (11.5 mg/kg) had to be killed on the fifth 
day, after they had only received four doses, as one o f the rats had begun to lose weight 
and the small bowel o f this animal was too badly ulcerated for ulcer analysis. The 
remaining animals had few ulcers (0.64 + 0.64% of the total surface area) but the degree 
of ulceration was severe. Chronic dosing was repeated using the ID75, ID100 and ID112.5 
values o f diclofenac (6.9, 9.2 and 10.35 mg/kg respectively). The animals (n = 3) dosed 
with the ID75 value o f diclofenac for 7 days did not have any form of ulceration at all and 
in the group (n = 3) given the ID 100 value chronically, one o f the rats also had no form of 
ulceration (mean percentage area 0.06 + 0.04%). (In this group of animals the ulcers 
were in the proximal jejunum and in the midileum only.) The animals (n = 3) given the 
ID112.5 value of diclofenac were only give 4 doses, as one of the rats had begun to lose 
weight, and were killed on the sixth day (mean percentage area of ulceration 1.31 ± 
0.26%). Ulceration among this group o f animals ranged from the proximal jejunum to 
the mid ileum and consisted mostly o f discrete ulcers except that all the animals had one 
extremely large ulcer (70.0 ±12.5 mm2) at the beginning o f the fifth segment which was 
part o f the distal jejunum.
5.1.1.2.2. Long Term Dosing
Groups o f four rats were dosed orally, once daily, for 21 days, over a four week period, 
with the ID125 values o f fenbufen (50.0 mg/kg), nabumetone (79.0 mg/kg), naproxen (5.0 
mg/kg) and piroxicam (7.0 mg/kg). No visible sign o f ulceration was found in either the 
stomachs or the small bowels o f these animals although during the course o f the 
experiment it was obvious that the groups of animals were gaining weight at a different 
rate. The mean weight gain between the four groups was not significantly different when
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comparing the four treatments simultaneously, however, the animals given fenbufen ID 125 
weighed significantly less (p < 0.05) than the animals dosed with naproxen ID125 (185.00 
± 8.10 g versus 140.00 ± 20.08 g) when calculating the least significant difference 
(L .S.D .(o.o5)) between a pair of treatments. The mean weight gain for the animals given 
nabumetone was 166.25 ± 6.10 g and for the animals given piroxicam it was 161.25 ± 
4.80 g. There was no significant difference in the lengths of the small bowels between 
the groups, the mean lengths were as follows, piroxicam 119.75 ± 3.88 cm, nabumetone
116.00 ± 1.37 cm, naproxen 114.50 ± 0.83 cm and fenbufen 111.75 ± 1.24 cm.
5.1.1.3 Pretreatment With Antibiotics
5.1.1.3.1 Individually
Groups of rats (n = 3) were dosed orally, once daily, for three days with one o f the six 
antibiotics selected, amoxycillin (50 mg/kg), cloxacillin (100 mg/kg), erythromycin (100 
mg/kg), metronidazole ( 1 0 0  mg/kg), nalidixic acid ( 2 0 0  mg/kg) and neomycin sulphate 
( 1 0 0  mg/kg). The rats were then given an acute dose o f indomethacin rD6o 24 hours 
after the final dose o f antibiotic and then killed 48 hours after the dose o f indomethacin.
Pretreatment for Three Days 





Area of Total 
Ulceration
Distilled Water 0 5.60 ± 1.62
Metronidazole 100 0.29 ± 0.05
Amoxycillin 50 0.45 ± 0.17
Distilled Water 0 3.13 ± 1.25
Neomycin Sulphate 100 2.11 ± 0.37
Cloxacillin 100 0.15 ± 0.09
Distilled Water 0 1.97 + 0.49
Nalidixic Acid 200 5.21 ± 2.87
Erythromycin 100 4.72 ± 1.76
Table 5.1.1.3.1 Comparison Between Animals Pretreated with Antibiotics or Distilled
Water (Mean ± SEM)
The animals pretreated with amoxycillin, cloxacillin and metronidazole had significantly 
(p < 0.05) less ulceration than the control animals which had only been pretreated with 
distilled water prior to the indomethacin challenge (see table 5.1.1.3.1). The animals 
pretreated with cloxacillin and metronidazole had a few ulcers in the proximal jejunum 
but no ulceration in the rest of the small bowel. The animals pretreated with amoxycillin
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Figure 5.1.1.31 Comparison Between Animals Pretreated with Antibiotics or Distilled Water (Mean ± SEM)
had a few ulcers distributed from the proximal jejunum to the distal ileum, where the 
ulcer ratio was slightly higher (see fig. 5.1.1.3.1).
The animals pretreated with erythromycin and nalidixic acid had significantly (p < 0.05) 
more ulceration than the control animals (see table 5.1.1.3.1), the ulceration in the 
erythromycin group was greater in the first half o f the small bowel whereas the animals in 
the nalidixic acid group had more ulcers in the latter half o f the small bowel (see fig.
5.1.1.3.1).
No significant difference in ulceration was found between the animals pretreated with 
neomycin sulphate and the control animals although the total percentage area of 
ulceration for the neomycin sulphate group (2.11 ± 0.37%) was lower than that o f the 
control animals (3.13 ± 1.25%). The majority of ulcers in the neomycin sulphate group 
were in the latter half o f the small bowel (see fig. 5.1.1.3.1).
5.1.1.3.2 Combined
No visible sign of ulceration was found at all in rats pretreated for three days with a 
combination o f metronidazole (100 mg/kg) and amoxycillin (50 mg/kg) followed 24 
hours later with an indomethacin challenge (either fD6o, fD6 5 or ID7o). The ulceration 
was less than that seen in the control animals (pretreated with distilled water) when the 
three day antibiotic pretreatment occurred seven days prior to the indomethacin LD6o 
challenge. The ulceration was still less than that seen in the control animals when the 
three day antibiotic pretreatment was given 14 days prior to the indomethacin challenge 
although the distribution of ulceration was beginning to mirror that seen in the control 
animals (see fig. 5.1.1.3.2). There was a significant difference (p < 0.05) in the degree of 
ulceration between the four groups.
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Figure 5.1.1.3.2 Comparison o f Ulceration Between Rats Pretreated With a Combination 
o f Antibiotics (Metronidazole 100 mg/kg/Amoxycillin 50 mg/kg) Two Weeks, One 
Week and Immediately Prior to an Indomethacin ED6o (6.0 mg/kg) Challenge (Mean ±
SEM)
5.1.1.4 Correlation Between Weight at Death and Small Bowel Length
Animals which had small bowel ulceration after an acute dose o f indomethacin had a 
shorter small bowel than control animals which had not been given NSAIDs. In the 
control rats (n = 50) there was a significant correlation (r = 0.52, p < 0.001) between the 
weight o f the animal and the small bowel length as measured by regression analysis (see 
fig. 5.1.1 4a). There was also a significant correlation (r = 0.49, p < 0.001) between the 
weight at death and the length o f the small bowels o f animals (n = 76) with indomethacin 
acute ulceration (see fig. 5.1.1.4b). There was no correlation (r = 0.1), however, 
between the weight at death and the length o f the small bowel o f animals (n = 43) which 
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Figure 5.1.1.4 Correlation Between Weight at Death and Small Bowel Length
Comparing animals which had been given NSAIDs chronically there was a significant 
correlation (r = 0 .5 3 ,p < 0 .0 1 ) between the weight at death and the length of the small 
bowels of animals (n = 29) which had NSAID-induced ulceration (see fig. 5.1.1.4c). In 
this instance there was also a significant correlation (r = 0.38, p < 0.001) between the 
weight at death and the small bowel length of animals (n = 63) dosed chronically with 
NSAIDs which had not developed any ulceration.
Surprisingly there was a greater correlation between the weight at death and the small 
bowel length of animals pretreated with antibiotics before the acute dose of 
indomethacin. In the animals (n = 36) which developed ulcers after pretreatment with 
antibiotics the correlation (r = 0.66) was significant (r > 0.52 = p < 0.001) and similarly 
in the animals (n = 12) which did not develop any ulcers the correlation (r = 0.69) was 
significant (r > 0.66 = p < 0.01).
5.1.1.5 Correlation Between Acute Indomethacin Dose and Small Bowel Length
There was a good correlation (r = 0.64) which was significant (r > 0.32 = p < 0.001) 
between the small bowel length of animals (n = 103) and the acute dose of indomethacin 
administered, as measured by regression analysis (see fig. 5.1.1.4d).
5.1.1.6 Measurement o f Small Bowel pH
The stomach contents o f all the control rats investigated (n = 6) were found to be at pH
3.0. However, immediately beyond the pyloric sphincter, the small bowel was found to 
have a pH of 7.0 until the distal ileum where the pH began to rise approximately 32 cm 
prior to the ileocaecal junction (see fig. 5.1.1.6). These pH values were used to 
calculate, using the Henderson-Hasselbalch equation, the gut/plasma ratios within the 
small bowel o f the NSAIDs used during this project (see table 5.1.1.6).
Henderson-Hasselbalch equation:-
R =  i _i_ if i(p Hg*pKa) gut/plasma 1 ^ _________
j  _|_ JQ(pHp-pKa)
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Small Bowel Contents From Caecal End o f  the Distil Ileum (2.0 cm)
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1 8 .75 22 .38 22 .37 2 2 .36 21 .97 20.81
2 8.92 33 .10 33 .09 33 .07 32 .48 30 .75
3 8 .42 10.47 10.47 10.46 10.29 9.77
4 8 3.98 3.98 3.98 3.92 3.76
5 8 .42 10.47 10.47 10.46 10.29 9.77
6 8.42 10.47 10.47 10.46 10.29 9.77
7 8.08 4 .79 4 .78 4.78 4.71 4.51
8 8.00 3.98 3.98 3.98 3.92 3.76
9 7.75 2 .24 2 .24 2.24 2.21 2.15
10 7.58 1.51 1.51 1.51 1.50 1.48
11 7.5 1.26 1.26 1.26 1.25 1.24
12 7 .33 0.85 0 .85 0.85 0.85 0.86
13 7 .08 0.48 0 .48 0.48 0.49 0.52
14 7 .08 0.48 0.48 0.48 0.49 0.52
15 7 .08 0.48 0 .48 0.48 0 .49 0.52
16 7 .08 0.48 0.48 0.48 0.49 0.52
17 7 0.40 0.40 0.40 0.41 0.44
18 7 0.40 0.40 0.40 0.41 0.44
19 7 0.40 0 .40 0.40 0.41 0.44
20 7 0.40 0 .40 0.40 0.41 0.44




5.1.2 Isolation of Small Bowel Flora Associated With NSAID Induced Lesions.
5.1.2.1 Tissue Scrapings From Ulcer Base
Agar Source Description Bacterium Identification
(%)
McConkey 3 Pink Colony Gram -ve rods Escherichia coli 99.1
McConkey 3 Pink Colony Gram -ve rods Escherichia coli 99.1
McConkey 3 Opaque Colony Gram -ve rods Proteus mirabilis 99.9
Nutrient Spreading Colony Gram -ve rods Proteus mirabilis 99.9
Nutrient Pink Colony Gram -ve rods Escherichia coli 99.1
Table 5.1.2.1 Bacteria Isolated and Identified from Tissue Scrapings from Ulcer Base
5.1.2.2 Complete Ulcers Excised Aerobically
Large gram-positive cocci were also isolated from one of the Blood Agar plates but this 
bacterium has yet to be identified. The only bacterium isolated via the anaerobic jars was 
a type of Escherichia coli which is a facultative anaerobe. As a result it was decided that 
ulcers would have to be excised anaerobically in order to try and isolate all the 
microorganisms which had been visualised and tentatively identified via scanning electron 
microscopy (see photos. 5.1.3 and 5.1.4).




Dark Pink Colony Gram -ve rods Escherichia coli 85.4
Deoxycholate
Citrate
Pale Pink Colony Gram -ve rods Proteus mirabilis 99.9
Deoxycholate
Citrate
Dark Pink Colony Gram -ve rods Escherichia coli 85.4
Blood Dark Black 
Colony
Gram -ve rods Escherichia coli 99.9
Blood Spreading Colony Gram -ve rods Salmonella ?
Table 5.1.2.2 Bacteria Isolated and Identified Complete Ulcers Excised Aerobically
100














































0 — 0 — 0 0 0 0 0 —
Metronidazole 
MTZ 50
0 — 0 — 0 0 0 0 0 —
Cloxacillin 
OB 5
































5.5 0 6.0 — 4.0 0 1.5 0 5.5 —
Penicillin G 
P2(v)
0 — 0 — 0.5
H
0 1.5 — 0 —
Erythromycin 
E 10
































































































































1.5 0 — 0 0 0 0 7.0
VH
—
Table 5 .1.2.4a Results of Antimicrobial Susceptibility Test of Microorganisms Cultured
in Cooked Meat Broth
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5.1.2.3 Complete Ulcers Excised Anaerobically
The only bacterium isolated via this procedure was again a type of Escherichia coli 
which is a facultative anaerobe. At this juncture it was decided that in order to isolate 
obligate anaerobes, such as Bacteroides and Fusobacterium, which were suspected as 
being some of the bacteria with a role in the ulcerative process, the ulcers would have to 
be excised in a totally oxygen free environment. The Atmosbag had not proved to be 
suitable for this purpose as it was very difficult to excise the ulcers under such 
circumstances. As a result a glove box was built and an oxygen trap was procured so as 
to ensure that the oxygen free nitrogen gas was completely free o f any oxygen.
The bacteria isolated via this procedure were to be investigated to determine whether or 
not they were capable o f performing chemical biotransformations in vitro. Unfortunately 
Dr Colin Soper, the supervisor for the microbiological aspects of this project, died 
suddenly in December 1994, and all work in this area o f the project ceased as a 
consequence.
5.1.2.4 Antibiotic Susceptibility.
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Table 5.1.2.4.b Results of Antimicrobial Susceptibility Test o f Microorganisms Cultured
in Brain Heart Infusion Broth.
The results of the antimicrobial susceptibility test for the microorganisms which had been 
cultured in Cooked Meat broth are presented in table 5.1.2.4.a. Unfortunately a problem 
was encountered when assessing the susceptibility of the organisms which had been 
cultured in Brain Heart Infusion broth. In all but one of the test cultures (Mixture 1 A) 
assayed the antimicrobial susceptibility discs had moved across the agar. It was planned 
to repeat this experiment but unfortunately Dr Soper died before this could be done.
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5.1.3 Electron Microscopy
5.1.3.1 Scanning Electron Microscopy (SEM)
5.1.3.11 Rat Small Bowel
The intestinal epithelium of the unulcerated areas of all the small bowel tissue, both from 
the control and experimental animals, had sloughed off the villi in an intact sheet (see 
photo. 5.1.2). This was due to autolysis which occurs rapidly in the gut once the blood 
supply is cut off from the cells of the gastrointestinal tract. It was possible to see, 
however, that in the small bowel tissue from the control animals (see photo. 5.1.2) and 
the animals given nabumetone that the epithelial cells, amongst intact layers of 
epithelium, were very close together with no visible gaps The intestinal epithelial cells 
from animals which had been given an acute dose o f indomethacin ID75, however, did 
have visible gaps between them. The intestinal epithelium immediately surrounding the 
ulcer had remained attached to the underlying surface o f the small bowel, probably 
because it was anchored in place by the ulcer which had penetrated into the muscle layer.
5.1.3.1.1.1 Control Rat Small Bowel Tissue
SEM of the rat duodenum, jejunum and ileum in control animals showed that very few 
bacteria were present in the small bowel o f normal animals and those seen tended to be 
bacilli (0.5 pm x2.0 pm). These bacteria looked very similar to Escherichia coli.
5.1.3.1.1.2 Experimental Rat Small Bowel Tissue
5.1.3.1.1.2.1 Indomethacin ED75 (7.5 mg/kg) Acute-Induced Ulcers
The discrete ulcers were very focal and the dividing line between the ulcerated and 
normal tissue was very marked. The deepest ulcers were found to be full o f bacteria, in 
the exponential phase o f growth, and it was impossible to see any o f the original villus 
structure under the mass o f bacteria (see photo. 5.1.3). In the shallower ulcers it was 
possible to see truncated villi, at the ulcer edge, which appeared to be full o f bacteria that 
had apparently burrowed into them (see photo. 5.1.3). There were also villi present at 
the ulcer edge which although they still retained their original structure also appeared to 
be full o f bacteria, burrowing inside them. These 'burrowing bacteria' all seemed to be 
bacilli. Surrounding areas of the small bowel, which did not have ulcers,
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Photo. 5.1.2 Control Rat Small Bowel Tissue
had very few bacteria and was similar in appearance to that seen in control animals. 
There were a few ulcers that appeared to be full o f just one type of bacteria and these 
were filamentous bacillary forms.
Bacteria seen in the small bowel ulcers of animals dosed with indomethacin included 
small cocci which were 1.0 pm in diameter, bacilli ranging in size from 0.5-1.0 pm x 1.5-
2.0 pm to 1.0 pm x 6.0 pm , fusiform bacilli (0.5 pm x 4.0 pm to 0.5 pm x 8.0 pm) and 
filamentous bacillary forms ranging in size from 0.25 pm x2.0 pm to > 0.25 pm x3.0 
pm. There were also what appeared to be both coccobacilli (1.0 pm xl .5 pm) and 
diplococci (0.75 pm x 2.0 pm) present in the ulcers. The bacilli and the fusiform bacilli 
were seen to be growing in close conjunction with one another and were intertwined 
whereas the cocci, which were far fewer in number, tended to be resting on top o f the 
mass of bacilli. The bacilli were either occurring singly, in pairs or in short chains.
Some o f these bacteria are probably Proteus spp. (straight rods, 0.4-0.8 pm in diameter 
x 1.0-3.0 pm in length) and Escherichia coli (straight rods, 1.1-1.5 pm in diameter x 
2.0-6.0 pm in length) as these bacteria had already been isolated from ulcers which had 
excised concurrently with those taken for SEM, from the same animal.
Some o f the rod-shaped bacteria could be Klebsiella sp. (straight rods, 0.3-1.0 pm in 
diameter x 0.6-6.0 pm in length), a gram-negative facultative anaerobe which is found in 
short chains, similar to some o f the bacteria seen within the ulcer base, and other 
researchers have isolated these microorganisms from the small bowel [Draser & Shiner, 
1969; Draser et a l, 1969]. Similarly, the rod-shaped bacteria could be Clostridium sp. 
(straight rods, 0.3-2.0 pm in diameter x 1.5-20.0 pm in length), a gram-positive 
anaerobe, as these species are known to be found in increased numbers within the small 
bowel o f rats with indomethacin-induced ulceration [Kent et al., 1969], Many o f the 
bacilli seen within the ulcer base were rod shaped with terminal swellings which can be 
indicative of Bacteroides [Holt et a l, 1994], a gram-negative anaerobe, and these 
bacteria are also known to be present in great numbers within the rat ileum [Draser & 
Shiner, 1969; Draser et a l, 1969; Simon & Gorbach, 1986, 1987].
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Photo. 5.1.3 Bacteria Within a Small Bowel Ulcer Taken From a Rat Dosed, Orally, Once, With Indomethacin ID7 5 (7.5 mg/kg)
The fusiform bacilli are possibly Fusobacterium sp., a gram-negative anaerobe which is a 
member o f the family Bacteroidaceae, as this bacterium, slender with tapered ends 
[Sonnenwirth, 1980; Holt et a l, 1994], has also been isolated from the ileum [Draser & 
Shiner, 1969; Draser e ta l ,  1969],
The cocci could either be Peptostreptococcus sp. (0.5-1.2 pm in diameter) or 
Peptococcus sp. (0.3-1.2 pm in diameter) which are both gram-positive anaerobes or 
alternatively Enterococcus sp. (0.6-2.0 pm x 0.6-2.5 pm), a gram-positive facultative 
anaerobe, as these are all found within the small bowel [Draser & Shiner, 1969; Draser et 
al., 1969; Morse, 1980],
The filamentous forms are probably the same species as the segmented filamentous 
bacteria which have been previously reported, viewed via SEM [Garland et al., 1978, 
1982; Klaasen et a l, 1992]. These bacteria, which are found in the distal ileum of 
healthy adult mice [Davis & Savage, 1974; Chase & Erlandsen, 1976] and rats [Garland 
et a l ,  1979], attached to Peyer's patches [Savage, 1969; Klaasen et a l, 1992; Jepson et 
a l, 1993], have yet to be cultured in a recognisable form [Savage, 1977; Lee, 1980; 
Klaasen et a l, 1992; Snel et a l, 1994] but are believed to be related to Clostridium 
[Snel e ta l ,  1994].
5.1.3.1.1.2.2 Indomethacin ID75 (7.5 mg/kg) Acute Post Combined Antibiotics
There was no evidence of ulceration and only one bacterium (0.5 pm xl6.0 pm) was 
seen out of all the samples viewed. This bacterium was possibly a strain of Escherichia 
coli which had become elongated as a result o f amoxycillin [Jawetz, 1987] binding to 
one o f the seven penicillin-binding proteins (PBP), as PBP3 is thought to be responsible 
for septum formation and cell division [Lambert, 1987],
5.1.3.1.1.2.3 Diclofenac ID112.5 (10.35 mg/kg) Chronically-Induced Ulcers
The discrete ulcers were very focal and the dividing line between the ulcerated and 
normal tissue was very marked. However, the diclofenac induced ulcer was surrounded 
by what appeared to be a ring of shrunken villi which were still relatively intact. (The 




Photo. 5.1.4 Bacteria Within a Small Bowel Ulcer Taken From a Rat Dosed Orally ,Once Daily, For Four Days With Diclofenac ID1 1 2 5  (10.35 mg/kg)
of bacteria.) The bacteria present in the ulcers were broadly the same as those seen in 
the indomethacin induced ulcer although there were some differences (see photo. 5.1.4). 
The bacilli ranged in size from 0.5 pm x 2.0 pm to 0.75 x 2.5 pm and two types of 
fusiform bacilli were seen (0.5 pm x 4.0 pm, 1.0 pm x 8.0 pm). The cocci, coccobacilli 
and diplococci were similar to those seen in the indomethacin treated animals but no 
filamentous bacillary forms were visible. This is probably due to the fact that most of the 
diclofenac-induced ulcers occurred within the jejunum so the ulcers taken for SEM were 
excised from this area only and these particular bacteria only occur in the distal ileum 
[Davis & Savage, 1974; Chase & Erlandsen, 1976],
5.1.3.1.1.2.4 Nabumetone ID125 (79.0 mg/kg) Acute Small Bowel Tissue
Although there were no ulcers in the small bowel tissue taken from animals treated with 
nabumetone a few bacteria were seen. These were present either singly or in isolated 
clumps o f three to four types o f microorganism. The bacteria present were coccobacilli 
(0.5 pm x 1.0 pm to 1.0 pm x 2.0 pm), bacilli (0.5 pm x 1.5 pm to 0.5 pm x 2.0 pm), 
fusiform bacilli (0.75 pm x 5.5 pm) and filamentous bacillary forms (0.25 pm x >4.0 
pm).
5.1.3.1.2 Human Small Bowel
The samples taken from the human duodenum, via endoscopy, were normal in 
appearance in all cases except for the sample taken from an elderly man suffering with 
rheumatoid arthritis. The villi were all rounded with smooth tops which were made up 
of a covering layer o f cells whose exposed surfaces were either pentagonal or hexagonal 
in shape, joined together in a manner similar to that seen in the chemical structure of C60 
('Bucky Ball'). The cell junctions were visible in some of the samples, but in others the 
junctions were so close they could not be visualised. However, in the elderly man with 
rheumatoid arthritis the villi were very rough in appearance (like a cauliflower) with 
sizeable gaps between the surface cells. Within these wide cell junctions it was possible 
to see many bacteria which appeared to be filamentous bacillary forms (see photo. 5.1.5).
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5.1.3.2. Transmission Electron Microscopy (TEM)
5.1.3.2.1 Rat Small Bowel
5.1.3.2.1.1 Control Small Bowel Tissue
5.1.3.2.1.1.1 Distilled Water or 10% Tween 80
The clarity o f the cristae within the mitochondria varied depending upon which cell the 
mitochondria were located and in some cells the mitochondria were very indistinct. This 
has been reported as a common problem when studying mitochondria in cells o f the 
gastrointestinal tract via TEM, particularly those within Paneth cells [Madara & Trier, 
1987], The mitochondria within the cells comprising the villus were the ones which were 
the most distinct (see photo. 5 .1.6a). Within some cells there was also a difference in the 
number of cristae visible within some o f the mitochondria and these half empty 
mitochondria were initially thought to be indicative o f damage, possibly caused during 
processing.
It has been reported, however, that mitochondria alter their internal conformation 
depending on whether or not they are in the resting (orthodox) or active (condensed) 
state. In the orthodox state the inner membrane displays the characteristic crests and the 
matrix, which is granular in appearance, almost fills the entire volume o f the 
mitochondrion. This orthodox state is induced when the level o f external ADP becomes 
low resulting in a lack o f ADP available for phosphorylation. In the presence o f ADP, 
however, on initiation o f electron transport; the matrix shrinks to a volume that is only 
about 50 per cent o f that seen in the orthodox state and the inner membrane and cristae 
become more tightly folded and more contorted as the respiring mitochondrion generates 
ATP at a maximum rate. In this condensed state, as the inner compartment o f the 
mitochondrion contracts, fluid accumulates in the outer compartment. [Lehninger, 1975, 
1982; De Robertis & De Robertis, 1980], Thus the empty looking mitochondria 
observed in the control tissues are probably normal mitochondria in the active state. 
Ultrathin sections o f tissue from animals dosed with 10% Tween 80 were very similar in 
appearance to animals which had been dosed with distilled water.
112
Photo. 5.1.6a
Photo. 5.1.6b Photo. 5.1.6c
Photo. 5.1.6 Mitochondria (M) Within Epithelial Cells o f Rat Small Bowel Tissue
a. Normal Mitochondria Within Epithelial Cell o f Villus Tip From Control Rat Small Bowel Tissue
b. Damaged Mitochondria Within Epithelial Cell Adjacent to a Small Bowel Ulcer Taken From a Rat 
Dosed Orally, Once. With Indomethacin IDgo (6.0 mg/kg)
c. Abnormal Mitochondria Within Epithelial Cell o f an Unulcerated Region of Small Bowel Tissue 
(Between Ulcers) Taken From a Rat Dosed Orally, Once, With Indomethacin ED6o (6.0 mg/kg)
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5.1.3.2.1.2 Experimental Small Bowel Tissue
5.1.3.2.1.2.1 Indomethacin ID6o
The mitochondria seen within the cells immediately surrounding the ulcer contained 
fewer cristae and did not have a healthy appearance (see photo. 5.1.6b). These 
mitochondria looked different to those seen in the normal control tissue which were 
believed to be actively respiring. In the unulcerated areas of the small bowel tissue, most 
of the mitochondria were similar in appearance to those seen in the normal control 
tissues. However, in some cells within the unulcerated areas o f small bowel tissue there 
were a few mitochondria which did look unusual and seemed to contain disrupted cristae 
(see photo. 5.1.6c).
5.1.3.2.1.2.2 Tissue from Animals Dosed with Remaining NSAIDs
There appeared to be no difference between the ultrastructure of the small bowel tissue 
of animals dosed with the ID6o values o f diclofenac, nabumetone, naproxen and 
piroxicam when they were compared with the control tissues.
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5.2. DISCUSSION - NSAIDS AND ULCER FORMATION
5.2.1 Production of Small Bowel Ulcers
5.2.1.1 Location and Distribution of NSATD-Induced Ulceration
5.2.1.1.1 Association o f Ulceration With Mesentery
The NSAID-induced ulceration within the small bowel occurred predominantly within 
the region bounded by the proximal jejunum and the mid to distal ileum. A few of the 
animals (3/19) given single low doses of indomethacin, which did not develop ulcers, had 
erosions only in the outer regions of this area of the small bowel. The animals given a 
single low dose o f indomethacin in which ulcers did occur tended to have them in the 
mid jejunum. The ulceration was on the mesenteric side and followed the blood supply 
so it would appear that proximity to the blood vessels within the mesentery is necessary 
for the ulcerative process, and the mesentery of the animals with ulcers within the small 
bowel was full o f inflammatory cells. The duodenum is a region of the small bowel 
where there is no mesentery so this may explain why NSAID-induced ulceration in the 
rat is not found in the duodenum.
5.2.1.1.2 Association o f Ulceration With pH
The pH of the small bowel contents is 7.0 all the way through to the distal ileum where it 
begins to rise. Raising the environmental pH from 7.0 to 7.4 can lead (depending on the 
pKa value) to a decrease in the proportion of un-ionised NSAID by a factor of four [Day 
et al., 1990] and it is only the un-ionised portion of the drug that is able to pass through 
the lipid bilayer o f the intestinal epithelial cell wall. Calculations using these raised pH 
figures in the Henderson-Hasselbalch equation for all the NSAIDs investigated indicate 
that when the unconjugated drugs are predominantly in the ionised form the majority of 
them are retained within the terminal ileum. Thus very little absorption by the small 
bowel, o f the unconjugated drug, goes on in this area as being ionised the NSAIDs are 
trapped within the terminal ileum; while they pass through to the caecum, and possibly 
this is the reason why very little ulceration if any occurs in this region.
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5.2.1.1.3 Association of Ulceration With Peyer's Patches
The lower acute doses of indomethacin resulted in small discrete ulcers, within the 
jejunum and ileum, which occurred at regular intervals, approximately one centimetre 
apart. As the ulceration increased in severity, in response to an increase in drug 
concentration, the discrete ulcers occurred approximately every 0.5 centimetres. A 
similar result was found in the small bowel o f rats dosed chronically with diclofenac. 
These discrete full thickness ulcers were associated with Peyer's patches and the area of 
necrosis involved the lymphoid follicle itself and the adjacent tissue. There were also 
erosions immediately above Peyer's patches in other regions the small bowel taken from 
animals exhibiting ulceration. Other researchers have reported that scattered discrete 
indomethacin-induced ulcers occur predominantly over the Peyer's patches within the 
small bowel [Stewert et a l, 1980; Del Soldato et al., 1987], although another group 
investigating the formation o f indomethacin-induced ulceration, solely within the 
jejunum, did not find this [Anthony et a l, 1993], These conflicting results could be a 
consequence of ulcers forming via alternative mechanisms, or by similar mechanisms but 
with certain steps being o f greater or lesser importance, depending on their position 
within the small bowel. In some o f the ulcerated small bowel tissue, viewed via light 
microscopy, there was evidence o f microscopic erosions in areas away from the fully 
developed ulcers associated with the Peyer's patches. It is possible that damage caused 
by indomethacin to cells o f the intestinal epithelium away from Peyer's patches does not 
initiate the catastrophic inflammatory response that may occur if the cell damage happens 
in close proximity to a Peyer's patch.
Aggregates of mucosal lymphoid follicles can be found throughout the small bowel, but 
the largest and most abundant occur within the ileum where they are called Peyer's 
patches [Madara & Trier, 1987]. Peyer's patches are a known site o f bacterial invasion 
by many microorganism, Shigella flexneri [Sonnenwirth, 1980], Yersinia enterocolitica 
[Grutzkau et a l, 1990; O'Loughlin, 1995] and Vibrio cholerae [Kuby, 1997] in man and 
Salmonella spp. in both man [Kuby, 1997] and the rat [Sonnenwirth, 1980]; although in 
rats this is believed to be inhibited in the distal ileum where the Peyer's patches are 
colonised by segmented filamentous bacteria [Garland et a l , 1979; Savage, 1979], 
Peyer's patches, which extend down to the submucosa, are responsible for the initiation
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and expression of mucosal immunity [Bockman & Cooper, 1973, Owen & Jones, 1974; 
Owen, 1977] and are thought to be the main site of antigen handling by the intestine 
[Kagnoff 1974, 1987a],
The epithelium covering the rounded surface of these follicles is made up o f absorptive 
cells, goblet cells and specialised epithelial cells called M cells [Owen & Jones, 1974; 
Owen & Nemanic, 1978], These M cells only occur in the region of lymphoid follicles 
and are associated with sites of multiple mononuclear cell infiltration as migrating 
lymphocytes, macrophages and plasma cells are visible in the intercellular space between 
M cells and neighbouring epithelial cells. Evidence suggests that M cells transport 
intraluminal antigens to the lymphoid tissue o f Peyer's patches [Bockman & Cooper, 
1973; Owen, 1977; Wolf et al., 1981] and many of these cells have central hollows, 
containing mononuclear cells, which may facilitate this [Madara & Trier, 1987], The 
mononuclear cells which are on the epithelial side of the basal lamina are able to pass 
easily back across the basal lamina into the lymphoid follicles. In addition to 
mononuclear cells, B and T lymphocytes also congregate within the central hollow of M 
cells [Bhalla & Owen, 1983]. The M cells therefore appear to transport microorganisms 
and macromolecular antigens from the intestinal lumen to the lymphoid follicles where 
they can be carried to mesenteric nodes and into the systemic circulation [Cebra et al., 
1977; Walker & Isselbacher, 1977], Thus this is also a site to which neutrophils can 
readily migrate in response to chemotactic cytokines released by activated macrophages 
and other mononuclear cells which have been in contact with bacteria and/or their toxins.
The formation o f ulcers above Peyer's patches may therefore be due to an inflammatory 
response initiated by indomethacin-induced damage to epithelial cells in close proximity 
to them. Peyer's patches appear to be a site o f attraction to various microorganisms 
[Garland et a l ,  1979; Savage, 1979; Sonnenwirth, 1980; Wolf, 1988; O'Loughlin, 1995; 
Sansonetti et a l, 1996; Kuby, 1997] where they bind preferentially to M cells [Savage, 
1969; Klaasen et al., 1992; Jepson et al., 1993; Sansonetti et al., 1996] and this in itself 
can lead to ulcer formation [Wassef et al., 1989; Jepson et al., 1993]. Small clusters o f 
bacteria (3-4 types), which may have been associated with Peyer's patches, were visible 
in some regions o f the small bowel tissue from nabumetone treated animals, viewed via
117
SEM. This was in contrast to the rest o f the small bowel tissue where bacteria were 
extremely rare. Thus when the initial microscopic erosions, which form in the intestinal 
epithelium as a result o f indomethacin, occur in the region of a Peyer's patch there may 
already be a number of bacteria present enabling bacterial toxins to readily infiltrate this 
area of compromised mucosa. This initiates an inflammatory response which results in 
neutrophils rapidly migrating to this area. Once the inflammatory cascade has started the 
surrounding tissue is damaged by neutrophil degranulation as the region is swamped with 
reactive oxygen metabolites and proteases, causing necrosis to the surrounding tissue.
In areas away from the Peyer's patches, however, the initial indomethacin-induced 
damage does not elicit an inflammatory response immediately as there are few if any 
bacteria in the immediate vicinity. In the absence o f luminal aggressors this type of 
damage, where the basal lamina remains intact, would usually be repaired by an increase 
in intestinal epithelial cell turnover [Eastwood, 1977], however, cellular turnover is 
decreased after NSAID ingestion due to inhibition o f prostaglandin synthesis [Robert, 
1976, 1979], (Damage to the gastric epithelium is repaired via restitution, a process 
whereby surrounding epithelial cells rapidly migrate over the defect, re-establishing 
epithelial continuity [Ito & Lacy, 1986], Restitution, which does not involve cell 
division, is not attenuated by NSAIDs and does not require prostaglandins [Levi & 
Shaw-Smith, 1994]. Possibly a similar mechanism occurs within the small bowel.) Once 
the bacterial overgrowth has started in the region of the Peyer's patch, however, as the 
microorganisms begin to multiply rapidly in the presence o f metabolites supplied by the 
necrotic tissue, bacterial toxins begin to diffuse and eventually invade these areas of 
microscopic erosion further away. This then initiates an inflammatory response causing 
ulcers to form away from Peyer's patches. In addition, the increase in bacterial numbers 
in the vicinity o f the Peyer's patch probably overwhelms the hosts immunological defence 
mechanisms enabling microorganisms to invade the lymphoid-follicle itself resulting in 
the full thickness ulcer.
5.2.1.1.4 Effect o f NSAID-induced Ulceration on Small Bowel Length
As the severity o f ulceration increased there was a corresponding shortening of the small 
bowel. This was most significant in the rats which had the longitudinal ulcers and was
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accompanied by the greatest weight loss. Similar findings have been reported by another 
group [Matsumoto et a l, 1994], There was a significant correlation between weight and 
small bowel length in both control animals and animals which had been dosed chronically 
with NSAIDs but had not developed ulcers. There was no correlation between weight 
and small bowel length, however, in animals which had been given a single dose of an 
NSAID and also had not developed ulcers. This was probably due to the fact that a 
single dose of the newer NSAIDs had very little effect on the small bowel, whereas a 
single dose o f the older NSAIDs did. All the NSAIDs had some effect, however, when 
given chronically and thus it would seem to indicate that NSAIDs have an effect on small 
bowel length even in the absence of ulceration.
One possibility is that, in spite o f cyclooxygenase inhibition by NSAIDs, there may still 
be an increase in prostaglandins, some o f which are vasoconstrictors. Long term use of 
NSAIDs, such as indomethacin, can result in diaphragm-like small bowel strictures 
[Bjamason et a l, 1988a; Levi et a l, 1990], These may occur as multiple, thin, 
concentric diaphragm-like septae (arising from submucosal fibrosis) [Lang et a l, 1988], 
which cause a narrowing of the lumen [Levi & Shaw-Smith, 1994]. Perhaps the 
decrease in small bowel length observed in the rat after NSAID administration may also 
be due to some form of fibrosis.
5.2.1.1.5 Association o f Ulceration With Increasing Concentration of NSAID
5.2.1.2.5.1 Gastric Ulceration
Indomethacin-induced ulceration was only found within the stomach on two occasions 
and this was when the second batch o f Interfauna rats were given an acute dose of 
indomethacin ID125. In one group (n = 3) which had been starved 21 hours before and 3 
hours after the acute dose of indomethacin ID125, two animals were found to have 
stomach ulcers. These ulcers were found in the antrum and similar findings have been 
reported previously in animals which have been starved before and after an acute dose of 
indomethacin [Satoh et a l, 1981, 1982], This is probably a result o f the antrum being 
exposed to the indomethacin for a longer period o f time than usual, as food was withheld 
until three hours after dosing. In addition to this the drug concentration within the empty 
stomach of these animals was probably greater than that found in animals which had been
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allowed free access to food. It has been reported that the degree of antral ulceration 
within the stomach of re-fed rats is dependent on the type of food they are given as a 
low-residue diet significantly decreased the ulceration whereas the reverse was found 
when rats were re-fed with high-bulk substances [Satoh et a l, 1982], This is thought to 
be due to the gastric mucosa being more susceptible to mechanical damage as the 
prolonged exposure to indomethacin would have resulted in a depletion o f cytoprotective 
prostaglandins. Similarly, high-bulk foodstuffs were found to increase ulcer formation 
within the small bowel o f re-fed rats [Satoh et a l, 1982]. The other group (n = 3) of 
Interfauna rats, that were given an acute dose o f indomethacin ED125, were allowed free 
access to food before and after dosing and one o f these animals developed ulcers within 
the antrum. This may have been due to the fact that the animal did not eat any food 
before and after dosing even though it was freely available or alternatively this batch of  
Interfauna rats were genetically more susceptible to gastric ulceration.
5.2.1.2.5.2 Small Bowel Ulceration
The difference between concentrations of what was and what was not an ulcerogenic 
dose o f NSAID in the case o f indomethacin was small. In both acute and chronic 
instances raising the dose of indomethacin slightly resulted in ulceration which was out o f 
proportion to the increase in the dose. Indomethacin ID50 (5.0 mg/kg) acute caused very 
little ulceration, if any, in Wistar rats whereas LD6o (6 . 0  mg/kg) acute could result in 
quite severe ulceration. Indomethacin ID40, (4.0 mg/kg) when given to animals for three 
consecutive days, caused very little ulceration whereas indomethacin ID45 (4.5 mg/kg) 
induced extremely severe ulceration after just two doses.
Similarly diclofenac ID 100 (9.2 mg/kg) administered daily for seven days caused very little 
ulceration whereas diclofenac ID112.5 (10.35 mg/kg) administered for four days was life 
threatening and the experiment had to be terminated early. Thus, once the concentration 
of these two drugs passes the ulcerogenic threshold the degree of ulceration increases 
dramatically. This threshold is due to the length of time that the drug takes to reach a 
steady state within the plasma The higher doses o f indomethacin reach this level very 
quickly whereas the smaller doses need to be administered over a longer period o f time 
in order to reach this stage. Once the drug has reached a steady state within the plasma,
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biliary excretion of these two NSAIDs (indomethacin and diclofenac), which both 
undergo enterohepatic recirculation in the rat [Hucker et a l, 1966; Yesair et a l, 1970; 
Duggan et al., 1975; Riess et a l, 1975], results in the small bowel being continuously 
exposed to drug over a significant period of time. The time at which a steady state is 
achieved within the plasma can vary considerably between individuals (human and 
animal) which is why it is difficult to produce a dose response curve with these 
compounds [Orme, 1985; Grennan e ta l ,  1985].
The other NSAIDs used in this study, fenbufen, nabumetone, naproxen and piroxicam, 
did not cause any form of ulceration in the animals even when the ID125 dose was 
administered daily over the course o f a month. The differences in ulcerogenesis between 
the NSAIDs used during this project may be due in part to their pharmacokinetic 
properties.
5.2.3 Pharmacokinetics o f the NSAIDs Used
5.2.3.1 Metabolism
All six NSAIDs used in these experiments are lipid soluble and readily absorbed from the 
gastrointestinal tract. Metabolism (biotransformation) o f foreign compounds 
(xenobiotics) occurs primarily in the liver [Boulton et a l, 1996] and consequently this is 
the site where the majority o f drugs, NSAIDs included, are metabolised. These 
metabolic processes usually cause an increase in water solubility (frequently accompanied 
by a decrease in lipid solubility) which enable compounds to be more readily eliminated 
renally [Wingard et a l, 1991]. Phase I reactions (oxidation, reduction, hydrolysis) 
usually convert the drug to a more polar metabolite by introducing a functional group (- 
OH, -NH2, -SH) and if these metabolites are sufficiently polar they are readily excreted. 
However, if the phase I metabolite is not readily eliminated it can undergo a phase II 
reaction whereby an endogenous substrate, such as glucuronic acid, sulphate, acetic acid 
or an amino acid, combines with an existing or newly established functional group to 
form a highly polar conjugate [Correia & Castagnoli, 1987], The six NSAIDs studied 
undergo phase II metabolism and in man become conjugated to glucuronic acid [Brune 
& Lanz, 1985] (glucuronic acid is a six carbon sugar moiety with a molecular weight of 
194), whereas in the rat they are usually conjugated to sulphate [Riess et a l, 1975;
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Brune & Lanz, 1985]. The factors determining whether or not a compound is secreted 
into the bile and subsequently enters the small bowel, are the possession of a large polar 
group, which Phase II metabolites in man possess, and the overall molecular weight. 
This is species dependent and in man the conjugate has to have a molecular weight in 
excess of 500 whereas in rat it only has to be greater than 300. Thus some phase II 
metabolites of NSAIDs, which in man are eliminated renally, undergo biliary excretion in 
the rat.
Diclofenac is conjugated in the liver and, in humans, is primarily eliminated, with its 
conjugated metabolites, via the kidneys (70 per cent) [Riess, et a l, 1978; Brune & Lanz,
1985], Diclofenac, with a molecular weight o f 318, readily enters the bile in man [Riess, 
et a l, 1975, 1978] as after conjugation with glucuronic acid it exceeds the 500 molecular 
weight threshold. In the rat excretion is predominantly biliary [Riess, et a l, 1978] and in 
contrast to man, where all the native drug is metabolised, the bile of the rat is found to 
contain considerable amounts o f unchanged drug as well as metabolites which can yield 
native drug on hydrolysis. Thus in the rat diclofenac undergoes extensive enterohepatic 
recirculation [Riess et a l, 1975] and this continued exposure may explain why small 
bowel ulcers form more readily in the rat than in man.
Fenbufen is a prodrug which is inactive in its native form but undergoes extensive 
metabolism within the liver, resulting in the formation o f its active metabolite, [1.1- 
biphenyl]-4-acetic acid (BPAA) together with other inactive metabolites [Chiccarelli et 
a l, 1980; Bimbaum et a l,  1982]. BPAA, with a molecular weight of 212, is conjugated 
in the liver and almost totally eliminated via the kidneys in both man and in the rat 
without undergoing any significant enterohepatic recirculation [Brune & Lanz, 1985], 
Consequently there is little exposure to the drug in the small bowel of both man and rat 
and this may partly explain its lack o f ulcerogenic properties.
Nabumetone, a nonacidic NSAID, is also a prodrug which is inactive in its native state 
and is converted, through extensive metabolism within the liver, to its active metabolite 
6-methoxy-2-naphthylacetic acid (6MNA) together with other minor metabolites 
[Hyneck, 1992], 6MNA, with a molecular weight of 216, is eliminated via the kidneys as
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a conjugate or as a demethylated metabolite, and does not undergo significant 
enterohepatic recirculation in man [Brett et al., 1988, 1992; Hyneck, 1992] as after 
conjugation with glucuronic acid it remains below the 500 molecular weight threshold. 
Similarly nabumetone does not undergo enterohepatic recirculation in the rat, (less than 
one per cent of the dose is found in the bile [Melarange et al., 1992]). Consequently 
there is little exposure to the drug in the small bowel of both man and rat and this may 
partly explain its lack of ulcerogenic properties.
Naproxen is metabolised in the liver and after conjugation is almost totally eliminated via 
the kidneys [Segre, 1973; Brune & Lanz, 1985]. Owing to the fact that it has a 
molecular weight of 230, it does not enter the bile in man, as after conjugation with 
glucuronic acid both naproxen and its major metabolite remain below the 500 molecular 
weight threshold. Consequently naproxen undergoes very little enterohepatic 
recirculation in man whereas it probably does occur in the rat.
Piroxicam is conjugated in the liver followed by primary elimination in the urine (65 per 
cent) with the remainder being excreted in the faeces. Secondary peaks, approximately 
six hours after administration, coupled with a long half life suggests that piroxicam 
undergoes enterohepatic recirculation in man [Wiseman & Hobbs, 1982; Hobbs, 1983; 
Brune & Lanz, 1985], although this supposition has been disputed [Verbeeck et a l,
1986], However, with a molecular weight of 331, piroxicam is probably incorporated 
into the bile as after conjugation with glucuronic acid it exceeds the 500 molecular 
weight threshold. Similarly piroxicam probably undergoes enterohepatic recirculation in 
the rat although the plasma half-life o f five hours in this species is less than that found in 
man [Schiantarelli etal., 1981],
Indomethacin is metabolised by the liver and after conjugation in man, is predominantly 
excreted in the urine, as are its conjugated metabolites (although a small amount is found 
in the faeces) [Duggan et al., 1975; Brune & Lanz, 1985]. With a molecular weight of 
358 indomethacin readily enters the bile in man, as conjugated with glucuronic acid it 
exceeds the 500 molecular weight threshold. As a consequence indomethacin undergoes 
extensive enterohepatic recirculation in both man [Hucker et al., 1966; Duggan et a l,
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1975; Kwan et al., 1976] and the rat [Hucker et al., 1966; Yesair et al., 1970; Duggan et 
al., 1975] with the result that the small bowel is re-exposed to the native drug after the 
conjugates have been deconjugated by the bacterial P-glucuronidase and sulphatase of 
the indigenous microflora [Lewis & Gorbach, 1972; Scheline, 1973; Plaa, 1975], Thus 
the parent drug is available for reabsorption and the cycle is repeated. The extensive 
enterohepatic recirculation in the rat is believed to be the primary reason for its 
ulcerogenic properties since indomethacin-induced ulcers do not occur in animals which 
have undergone bile duct ligation [Brodie et al., 1970], Indomethacin-induced 
ulceration, o f equal severity, also occurs when indomethacin is administered parenterally, 
either subcutaneously [Brodie et al., 1970] or intravenously [Yesair et al., 1970], 
Animals with Thiry loops, however, when they are given indomethacin parenterally, do 
not develop ulcers within the Thiry loops, although ulceration does occur in the rest of 
the small bowel [Brodie et al., 1970]. This confirms that the gastrointestinal mucosa has 
to be in contact with the drug in order for the ulcerative process to begin and with 
parenteral dosing this can only occur via enterohepatic recirculation. Similarly, animals 
which are starved for 24 hours after an oral dose o f indomethacin are protected from 
indomethacin-induced ulceration because withholding food inhibits enterohepatic 
circulation [Brodie et a l, 1970]. However, when the rat is starved prior to an oral dose 
of indomethacin, and the food is returned shortly afterwards, the ulceration is more 
severe because enterohepatic circulation has been enhanced as a result of the hungry rat's 
increased food intake.
5.2.3.2 Effect o f pKa Values
All the NSAIDs used during this project are weak acids except for nabumetone. In 
regions of low pH, as in the stomach, they are predominantly in a un-ionised form and as 
such are able to pass through the lipid bilayer o f cells which constitute the gastric 
epithelium. In the instance of diclofenac, naproxen and indomethacin, which have the 
lowest pKa values, the drugs become ionised once inside the intracellular compartment, 
where the pH is maintained around 7.4, and as a result become trapped within the cells. 
This phenomenon of 'ion-trapping' does not occur significantly with the other three 
NSAIDs used during this study as they are predominantly in a un-ionised state within the 
cells of the gastric epithelium and are thus able to pass back through the lipid bilayer into
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the gastric lumen. Fenbufen and piroxicam, because they have a higher pKa value and 
remain almost completely un-ionised until they reach a pH of approximately two pH 
units above their respective pKa values, and nabumetone because it is a neutral 
compound unable to dissociate.
To a lesser extent the process o f 'ion trapping' continues within the small bowel. 
Although at pH 7 .0 a predominant portion of the three drugs, diclofenac, naproxen and 
indomethacin are ionised, a small proportion is still un-ionised and it is this portion which 
is able to pass through into the epithelial cells of the small bowel and become trapped as 
a result. With naproxen this is only able to occur when the drug initially passes down the 
gastrointestinal tract, as once absorbed and metabolised by the liver it is excreted in the 
urine via the kidneys. However, in the case of indomethacin and diclofenac, which both 
undergo efficient enterohepatic recirculation in the rat [Hucker et al., 1966; Yesair et al., 
1970; Duggan et al., 1975; Riess et al., 1975], the small bowel is exposed repeatedly to 
the drug, long after the initial oral administration.
The other three NSAIDs, fenbufen, piroxicam and nabumetone, are still un-ionised as 
they pass through the small bowel, fenbufen and piroxicam because their higher pKa 
values mean that only an insignificant proportion dissociates at pH 7.0, and nabumetone 
because it is a neutral compound. As a result these three compounds are still actively 
absorbed as they pass down through the small bowel and this is in fact their main site of 
absorption. As with the gastric epithelial cells these drugs remain un-ionised within the 
cells o f the intestinal epithelium so damage due to 'ion trapping' cannot occur. 
Piroxicam, like diclofenac and indomethacin, undergoes enterohepatic recirculation, but 
continual exposure to the small bowel, after the initial administration, does not cause 
significant damage due to its higher pKa value. Fenbufen and nabumetone are prodrugs 
and as such have very little activity in their native form and only acquire antiinflammatory 
properties after they have been metabolised by the liver into the active metabolites. Thus 
the small bowel is only repeatedly exposed to a single dose o f diclofenac, indomethacin 
and piroxicam.
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5.2.3.2.1 Comparison Between Diclofenac and Indomethacin
It would be expected from the pKa values that diclofenac, which has a lower pKa value 
than indomethacin, would be at least as ulcerogenic in rats, as these two drugs both 
undergo enterohepatic recirculation in the rat [Hucker et al., 1966; Yesair et al., 1970; 
Duggan et a l, 1975; Riess et al., 1975], In some ways indomethacin and diclofenac are 
very similar as both have structural formulae which contain two aromatic rings that are 
twisted relative to one another [Sallman, 1979]. However, despite their similarities there 
are important differences in their chemical properties. Diclofenac has been reported to 
enhance the sequestration o f arachidonic acid into lipid (largely triglyceride) pools [Day 
et a l, 1990] from where it can be re-incorporated into the inner membrane o f the cell. 
This property is most marked in monocytes and is accompanied by a decrease in the 
production o f leukotrienes and other products o f the enzyme 5-lipoxygenase [Ku et a l,
1985],
All NSAIDs are inhibitors o f cyclooxygenase (COX-1 and COX-2), indomethacin being 
the most potent inhibitor, and it has been proposed that the inhibition of this enzyme 
causes all the arachidonic acid, which has been cleaved from the membrane by the 
enzyme phospholipase A2, to be channelled into the production o f leukotrienes via the 
enzyme 5-lipoxygenase [Rainsford, 1987; Bjamason et a l, 1989], Leukotrienes are very 
inflammatory compounds which are believed to be responsible for some of the NSAID- 
induced damage to the gastrointestinal tract. The fact that diclofenac prevents some of 
the surplus arachidonic acid, which is a direct result o f the inhibition of cyclooxygenase, 
from being channelled into increased leukotriene synthesis [Ku et a l, 1985], is probably 
why it is less ulcerogenic than indomethacin.
5 .2.4 Effect o f Indomethacin on Small Bowel Permeability
The results obtained via scanning electron microscopy (SEM) and transmission electron 
microscopy (TEM) appeared to reveal some of the initial steps of indomethacin-induced 
ulcerogenesis. The epithelial cells covering the villi o f human duodenum samples taken 
from patients who were not taking NSAIDs, viewed via SEM, were very close together 
and the cell junctions were difficult to discern. In patients taking NSAIDs, however, the 
cell junctions were clearly visible and in one elderly man who was suffering with
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rheumatoid arthritis there were sizeable gaps between the epithelial cells. Similar gaps 
were found in the small bowel tissue taken from rats dosed with indomethacin ID75. The 
samples o f unulcerated rat small bowel, which had also been taken from animals dosed 
with indomethacin, appeared to show damaged mitochondria within some of the cells of 
the intestinal epithelium, when viewed via TEM. These were different in appearance to 
the damaged mitochondria seen within cells immediately surrounding an ulcer.
It has been reported that within six hours of administering a dose o f indomethacin to 
humans there is an increase in small bowel permeability [Bjamason et a l, 1992a], This 
initial response is likely to be due to a direct topical effect o f the drug and is probably a 
result o f the drug being trapped within the cells o f the intestinal epithelium. NSAIDs are 
capable o f uncoupling oxidative phosphorylation within the mitochondria of cells of the 
intestinal epithelium [Brody, 1956; Penniall, 1958; Packer et a l, 1959; Jeffrey & Smith, 
1959; Whitehouse, 1964; Smith & Dawkins, 1971; Kawai et al., 1985], and it has been 
reported that the NSAIDs with the lower pKa values are more effective uncouplers 
[Mahmud et a l, 1996], Experiments conducted in vitro, with rat liver mitochondria, 
show that there is a significant inverse correlation between the NSAID concentration 
required for maximum stimulation and the pKa value [Mahmud et a l, 1996], These 
findings are in agreement with the knowledge that some acidic aromatic compounds, 
such as 2,4-dinitrophenol, are able to disrupt the tight coupling o f electron transport and 
phosphorylation by carrying protons across the inner mitochondrial membrane thus 
preventing phosphorylation o f ADP to ATP [Lehninger, 1975; Stryer, 1981], and 
NSAIDs are also acidic aromatic compounds. In the presence of such uncouplers, 
electron transport from NADH to O2 proceeds normally, but ATP is not formed by the 
mitochondrial ATPase as the proton-motive force across the inner mitochondrial 
membrane is dissipated [Stryer, 1981], Indomethacin is particularly toxic to cells, as not 
only does it uncouple oxidative phosphorylation, it also inhibits the respiratory chain by 
preventing phosphorylation, via suppression o f respiration, at multiple sites [Tokumitsu 
et a l, 1977]. ATP is necessary for the maintenance of the tight junctions within the 
intestinal epithelium [Meza et a l, 1980; Madara & Dharmsathaphom, 1985; Madara et 
a l, 1986, 1987] so a direct result o f a cessation o f ATP production would be for these 
tight junctions to break down, leading to a widening within the intercellular space
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between the cells, thus allowing noxious and toxic substances to enter from the lumen 
into the compromised intestinal epithelium.
Additional initial damage within the cell could be due to the NSAID inhibiting various 
enzymes involved in glycolysis and/or the tricarboxylic acid cycle. NSAIDs have been 
shown to inhibit dehydrogenases [Smith & Dawkins, 1971] and such enzymes play an 
important role in the tricarboxylic acid cycle which also occurs within the mitochondria. 
Inhibition o f these enzymes would prevent the formation of NADH and FADH2, 
important products o f the tricarboxylic acid cycle, resulting in a depletion of these 
substrates which are required for the electron transport chain, itself necessary for 
oxidative phosphorylation [Lehninger, 1975; Stryer, 1981]; thus leading to a reduction in 
ATP. Both occurrences could explain the changes seen in the mitochondria o f cells 
within the small bowel tissue, viewed via transmission electron microscopy, o f rats dosed 
with indomethacin; which has also been reported by other researchers [Bjamason et a l, 
1993; Bjamason & Hayllar, 1996]; and the widening o f the intercellular spaces in the 
intestinal epithelium seen via scanning electron microscopy.
Ultimately the uncoupling of oxidative phosphorylation and the inhibition of the 
tricarboxylic acid cycle could lead to cell death. The cytoplasm of all cells contains many 
ions and charged molecules as does the extracellular space. ATP is required for the 
transfer o f many molecules across membranes in order to maintain the ion balance both 
within the intracellular compartment and between it and the extracellular space [Harrison 
& Lunt, 1980], Failure to maintain this ion balance can lead to membrane disruption as 
the cell swells and bursts resulting in the intracellular contents being exposed to the 
outside milieu. Such necrosis is cytotoxic to surrounding cells in the intestinal epithelium 
as many o f the cell contents are chemotactic. Recent studies have shown that 
mammalian mitochondria produce N-formylmethionyl peptides, similar to the protein 
synthesis-initiation sequence in bacteria, which are potent chemoattractants for 
neutrophils [Carp, 1987], Thus the release o f such mitochondrial contents as a result of  
tissue injury or anoxia could explain the recruitment o f neutrophils to a non-infectious 
inflammatory site [Malech & Gallin, 1987]. The microscopic erosions, visible in the rat
128
small bowel tissue from rats dosed with indomethacin, which were away from Peyer's 
patches, however, did not appear to be at the centre of an inflammatory response.
5.2.5 Pretreatment With Antibiotics
5.2.5.1 Individually
The degree of ulceration produced by an acute dose indomethacin ID 6o was significantly 
reduced by pretreatment for three days with each of the antibiotics amoxycillin, 
metronidazole and cloxacillin as described previously. This would suggest that some of 
the microflora within the small bowel, which are susceptible to these antibiotics, are 
responsible in some way for the ulcerative process. Bacteria have been implicated as 
having a role in NSAID-induced ulceration [Kent et a l, 1969] although the identity of all 
the ones which are involved in ulcerative pathogenesis is unknown. Germ-free rats do 
not develop NSAID-induced ulcers [Robert & Asano, 1977] although they do when 
mono-contaminated with Escherichia coli [Robert & Asano, 1977], The ulceration 
under these circumstances, however, is not as severe and when germ-free rats are 
infected with the small bowel flora o f normal rats the degree of ulceration is similar in 
severity to that seen in conventional animals [Robert & Asano, 1977].
5.2.5.1.1 Metronidazole
The animals pretreated with metronidazole, three days prior to the acute dose of 
indomethacin rD6o, had very little ulceration although what there was occurred within the 
proximal/midjejunum. Therefore it would appear that the drug had killed one or some of 
the bacteria responsible for part o f the ulcerative process and in this instance these 
species are mostly anaerobic although ulceration was greatly reduced in the first half of 
the small bowel as well when compared to control animals (see fig. 5.1.1.3.1). The 
bactericidal action o f metronidazole is specific for obligate anaerobes [Pratt & Fekety,
1986] and in vitro it is effective against Bacteroides fragilis and other Bacteroides spp., 
Fusobacterium spp., Clostridium perfringens, Clostridium difficile and other 
Clostridium spp. [Sigeti et al., 1983; Pratt & Fekety, 1986; Elliot & Stone, 1990; 
Church et a l, 1996]. It is less active against anaerobic gram-positive cocci but most 
strains of Peptococcus and Peptostreptococcus are susceptible [Pratt & Fekety, 1986;
129
Church et al., 1996], Metronidazole is able to diffuse into both aerobic and anaerobic 
bacteria but it is only within anaerobic bacteria that it is reduced to an unstable 
intermediate which rapidly causes cell death by inhibiting DNA synthesis [Edwards, 
1977; Sigeti et al., 1983], It is thought to interact with biochemical pathways that are 
only present in obligate anaerobes [Edwards, 1977] but it has been shown to be effective 
against facultative anaerobes, such as Escherichia coli and Proteus spp., under strict 
anaerobic conditions [Ingham et al., 1980], Metronidazole was ineffective against the 
three isolates and the two mixtures which were used in the antimicrobial susceptibility 
test which would appear to indicate that at least one of the bacteria with a role in the 
ulcerative process had not been not isolated.
5.2.5.1.2 Cloxacillin
Animals pretreated for three days with cloxacillin had very little ulceration in the small 
bowel, less than the group treated with metronidazole, and similarly to the metronidazole 
group the ulceration occurred within the proximal/midjejunum with no ulceration at all in 
the latter half o f the small bowel. This would seem to indicate that cloxacillin is effective 
against one or some o f the bacteria responsible for part of the ulcerative process and in 
this instance these species are mostly anaerobic as ulceration within the distal region of 
the small bowel was reduced in comparison with the control animals (see fig. 5.1.1.3.1). 
Cloxacillin was ineffective against the three isolates and the two mixtures which were 
used in the antimicrobial susceptibility test which indicates once again that at least one of 
the bacteria with a role in the ulcerative process had not been isolated. Cloxacillin is a 
narrow spectrum penicillin type antibiotic which is primarily used against gram-positive 
cocci such as Staphylococcus aureus in humans or staphylococcal mastitis in cattle 
[Glasby 1979; Pratt & Fekety, 1986] and unlike penicillin G, is usually ineffective against 
gram-negative bacteria although it does have some degree of activity against gram- 
negative cocci [Russell, 1989], A large gram-negative coccus was isolated from one 
ulcer but it has yet to be identified and possibly this may be one o f the bacterial species 
responsible for the ulcerative process.
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5.2.5.1.3 Amoxycillin
The animals which were pretreated with amoxycillin for three days prior to the acute 
dose of indomethacin ID60 had very little ulceration in the small bowel but the little 
ulceration present was distributed throughout the small bowel, slightly more in the distal 
region (see fig. 5.1.1.3.1). This would suggest that amoxycillin was primarily effective 
against the aerobic bacteria although it did reduce ulceration in the ileum to some extent, 
when compared to the control animals. Amoxycillin was also effective in the 
antimicrobial susceptibility test against the unknown bacteria, Isolates 1, 2 and 3, 
although there appeared to be some resistant colonies. Amoxycillin works by inhibiting 
bacterial cell wall synthesis and is effective against Streptococcus spp., Enterococcus 
spp., Salmonella spp., Shigella spp., Proteus mirabilis and Escherichia coli [Neu, 1974; 
Pratt & Fekety, 1986],
5.2.5.1.4 Erythromycin
The animals which were pretreated for three days with erythromycin prior to the acute 
dose o f indomethacin DD6o had more ulceration within the small bowel than the control 
animals which had been dosed with distilled water. The majority of the ulceration was in 
the first half o f the small bowel and the increase in ulceration was approximately o f the 
same magnitude throughout when compared to the control animals (see fig. 5.1.1.3.1). 
It would appear that erythromycin killed one or more strains o f bacteria which are 
responsible for keeping a healthy balance between the microflora within the small bowel 
[Simon & Gorbach, 1986, 1987], In optimum conditions most coliform bacteria divide 
every 20 minutes but if this happened in vivo the host organism would soon be 
overwhelmed [Simon & Gorbach, 1986, 1987]. In the small bowel bacteria usually only 
replicate about four times a day [Gibbons & Kapsimalis, 1967] as other bacteria within 
the vicinity inhibit their growth [Simon & Gorbach, 1986, 1987], In this instance it 
would appear that the bacteria responsible for the ulcerative process were able to 
multiply rapidly once the inhibiting strains were destroyed. Erythromycin is both 
bacteriostatic and bactericidal for susceptible organisms and acts by inhibiting protein 
synthesis by acting on the 50S unit o f ribosomes [Mao & Putterman, 1969]. 
Erythromycin is primarily effective against gram-positive bacteria especially 
Pneumococcus, Streptococcus spp., Staphylococcus spp. and Enterococcus spp..
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Although it is effective against some gram-negative bacilli, such as Bacteroides fragilis, 
other gram-negative bacteria, notably the Enterobacteriaceae, are intrinsically resistant 
[Pratt & Fekety, 1986], Erythromycin was ineffective against the three isolates and the 
two mixtures, which were used in the antimicrobial sensitivity test, that had been 
cultured in the Cooked Meat broth. This would appear to indicate that the bacteria 
which are susceptible to erythromycin are not associated with the small bowel ulcers and 
to confirm that they are not responsible for the ulcerative process.
5.2.5.1.5 Nalidixic Acid
The animals which were pretreated for three days with nalidixic acid prior to the acute 
dose o f indomethacin ID 6o also had more ulceration within the small bowel than the 
control animals which had been dosed with distilled water. The ulceration was quite 
evenly distributed although it was greater in the latter half of the small bowel (see fig. 
5.1.1.3.1). As with erythromycin it would appear that nalidixic acid killed one or more 
strains o f bacteria which are responsible for maintaining a healthy balance between the 
microflora within the small bowel [Simon & Gorbach, 1986, 1987], Nalidixic acid is 
unusual in that it is active against several different types of gram-negative bacteria 
whereas gram-positive organisms are mostly resistant [Deitz et al., 1964; Russell, 1989], 
Nalidixic acid rapidly and reversibly inhibits DNA replication, in susceptible bacteria, by 
binding to a subunit o f the DNA gyrase enzyme [Sugino et a l, 1977; Gellert et a l, 
1977], Most strains of Escherichia coli, Klebsiella, Enterobacter and Proteus 
(mirabilis, morganii, vulgaris) are susceptible as are most species of Salmonella and 
Shigella [Brumfitt & Pursell, 1971; Stamey, 1971]. Bacteria that are resistant to 
nalidixic acid include most gram-positive cocci and anaerobic bacteria in general 
[Gleckman et al., 1979], Nalidixic acid was effective against all three isolates and both 
mixtures although there was evidence of resistant microorganisms as there were colonies 
growing within the zone of resistance for Isolates 1 and 2.
5.2.5.1.6 Neomycin Sulphate
The animals which were pretreated for three days with neomycin sulphate prior to the 
acute dose o f indomethacin rD6o also had less ulceration within the small bowel than the 
control animals which had been dosed with distilled water although this was not
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significant. The ulceration was reduced in the first half of the small bowel, when 
compared to the control animals, whereas the degree of ulceration within the latter half 
of the small bowel was approximately the same (see fig. 5.1.1.3 .1). This suggested that 
one or some of the bacteria involved in the ulcerative process were aerobes. Neomycin 
sulphate is bactericidal for many gram-positive and gram-negative bacteria and acts by 
binding to the 30S subunit o f bacterial ribosomes [Davies, 1964] which irreversibly 
inhibits protein synthesis [Pestka, 1971], Anaerobic bacteria are not susceptible because 
active uptake of the drug requires respiration (electron transport) [Brynan et al., 1979] 
but bacteria which are susceptible include Escherichia coli, Klebsiella spp., 
Enterobacter spp. and Proteus spp. [Pratt & Fekety, 1986], Neomycin sulphate was 
effective against all three isolates and both mixtures (mostly under aerobic conditions) 
although there was evidence o f resistant microorganisms as there were colonies growing 
within the zone o f resistance for Isolates 1 and 2.
5.2.5.2 Combined Treatment
Animals pretreated with a combination o f metronidazole and amoxycillin three days prior 
to an indomethacin acute (rD6o, ID65 and ID70) challenge did not exhibit any form of 
ulceration. The animals pretreated with the combined antibiotics a week or two weeks 
prior to the indomethacin acute fD6o challenge were still protected from the ulcerative 
process to some degree although the effect of the antibiotics was beginning to wear off 
after two weeks. The distribution o f ulceration within the small bowel of the animals 
which had received the antibiotics a week before the indomethacin challenge was equally 
distributed (see fig. 5.1.1.3.2). The animals which had been pretreated with combined 
antibiotics two weeks prior to the indomethacin challenge, however, had a distribution of 
ulceration which was similar to that seen in the control animals although still significantly 
(p < 0.05) less. This would appear to indicate that initially most o f the small bowel flora, 
including those responsible for the ulcerative process, recovered from the antibiotic 
challenge at approximately the same rate. Two weeks after the combined antibiotics, 
however, the usual balance between the bacterial species was beginning to reassert itself 
with the majority of bacteria responsible for the ulcerative process being present in the 
first half o f the small bowel. This probably occurs as a result o f the presence of one 
species o f microorganism radically affecting the proliferation o f another.
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Interactions between the indigenous microflora are the major regulatory factor in 
maintaining a healthy balance within the small bowel [Wolin, 1974; Savage, 1977, 
Mackowiak, 1982; Rolfe, 1984] and there are several mechanisms whereby bacteria may 
interact to promote or prevent the growth of other microorganisms [Simon & Gorbach, 
1986, 1987], Some coliform bacteria, which compete for carbon [Freter, 1962], can 
inhibit the growth of Shigella flexineri by depleting the surrounding area o f the substrate 
necessary for its growth. Other bacteria produce metabolic end products, such as short 
chain fatty acids, which can inhibit bacterial proliferation [Mackowiak, 1982; Byrne & 
Dankert, 1979] in susceptible organisms such as Shigella flexineri [Hentges & Maier, 
1970]. Alternatively other bacteria such as the facultative anaerobes can deplete an area 
of oxygen and thus create an environment in which obligate anaerobes can survive 
[Simon & Gorbach, 1986, 1987], Some bacteria are even able to produce their own 
specific antibiotic-like substance such as bacitracin, which is produced by a strain of 
Bacillus subtilis [Meleney & Johnson, 1949], and colicins, which are produced by strains 
of Escherichia coli [Luckey, 1977], that inhibit the growth o f other species or even 
control their own growth in an autoregulatory fashion [Simon & Gorbach, 1986, 1987],
5 .2.6 Bacteria Which Could be Involved in the Formation o f Ulcers
All these results would suggest that there is more than one species of bacteria responsible 
for the ulcerative process and that at least one o f these bacteria is aerobic and another an 
anaerobe as it requires a combination o f amoxycillin and metronidazole together to 
prevent the ulcerative process. Escherichia coli have already been implicated, as germ- 
free rats, mono-contaminated with this bacterium, are susceptible to indomethacin- 
induced ulceration [Robert & Asano, 1977], although this is less severe than that seen in 
conventional animals. Some of the bacteria responsible may also act together 
synergistically, as removing one or two of the bacterial participants in the ulcerative 
process, via treatment with certain individual antibiotics, leads to a significant decrease in 
ulceration. Three bacteria which could be responsible are Bacteroides, Peptococcus, and 
Peptostreptococcus which are already known to act synergistically [Morse, 1980], 
These particular microorganisms are resistant to the antibiotic nalidixic acid, but 
susceptible to metronidazole, which could explain the increase in ulceration seen in the 
animals pretreated with nalidixic acid and the lack o f ulceration with metronidazole.
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Bacteroides spp., anaerobic gram-negative bacteria, are commensal organisms, but can 
cause severe, often life-threatening infections, mostly in proximity to the mucosal 
surfaces where they exist normally (as 'potential pathogens') [Sonnenwirth, 1980]. 
Bacteroides fragilis is frequently isolated from clinical cases of sepsis involving 
anaerobic gram-negative rods and accounts for the majority of infections within the 
peritoneal cavity [Gorbach & Bartlett, 1974; Polk & Kasper, 1977], Abscess formation 
as a result of small or large bowel perforations (similar to those observed in rats dosed 
with indomethacin ID 125) are caused primarily by a major virulence factor of Bacteroides 
fragilis, the capsular polysaccharide complex (CPC). This surface associated protein is 
responsible for abscess formation in both the rat and mouse models of peritoneal sepsis 
[Onderdonk et a i, 1977; Shapiro et a l, 1982], Peptococcus spp. and 
Peptostreptococcus spp., anaerobic gram-positive bacteria, are also part o f the 
indigenous flora of the gastrointestinal tract and are responsible for a variety of 
infections, mostly in synergy with other microorganisms. When in mixed infections with 
Bacteroides spp. the result is severe necrosis o f the surrounding tissue [Morse, 1980], 
similar to that seen in the indomethacin-induced small bowel ulcer. Other bacteria which 
could have a role in ulcerogenesis are Fusobacterium spp, gram-negative spindle-shaped 
rods, similar to those seen within the ulcers via SEM, which are obligate anaerobes. 
These bacteria are found within the gastrointestinal tract and have also been isolated 
from various purulent lesions, in both man and animals, as well as from tropical ulcers.
5.2.6.1 Possible Mechanisms by Which Bacteria May Facilitate Ulcerogenesis
One of the ways in which bacteria could facilitate the ulcerative process is via an 
inflammatory response caused by bacterial toxins permeating through the intestinal 
epithelium as a result o f the increased permeability caused by indomethacin. Endotoxins, 
such as lipopolysaccharide, a large molecule in the outer wall o f gram-negative bacteria 
is extremely proinflammatory and induces the inflammatory cytokine cascade [Dinarello, 
1991], Another bacterial product, N-formylmethionylleucylphenyalanine (FMLP) is a 
tripeptide known to be released by Escherichia coli during replication [Grisham & 
Granger, 1988], FMLP is nontoxic to mammalian cells but is extremely chemotactic for 
neutrophils, activating them to release oxygen-derived free radicals [Tauber & Babior,
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1985]. (The role of cytokines in indomethacin-induced ulceration will be discussed in the 
next chapter.)
Another way in which bacteria may mediate the ulcerative process is through their end 
products of metabolism. The intraluminal pH of germ-free animals is more alkaline than 
that of normal rats [Simon & Gorbach, 1986, 1987], colonised by the usual complement 
of gastrointestinal microflora, and the more acidic environment is probably due to the 
metabolic end products o f the various bacteria. The family of bacteria called 
Bacteroidaceae are gram-negative bacilli which are obligate anaerobes and these bacteria 
outnumber coliforms in the gastrointestinal tract a 100 fold. Two genera, Bacteroides 
and Fusobacterium, both produce short chain fatty acids as by products o f metabolism. 
Most Bacteroides spp. produce a combination of succinic, lactic, acetic, formic, 
propionic and isovaleric acid whereas some produce a mixture of butyric and acetic acid 
[Sonnenwirth, 1980; Holt et al., 1994], The Fusobacterium spp. yield butyric acid as a 
major product o f metabolism from peptone or carbohydrates, often in conjunction with 
acetic and lactic acid, although occasionally with propionic, formic and succinic acid 
[Sonnenwirth, 1980; Holt et al., 1994]. In addition to these bacteria the facultative 
anaerobes, such as Enterobacter, Klebsiella, Proteus and Escherichia coli, are known to 
produce acid and gas from a variety o f carbohydrates [Sonnenwirth, 1980, Holt et al., 
1994]. Gram-positive anaerobic cocci such as Peptostreptococcus metabolise peptone, 
mainly to acetic acid [Holt et al., 1994] and some aerobic bacteria also have volatile fatty 
acids as a by product of metabolism [Byrne & Dankert, 1979], Thus the presence of 
these acidic bacterial by products must contribute towards the lowering of the pH within 
the gastrointestinal tract of conventional rats, when compared to germ-free animals, 
increasing the un-ionised proportion o f NSAIDs.
Conceivably, in the areas immediately surrounding the small discrete ulcers, where the 
bacterial numbers have already begun to increase dramatically, the environmental pH 
may become significantly more acidic than that o f the non ulcerated areas o f small bowel. 
These ulcers are also full o f bacteria, such as Escherichia coli and probably Bacteroides 
spp., which are able to deconjugate the indomethacin conjugate [Lewis & Gorbach, 
1972; Scheline, 1973; Plaa, 1975]; thus releasing the parent drug into a region where the
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pH is probably low enough for a significant proportion of the drug to be un-ionised. 
This decrease in environmental pH may lead to even more of the NSAID being able to 
pass through the lipid bilayer into the cells of the surrounding epithelium, where it 
becomes trapped, exacerbating the initial damage and resulting in an increase in size of 
the original ulcer. (Indomethacin is known to be one of the most toxic NSAIDs to 
cultures of intestinal epithelial cells [Allen et a l, 1991; Yamada et a l, 1992] and this 
toxicity is enhanced as the pH is reduced from 7.4 to 6.0 [Chmaisse et a l, 1994].) This 
process may continue, with a large proportion o f the deconjugated drug passing through 
the small bowel wall into the systemic circulation as absorption from the small bowel is 
also increased with the lowering of the intraluminal pH (see table 5.2.6.1). After 
reabsorption the NSAID is returned to the liver, remetabolised and excreted once again 
in the bile. Thus, as a consequence o f the increase in bacterial numbers in conjunction 
with a lowering of the environmental pH, the enterohepatic recirculation of a single dose 
of indomethacin may be prolonged and far exceed the length of time generally expected. 
As the size o f the ulcers and the numbers o f bacteria within them increase, the area of 
small bowel with a lower pH becomes larger and eventually the individual ulcers 
coalesce. This could explain the longitudinal ulceration seen with high acute doses of 
indomethacin and the extended ulcers seen in the animals chronically dosed with 
diclofenac. This could also explain why, in severely ulcerated animals, a few discrete 
ulcers occasionally appear in the terminal ileum. The bacterial overgrowth, within the 
rest o f the small bowel, may cause the pH to drop within the terminal ileum resulting in a 
significant proportion of the unconjugated drug being un-ionised in this region and being 

















7.00 0.40 0.40 0.40 0.41 0.44
6.75 0.22 0.22 0.22 0.24 0.28
6.50 0.13 0.13 0.13 0.14 0.19
6.25 0.07 0.07 0.07 0.09 0.14
6.00 0.04 0.04 0.04 0.06 0.11
Table 5.2.6.1 Predicted Gut/Plasma Ratios Calculated by the Henderson-Hasselbalch
Equation
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5 .2.6 .2 Effect of Variations in Composition of Intestinal Microflora
The degree and distribution of ulceration within the small bowel appears to be dependent 
on the bacterial species which may be colonising it at the time and on their numbers. 
There is a balance between protective and pathogenic bacteria with regard to the 
ulcerative process and if this balance is disturbed the severity of ulceration increases as a 
result. This finding probably explains the difference in response to the NSAIDs seen 
between the Wistar rats purchased from Interfauna and the Wistar rats bred by the 
Animal House at the University of Bath. At the beginning of the project, the rats from 
Interfauna were more resistant to ulcer formation because the balance of microflora 
within their gastrointestinal tract was different to that present in the Bath strain and 
probably had a higher ratio o f protective species of bacteria to ulcerogenic ones. The 
original Bath strain were more susceptible to ulceration as the ratio of ulcerogenic 
bacteria present was probably higher and in fact at that time the Bath strain were 
susceptible to diarrhoea. This indicates that these rats already had greater numbers of 
bacteria within the gastrointestinal tract than would be expected and so the increase in 
bacterial numbers, in response to the dose o f indomethacin, occurred more rapidly. The 
difference between the Interfauna rats and the Bath strain, seen at a later date, was 
probably due to the Bath animals having been bred from new healthier breeding stock 
and the Interfauna animals probably being colonised by a microflora of different 
population proportions to that found previously.
The balance between the populations o f colonising bacteria would appear to differ 
between rats o f the same strain over a period o f time and the new strain o f Bath 
University rats did appear to become more susceptible to ulceration after a few months 
duration. The differences in the balance between the gastrointestinal microflora could be 
due to a number o f reasons, cross contamination with bacteria from other rat strains 
within the animal house being one of them. The most probable reason, however, is that 
this change was due to the food that the rats were fed as the Bath University strain (new 
breeding stock) had originally been supplied by Interfauna. It has been reported that a 
change o f diet can affect the balance between the indigenous microflora within the 
gastrointestinal tract [Sharma et a l, 1995] and also alter their metabolic activity [Simon
6  Gorbach, 1986, 1987],
138
Interestingly, it has also been reported that starving a rat for 24 hours can lead to a 
variable and sometimes extensive alteration in the numbers o f some of the indigenous 
gastrointestinal microflora within the small bowel [Smith, 1965; Stephen, 1985; Butzler, 
1987], This could possibly explain the anomalous result when the second batch of 
Interfauna rats, which had been given an acute indomethacin ID75 dose after a 21 hour 
fast, had very little ulceration. Under these circumstances the ulceration would have 
been expected to be more severe than that observed in the animals allowed free access to 
food before and after dosing. After the 21 hour fast there could have been a significant 
decrease o f the bacterial species responsible for ulceration within the small bov/el of the 
Interfauna rats (second batch) so that there were insufficient numbers available for 
ulcerogenesis after ingestion o f the indomethacin ID75 dose. Thus within the animals 
given the lower dose of indomethacin the physiological repair processes were probably 
able to rectify the topical damage before sufficient bacteria were available to initiate an 
inflammatory response. After administration of the indomethacin ID 125 dose to 
Interfauna rats (second batch) following a 21 hour fast, however, the repair processes 
were probably delayed by the increased inhibition of cyclooxygenase (COX-1 and COX- 
2). This in conjunction with the increase in enterohepatic recirculation o f the drug may 
have given the bacteria enough time in which to multiply to sufficient numbers thus 
enabling them to initiate an inflammatory response.
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6,0 RESULTS AND DISCUSSION - ROLE OF CYTOKINES
6 .1 RESULTS - ROLE OF CYTOKINES IN ULCER FORMATION
6.1.1 Anti-Mouse TNF-a
6.1.1.1 Formalin-Fixed Paraffin-Embedded Tissue - RUH, Bath
6.1.1.11 Donated Polyclonal Rabbit Anti- Mouse TNF-a in Hyperimmune Serum
6.1.1.1.11 Positive Control Tissue - Activated Rat Lung
Sections taken from formalin-fixed paraffin-embedded tissue were titrated against the 
donated polyclonal anti-mouse TNF-a (1/50, 1/100, 1/200, 1/500 and 1/1000) with and 
without the trypsin antigen retrieval step. Optimum binding was found to occur after the 
trypsin step so for this antibody it was decided to include this antigen retrieval step every 
time. The 1/100 dilution o f the antibody gave the optimum degree of staining, however, 
when the experiment was repeated using control rabbit serum, which had been obtained 
from a control rabbit (Animal House (AH), Bath University), a high degree of staining 
was found at the equivalent dilution. As a consequence it was decided that the antibody 
should be used at a dilution of 1 / 2 0 0  as at this dilution the staining obtained with the 
control rabbit (AH) serum was visibly less than that found in the sections treated with the 
equivalent amount o f antiserum.
Unfortunately, there was still a noticeable degree of binding to the tissue by the control 
rabbit (AH) serum. (Increasing the dilution of the antiserum and the control serum had 
lead to there being no visible staining with either o f the sera.) No staining had been 
found in the negative control sections, treated as the other sections except that they had 
been incubated with buffer only during the primary incubation step, (when the other 
sections had been incubated with either antiserum or control serum) which illustrated 
that there was not any non-specific binding. Therefore the binding of the control rabbit 
(AH) serum to the tissue was specific. (The rabbit from the Animal House had probably 
developed antibodies against the rats which also shared the complex.)
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6.1.1.1.1.2 Experimental Ulcerated Rat Small Bowel Tissue - Indomethacin ID 6o 
Sections taken from formalin-fixed paraffin-embedded tissue were titrated against the 
donated polyclonal anti-mouse TNF-a (1/50, 1/100, 1/200, 1/500 and 1/1000) as 
described above, for the control activated lung tissue, with the same result. The binding 
of the control rabbit serum to the small bowel tissue was less than that seen in the 
sections treated with the antiserum, but the staining was still quite strong in the region of 
the ulcer, even at a 1/200 dilution. At this time it was decided that a commercially 
available anti-mouse TNF-a might provide better results.
6.1.1.1.2 Genzyme Polyclonal Rabbit Anti- Mouse TNF-a in Hyperimmune Serum
6.1.1.12.1 Positive Control Tissue - Activated Rat Lung
Genzyme was the only company that had antibodies available, reported as cross reacting 
with the relevant rat protein, which were also suitable for immunohistochemistry 
[Diamond et al., 1991; Merrill et al., 1993; Teti et al., 1993], Sections o f activated lung 
were titrated as already described. As before, the staining was greater in the sections 
which had been trypsinised first. The rabbit control serum used for comparison with this 
antisera had been purchased from Sigma. However, at the same dilution the control 
rabbit serum {Sigma} displayed approximately twice the staining found in the sections 
treated with the polyclonal anti-mouse TNF-a {Genzyme}. The company was contacted 
and after a visit from their representatives an alternative sample of the antibody was 
supplied. However, a similar result was found when using the substitute antiserum.
6.1.1.1.2.2 Experimental Ulcerated Rat Small Bowel Tissue - Indomethacin ID6o 
These sections were processed as described above in section 6.1.1.1.2.1.
6.1.1.1.3 Donated Polyclonal Rabbit Anti- Mouse TNF-a (IgG Fraction)
6.1.1.1.3.1 Positive Control Tissue - Activated Rat Lung
The original antiserum, which was a gift from Dr Steven Kunkel, was quite old 
(approximately 5 years since exsanguination) so it was suggested [Watson, 1995] that an 
improvement in specificity might be obtained using the IgG fraction of the antiserum. As 
a result a partial antiserum fractionation was carried out on the antiserum and the control
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serum. The volume of the resultant IgG fractions was approximately 2.5 times that of 
the original volumes of the antiserum and the control rabbit (AH) serum. The tissue 
sections were titrated against the IgG fractions of the donated polyclonal anti-mouse 
TNF-a and the control rabbit (AH) serum but at dilutions which had been corrected to 
account for the increase in volume (1/20, 1/40, 1/80, 1 / 2 0 0  and 1/400). As expected the 
1/80 dilution was found to be the most suitable. At this concentration the IgG fraction 
of the anti-mouse TNF-a bound well, producing good staining (see photo. 6.1.4a {A & 
B}), whereas the tissue which had been incubated with the IgG fraction of the control 
rabbit (AH) serum displayed very little staining at all (see photo. 6 . 1 ,4a {C}). All further 
immunohistochemical experiments, investigating the presence o f TNF-a in tissue 
sections, were conducted using this antiserum.
6 .1 .1.1.3.2 Experimental Ulcerated Rat Small Bowel Tissue - Indomethacin ED6o
Sections taken from formalin-fixed paraffin-embedded tissue were titrated against the 
IgG fraction o f the donated polyclonal anti-mouse TNF-a (1/20, 1/40, 1/80, 1/200 and 
1/400) as described above. As expected the 1/80 dilution was found to be the most 
suitable. At this concentration the IgG fraction of the anti-mouse TNF-a bound well 
producing good staining (see photo. 6 . 1 . la) whereas the tissue which had been incubated 
with the RyG fraction o f the control rabbit (AH) serum displayed very little staining at all 
(see photo. 6 .1. lb {C & D}). This result confirmed that all further immunohistochemical 
experiments, investigating the presence of TNF-a in tissue sections, should be conducted 
using this antiserum at this dilution. The degree o f antibody staining in this tissue was 
very slight in the unulcerated regions of the small bowel tissue, between the discrete 
ulcers (see photo. 6 .1. la {C & D}), whereas the staining was very strong in the region of 
the Peyer's patch associated with the ulcer (see table 6 .1.1.1.3 and photo. 6.1.1a {A & 
B}). The staining was quite evenly distributed throughout the tissue except within the 
Peyer's patches where individual cells appeared to be positively stained for TNF-a.
6 .1.1.1.3.3 Experimental Unulcerated Rat Small Bowel Tissue - Indomethacin ID30
Sections were incubated with the IgG fraction o f the donated polyclonal antibody, after 
the trypsin antigen retrieval step, at a dilution o f 1/80 (1/200). The degree of staining
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Photo. 6.1.1 FFPE Small Bowel Tissue From Rats Dosed Once, Orally, With Indomethacin ID6o (6.0 
mg/kg)
a. Ulcerated Rat Small Bowel Tissue Incubated With Polyclonal Anti-Mouse TNF-a (IgG Fraction). 
Brown Staining (S) Indicates the Presence o f TNF-a
A & B = Intensely stained Peyer's patch indicates increased levels o f TNF-a { A x 6 0 & B x  120}
C & D = Lightly stained unulcerated region (between ulcers) indicates decreased levels of TNF-a .{C x 
60 & D x 120}
b. Ulcerated Rat Small Bowel Tissue Incubated Without Anti-Mouse TNF-a (Primary Antibody)
A & B = Peyer's patch incubated with buffer instead o f primary antibody (Negative Control). Lack of 
positive staining indicates absence of any non-specific binding to this tissue {A x 60 & B x 120}
C & D = Peyer's patch incubated with control rabbit (AH) serum (IgG fraction) instead of primary 
antibody (Serum Control). Lack of significant positive staining indicates that binding of the rabbit 
serum (IgG fraction) to other antigens within this tissue is insignificant at the dilution used for the 





Photo. 6.1.2 FFPE Small Bowel Tissue From Rats Dosed Once, Orally, With Indomethacin LD30 (3.0 
mg/kg) (Non Ulcer Causing Dose)
Unulcerated Rat Small Bowel Tissue Incubated With Polyclonal Anti-Mouse TNF-a (IgG Fraction). 
Brown Staining (S) Indicates the Presence o f TNF-a
A & B = Lightly stained small bowel tissue indicates reduced levels of TNF-a when compared with 
normal control tissue, but more than that observed in unulcerated regions (between ulcers) in tissue 
taken from rats with ulcers { A x 6 0 & B x  120}
C & D = As above {C x 60 & D  x 120}
Photo. 6.1.3 FFPE Rat Small Bowel Control Tissues Incubated With Polyclonal Anti-Mouse TNF-a  
(IgG Fraction). Brown Staining (S) Indicates the Presence o f TNF-a
A & B = Moderately stained unulcerated control tissue indicates that there are significant levels o f TNF- 
a  within the normal rat small bowel {A  x 60 & B x 120}
C & D = Light/Moderately stained vehicle (10% Tween-80) control rat small bowel tissue indicates 
reduced lev els of TNF-a when compared with normal control tissue, but more than that observ ed in 
tissue from animals dosed with indomethacin ID30 (3.0 mg/kg) {C x 60 & D x 120}
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was slightly greater than that seen in the unulcerated region of the ulcerated ED6o small 
bowel tissue (see table 6 .1.1.1.3 and photo. 6 .1.2).
6 .1.1.1.3.4 Experimental Unulcerated Rat Small Bowel Tissue - Vehicle Control
Sections were incubated with the IgG fraction o f the donated polyclonal antibody, after 
the trypsin antigen retrieval step, at a dilution o f 1/80 ( 1 /2 0 0 ). The degree o f staining 
was greater than that seen in the unulcerated region of the ulcerated ID 6o small bowel 
tissue and slightly more than that seen in the ID 30 small bowel tissue (see table 6 . 1 . 1 .1.3 
and photo. 6.1.3 { C & D } ) .
6 .1.1.1.3.5 Experimental Unulcerated Rat Small Bowel Tissue - Control
Sections were incubated with the IgG fraction o f the donated polyclonal antibody, after 
the trypsin antigen retrieval step, at a dilution o f 1/80 (1/200). The degree o f staining 
was greater than that seen in the unulcerated region of the ulcerated ID 6o small bowel 
tissue and the ID30 small bowel tissue (see table 6 .1.1.1.3 and photo. 6 .1.3 {A & B}).
6 .1.2 Genzyme Polyclonal Rabbit Anti- Mouse IL-la in Hyperimmune Serum
6 .1.2.1 Formalin-Fixed Paraffin-Embedded Tissue - RUH, Bath
6 .1.2.1.1 Positive Control Tissue - Activated Rat Lung
Sections taken from formalin-fixed paraffin-embedded tissue were titrated against the 
polyclonal anti-mouse EL-la (1/50, 1 / 1 0 0 , 1 /2 0 0 , 1/500 and 1/1000) with and without 
the trypsin antigen retrieval step. Optimum binding was found to occur in the sections 
which were not treated with trypsin so for this antibody it was decided not to include this 
antigen retrieval step. The 1/500 dilution of the antibody gave the optimum degree of 
staining (see photo. 6.1.4b {A & B}) and the sections treated with the control rabbit 
serum {Sigma} at the same dilution had no staining at all (see photo. 6.1.4b {C}).
6 .1.2.1.2 Experimental Ulcerated Rat Small Bowel Tissue - Indomethacin ID60
Sections taken from formalin-fixed paraffin-embedded tissue were titrated against the 




Phot). 6.1.4 FFPE Activated (Incubated with LPS for 1 hr at 37°C) Rat Lung Used as Positive Control 
Tissue for Both the Polyclonal Anti-Mouse TNF-a (IgG Fraction) and the Polyclonal Anti- 
Mouse DL-la.
a. Ptsitive Control Tissues For Polyclonal Anti-Mouse TNF-a (IgG Fraction). Brown Staining (S) 
Indicates the Presence of TNF-a
A & 3 = Activated rat lung incubated with poly clonal anti-mouse TNF-a (IgG fraction). Moderate 
stainng indicates that the polyclonal anti-mouse TNF-a has bound to the TNF-a within the activated rat 
lungtissue demonstrating that the antibody has bound successfully { A x 6 0 & B x  120}
C = activated rat lung incubated with control rabbit (AH) serum (IgG fraction) instead of primary 
antibdy (Serum Control). Lack of significant positive staining indicates that binding of the rabbit 
serun (IgG fraction) to other antigens within this tissue is insignificant at the dilution used for the 
primiry antibody (C x 120}
D = Activated rat lung incubated with buffer instead o f primary antibody (Negative Control). Lack of 
positve staining indicates absence of any non-specific binding to this tissue {D x  120}
b. A Above But For The Polyclonal Anti-Mouse IL -la .
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Table 6 .1.1.1.3 Comparison o f Immunohistochemical Staining With Anti-Mouse TNF-a
in Experimental Rat Small Bowel Tissue











IL-la X XXXXX XXX XXX
Table 6 .1.2 Comparison of Immunohistochemical Staining With Anti-Mouse IL-la in
Experimental Rat Small Bowel Tissue
XXXXX = Most Staining 
X = Least Staining
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the trypsin antigen retrieval step, as with the positive control tissue. As before, optimum 
binding was found in the sections which were not treated with trypsin, this confirmed 
that this antibody should be used without the trypsin antigen retrieval step. The 1/500 
dilution of the antibody gave the optimum degree o f staining and the sections treated 
with the control rabbit serum {Sigma} at the same dilution had no staining at all (see 
photo. 6.1.5b {C & D}). However, there was some degree of background staining in the 
small bowel tissue sections treated with the antiserum. As a result it was decided to 
experiment with the conditions under which the immunohistochemical procedure was 
carried out. The incubation of the tissue with antibody was compared at 30, 45 and 60 
minutes, at 37°C and at room temperature, and the incubations with the secondary 
antibody and the ABComplex were similarly shortened. After experimenting with the 
incubation times and temperature it was found that optimum staining occurred when 
following the basic protocol but with the incubation time of the secondary antibody 
reduced from 40 minutes to 30 minutes (see photo. 6.1.5a). Thus all tissue sections 
treated with this antibody were processed accordingly (including the control sections).
The degree o f staining was less in the ulcerated small bowel tissue from animals which 
had been dosed with indomethacin ID6o than in the other experimental small bowel tissue 
(see table 6.1.2 and photo. 6.1.5a {A & B}). However, in areas of this tissue which 
were totally free o f ulceration (see photo. 6.1,5a {C & D}) the staining was slightly more 
intense than that seen in tissue adjacent to (see photo. 6.1.5a {A & B}) and between the 
ulcers (see photo. 6.1.6 {A & B}). The ulcers were associated with Peyer's patches and 
the area o f necrosis, which was surrounded by neutrophils, included the adjacent tissue 
as well as the lymphoid follicle and extended into the muscle layer. The lamina propria 
was full o f inflammatory cells (lymphocytes, macrophages and plasma cells) as was the 
mesentery (macrophages, lymphocytes and neutrophils) and the muscle layer was itself 
the centre o f an inflammatory response. In other areas o f this tissue there was evidence 
of erosions above active Peyer's patches and away from the ulcerated areas normal 
Peyer's patches were visible. In areas o f small bowel tissue away from Peyer's patches 
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Photo. 6.1.5b
Photo. 6.1.5 FFPE Small Bowel Tissue From Rats Dosed Once, Orally. With Indomethacin ID60 (6.0 
mg/kg)
a. Ulcerated Rat Small Bowel Tissue Incubated With Polyclonal Anti-Mouse IL -la. Brown 
Staining (S) Indicates the Presence o f IL -la
A & B = Lightly stained Peyer's patch indicates decreased levels o f IL -la  {A  x 60 & B x 120}
C & D = Light/moderately stained unulcerated region (away from ulcers) indicates decreased levels of 
IL -la  when compared with control and vehicle control tissues {C x 60 & D x 120}
b. Ulcerated Rat Small Bowel Tissue Incubated Without Anti-Mouse IL -la  (Primary Antibody)
A & B = Peyer's patch incubated with buffer instead of primary antibody (Negative Control). Lack of 
positive staining indicates absence o f any non-specific binding to this tissue {A x 60 & B x 120}
C & D = Peyer's patch incubated with control rabbit (AH) serum instead of primary antibody (Serum 
Control). Lack of significant positive staining indicates that binding o f the rabbit serum to other 
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Photo. 6.1.7
Photo 6.1.6 FFPE Unulcerated Rat Small Bowel Tissue Incubated With Polyclonal Anti-Mouse IL -la. 
Brown Staining (S) Indicates The Presence of IL -la.
A & B  = Small bowel tissue from rats dosed once, orally, with indomethacin ID^ (6.0 mg/kg). Lightly 
stained unulcerated region (between ulcers) indicates decreased levels o f IL -la  when compared with 
control and vehicle control tissues {A x 60 & B x 120}
C & D = Small bowel tissue from rats dosed once, orally, with indomethacin ED30 (3.0 mg/kg). (Non 
ulcer causing dose). Densely stained small bowel tissue indicates increased levels of IL -la
Photo. 6.1.7 FFPE Rat Small Bowel Control Tissues Incubated With Polyclonal Anti-Mouse IL -la. 
Brown Staining (S) Indicates the Presence of IL -la
A & B = Moderately stained unulcerated control tissue indicates that there are significant levels of IL -la  
within the normal rat small bowel {A  x 60 & B x 120}
C & D = Moderately stained vehicle (10% Tween-80) control rat small bowel tissue indicates that there 
are significant levels o f IL -la , equivalent to that found within the control rat tissue {C x  60 & D x  120}
6.1.2.1.3 Experimental Unulcerated Rat Small Bowel Tissue - Indomethacin ID30
Tissue sections were incubated as above with the polyclonal anti-mouse IL-la, without 
the antigen retrieval step, at a dilution o f 1/500. There was a high degree o f staining and 
these sections were the most densely staining small bowel tissue (see table 6.1.2 and 
photo. 6.1.6 {C & D}). Although there was no sign of ulceration within this tissue and 
the Peyer's patches were normal in appearance, the lamina propria contained many 
mononuclear cells (lymphocytes, macrophages and plasma cells) far more than in the 
lamina propria o f the control tissues. There was no evidence o f any inflammatory 
response within the muscle layer. Individual cells o f the epithelium covering the villi 
were positively stained for IL-la, almost twice as many as observed in the control 
tissues, with the epithelium on the tips staining more than the epithelium in the crypts.
6.1.2.1.4 Experimental Unulcerated Rat Small Bowel Tissue - Vehicle Control
Tissue sections were incubated as above with the polyclonal anti-mouse EL-la, without 
the antigen retrieval step, at a dilution o f 1/500. There was a good degree o f staining 
which was approximately half that seen in the unulcerated small bowel tissue from 
animals dosed with indomethacin ID30, but double that seen in the slightly stained 
ulcerated bowel tissue (see table 6.1.2 and photo. 6.1.7 {C & D}). The mesentery o f the 
control tissue was empty of cells, the lamina propria contained few mononuclear cells 
and the Peyer's patches were normal in appearance. Individual cells o f the epithelium 
covering the villi stained positive for EL-la although staining was absent from goblet 
cells.
6.1.2.1.5 Experimental Unulcerated Rat Small Bowel Tissue - Control
Tissue sections were incubated as above with the polyclonal anti-mouse EL-la, without 
the antigen retrieval step, at a dilution o f 1/500. There was a good degree of staining 
which was approximately equal to that seen in the small bowel tissue from the animals 
dosed with vehicle (Tween-80 1.9 distilled water) (see table 6.1.2 and photo. 6.1.7 {A & 
B). The mesentery of the control tissue was empty o f cells, the lamina propria contained 
few mononuclear cells and the Peyer's patches were normal in appearance. Individual
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cells of the epithelium covering the villi stained positive for IL-la although staining was 
absent from goblet cells.
6.1.3 Genzyme Monoclonal Hamster Anti- Mouse IL-1 p
6.1.3.1 Formalin-Fixed Paraffin-Embedded Tissue - RUH, Bath
6.1.3.11 Positive Control Tissue - Activated Rat Spleen
Sections taken from formalin-fixed paraffin-embedded tissue were titrated against the 
monoclonal anti-mouse EL-lp (1/50, 1/100, 1/200, 1/500 and 1/1000) with and without 
the trypsin antigen retrieval step. There was no visible staining so the process was 
repeated using the antibody at a higher concentration (1/10, 1/20, 1/30, 1/50 and 1/100) 
but without success. Initially it was thought that the monoclonal antibody was binding to 
the inside o f the polystyrene LP3 tubes so these were replaced with polypropylene LP3 
tubes and 1.0 per cent (w/v) bovine serum albumin was added to the buffer as a carrier 
protein. There was still no evidence o f staining so it was decided to microwave the 
sections in order to try and improve the amount of antigen in the tissue. After this step 
there was some degree o f staining but this was also visible in the negative control 
sections and it turned out to be the result o f the DAB binding to endogenous peroxidase 
which had become 'unquenched' during the microwaving procedure. The 
immunohistochemical procedure was repeated again using the microwave antigen 
retrieval step but with the peroxidase quenching step after the microwaving procedure 
rather than prior to it. On this occasion there was no evidence o f staining. It was then 
decided to use the pressure cooker technique to try and unmask any o f the antigen which 
might have been present but this time the monoclonal anti-mouse IL-lp bound to all the 
sections, as with the microwaving technique, because the endogenous peroxidase activity 
in the tissue had become 'unquenched'. The immunohistochemical procedure was 
repeated, again using the pressure cooker antigen retrieval step but with the peroxidase 
quenching step after the pressure cooking procedure rather than prior to it but on this 
occasion there was no evidence o f staining. At this point it was decided to use frozen 
sections.
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6.1.3.1.2 Experimental Ulcerated Rat Small Bowel Tissue - Indomethacin ID 6o
These sections were processed as described above in section 6.1.31.1.
6.1.3.2 Frozen Sections
6.1.3.2.1 Positive Control Tissue - Activated Rat Spleen
Frozen sections taken from activated spleen tissue were titrated against the monoclonal 
hamster anti-mouse IL-lp (1/50, 1/100, 1/200, 1/500 and 1/1000), however, there was a 
lot of staining in the negative control sections. After experimenting to determine the 
nature of the non-specific binding it was found to be a combination of the secondary 
antibody binding to the spleen tissue and also the DAB binding to endogenous 
peroxidase which had been insufficiently quenched. The problem of the non-specific 
binding of the secondary antibody was solved by using the biotinylated F(ab') 2  fragment 
of the rabbit anti-hamster immunoglobulins rather than the total IgG fraction. The 
F(ab')2 fragments are more suitable with frozen sections as it avoids the binding that can 
occur between the Fc portion o f the reagent and cell-surface Fc receptors, and spleen 
tissue is particularly susceptible to this type of non-specific binding. The problem of the 
DAB binding to the endogenous peroxidases was solved by increasing the concentration 
of hydrogen peroxide used in the quenching step from 0.6 per cent (v/v) to 2.5 per cent 
(v/v).
Frozen sections taken from activated spleen tissue were again titrated against the 
monoclonal hamster anti-mouse IL-ip (1/50, 1/100, 1/200, 1/500 and 1/1000), under the 
new conditions, however, this time there was no staining visible in any of the tissue 
sections. The frozen sections were again titrated against the antibody, this time at 
different dilutions (1/10, 1/20, 1/30, 1/50 and 1/100) but still there was no evidence of 
the antibody binding to the tissue. The antibody had been reported to bind to frozen 
sections o f rat kidney glomeruli, at a concentration of 50 jig/ml (1/20 dilution) [Wu et 
a l, 1994], so it had been expected that the antibody would have bound to the rat spleen 
tissue under these experimental conditions. An attempt was made to increase the amount 
of antigen in the rat tissue by permeabilising the tissue with 0.1 per cent (v/v) saponin in 
tris buffered saline, pH 7.6 prior to the immunohistochemical procedure but still there 
was an absence of binding. At this stage it was decided to stop using this particular
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antibody. Unfortunately all laboratory work ceased before an alternative antibody could 
be found.
6.1.4 Genzyme Monoclonal Mouse Anti-Human IL 4
6.1.4.1 Formalin-Fixed Paraffin-Embedded Tissue - RUH, Bath
6.1.4.1.1 Positive Control Tissue
6.1.4.1.1.1 - Reactive Human Tonsil
These sections were processed as described in section 6.1.3.1.1 (for the monoclonal 
hamster anti-mouse IL-1P) with a similar lack of success. At this point it was decided to 
try the anti-human IL-4 on bowel tissue from a patient with ulcerative colitis as this 
tissue is reported as containing high levels o f IL-4 [Sartor, 1994],
6.1.41.1.2 Bowel Tissue From Patient With Ulcerative Colitis
Sections taken from formalin-fixed paraffin-embedded tissue were titrated against the 
monoclonal anti-human IL-4 (1/50, 1/100, 1/200, 1/500 and 1/1000) with and without 
the trypsin antigen retrieval step. There was no visible staining so at this point it was 
decided to use frozen sections.
6.1.4.1.2 Experimental Ulcerated Rat Small Bowel Tissue - Indomethacin ED6o 
These sections were processed as described above in section 6.1.4.1.1.1.
6.1.4.2 Frozen Sections
6.1.4.2.1 Positive Control Tissue - Reactive Human Tonsil
Frozen sections taken from reactive human tonsil tissue were titrated against the 
monoclonal mouse anti-human IL-4 (1/50, 1/100, 1/200, 1/500 and 1/1000), however, 
there was no staining visible. The frozen sections were again titrated against the 
antibody, this time at different dilutions (1/12.5, 1/25, 1/50 and 1/100) but still there was 
no evidence o f the antibody binding to the tissue. The antibody had been reported to 
bind to frozen sections of rat brain [Khoury et a l, 1992] and rat heart [Hancock et a l, 
1993], so it had been expected that the antibody would have bound to the human tissue
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under the experimental conditions tried. An attempt was made to increase the amount of 
antigen in the tonsil tissue by permeabilising the tissue with 0.1 per cent (v/v) saponin in 
tris buffered saline, pH 7.6 prior to the immunohistochemical procedure but still there 
was an absence of binding. At this stage it was decided to stop using this particular 
antibody until a suitable control tissue or an alternative antibody could be found. 
Unfortunately all laboratory work ceased before either alternative could be found.
6.1.5 Genzyme Polyclonal Rabbit Anti-Human TNF-a in Hyperimmune Serum
6.1.5.1 Formalin-Fixed Paraffin-Embedded Tissue - RUH, Bath
6.1.5.1.1 Positive Control Tissue - Reactive Human Tonsil
Sections taken from formalin-fixed paraffin-embedded tissue were titrated against the 
polyclonal anti-human TNF-a (1/50, 1/100, 1/200, 1/500 and 1/1000) with and without 
the trypsin antigen retrieval step. There was no visible staining so the process was 
repeated using the antibody at a higher concentration (1/12.5, 1/25, 1/50 and 1/100). 
There was still no evidence o f staining so it was decided to microwave the sections in 
order to try and improve the amount of antigen in the tissue. After this step there was 
some degree o f staining but this was also visible in the negative control sections and it 
turned out to be the result o f the DAB binding to endogenous peroxidase which had 
become 'unquenched' during the microwaving procedure. The immunohistochemical 
procedure was repeated again using the microwave antigen retrieval step but with the 
peroxidase quenching step after the microwaving procedure rather than prior to it. On 
this occasion there was no evidence of staining. It was then decided to use the pressure 
cooker technique to try and unmask any of the antigen which might have been present 
but this time the polyclonal anti-human TNF-a bound to all the sections, as with the 
microwaving technique, because the endogenous peroxidase activity in the tissue had 
become 'unquenched'. The immunohistochemical procedure was repeated, again using 
the pressure cooker antigen retrieval step but with the peroxidase quenching step after 
the pressure cooking procedure rather than prior to it but on this occasion there was no 
evidence o f staining.
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This result was unexpected as the Genzyme polyclonal rabbit anti-human TNF-a had 
been reported as binding to formalin-fixed paraffin embedded canine patella tissue 
[Pickvance et al., 1993] so it had been expected to bind to human tissue. At this point it 
was decided to use frozen sections.
6.1.5.1.2 Experimental Human Gastric Mucosa Tissue
These sections were processed as described above in section 61.5.1.1.
6.1.5.2 Frozen Sections
6.1.5.2.1 Positive Control Tissue - Reactive Human Tonsil
Frozen sections taken from reactive human tonsil tissue were titrated against the 
polyclonal rabbit anti-human TNF-a (1/50, 1/100, 1/200, 1/500 and 1/1000) and there 
was a little staining visible in the section incubated with the antiserum at the 1/50 
dilution. The frozen sections were again titrated against the antibody, this time at 
different dilutions (1/12.5, 1/25, 1/50 and 1/100). Surprisingly, at these dilutions, the 
control rabbit serum {Sigma} was binding extremely strongly to the human tonsil tissue. 
This was specific binding as there was no evidence of staining in the negative control 
sections (see photo. 6.1.10 {C & D}). (The rabbits that the control serum had come 
from must have had anti-human antibodies within their circulation (probably against the 
humans who had looked after them).) Fortunately the polyclonal anti-human TNF-a 
showed its optimum binding at the 1/25 dilution (see photo. 6.1.10 {A & B}) whereas 
the control serum displayed optimum binding at the 1/12.5 dilution, so it was conclusive 
that the antiserum was binding to TNF-a within the tissue. An attempt was made to 
dilute the antiserum sufficiently so that all equivalent binding of the control rabbit serum 
would be negligible but unfortunately the antiserum did not bind to the tissue sections 
satisfactorily at greater dilutions
6.1.5.2.2 Experimental Human Gastric Mucosa Tissue
These sections were processed as described above in section 6.1.5.2.1.
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The degree of staining was greater in the patients who were Helicobacter pylori- 
positive, both with (see photo. 6.1.8a) and without gastritis (see photo. 6.1.8b) than 
those patients who were Helicobacter pylori-negative (see photo. 6.1.9) All the samples 
had some degree of staining within the gastric glands of the antrum. Sections from the 
patients who were Helicobacter pylori-positive had significantly more staining within the 
lamina propria and this was greater in the samples from patients with gastritis. This was 
accompanied by an inflammatory response within the tissue as the lamina propria 
contained many mononuclear cells such as lymphocytes, macrophages and plasma cells. 
Neutrophils were visible within all the gastric mucosa samples although they were in 
greater numbers in the samples from patients with gastritis. The lamina propria of the 
patients who were Helicobacter /^/on-negative contained very few mononuclear cells. 
Helicobacter pylori were also visible within the gastric pits of the antrum in tissue from 
patients who were Helicobacter pylori-positive. (These bacteria are difficult to visualise 
in frozen sections which have not been H & E stained, however, one is visible in the 
FFPE gastric mucosa tissue (see photo. 6.1.14b.))
6.1.6 Genzyme Polyclonal Rabbit Anti-Human IL -la (IgG Fraction)
6.1.6.1 Formalin-Fixed Paraffin-Embedded Tissue - RUH, Bath
6.1.6.1.1 Positive Control Tissue - Reactive Human Tonsil
These sections were processed as described in section 6.1.5.1.1 (for the polyclonal rabbit 
anti-human TNF-a) with a similar lack o f success.
This result was unexpected as the Genzyme polyclonal rabbit anti-human IL-la had been 
reported as binding to formalin-fixed paraffin embedded human brain tissue at a 1/1000 
dilution [Griffin et a l, 1989], At this point it was decided to use frozen sections.
6.1.6.1.2 Experimental Human Gastric Mucosa Tissue













Photo. 6.1.8 Frozen Sections o f Human Gastric Mucosa Taken From the Antrum of Helicobacter pylori- 
Positive Patients. Brown Staining (S) Indicates the Presence o f TNF-a
a. Helicobacter pylori-Positive With Gastritis
A & B = Gastric mucosa incubated with polyclonal anti-human TNF-a. Moderate staining within the 
lamina propria indicates increased levels o f TNF-a when compared with normal control tissue.
C & D = Gastric mucosa incubated with buffer instead of primary antibody (Negative Control). Lack of 
positive staining indicates absence o f any non-specific binding to this tissue {C x 60 & D x 120}
b. Helicobacter pylori -Positive Without Gastritis
A & B = Gastric mucosa incubated with polyclonal anti-human TNF-a. Light/moderate staining within 
the lamina propria indicates increased levels o f TNF-a when compared with normal control tissue 
although levels are lower than those observed in patients with gastritis.
C & D = Gastric mucosa incubated with buffer instead o f primary antibody (Negative Control). Lack of 
positive staining indicates absence o f any non-specific binding to this tissue {C x 60 & D x 120}
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Photo. 6.1.9 Frozen Sections of Human Gastric Mucosa Taken From the Antrum of Helicobacter pylori- 
Negative Patients (Normal Control). Brown Staining (S) Indicates the Presence of TNF-a
A & B = Gastric mucosa incubated with polyclonal anti-human TNF-a. Light staining within the 
lamina propria indicates low levels o f TNF-a within normal control tissue.
C & D = Gastric mucosa incubated with buffer instead of primary antibody (Negative Control). Lack of 
positive staining indicates absence of any non-specific binding to this tissue {C x 60 & D x 120}
Photo. 6.1.10 Frozen Sections o f Human Reactive Tonsil Used as Positive Control Tissue for the
Polyclonal Rabbit Anti-Human TNF-a. Brown Staining (S) Indicates the Presence of 
TNF-a
A & B = Reactive tonsil incubated with polyclonal anti-human TNF-a. Light/moderate staining 
indicates that the polyclonal anti-human TNF-a has bound to the TNF-a within the tonsil tissue 
demonstrating that the antibody has bound successfully {A x 60 & B x 120}
C & D = Reactive tonsil incubated with buffer instead of primary antibody (Negative Control). Lack of 
positive staining indicates absence o f any non-specific binding to this tissue {C x 60 & D x 120}
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6.1.6.2 Frozen Sections
6.1.6.2.1 Positive Control Tissue - Reactive Human Tonsil
Frozen sections taken from reactive human tonsil tissue were titrated against the 
polyclonal rabbit anti-human IL-la (IgG fraction) (1/50, 1/100, 1/200, 1/500 and 
1/1000), however, there was no evidence of staining visible. The frozen sections were 
again titrated against the antibody, this time at different dilutions (1/12.5, 1/25, 1/50 and 
1/100). On this occasion there was some staining visible at the 1/12.5 and 1/25 dilutions. 
Surprisingly, at these dilutions, the control rabbit serum (IgG fraction) {DAKO} was 
binding as strongly to the human tonsil tissue. This was specific binding as there was no 
evidence o f staining in the negative control sections (see photo. 6.1.13 {C & D}). (The 
rabbits that the control serum had come from must have had anti-human antibodies 
within their immune system (probably against the humans who had looked after them).) 
Unfortunately the control rabbit serum (IgG fraction) {DAKO} and the polyclonal anti­
human IL -l-a showed optimum binding at the 1/12.5 dilution (see photo. 6.1.13 {A & 
B}), so it was inconclusive that the antiserum was binding to IL-la within the tissue. 
This result was surprising as the Genzyme anti-human EL-la had been reported as 
binding to frozen sections of human chorionic villi at a dilution of 1/50 [Haynes et a i, 
1993],
6.1.6.2.2 Experimental Human Gastric Mucosa Tissue
These sections were processed as described above in section 6.1.6.2.1.
The degree o f staining was greater in the patients who were Helicobacter pylori- 
positive, both with (see photo. 6.1.11a) and without gastritis (see photo. 6.1.11b) than 
those patients who were Helicobacter pylori-negative (see photo. 6.1.12) All the 
samples had some degree of staining within the gastric glands o f the antrum. The lamina 
propria o f the patients who were Helicobacter pylori-positive with gastritis was full of 
inflammatory cells, such as lymphocytes, macrophages and plasma cells, and was 
positively stained for anti-human IL-la whereas this response was absent in the samples 
from patients who were Helicobacter py/on'-negative. There was very little if any 







Photo. 6.1.11 Frozen Sections o f Human Gastric Mucosa Taken From the Antrum of Helicobacter 
pylori -Positive Patients. Brown Staining (S) Indicates the Presence of IL -la
a. Helicobacter pylori-Positive With Gastritis
A & B = Gastric mucosa incubated with polyclonal anti-human IL -la. Light/moderate staining within 
the lamina propria indicates increased levels o f IL -la  when compared with normal control tissue.
C & D = Gastric mucosa incubated with buffer instead o f primary antibody (Negative Control). Lack of 
positive staining indicates absence o f any non-specific binding to this tissue {C x 60 & D x 120}
b. Helicobacter pylori -Positive Without Gastritis
A & B = Gastric mucosa incubated with polyclonal anti-human IL -la. Light staining within the lamina 
propria indicates increased levels o f IL -la  when compared with normal control tissue although levels 
are lower than those observed in patients with gastritis.
C & D = Gastric mucosa incubated with buffer instead o f primary antibody (Negative Control). Lack of 












Photo. 6.1.12 Frozen Sections o f Human Gastric Mucosa Taken From the Antrum of Helicobacter
py/ori-Negative Patients (Normal Control). Brown Staining (S) Indicates the Presence of 
IL -la
A & B = Gastric mucosa incubated with polyclonal anti-human IL -la. Slight staining within the 
lamina propria indicates low levels o f IL -la  within normal control tissue.
C & D = Gastric mucosa incubated with buffer instead of primary antibody (Negative Control). Lack of  
positive staining indicates absence o f any non-specific binding to this tissue {C x 60 & D x 120}
Photo. 6.1.13 Frozen Sections o f Human Reactive Tonsil Used as Positive Control Tissue for the
Polyclonal Rabbit Anti-Human IL -la. Brown Staining (S) Indicates the Presence o f IL -la
A & B = Reactive tonsil incubated with polyclonal anti-human IL -la. Light/moderate staining indicates 
that the polyclonal anti-human IL -la  has bound to the IL -la  within the tonsil tissue demonstrating that 
the antibody has bound successfully {A  x 60 & B x 120}
C & D = Reactive tonsil incubated with buffer instead of primary antibody (Negative Control). Lack of  
positive staining indicates absence o f any non-specific binding to this tissue {C x 60 & D x 120}
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Helicobacter pylori-positive without gastritis. Helicobacter pylori were visible within 
the gastric pits of the antrum in samples from patients who were Helicobacter pylori- 
positive. (These bacteria are difficult to visualise in frozen sections which have not been 
H & E stained, however, one is visible in the FFPE gastric mucosa tissue (see photo. 
6.1.14b.))
6.1.7 Anti-Human IL-8
6.1.7.1 Serotec Monoclonal Rabbit Anti-Human IL-8 (IgG Fraction)
6.1.7.1.1 Formalin-Fixed Paraffin-Embedded Tissue - RUH, Bath
6.1.7.1.1.1 Positive Control Tissue - Reactive Human Tonsil
These sections were processed as described in section 6.1.3.1.1 (for the monoclonal 
hamster anti-mouse IL-ip) with a similar lack of success. At this point it was decided to 
use frozen sections.
6.1.7.1.1.2 Experimental Human Gastric Mucosa Tissue
These sections were processed as described above in section 6.1.7.1.1.1.
6.1.7.1.2 Frozen Sections
6.1.7.1.2.1 Positive Control Tissue - Reactive Human Tonsil
Frozen sections taken from reactive human tonsil tissue were titrated against the Serotec 
monoclonal mouse anti-human IL-8 (IgG fraction) (1/50, 1/100, 1/200, 1/500 and 
1/1000), however, there was no evidence of staining visible. The frozen sections were 
again titrated against the antibody, this time at different dilutions (1/12.5, 1/25, 1/50 and 
1/100), again there was no evidence o f staining. As a result it was decided to cease work 
with this antiserum and to purchase a polyclonal anti-human IL-8 as it was thought that 
this might be more suitable for immunohistochemistry.
6.1.7.1.2.2 Experimental Human Gastric Mucosa Tissue
These sections were processed as described above in section 6.1.7.1.2.1.
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6.1.7.2 Genzyme Polyclonal Rabbit Anti-Human IL-8 (IgG Fraction)
6.1.7.2.1 Formalin-Fixed Paraffin-Embedded Tissue - RUH, Bath
6.1.7.2.1.1 Positive Control Tissue - Reactive Human Tonsil
These sections were processed as described in section 6.1.5.1.1 (for the polyclonal rabbit 
anti-human TNF-a) with a similar lack o f success. At this point it was decided to use 
frozen sections.
6.1.7.2.1.2 Experimental Human Gastric Mucosa Tissue
These sections were processed as described above in section 6.1.7.2.1.1.
6.1.7.2.2 Frozen Sections
6.1.7.2.2.1 Positive Control Tissue - Reactive Human Tonsil
Frozen sections taken from reactive human tonsil tissue were titrated against the 
polyclonal rabbit anti-human IL-8 (IgG fraction) (1/50, 1/100, 1/200, 1/500 and 1/1000), 
however, there was no evidence o f staining visible. The frozen sections were again 
titrated against the antibody, this time at different dilutions (1/12.5, 1/25, 1/50 and 
1/100), again there was no evidence of staining. As a result it was decided to cease work 
with this antiserum and to try and find an alternative source o f anti-human IL-8, as 
commercially available antibodies did not appear to be of a high enough standard for 
immunohistochemistry
6.1.7.2.2.2 Experimental Human Gastric Mucosa Tissue
These sections were processed as described above in section 6.1.7.2.2.1.
6.1.7.3 Donated Monoclonal Mouse Anti-Human EL-8
6.1.7.3.1 Formalin-Fixed Paraffin-Embedded Tissue - RUH, Bath
6.1.7.3 .1.1 Positive Control Tissue - Reactive Human Tonsil
This monoclonal antibody had already been used for immunohistochemistry on bowel 
tissue, at a 1/100 dilution without the trypsin antigen retrieval step, by another research
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Photo. 6.1.14b
Photo. 6.1.14 FFPE Human Gastric Mucosa Taken From the Antrum of Helicobacter pylori-Positive 
Patient With Gastritis. Brown Staining (S) Indicates the Presence o f IL-8
a. Gastric mucosa tissue incubated with monoclonal anti-human IL-8.
A & B = Intense staining within the lamina propria and individual cells within the glandular tissue 
indicates the presence of high levels o f IL-8. Staining within this infected tissue is greater than that 
observed in similar normal control tissue {A x  6 0 & B  x 120}
C & D = Moderate staining within the lamina propria and individual cells lining the gastic pits indicates 
increased levels o f IL-8 when compared with similar normal control tissue {C x 60 & D x 120}
b. Gastric mucosa incubated with buffer instead o f primary antibody (Negative Control).
A & B = Lack o f positive staining indicates absence of any non-specific binding { A x 6 0 & B x  120}
C & D = As above. Helicobacter pylori (Hp) bacterium is visible within one o f the gastric pits (C x 60 








Photo. 6.1.15 FFPE Human Gastric Mucosa Taken From the Antrum of Helicobacter pylori -Negative 
Patient (Normal Control) incubated with monoclonal anti-human IL-8. Brown Staining 
(S) Indicates the Presence o f IL-8
A & B = Intense staining within the lamina propria and individual cells within the glandular tissue 
indicates the presence o f high levels o f IL-8 within normal control tissue. {A  x 60 & B x 120}
C & D = Moderate staining within the lamina propria and slight staining within cells lining the gastic 
pits demonstrates normal levels o f IL-8 within this tissue {C x  60 & D x  120}
Photo. 6.1.16 FFPE Human Reactive Tonsil Used as Positive Control Tissue for the Monoclonal Anti- 
Human IL-8. Brown Staining (S) Indicates the Presence o f IL-8
A & B = Reactive tonsil incubated with monoclonal anti-human IL-8. Slight staining indicates that the 
monoclonal anti-human IL-8 has bound to the IL-8 within the tonsil tissue demonstrating that the 
antibody has bound successfully {A  x 60 & B x 120}
C & D = Reactive tonsil incubated with buffer instead of primary antibody (Negative Control). Lack of 
positive staining indicates absence of any non-specific binding to this tissue {C x 60 & D x 120}
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group working in the same department. The degree of binding obtained was slight but 
suitable within the positive control tissue (see photo. 6.1.16 {A x B}) and there was no 
staining visible within the negative control section (see photo. 6.1.16 {C x D}) so all 
further work was carried out under these experimental conditions.
6.1.7.3.1.2 Experimental Human Gastric Mucosa Tissue
These sections were processed as described above in section 6.1.7.3 .1.1.
The staining in the tissue sections of samples from both Helicobacter pylori-positive 
patients (see photo. 6.1.14a) and Helicobacter pylori-negative patients was very strong 
(see photo. 6.1.15) which was absent from the negative control sections (see photo. 
6.1.14b). In all subjects individual cells within the glandular tissue had a similar degree 
of binding of the anti-human IL-8. There was also positive staining within the lamina 
propria of samples from patients who were Helicobacter /Ty/on-positive and 
Helicobacter /^/on-negative but overall this tended to be more intense in the samples 
from infected tissue. This was accompanied by an inflammatory response within this 
tissue as the lamina propria contained many inflammatory cells such as lymphocytes, 
macrophages and plasma cells. Macrophages and lymphocytes were also visible within 
the mucosal tissue as were some neutrophils. The lamina propria and the gastric mucosa 
of the Helicobacter /?y/on-negative patients contained very few if any mononuclear cells. 
Helicobacter pylori were visible, adhering to the inside of the gastric pits o f the antrum, 
in tissue taken from patients who were Helicobacter /ry/on-positive (see photo. 6.1.14b).
6.1.7.3.2 Frozen Sections
6.1.7.3.2.1 Positive Control Tissue - Reactive Human Tonsil
Frozen sections taken from reactive human tonsil tissue were incubated against the 
donated monoclonal mouse anti-human IL-8 at a dilution o f 1/100. However, no 
staining was visible in the tonsil tissue. Due to lack of time and antibody it was 
impossible to carry out a titration of the donated anti-human IL-8 on the frozen sections 
to determine whether or not it would bind to frozen tissue and if so at what 
concentration.
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6.1.7.3.2.2 Experimental Human Gastric Mucosa Tissue
These sections were processed as described above in section 6.3.7.2.2.1.
6.1.8 Protein Blotting
All three of the anti-mouse TNF-a antisera, the polyclonal anti-mouse IL-a and the 
polyclonal anti-human TNF-a gave a positive result during 'dot blot' analysis. However, 
the polyclonal anti-human IL-la and the monoclonal anti-human IL-4 did not bind to 
their respective recombinant proteins at any of the concentrations blotted onto the 
membrane (50, 10, 1, 0.1 and 0.01 pg). It was not possible to conduct 'dot blot' analysis 
with the hamster monoclonal anti-mouse IL-lp as recombinant IL-ip was unavailable. 
The donated monoclonal anti-human IL-8 had been reported as recognising the 
respective human protein [Jordan e ta l ., 1996] and 'dot-blot' analysis had been conducted 
by another research group within the department. Consequently it was not considered 
necessary to repeat the experiment for this project.
6.1.9 Neutralisation
The staining intensity was significantly reduced in the sections of positive control tissue 
which had been incubated with either the polyclonal anti-mouse TNF-a or polyclonal 
anti-mouse IL -la after the buffer containing the respective antiserum had been pre­
incubated with the relevant recombinant protein. The maximum staining for both the 
polyclonal anti-mouse TNF-a and the polyclonal anti-mouse IL-la was visible in the 
control sections which had been incubated with buffer which itself had been pre­
incubated in the absence of the relevant recombinant protein. The minimum staining 
observed for both the polyclonal anti-mouse TNF-a and the polyclonal anti-mouse IL-la  
was in the control tissue sections which had been incubated with buffer containing 
antiserum which had been incubated previously with 5 ng o f the relevant recombinant 
protein.
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6.2 DISCUSSION - ROLE OF CYTOKINES IN ULCER FORMATION
6.2.1 Formalin-Fixed Paraffin-Embedded Tissue - The Bath Clinic, Bath
6.2.1.1 Rat Small Bowel Tissue
Initially the Genzyme polyclonal rabbit anti-mouse IL -la was used with sections of 
formalin-fixed paraffin-embedded tissue which had been processed by The Bath Clinic. 
(Problems had been encountered in obtaining sections from the RUH.)
The activated lung sections were treated as previously described for sections which had 
been processed by the RUH. However, there was always a very high level of 
background staining, which proved impossible to remove at a 1/500 dilution, and this 
problem was even worse in sections of rat small bowel tissue. Incubation times were 
altered, as previously described for this antibody, and differing dilutions were also tried 
to no avail. In addition the level of staining was inconsistent as one dilution which would 
cause intense staining on some occasions (1/1000) would result in no staining at all 
during further immunohistochemical procedures, even though it was being used on tissue 
sections from the same block. Initially it was thought that the problem lay with the 
antibody, however, it was eventually discovered that the embedding and sectioning 
procedures had been at fault. This was realised when further experiments using the IgG 
fraction o f the anti-mouse TNF-a on these sections, processed by The Bath Clinic, 
resulted in similar inconsistencies.
Firstly the tissue had been embedded at a temperature approximately 10 °C higher than 
that recommended for immunohistochemistry and secondly the sections had been dried at 
70 °C for one hour rather than at 37 °C for 24 to 48 hours. As a result the proteins in 
the sections had become denatured and this was responsible for the high level of 
background staining found in conjunction with the polyclonal antibodies. Once these 
mistakes had been realised, more sections were cut from the paraffin blocks and dried at 
37 °C for 24 to 48 hours. However, there was still a problem with staining as a 1/1000 
dilution o f the anti-mouse IL -la  would give a high degree o f staining on some sections 
but none on others. It was then discovered that if sufficient sections were cut from the 
block initially (approximately 24) the ensuing sections would respond to the antibody in a
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similar manner to sections cut from tissue processed by the RUH, as the proteins in the 
middle of the tissue block had not been denatured. The results obtained from these rat 
small bowel sections, cut from blocks processed by The Bath Clinic, then confirmed the 
results obtained from sections prepared by the RUH.
6.2.1.2 Human Gastric Mucosa Tissue
A similar problem was encountered with sections from blocks of gastric mucosa tissue 
which had been processed by The Bath Clinic. However, these samples were so small 
that the proteins were denatured all through the tissue blocks. The monoclonal anti­
human IL-8 did bind to tissue sections cut from these blocks, not with the same intensity 
as that seen in the sections cut from blocks processed by the RUH, but sufficiently to 
confirm the results obtained with RUH processed tissue.
6.2.2 Commercially Available Antibodies
6.2.2.1 Genzyme Polyclonal Anti-Mouse TNF-a
This antibody had been reported to bind to sections of formalin-fixed paraffin-embedded 
rat kidney [Diamond & Pesek, 1991]. It did in fact bind to sections taken from activated 
rat lung, activated rat spleen and ulcerated rat small bowel tissue, with a varying degree 
of staining, but with only half the intensity of that obtained with the control rat serum at 
an equivalent protein concentration. The possible explanation for this could be that the 
standard o f the antiserum had deteriorated since the original reported experiments 
[Diamond & Pesek, 1991] or that it had not been compared with control rat serum, as 
Diamond & Pesek [1991] did not make any reference to such control serum sections 
being included during the immunohistochemical procedures.
This antibody did recognise recombinant mouse TNF-a during 'dot blot' analysis but with 
less than half the response o f that seen with the donated anti-mouse TNF-a at the 
equivalent concentration. Although this was a positive result the antibody was not 
suitable for immunohistochemistry because the control sera bound with greater intensity. 
While using the IgG fractions o f the donated anti-mouse TNF-a and control rabbit (AH) 
serum it was noticed that the IgG fraction o f the antiserum lost activity after
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approximately six months so that the IgG fraction o f the control rabbit serum produced 
staining of twice the intensity when used at the equivalent concentration. (This was in 
spite o f the fact that the two IgG fractions had been processed at the same time and kept 
in the same freezer at -20°C.) The possibility is that the two Genzyme polyclonal anti­
mouse TNF-a antisera had deteriorated in a similar fashion prior to purchase.
6 2 2 .2  Genzyme Monoclonal Anti-Mouse IL-ip and Monoclonal Anti-Mouse IL-4
The lack of results with these two antibodies was very disappointing. It had been 
suspected that they might not be suitable for use on formalin-fixed paraffin-embedded 
tissue but initially this was the only type o f section available. (The two histopathology 
laboratories regularly processed formalin-fixed tissue, so it was relatively easy to include 
samples required for research purposes along with the routine samples, whereas the 
cutting of frozen sections was considered to be too laborious to be conducted on a 
regular basis.) It had been hoped that the newer methods o f antigen retrieval would 
result in these two antibodies binding to the formalin-fixed paraffin-embedded tissue but 
unfortunately they did not. These antibodies had been reported to bind to frozen 
sections [Khoury et a l , 1992; Hancock et ah, 1993; Wu et ah, 1994], so it was 
unexpected when they did not.
The negative result obtained during 'dot blot' analysis indicated that even if the anti­
human IL-4 had bound to the positive control tissue (human reactive tonsil) it was 
unlikely to have bound to the rat IL-4 protein despite having been reported in the 
literature as doing so [Khoury et a l, 1992; Hancock et ah, 1993]. It was possible that 
the lack o f positive staining with these two monoclonal antibodies may have been 
because the respective antigens had been destroyed during the endogenous peroxidase 
quenching step as this is not recommended for frozen sections [Boenisch, 1989], 
Usually an alkaline phosphatase staining procedure is used on frozen sections [Boenisch, 
1989] as this does not require the endogenous peroxidase activity to be quenched, thus 
the hydrogen peroxide/methanol step can be omitted. Unfortunately the reagents 
necessary for this procedure were not available.
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6.2.2.3 Genzyme Polyclonal Anti-Human TNF-a and Polyclonal Anti-Human IL-la
These two antibodies were similarly disappointing as both the anti-human TNF-a and the 
anti-human IL-la had been reported as being suitable for use on formalin-fixed paraffin 
embedded tissue in immunohistochemistry [Griffin et al., 1989; Pickvance et al., 1993], 
Although the anti-human TNF-a did bind faintly to frozen sections at a 1/50 dilution the 
control serum bound to a similar extent and it was only at the 1/25 dilution that the 
staining intensity with the antiserum was more (two-fold) than that seen with the control 
serum. Similarly the anti-human IL -la did bind to frozen sections of gastric mucosa 
tissue at a dilution o f 1/12.5 but always the staining observed was of equal intensity to 
that obtained with the control rabbit serum.
During routine immunohistochemical procedures most antibodies are used at dilutions of 
1/400-1/500 so the fact that these antibodies had to be used at such a high concentration 
was indicative of how poor they were. The minimum volume o f buffer required to cover 
a small section is lOOpl which meant that when using the anti-human TNF-a a minimum 
of 4 pi per section had to be used whereas when using the anti-human IL -la the 
minimum was 8 pi per section. Consequently these antibodies were used up very quickly 
which made them extremely expensive to use.
The positive result obtained with the anti-human TNF-a during the 'dot blot' analysis 
confirmed that this antibody was binding to TNF-a present in the gastric mucosa 
samples. However, the negative result with the anti-human IL-la would appear to 
suggest that this antiserum (IgG fraction) was not binding specifically to the IL-la  
protein but to other antigens within the tissue, which were also recognised by the 
naturally occurring antibodies within the IgG fraction of the control rabbit serum. The 
Genzyme polyclonal anti-human IL -la had been reported by Genzyme as binding to 
frozen sections of human tissue at a 1/50 dilution [Haynes et al., 1993], This antibody 
had in fact been used at that concentration but on reading the literature [Haynes et al., 
1993] it would appear that no trace o f IL -la was found in the tissue they were 
investigating. This research group had compared the binding of the antiserum with 
control rabbit serum but had not apparently included a positive control tissue in with
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their experimental procedure. As a result it was impossible to say for certain that IL-la  
was not present in their experimental tissue. The positive staining obtained when using 
the anti-human IL -la on the gastric mucosa samples did appear to indicate that this 
antiserum may be binding to IL-la and the presence of TNF-a within the same tissue 
would seem to suggest that IL-la could be present. It would appear, however, that this 
polyclonal anti-human IL-la was never suitable for immunohistochemistry.
6.2.3 Comparison o f Staining Intensity in Rat Small Bowel Tissue
6.2.3.1 Donated Polyclonal Rabbit Anti- Mouse TNF-a (IgG Fraction)
The staining in tissue sections, taken from animals with ulcers which had been dosed with 
indomethacin D36o acute, was mostly very slight. The only area of these tissue sections 
where the anti-TNF-a bound strongly was in the area of the Peyer's patches associated 
with an ulcer or an erosion. The unulcerated tissue immediately surrounding the ulcer 
and the unulcerated areas o f small bowel between ulcers were all stained very slightly 
when compared with the rest of the experimental small bowel tissue. The positive 
staining for TNF-a was observed in mononuclear cells within the lymphoid follicle of the 
activated Peyer's patches. Tissue sections taken from the rats which had been given an 
acute dose of indomethacin ID30 had approximately double the staining seen in the 
unulcerated areas o f the indomethacin rD6o animals as did the sections taken from the 
animals which had received the vehicle (10 per cent (v/v) Tween-80) although the 
staining was slightly greater in the latter. The small bowel samples which had the highest 
degree o f staining throughout the whole tissue section came from the control animals 
(see table 6.1.1.1.3).
TNF-a is the pivotal cytokine involved in the inflammatory process and from these 
results it would appear that there are high levels o f the cytokine present in the normal 
small bowel tissue of rats. The animals with ulcers had very little TNF-a in the 
unulcerated areas o f small bowel which would suggest that the normal TNF-a 'pool' had 
been depleted. In the animals treated with indomethacin ID30, where ulcers had not 
formed, the inflammatory response had probably already begun, resulting in a lowering of
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the normal TNF-a 'pool' but not to the extent of that seen in the indomethacin ID 6o 
animals.
6.2.3.2 Genzyme Polyclonal Rabbit Anti- Mouse IL -la in Hyperimmune Serum
The staining in tissue sections containing ulcers, taken from animals which had been 
dosed with indomethacin rD6o acute, was very slight throughout the entire tissue section 
although in some unulcerated areas the degree of staining was slightly greater. Staining 
with the anti-mouse EL-la, however, was greatest in the animals given indomethacin 
ED3o and the antiserum bound with equal intensity all through the small bowel tissue. 
The majority of the positive staining was visible within individual cells of the intestinal 
epithelium covering the villi tips although there was also some positive staining within 
the lamina propria which contained many mononuclear cells associated with an 
inflammatory response. The staining in the sections cut from tissue which had come 
from the control and vehicle control animals was o f equal intensity and was 
approximately twice that seen in the ulcerated tissue but half that visible in tissue from 
animals dosed with indomethacin ED30. The positive staining in the control tissues was 
mostly confined to individual cells o f the epithelium covering the villi, as the lamina 
propria contained few mononuclear cells in comparison with the other tissues. These 
results appear to show that normal rat small bowel tissue has high levels of IL-la. The 
higher levels o f IL -la  seen in the tissue from rats dosed with indomethacin ID 3o, would 
seem to suggest that the inflammatory response was at a maximum as there were many 
inflammatory cells within the lamina propria and twice the number of intestinal epithelial 
cells than normal were positively stained. Thus it would appear that there was an initial 
inflammatory cytokine response, prior to ulcer formation, as a result of indomethacin 
ingestion. The low levels o f IL -la  in the small bowel tissue from the animals with the 
ulcers would appear to indicate that the initial inflammatory response has diminished and 
the normal 'pool' o f IL -la  has been depleted. This could be due to the production of IL- 
1 receptor antagonist (IL-lra) and IL-4 which down regulate the cellular immune 
response to infection by inhibiting many of the leucocyte responses [Danzer et a l, 1994; 
D'Andrea et a l, 1995],
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6.2.4 Presence of Cytokines in Rat Small Bowel Tissue
Other researchers have reported that IL-1 is abundant in epithelial lining cells [Guenard 
et al., 1991] and the relatively high levels of TNF-a and IL-la within the normal small 
bowel tissue o f the rat would seem to indicate that the gastrointestinal epithelium is 
usually in an 'inflammatory state', probably as a direct result o f the normal bacteria within 
the lumen.
The structure and function o f the gastrointestinal tract is dependent upon the presence of 
resident bacterial flora [Abrams et a l, 1963; Thompson & Trexler, 1971; Coates & 
Fuller, 1977; Simon & Gorbach, 1986, 1987] and studies in germ-free rats reveal that in 
these animals the intestinal wall is significantly thinner and less cellular. The villi also are 
thinner and more pointed, the crypts are shallower and the total mucosal surface is much 
reduced [Gordon & Bruchorer-Kardoss, 1961; Heneghan, 1984], In normal rats the 
mucosal cells are columnar whereas in germ-free rats they are cuboidal and uniform in 
both size and shape. The lack o f bacteria also results in a lamina propria which consists 
of a sparse stroma infiltrated with only a few macrophages and lymphocytes. As there is 
little to stimulate an immunological reaction, plasma cells are absent and Peyer's patches 
are smaller with fewer germinal centres. Cellular turnover is also decreased, with the 
mucosal cells taking twice as long to migrate from crypt to villus as those in conventional 
rats [Abrams et a l, 1963; Lesher et a l, 1964], Once germ-free rats have been colonised 
by the normal rat gastrointestinal microflora, the small and large bowel rapidly assumes a 
conventional appearance [Abrams et a l, 1963; Kenworthy, 1971], The lamina propria 
takes on its customary mien and becomes infiltrated by lymphocytes, macrophages and 
plasma cells. Thus, what is termed normal morphology is suggestive of a chronic 
inflammatory response [Simon & Gorbach, 1986, 1987], This would appear to provide 
additional evidence that the gastrointestinal epithelium is constantly under attack from 
luminal bacteria, their toxins and by products, and explains the relatively high level of 
cytokine activity seen when compared to other areas of the body. The simultaneous 
production o f prostaglandins probably attenuates this 'chronic inflammatory response' 
maintaining a delicate balance.
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6.2.5 Possible Role of NSAIDs
The delicate balance between the proinflammatory and antiinflammatory processes within 
the gastrointestinal epithelium is disturbed by the administration of NSAIDs, particularly 
the more acidic ones such as indomethacin and diclofenac. The initial topical damage is 
probably due to their ability to enter into the cells of the epithelium lining the 
gastrointestinal tract where they alter mitochondrial respiration by uncoupling oxidative 
phosphorylation [Brody, 1956; Penniall, 1958; Packer et a l, 1959; Jeffrey & Smith, 
1959; Whitehouse, 1964; Smith & Dawkins, 1971; Kawai et al., 1985], This initiates a 
fall in the production o f ATP which is necessary for maintaining the tight junctions 
between the epithelial cells o f the gastrointestinal tract [Meza et al., 1980; Madara & 
Dharmsathaphom, 1985; Madara et a l, 1986, 1987] and probably is the cause of the 
small bowel permeability, observed within six hours o f NSAID administration [Bjamason 
et a l, 1992a], ATP is also required for the transfer o f many molecules across 
membranes in order to maintain the ion balance both within the intracellular compartment 
and between it and the extracellular space [Harrison & Lunt, 1980], Failure to maintain 
this ion balance can lead to membrane disruption as the cell swells and bursts resulting in 
the intracellular contents being exposed to the outside milieu. The protection afforded 
by concomitant administration of prostaglandin E2 and its analogues [Robert, 1974, 
1975, 1979; Fang et a l, 1977; Tabata & Okabe, 1983; Romain et a l, 1987] is probably 
partly mediated through this process as these compounds help maintain the ion balance 
within the intracellular compartment and as a result the integrity o f the cell membrane is 
maintained [Miller & Jacobson, 1979],
Once the intestinal barrier has been compromised, bile, bacterial toxins and other noxious 
agents are able to pass through into the gastrointestinal epithelium. This probably causes 
an inflammatory response as bile salts are able to induce IL-1 synthesis [Dinarello, 1991] 
and bacterial endotoxins and exotoxins stimulate leucocytes to secrete TNF-a [Dinarello, 
1991], This initiates the inflammatory cytokine cascade [Fong et a l, 1989; Tracey & 
Cerami, 1993] by stimulating the surrounding epithelial cells and leucocytes to secrete 
IL-la in response to the TNF-a and this may explain the increased production of IL-la  
observed within the intestinal epithelial cells o f animals dosed with indomethacin ID3o-
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The decreased staining for TNF-a observed within the indomethacin ID30 and ID60 
tissues is probably due to cellular responses to TNF-a.
In experimental animals injected with LPS, a TNF-a peak is visible at 1.5 hours [Tracey 
& Cerami, 1993] but after 3-4 hours the amount o f TNF-a within the serum is very small 
[Zuckerman et al., 1991], The serum half-life of TNF-a and other cytokines in humans 
and laboratory animals is short (6 to 20 min) [Tracey & Cerami, 1993] and the rapid 
decline o f circulating TNF-a after peak levels is probably due to the numerous receptors 
for this cytokine on other cells [Tracey & Cerami, 1993], A second injection of LPS, 20 
hours later, does not elicit a second peak as once mononuclear cells have been exposed 
to LPS they do not immediately release TNF-a on subsequent exposure [Zuckerman et 
a l, 1991], This mechanism of endotoxin tolerance lasts for three to four days and after 
that time is reversible [Williams et a l, 1983; Madonna & Vogel, 1985; Madonna et a l, 
1986; Haslberger et a l, 1988], Thus tolerance to LPS and related substances was 
probably why there was very little TNF-a within the sections of small bowel tissue from 
animals dosed with indomethacin ED30 and ED6o as the resident mononuclear cells within 
the small bowel tissue would have been exposed to TNF-a during the initial 
inflammatory response, hours before the tissue was excised. The maximal levels for 
TNF-a within the experimental tissue probably occurred within six hours of drug 
administration. The intense staining visible within areas o f the Peyer's patches, 
associated with ulcers and erosions, were probably sites o f newly recruited leucocytes to 
the region o f inflammation, as the lymphoid follicles are readily accessible to 
inflammatory mononuclear cells, such as macrophages, lymphocytes and mast cells. 
These mononuclear cells were probably secreting TNF-a in response to coming into 
contact either with EL-1 or with the bacteria and/or their toxins diffusing out o f the area 
of necrosis. The kinetics o f EL-1 production are different, however, to those of TNF-a. 
After the initial injection o f LPS there is a broad peak at 3-4 hours which continues for 
2-3 hours before returning to basal rates at 20 hours post LPS [Zuckerman et a l, 1991], 
Following a second injection o f LPS there is a corresponding second peak which is often 
greater in magnitude than the peak obtained initially [Zuckerman et a l, 1991], Thus the 
elevated levels o f EL-la within the tissue from animals dosed with indomethacin ID30 are 
probably either due to a protracted response to the original TNF-a exposure, EL-1 can
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stimulate its own production and release [Dinarello et a l, 1987; Warner et a l, 1987a, 
1987b; Schindler et a l, 1990], or the result of additional exposure to TNF-a from newly 
recruited leucocytes. The decrease in staining for IL-la in the ulcerated tissue is 
probably due to the production of both IL-1 receptor antagonist (IL-lra) and IL-4 which 
between them down regulate the cellular immune response to infection by inhibiting 
many o f the leucocyte responses [Danzer et al., 1994; D'Andrea et al., 1995], IL-4 is 
believed to mediate the balance between the production of IL-1 and IL-lra by increasing 
the formation o f IL-lra [Kam et al., 1995] as well by as decreasing the production of IL- 
1 itself [Hart et a l, 1989; Vannier et a l, 1992], Formation o f EL-Ira follows shortly 
after production of IL-1 [Arend et a l, 1991; Andersson et a l, 1992] and is thought to 
protect the host from the catastrophic synergistic effects o f TNF-a and IL-1 which can 
be lethal [Waage & Espevik, 1988; Fong et a l, 1989; Waage et a l, 1989; Munoz et a l, 
1991; Cannon et a l, 1992]. Thus the ability o f an animal to become tolerant to bacteria 
and their toxins is essential if the host is to survive and elicit a controlled inflammatory 
response [Zuckerman et a l,  1991; Andersson, et a l, 1992], (It would have been 
interesting to see how much IL-4 activity there was within the rat small bowel tissue but 
unfortunately the anti EL-4 purchased for this purpose was unsuitable.)
There was evidence of increased neutrophil activity within the small bowel tissue from 
animals dosed with indomethacin ED6o, especially surrounding the area of necrosis 
associated with the ulcer. The primary chemoattractant for neutrophils in rats which 
have been exposed to bacterial LPS is cytokine-induced neutrophil chemoattractant 
(CENC) [Rinaldo et a l, 1984; Christman et a l, 1985, 1989; Watanabe et a l, 1991; Iida 
et a l,  1992]. CINC is produced and secreted by epithelial cells [Watanabe & Nakagawa, 
1987, 1990; Watanabe et a l, 1989a, 1989b, 1993] after activation either by TNF-a or 
IL-1 [Watanabe et a l, 1989b; Nakagawa et a l, 1993; Zagorski & De Larco, 1993; 
Wittwer et a l, 1993] in a parallel fashion to IL-8 generation in humans.
The influx o f neutrophils into the area o f bacterial invasion results in serious damage to 
the surrounding tissue as the toxins used to defend the host against the invading bacteria 
also damage the intestinal epithelial cells in the immediate vicinity of degranulation. All 
cells possess a number of antioxidant enzymes and scavengers to protect themselves
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from these injurious agents but often the production of reactive oxygen metabolites 
overwhelms these defences [Grisham & Granger, 1988], This inability of the neutrophil 
to differentiate between foreign and host antigens [Weiss, 1989] thus results in necrosis 
of the surrounding tissue and this is probably instrumental in the formation of the ulcer. 
Epithelial cell death is in itself extremely inflammatory as many of the cell products, 
released into the extracellular space when a cell is destroyed, are themselves exceedingly 
chemoattractant for neutrophils [Kuby, 1997], NSAID-induced damage to the 
gastrointestinal tract is significantly reduced in animals which have been depleted of 
neutrophils either by methotrexate or anti-neutrophil serum prior to NSAID 
administration [Wallace et a l, 1990. 1991; Lee et al., 1992]. Similarly prevention of 
neutrophil adherence to the endothelium by an antiserum directed against the neutrophil 
adhesion protein CD 18 also reduces indomethacin-induced ulceration [Vedder et a l, 
1988; Wallace et a l, 1991]. These findings would appear to give support to the 
proposal that neutrophils are the major culprits responsible for indomethacin-induced 
injury in rats [Del Soldato et a l, 1985; Pihan et a l,  1987; Vaananan et a l, 1991].
Neutrophils are also attracted to sites o f infection by N- 
formylmethionylleucylphenylalanine (FMLP) [Carp, 1982; Tauber & Babior, 1985], a 
tripeptide which is released by Escherichia coli during replication. Escherichia coli are 
known to have a role in ulcer formation [Robert & Asano, 1977] so once the ulcer has 
become established and the lesion is full o f replicating bacteria the amount o f FMLP 
diffusing out o f the necrotic tissue is significant enough to induce an additional 
neutrophilic response. This probably accounted for the high numbers o f neutrophils 
observed on the periphery of the ulcer in the ulcerated rat small bowel tissue. Although 
FMLP is nontoxic to mammalian cells it not only attracts neutrophils but also activates 
them to produce oxygen free radicals, hydrogen peroxide and hypochlorous acid [Tauber 
& Babior, 1985; Klebanoff, 1992], These reactive oxygen metabolites are extremely 
cytotoxic to cells in the surrounding tissue, as well as being lethal to bacteria, and minute 
amounts o f FMLP are known to cause mucosal injury within the small bowel as a direct 
result of neutrophil activation [Granger et a l, 1987; Von Ritter et a l, 1988],
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In humans neutrophils are also attracted to sites of inflammation by leukotrienes, 
particularly leukotriene B4 (LTB4) [Goetzl & Pickett, 1980; Bray et al., 1981; Palmblad 
et al., 1981; Grisham & Granger, 1988], however, these agents are not such specific 
neutrophil chemoattractants as the chemokines, CINC and IL-8, and are able to attract 
other mononuclear cells to the region of inflammation. It has been reported that LTB4 is 
not chemotactic for rat neutrophils [Kreisle et al., 1985; Sugawara et al., 1995], 
nevertheless it does stimulate the expression of the CD11/CD18 leucocyte adhesion 
glycoprotein [Zimmerman & McIntyre, 1988; Harlan & Liu, 1992] which enhances 
neutrophil adherence [Wallace et al., 1991] Thus the additional neutrophils observed 
within the experimental rat small bowel tissue are unlikely to be there in response to this 
inflammatory mediator. Mononuclear cells which are attracted to LTB4, however, 
probably release neutrophilic chemoattractants themselves once they have migrated to 
the area of inflammation and LTB4 itself stimulates the synthesis o f IL-1 [Hwang, 1989].
Initially the up-regulation o f LTB4 synthesis would have occurred as a direct result of 
cyclooxygenase (COX-1 and COX-2) inhibition by indomethacin. As a consequence 5- 
lipoxygenase, the first dedicated enzyme in leukotriene synthesis, channels the surplus 
arachidonic acid down this pathway [Rainsford, 1987; Bjamason et al., 1989], This 
increase in inflammatory leukotrienes is accompanied by the loss of prostaglandin 
mediated antiinflammatory properties which include prostaglandin inhibition of free 
radical production and enzyme release by neutrophils [Gryglewski et al., 1987; Kainoh et 
al., 1990] plus prostaglandin stabilisation of mucosal mast cells [Bickel & Kauffman, 
1981; McQueen et a l, 1983] and lysosomal membranes [Ferguson et al., 1973], Mast 
cells release preformed cytokines [Galli, 1993; Kubes & Granger, 1996] such as TNF-a 
which is stored prepackaged in granules, readily available for release [Gordon & Galli, 
1991, 1994],
An additional stimulus for leukotriene synthesis occurs once the inflammatory cytokine 
cascade has been initiated as EL-1 also stimulates the production of inflammatory 
eicosanoids [Cominelli et al., 1989] such as PGE2 and LTB4. Evidence supporting this 
comes from the fact that the increase in hypothalamic PGE2, observed in fever, is caused 
by IL-1 mediated release o f arachidonic acid via the hydrolysis o f phospholipid from cell
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membranes [Dinarello, 1991,1994]; and protection against colitis and hyperoxia is partly 
mediated by EL-1 stimulated prostaglandins [Vannier et a l, 1989; White & Ghezzi, 
1989], TNF-a is also capable of stimulating the formation of arachidonic acid 
[Dinarello, 1994] so an inflammatory response, in the presence of NSAIDs which are 
inhibitors o f cyclooxygenase (COX-1 and COX-2), results in most of the arachidonic 
acid being channelled into the production o f even more inflammatory leukotrienes 
[Asako et a l, 1992; Hudson et a l, 1993], This increase in inflammatory leukotrienes is 
particularly significant when the increased manufacture of arachidonic acid occurs after 
ingestion of an NSAID such as indomethacin which predominantly inhibits the COX-1 
enzyme [Meade, et a l, 1993; Mitchell et a l, 1993], COX-1 is the constitutive form of 
the enzyme and is responsible for the physiological synthesis o f prostaglandins in the gut, 
kidney, blood platelets [Funk et a l, 1991] and other tissues [Simmons et a l,  1991]. It is 
inhibition o f this enzyme by NSAIDs which is believed to be responsible for the damage 
caused to the gastrointestinal epithelium as prostaglandins enhance cellular resistance to 
injury [Tamawski et a l, 1988], NSAIDs such as nabumetone, however, selectively 
inhibit the COX-2 enzyme [Meade, et a l, 1993] which is the inducible form responsible 
for inflammatory prostaglandin synthesis within mononuclear cells such as neutrophils 
[Kuby, 1997], mast cells [Kuby, 1997], macrophages and monocytes [Aderem et a l, 
1986; Fu et a l,  1990; Hla & Neilson, 1992; O’ Sullivan, 1992a, 1992b], Thus the 
constitutive form of cyclooxygenase, COX-1, is only partially inhibited after nabumetone 
ingestion enabling it to fulfil its cellular 'housekeeping' functions [Meade et a l, 1993] 
relatively unhindered. Consequently nabumetone causes very little damage if any to the 
gastrointestinal epithelium.
In addition to its role of being the primary initiator of the inflammatory cytokine cascade, 
TNF-a has many other inflammatory properties. TNF-a induces the synthesis and 
expression o f the intercellular adhesion molecules ICAM-1 and ELAM-1 on endothelial 
cells [Pohlman et a l, 1986] and LFA-1 (CDlla/CD18) and MAC-1 (CDllb/CD18) on 
neutrophils [Dustin & Springer, 1989] which are potent stimuli for neutrophil adherence. 
Consequently administration o f TNF-a to rats results in vasocongestion, leucocyte 
margination and tissue damage, predominantly within the gastrointestinal tract [Tracey et 
al, 1986; Remick et a l, 1987; Sayers et a l, 1988; Sartor et a l, 1994] which manifests
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itself as a spotty necrosis on the surface of the intestinal epithelium [Remick et a l, 
1987], It has been proposed that some of this damage may be due to TNF-a exerting a 
direct cytotoxic effect on the cells of the gastrointestinal epithelium [Santucci et a l, 
1995], Evidence supporting this proposal is provided by the observation that isolated 
gastric chief cells express TNF receptors and that exposure to TNF causes a dose- 
dependent necrosis that is prevented by pretreatment with specific anti-TNF receptor 
monoclonal antibodies [Fiorucci et a l, 1993], An excess of TNF-a would also appear to 
increase small bowel permeability, as in cultured monolayers of a pig kidney epithelial 
cell line, TNF-a decreases the resistance in epithelial tight junctions leading to leakage of 
solutes across electrolyte-secreting epithelial cells [Mullin & Snock, 1990]. Thus high 
levels o f TNF-a within the small bowel, as a consequence o f inflammation, would in 
itself appear to mediate ulcer formation.
6.2.6 Role of Cytokines in Human Gastric Mucosa Tissue
The degree of positive staining obtained for the three antisera used, anti-human TNF-a, 
anti-human IL-la and anti-human IL-8, was not significantly different within the 
epithelial cells surrounding the antral gastric pits o f gastric mucosa samples taken from 
patients who were either Helicobacter pylori-positive or Helicobacter /?>>/cv7-negative. 
There was an increase in positive staining within the lamina propria, however, which was 
full o f inflammatory mononuclear cells in the samples taken from patients who were 
Helicobacter pylori-positive. The positive staining observed within the epithelial cells of 
gastric mucosa samples from patients who were Helicobacter /?y/or/-negative would 
seem to suggest that, as with the control rat small bowel samples, normal gastrointestinal 
epithelium is home to considerable cytokine activity. A similar observation has been 
made, in respect o f gastric mucosa, by other researchers [Ishihara et a l, 1996] and is 
probably the result o f exposure to antigens which are ingested into the stomach as a 
matter o f course. There was, however, increased cytokine activity within the gastric 
mucosa samples which were infected with the bacterium Helicobacter pylori. This was 
probably a result o f an inflammatory response to the various toxins of Helicobacter 
pylori [Craig et a l, 1992; Neilsen & Andersen, 1992] which include the bacterium's 
urease [Mai et al., 1992; Harris et al, 1996], lipopolysaccharide [Neilsen et a l, 1994], 
the water soluble Helicobacter pylori neutrophil activating protein (HP-NAP) [Evans et
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a l, 1994; 1995] and another, as yet unidentified, protein which is thought to be 
coexpressed with the product of the cagA  gene [Akopyants et al., 1995; Lange et a l, 
1995], This bacterium and its associated toxins are chemoattractant for 
monocytes/macrophages [Craig et a l, 1992] which are known to secrete EL-ip and 
TNF-a (and probably IL-la) in response to contact with these toxins [Crabtree et a l, 
1991; Mai et a l, 1991; Moss et a l, 1994; Noach et a l, 1994; Peek et al., 1995] and the 
Helicobacter pylori urease protein has been found within macrophages inside the lamina 
propria of biopsy specimens from patients with Helicobacter pylori gastritis [Mai et a l, 
1991], Thus the inflammatory cytokine cascade, as previously described, is initiated 
within the gastric mucosa o f infected patients.
There was also evidence of increased neutrophil activity within the gastric mucosa of the 
Helicobacter pylori-positive patients especially those with gastritis. Recruitment of 
neutrophils to the region o f inflammation probably occurred as a result of the release of 
IL-8 from gastric epithelial cells [Crabtree et a l, 1994 1995; Crowe et a l, 1995; Huang 
et a l, 1995; Sharma et a l, 1995], macrophages [Walz et a l, 1987; Yoshimura et a l, 
1987b], T cells [Gregory et a l, 1988] and neutrophils [Strieter et a l, 1990] which had 
been stimulated by IL -la and TNF-a [Yashimoto et a l, 1992; van Damme, 1994], EL-8 
is a potent chemoattractant for neutrophils, directing their migration [Schroder et a l, 
1987; Yoshimura et a l, 1987a, van Damme et a l, 1988] to sites of infection and 
inflammation, although to a lesser extent IL-8 also attracts T cells [Larsen et a l, 1989b] 
and basophils [White et a l,  1989]. IL-8 is essential for the invasion of neutrophils across 
endothelial cell monolayers and synthetic blood-vessel walls [Huber et a l, 1991; Smith et 
a l, 1991; Kuijpers et a l, 1992], which suggests that it is the mediator prerequisite for 
neutrophils leaving the systemic circulation in order to reach the area of inflammation. 
IL-8 also induces neutrophil degranulation at the site of infection which results in the 
release of lysosomal enzymes such as myeloperoxidase, a-mannosidase, P-glucuronidase, 
elastase, gelatinase B, vitamin Bi2-binding protein and lactoferrin [Schroder et a l, 1987; 
Peveri et a l, 1988; Willems et a l, 1989; Masure et a l, 1991], This particular 
inflammatory response is believed to have a role in the gastritis associated with 
Helicobacter pylori as levels of EL-8 are markedly increased in areas with chronic 
gastritis [Crabtree et a l, 1993, 1994], This probably results in an influx of neutrophils
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into the infected area and their subsequent adhesion and degranulation results in the 
neutrophil mediated damage previously described. This is a chronic inflammatory 
response, however, unlike the acute inflammatory response obtained with an ulcerogenic 
dose of indomethacin which is heightened by indomethacin's inhibition of cyclooxygenase 
(COX-1 and COX-2). In most instances Helicobacter pylori infection does not 
automatically result in the formation of a gastric or duodenal ulcer [Sipponen et al., 
1989], however, patients taking NSAIDs are more at risk of developing one [Jones et 
al., 1991],
Helicobacter-pylori positive patients with duodenal ulcer have been found to have higher 
fasting serum gastrin levels than those patients who only have gastritis [Haruma et al., 
1995] and it has been suggested that this hypergastrinaemia is caused by the bacterium's 
urease activity. The modification o f the gastric surface pH via neutralisation of gastric 
acid by ammonia [Levi et al., 1989b] is believed to result in a lower antral somatostatin 
concentration [Kaneko et al., 1992]. An alternative explanation for the cause of 
hypergastrinaemia, however, is that it may be a direct result o f the local immunological 
inflammatory response to the bacterium by the host's innate immune system [Graham et 
al., 1993], Samples o f gastric mucosa taken from Helicobacter /^/on-positive subjects, 
infected with the type 1 strain, have been shown to have elevated levels of the major 
proinflammatory cytokines IL-1 (3 and TNF-a as well as IL-6, IL-7, IL-8 and IL-10 
[Crabtree et a l, 1991; Noach et al., 1994; Peek et al., 1995; Harris et al, 1996; 
Yamaoka et al. 1996], The initial inflammatory response being mediated by the various 
bacterial toxins [Craig et al., 1992; Neilsen & Andersen, 1992] as previously described. 
Soluble factors from activated monocytes are known to stimulate gastrin release in vitro 
[Golodner et a l, 1992; Lehmann et al., 1996] and IL-lp and TNF-a have been shown to 
induce gastrin release from primary cultures of rat [Weigert et a l, 1992], rabbit [Weigert 
et a l, 1996] and canine [Golodner et a l, 1993; Lehmann et a l, 1995] antral G cells. 
Therefore it is possible that activated macrophages stimulate the antral G cells to release 
gastrin in vivo. Evidence supporting this theory comes from results which show that 
reduction in gastrin release after eradication of Helicobacter pylori [Marshall et a l, 
1988; Levi et a l, 1989b; Graham et a l, 1990] correlates with a decrease in mononuclear 
cells within the gastric mucosa rather than the clearance o f neutrophils and bacterial
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products [Graham et a i , 1993], Whichever mechanism is responsible for
hypergastrinaemia, however, cytokine levels in the antral mucosa are directly related to 
Helicobacter pylori infection and eradication of the bacterium, in patients with duodenal 
ulcer, leads to a marked drop in levels of IL-8 and TNF-a [Moss et a i, 1994],
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7.0 RESULTS - DISCUSSION IN  VIVO PROTEIN MARKERS OF SMALL
BOWEL ULCERATION
7.1 RESULTS - IN VIVO PROTEIN MARKERS OF SMALL BOWEL ULCERATION
7.1.1 Results - Haptoglobin
7.1.1.1 Development o f the Immunoelectrophoresis Procedure
The first gel using the DAKO rabbit anti-human haptoglobin was run using the antiserum 
at a concentration o f 0.25 pl/sq cm gel area, as recommended in the information leaflet 
supplied by DAKO, and this antiserum did cross react with the rat protein. The result 
was that the DAKO Human Serum Calibrator (DHSC) and the trial human serum 
produced nice clear rockets, with well defined peaks, which remained within the confines 
of the gel whereas the rat sera rockets were very faint and had run off the edge of the gel 
without forming a peak. However, it was possible to see that the control rat serum 
(pooled serum from four untreated rats from the Animal House, 0.25 ml per animal,) 
contained less haptoglobin than the serum from the rat with small bowel ulcers.
The experiment was repeated but this time the concentration o f antibody was doubled to 
0.50 pl/sq cm gel area. This time the rockets formed by the DHSC and the trial human 
serum were shorter, darker and more compact as would be expected. The rockets 
formed by the rat sera were also easier to see and the control rat serum peaks had 
remained within the confines of the gel and at a 1/50 dilution were measurable. 
However, the track formed by the serum from the ulcerated rat still trailed off the gel at a 
1/50 dilution and at 1/100 was not distinct enough to measure.
The experiment was repeated again but this time the gel contained 1% PEG 6000 as well 
as an antibody concentration o f 50 pl/sq cm gel area. (The immune complexes would 
precipitate out more rapidly in the presence o f the PEG 6000.) This time the rockets 
formed by the DHSC were very short which confirmed that this particular serum would 
not be suitable for a standard curve. The peaks for the rat sera were bolder, shorter and 
more defined. The rockets formed by rat sera at a dilution of 1/100 were considered the 
clearest and easiest to measure for both the control rat serum and the ulcerated rat 
serum. On this particular gel an experimental standard curve, 1/12.5 to 1/100, had been
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Well Number Sample Number Sera ID Value Dilution Ulcers
36 Internal Control Serum Sigma 1/100
35 JR337 Normal Control 1/100
34 JR335 Normal Control 1/100
33 JR318 Normal Control 1/100
32 JR303 Normal Control 1/100
31 JR261 Indomethacin 65 1/100 *
30 JR260 Indomethacin 65 1/100 *
29 Standard 5 DAKO 1/160
28 Standard 4 DAKO 1/80
27 Standard 3 DAKO 1/40
26 Standard 2 DAKO 1/20
25 Standard 1 DAKO 1/10
24 IJR259 Indomethacin 65 1/100 *
23 •JR258 Indomethacin 60 1/100 *
22 IJR257 Indomethacin 60 1/100 *
21 IJR256 Indomethacin 60 1/100 *
20 IJR255 Indomethacin 65 j 1/100 *
19 IJR254 Indomethacin 65 j 1/100 *
18 IJR253 Indomethacin 65 j 1/100 *
17 IJR230 Diclofenac 112.5 i 1/100 *
16 IJR229 Diclofenac 112.5 j 1/100 *
15 IJR228 Diclofenac 112.5 j 1/100 *
14 IJR224 Diclofenac 100 j 1/100 *
13 IJR222 Diclofenac 100 ; 1/100 *
12 IJR199 Vehicle Control j 1/100
11 | Standard 1 DAKO j 1/10
10 | Standard 2 DAKO j 1/20
9 j Standard 3 DAKO j 1/40
8 | Standard 4 DAKO j 1/80
7 | Standard 5 DAKO j 1/160
6 IJR195 Vehicle Control j 1/100
5 IJR192 Vehicle Control j 1/100
4 IJR191 Vehicle Control j 1/100
3 IJR178 Normal Control j 1/100
2 IJR176 Normal Control j 1/100
1 j Internal Control Serum Sigma j i/ ioo
Table 7.1.1.1 Description of Sera Run on Gel Reproduced on Facing Page
00-J
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Photo 7.1.1 Example o f Gel Produced During Rocket Immunoelectrophoresis Assay o f Serum Haptoglobin (See Table 7.1.11)
run using pooled rat serum {Sigma} but this rat serum contained less haptoglobin than 
the control rats from the Animal House at an equivalent dilution. The experiment was 
repeated using the pooled rat serum {Sigma} at 100% and 1/6.25 for the highest points 
on the standard curve, however, on this occasion the tracks for the undiluted serum and 
the 1/6.25 dilution ran off the end o f the gel.
It was decided to use the pooled rat serum from Sigma as a standard, 1/12.5 to 1/100, 
and to dilute the rat sera samples accordingly so that the peaks of the rockets fell within 
the confines of the standard curve. The samples were routinely diluted 1/50 and 1/100 
but the serum from rats with severe ulceration had to be assayed at a 1/200 dilution. 
However, it was found that the value on the standard curve for a 1/50 dilution was more 
than double that obtained for a dilution of 1/100 and that the discrepancy increased 
between the 1/200 dilution and the 1/50. Therefore it was decided that the pooled rat 
serum {Sigma} was unsuitable for a standard curve and that it should be used as an 
internal control instead. Consequently each time a gel was run the value obtained for a 
1/100 dilution o f this serum showed whether the gel had worked correctly or not. 
Eventually the problem of a suitable serum for use as a standard curve was solved by 
DAKO who sent a human serum calibrator which had very high levels o f haptoglobin.
Using these experimental parameters it was possible to run all the rat serum samples at a 
1/100 pi dilution so that the values obtained for each sample could be compared directly. 
Care was also taken to ensure that samples belonging to the same set o f experiments 
were run on the same gel so that these too could be compared directly thus ensuring that 
any differences between them could not be due to an experimental artefact (photo. 
7.1.1).
The serum haptoglobin concentration corresponding to the peak height was determined 
via a standard curve (see fig. 7.1.1.1) and the relative concentration calculated for each 
sample, taking the dilution factor into account. The results although expressed as mg/ml 
are not strictly accurate as the anti-human haptoglobin would not have bound to the rat 
protein with the same intensity as to the human serum that comprised the standard curve. 
However, the results are comparable within the rat serum samples.
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Standard Curv e for Haptoglobin
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Figure 7.1.1.1 Standard Curve for Serum Haptoglobin 
7.1.1.2 Correlation Between Ulceration and Serum Haptoglobin
There appeared to be a significant correlation (r = 0.63, p < 0.001) between the 
percentage area o f total small bowel ulceration and the concentration o f haptoglobin in 
the rat serum as measured by regression analysis (see fig. 7 1.1 2a).
Ratio Between Total Small Bowel Ulceration and Serum Haptoglobin
Y = 13 0462 + 7 30E-02X
R -S quared  =0 184
Percentage A rea of Total SmallBowelUlceration
Figure 7.1.1.2a
However, it was noticed that animals treated with NSAIDs that did not develop ulcers 
had higher levels o f serum haptoglobin than controls. It was decided to see if there was 
a correlation between the actual dose o f an NSAID and the concentration o f serum
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haptoglobin. The only drug that this was possible with was indomethacin so the acute 
dose of indomethacin (mg/kg) was plotted against the concentration of serum 
haptoglobin There appeared to be a better correlation (r = 0.73, p < 0.001) between 
these two parameters as measured by regression analysis (see fig. 7.1.1,2b).








Indomethacin A cute (mg/kg)
Figure 7.1.1.2b
7.1.13 Chronic Oral Administration o f NSAIDs
As a result o f the above correlation it was decided to analyse the serum haptoglobin 
concentrations found in the samples from animals without ulceration which had been 
dosed chronically with NSAIDs.
7.1.1.31 Short Term - Chronic Diclofenac
Animals had been dosed once daily for seven days either with diclofenac ID75 (6.9 
mg/kg) or diclofenac ID 100 (9.2 mg/kg) and killed on day ten. On comparing the 
concentration o f haptoglobin, assayed in the serum of these animals, the concentration 
was found to be significantly higher (p < 0.05) in the animals dosed with diclofenac ID 100 
(5.98 ± 0.25 mg/ml) than in the animals dosed with diclofenac ID 75 (4.54 ± 0.23 mg/ml). 
(Two o f the animals dosed with diclofenac ID 100 did have one small ulcer each, 
equivalent to 0.15 per cent or 0.04 per cent o f the total small bowel area respectively, 
but as the serum haptoglobin concentration was less in the animal with the larger area of
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ulceration than the in the animal without any ulceration (0.15% = 5.6 mg/ml:0.0% = 5.75 
mg/ml) it was deemed to be insignificant.) Animals which had been dosed chronically 
with diclofenac ID112.5 (10.35 mg/kg) but for only four days had significantly higher (p < 
0.05) levels o f serum haptoglobin (16.33 ± 2.50 mg/ml) than the animals treated with the 
lower doses of diclofenac over a longer period of time. All these animals had ulcers in 
the small bowel but the mean total area o f ulceration was only 1.31 ±0.21 mg/ml. The 
serum haptoglobin concentration found in the vehicle control animals dosed chronically 
with 10 per cent (v/v) Tween-80 (2.0 ml/kg) for seven days and killed on day ten was 
slightly higher (4.84 ± 0.90 mg/ml) than that found in control animals dosed concurrently 
with 2.0 ml/kg distilled water (4.66 ± 0.24 mg/ml). However this was not significant.
The serum haptoglobin concentration o f 4.66 ± 0.24 mg/ml for control rats was high 
when compared with the report that concentration of haptoglobin in normal rats is 0.5 
mg/ml [Wassdal etal., 1991]. This is due to the fact that the anti-human haptoglobin did 
not bind so well to the rat protein which is why the peaks on the gel were fainter (see fig. 
7.1.1.1a). These peaks would have been a lot shorter had the antiserum been more 
specific and this explains the elevated result. Although the values are approximately ten 
fold higher than what would be expected these results are still comparable between the 
animals used during the course o f these experiments.
7.1.1.3.2 Long Term
The serum haptoglobin levels o f the animals dosed with the ID125 values o f fenbufen 
(50.0 mg/kg), nabumetone (79.0 mg/kg), naproxen (5.0 mg/kg) and piroxicam (7.0 
mg/kg) for 21 days over a four week period were also investigated. The concentration 
of serum haptoglobin for the animals dosed with piroxicam (10.08 ± 1.65 mg/ml) was 
significantly higher (p < 0.05) than the values obtained for naproxen (6.24 ± 0.75 
mg/ml), fenbufen (5.04 ±0.1 mg/ml) and nabumetone (4.83 ± 0.37 mg/ml).
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7.1.2 Results - Myoglobin
7.1.2.1 Isocratic System
Standards and serum samples were run on the isocratic system but during the course of 
the proceedings the pressure in the system began to decrease and the myoglobin peak 
was found to be getting broader, indicative of a 'hole' at the top of the column. The top 
was removed from the column and a gap o f approximately 1.0 mm was found. The mesh 
was cleaned and the column tested with the standard solution (supplied with the column) 
under test conditions. The subsequent chromatogram obtained was identical to that 
supplied with the column which showed that the column had not deteriorated during the 
40 hours that it had been in use. The procedure was halted until the problem with the 
column could be resolved.
Although this system was only used for a short period o f time it did provide some useful 
information. Analysis was conducted to determine whether or not serum myoglobin was 
stable in distilled water, as the serum samples would have to be diluted prior to injecting 
them onto the column. (It had been reported that myoglobin was very unstable and that 
it was at its most stable within 100 per cent serum [Powell et a l , 1984].) A comparison 
between myoglobin standards diluted either with serum or with distilled water revealed 
that myoglobin was stable in distilled water (see figs. 7.1.2. la and 7.1.2. lb).
During the course o f this work it was found that levels of myoglobin in rat serum were 
very low so it was decided to collect urine for analysis instead as it was reported that 
myoglobin levels in urine were generally higher [Powell et a l  1884], In addition to this 
urine samples were 'cleaner' than serum samples which meant that higher concentrations 
of sample could be passed through the column without the risk o f it becoming blocked. 
It was also decided that the separation may be improved if the analysis was conducted 
using a gradient system. Consequently myoglobin analysis was suspended until suitable 
apparatus was available, a gradient system and a replacement column, and sufficient 
urine samples had been collected.
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Standard Curve for M yoglobin in Serum
y = 0.3141x 
r = 0.994
20 40 60 80
Myoglobin Concentration (ug/'ml)
Figure 7 .1.2.1a Standard Curve for Myoglobin in Serum
Standard Curve for Myoglobin in Distilled Water
y = 0.3602x 
r = 0.999
20 40 60 80
Myoglobin Concentration (ug/ml)
Figure 7.1.2.1b Standard Curve for Myoglobin in Distilled Water
Although only a few samples had been analysed (n = 15) there did appear to be a trend as 
samples from animals without ulcers had more serum myoglobin than animals with small 
bowel ulceration, however, the correlation was not significant. (Pooled control rat 
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Figure 7.1.22 Chromatograms Illustrating Lack of Serum Myoglobin Within Rat Serum Samples
a. Sample Superimposed With Sample Spiked With Myoglobin (lOOpg/ml)
b. Sample Spiked With Myoglobin (lOOpg/ml) Superimposed With Myoglobin Standard (lOOpg/ml) 
M = Myoglobin Peaks
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7.1.2.2 Gradient System
Initially a few rat and human urine samples were run on this system to assess its 
suitability and then it was decided to postpone all further analysis until the end of the 
project so that all the samples could be run at the same time. Owing to the scarcity of rat 
urine samples, as a consequence o f a lack o f success in urine collection, serum samples 
had to be used. However, when using a 100 pi loop, with the serum sample diluted 1:9 
with filtered distilled water, the myoglobin peak was undetectable (see fig. 7.1.2.2a and 
7.1.2.2b). As a result neat serum was used but the protein tended to block the column. 
In order to try and facilitate analysis, the serum was filtered using a micropartition 
system {MPS-1, Amicon} but this filtered out all the protein which had been seen to be 
eluting from the column.
There was always a problem in that the system never seemed to stabilise as the peaks 
produced on the chromatogram by the myoglobin standards appeared progressively later 
as the protein took longer to elute each time a standard was injected. This may have 
been due to the fact that the column required a longer time than usual to become 'loaded' 
and as availability o f the HPLC equipment was limited to short periods o f time (two 
weeks) when it was not being used by other researchers the gradient system procedure 
probably never stabilised. Unfortunately at this point all work in the laboratory had to 
cease as it was decided that insufficient time was available for any more practical work. 
As a consequence no further analysis was conducted on these samples.
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1.2 DISCUSSION - IN VIVO PROTEIN MARKERS OF SMALL BOWEL
ULCERATION
7.2.1 Discussion - Haptoglobin
Haptoglobin, an acute phase glycoprotein with a molecular weight o f approximately 90 
kDa, has a tetrameric (3aap structure, where the a-chains are linked by a disulphide 
bond. These a-chains are each linked to a p-chain by an additional disulphide bond 
[Malchy et a l, 1983]. Acute phase proteins are a group of mainly glycoproteins which 
are synthesised by hepatocytes [Putnam, 1975] in response to cytokines produced by 
leucocytes and macrophages which have themselves been stimulated by infection or 
inflammation [Bomstein, 1982; Marinkovic et a l,  1989; Kent, 1992], Thus serum 
haptoglobin concentrations increase after inflammatory stimuli [Murray & Connell, 1960; 
Bowman & Kurosky, 1982; Eckersall & Conner, 1988; Morimatsu etal., 1992], which is 
why it is used as an indicator o f inflammatory diseases [Bowman & Kurosky, 1982; 
Heinrich et a l, 1990],
Haptoglobin is also believed to have antiinflammatory properties as it has been shown to 
decrease both neutrophil metabolism [Oh et al., 1990a; El Ghmati et al., 1996], the 
chemotactic response o f monocytes and to inhibit the proliferation o f peripheral blood 
mononuclear cells [Samak et a l, 1982], Heterologous haptoglobin may also modulate B 
cell proliferation and decrease antibody production [Oh et al., 1990b]. Haptoglobin is 
also thought to be a natural bacteriostat [Eaton et al., 1982] by preventing the utilisation 
of haemoglobin iron by various pathogenic bacteria, especially those which may be 
present in abscesses and those which escape into the peritoneal cavity from a perforated 
ulcer [Eaton et a i, 1982].
Haptoglobin as a Possible Indicator o f Small Bowel Ulceration
There was a significant correlation (r = 0.63 = P < 0 .001) between the percentage area of 
total small bowel ulceration and the concentration of haptoglobin in the rat serum (see 
fig. 7.1.1.2a). However, the correlation between an actual acute dose of indomethacin 
and the concentration o f serum haptoglobin was more significant (r = 0.73, p < 0.001). 
Similarly animals which had been dosed chronically with diclofenac for seven days
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without developing ulceration had significantly (p < 0.05) higher concentrations of serum 
haptoglobin than control animals. The serum haptoglobin levels of the animals dosed 
chronically with the ID125 values of fenbufen, nabumetone and naproxen for 21 days over 
a four week period were not significantly different to those found in control animals (p > 
0.05), although the value obtained for naproxen (6.24 ± 0.75 mg/ml) was slightly higher 
than those obtained for fenbufen (5.04 ± 0.1 mg/ml) and nabumetone (4.83 ± 0 .3 7  
mg/ml). However, the concentration o f serum haptoglobin for the animals dosed over a 
four week period with piroxicam (10.08 ± 1.65 mg/ml) was significantly higher (p < 
0.05). Therefore there would appear to be a greater correlation between the serum 
haptoglobin level and an inflammatory response within the animal rather than the degree 
of ulceration.
Evidence which would appear to support this supposition comes from the experiments 
investigating the role of cytokines in ulcer formation. The lowest levels o f the 
inflammatory cytokines, TNF-a and IL-la, were found within the intestinal mucosa of 
the animals which had developed small bowel ulcers. The animals given indomethacin 
ED3o, however, a dose which did not produce ulcers, had the highest levels of IL-la  
within the small bowel tissue accompanied by many mononulcear cells within the lamina 
propria, all indicative o f an inflammatory response.
These results correlate well with the ulcerogenic properties o f the drugs under 
investigation. Indomethacin was found to be the most toxic o f the NSAIDs investigated 
during this project followed by diclofenac and the serum haptoglobin levels reflect this. 
The degree of gastrointestinal damage caused by an NSAED appears to be related to the 
degree o f enterohepatic recirculation that the drug undergoes and the pKa value. Thus 
the most damage is caused by indomethacin and diclofenac which have a combination of 
significant enterohepatic recirculation in conjunction with a low pKa value. The 
haptoglobin results obtained from the long term dosing experiment, however, would 
appear to indicate that it is the extent to which a drug undergoes enterohepatic 
recirculation which is critical to ulcer formation within the small bowel.
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Animals dosed with indomethacin ID30 would appear to illustrate that an inflammatory 
response within the small bowel, as a result of NSAID ingestion, is indicative of 
imminent ulcerogenesis. Thus the serum haptoglobin levels found in animals dosed long 
term with piroxicam would appear to indicate that there was a distinct possibility that 
the animals would have developed small bowel ulcers if treatment had continued. These 
results would appear to show that after indomethacin and diclofenac, piroxicam is the 
most toxic NSAID of the drugs investigated. Thus in spite of piroxicam having the 
highest pKa value of the drugs used during this project it is the fact that it undergoes 
greater enterohepatic recirculation than the remaining drugs (naproxen, fenbufen and 
nabumetone) that results in the increased inflammation. The serum haptoglobin 
concentration for animals dosed long term with naproxen was slightly higher than that 
found in control animals and this is probably due to its low pKa value. The fact that 
naproxen undergoes significantly less enterohepatic recirculation within the rat than 
indomethacin, diclofenac and piroxicam, is what makes it less toxic.
The serum haptoglobin level o f fenbufen treated animals (5.04 ± 0.1 mg/ml) was slightly 
higher than that of nabumetone (4.83 ±0 .37  mg/ml) although this was not significant (p 
> 0.05). However, during this particular experiment (long term chronic dosing) the 
animals dosed with fenbufen gained the least weight over the four week period. The 
mean weight gain between the groups was not significantly different although the animals 
given fenbufen ID125 weighed significantly less (p < 0.05) than the animals dosed with 
naproxen ID125 (140.00 ± 20.08 g versus 185.00 ± 8 . 1 0  g). This result may be indicative 
of the fact that although fenbufen is quite innocuous when compared to indomethacin, 
diclofenac, piroxicam and naproxen, it is more toxic than nabumetone. Therefore, 
comparing the six NSAIDs used during this research nabumetone causes the least side 
effects followed by fenbufen, naproxen, piroxicam, diclofenac and indomethacin.
Levels o f serum haptoglobin would appear to be a useful in vivo protein marker o f small 
bowel inflammation which could be an indicator o f those at risk o f developing a small 
bowel ulcer when taking NSAIDs long term. The serum haptoglobin levels would 
probably still be elevated once an ulcer had formed, although from the experiments
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within the rat model it would appear that serum haptoglobin levels begin to fall in the 
presence of small bowel ulceration.
Patients suffering with rheumatoid arthritis have increased serum haptoglobin 
concentrations when compared to normal individuals [Hallgren et a l, 1985; Kirstein & 
Mathieson, 1987] and this is due to the tissue inflammation which is associated with the 
disease. The serum haptoglobin results obtained in the rat model after NSAID 
administration would seem to suggest that increased levels in patients with rheumatoid 
arthritis may also be due in part to long term ingestion of NSAIDs.
7.2.2 Discussion - Myoglobin
Myoglobin, a relatively small oxygen-binding protein with a molecular weight of about 
16.7 kDa, is found primarily in muscle cells [Lehninger, 1982]. Both myoglobin and 
haemoglobin can be liberated at sites o f tissue injury [Odeh, 1991; Halliwell, et a l, 1992] 
such as that seen in small bowel ulceration or in the inflamed rheumatoid joint [Blake et 
a l, 1981], Antiinflammatory drugs [Evans et a l, 1994], particularly indomethacin have 
been shown to be capable o f generating damaging radicals [Vaananen et a l, 1991] and 
this process is possibly mediated via myoglobin which is thought to act as a catalyst for 
the formation o f strong oxidants [Evans et a l, 1994; Phung et a l, 1994],
The lack o f results for this part of the project was very disappointing. There did appear 
to be a trend although this correlation (r = 0.36) was not significant (r < 0.48 = p > 0.05) 
within the number of samples (n = 15) analysed. The animals with small bowel ulcers 
tended to have serum myoglobin levels which were lower than those found in control 
animals. Similarly animals given an NSAID which had not developed small bowel 
ulceration had levels lower than the control animals although the serum myoglobin 
concentration was more than that found in the animals with small bowel ulcers. Further 
investigation o f the change in serum myoglobin concentration as a result o f ulceration is 
probably worthwhile.
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8.0 MECHANISMS INVOLVED IN ULCERATION OF THE STOMACH AND
SMALL BOWEL : GENERAL DISCUSSION
Synthetic NSAIDs have been available for almost 100 years the first, acetylsalicylic acid 
(aspirin), being manufactured in 1899 [Wallace, 1997]. Although being very efficacious 
in the treatment of arthritis and other musculosketal disorders, long term use of 
acetylsalicylic acid was found to be acutely toxic to the gastric and duodenal mucosa 
[Levi & Shaw-Smith, 1994] and consequently pharmaceutical companies across the 
world began conducting research into finding a more innocuous alternative. As a result 
there are now currently 23 NSAIDs available for use in the UK alone [Levi & Shaw- 
Smith, 1994] and the world market for NSAIDs now exceeds £4 billion per year 
[Gamer, 1992; Wallace, 1997], Although the newer NSAIDs are less damaging to the 
stomach it would appear that many o f them have harmful side-effects throughout the 
remainder of the gastrointestinal tract [Sturges & Krone, 1973; Schwartz, 1981; 
Hawkey, 1990].
The process o f NSAID-induced ulceration would appear to be extremely complex with 
the entire procedure being dependent on many separate contributory mechanisms, the 
removal o f just one o f these parameters being sufficient to prevent ulcerogenesis. The 
first mechanism of damage to be determined was the ability of NSAIDs to inhibit the 
enzyme cyclooxygenase (COX-1 and COX-2), the first dedicated enzyme in 
prostaglandin (PG) synthesis. Unfortunately it is also through the inhibition of this 
enzyme that NSAIDs mediate their antiinflammatory properties [Vane, 1971], 
Prostaglandins o f the E and F series have been shown to be instrumental in initiating 
some of the local and systemic characteristics of inflammation, such as vasodilation, 
increased vascular permeability, swelling, increased leucocyte migration and pain 
[Swingle & Kvam, 1986]. Prostaglandins are also believed to be one of the mediators of 
rheumatoid arthritis so it would be expected that drugs which inhibit their synthesis 
would ameliorate arthritic diseases [Lewis & Keft, 1995], The problem is that 
prostaglandins and their properties are numerous, they affect almost every biological 
system and many of the functions they exhibit are diametrically opposed to one another 
[Robert, 1979], Prostaglandins are necessary for the maintenance of the epithelial cells 
within the gastrointestinal tract [Miller & Jacobson, 1979; Robert, 1979] where they
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protect the gastrointestinal epithelium against a variety of noxious agents and thus they 
confer a cytoprotective effect [Miller & Jacobson, 1979; Robert, 1979], Therefore when 
rats are dosed with prednisolone, an inhibitor o f the enzyme phospholipase A, which 
prevents the release of arachidonic acid from the cell membrane [Gryglewski et a l , 
1975] they develop multiple necrotic ulcers in the ileum [Lancaster & Robert, 1978], 
similar to those caused by indomethacin. In this instance it is the lack of prostaglandins 
which is responsible for the small bowel damage and this is indicative of their importance 
in maintaining the integrity of the gastrointestinal epithelium. Consequently a similar 
result would be expected when their production is prevented by NSAID inhibition of 
cyclooxygenase (COX-1 and COX-2).
The inhibition of cyclooxygenase (COX-1 and COX-2) by NSAIDs results in similar 
damage occurring, although in this instance the damage is more severe. Inhibition of 
phospholipase A by prednisolone results in a lack o f arachidonic acid which means that 
neither prostaglandins nor leukotrienes can be formed. However, when cyclooxygenase 
(COX-1 and COX-2) is inhibited by NSAIDs, the production of leukotrienes is increased 
as the surplus arachidonic acid is channelled into their production via the enzyme 5- 
lipoxygenase [Rainsford, 1987, 1993a; Bjamason et a l, 1989], This overproduction of 
leukotrienes, in conjunction with a depletion in cellular prostaglandins, results in an 
inflammatory response as leukotrienes are chemoattractants for a number of 
mononuclear cells [Kuby, 1997b], This inflammatory process can be attenuated either by 
the concomitant administration of PGE2 or one o f its analogues [Robert, 1974, 1975, 
1979; Fang et a l, 1977; Tabata & Okabe, 1983; Romain et a l, 1987] or by an inhibitor 
of 5-lipoxygenase [Rainsford, 1987; Rainsford, 1993b].
This particular mechanism is a property o f the older NSAIDs such as indomethacin, 
diclofenac and naproxen which tend to inhibit COX-1, the constitutive form of  
cyclooxygenase, rather than COX-2, the inducible form. COX-1 is the enzyme 
responsible for maintaining the integrity o f cells within various organs and other 
physiological tissues [Funk et a l, 1991; Simmons et a l, 1991]. Thus inhibition of COX- 
1 leads to the small bowel damage which is associated with NSAIDs. The newer 
NSAIDs, such as nabumetone, selectively inhibit COX-2 [Meade et a l, 1993] which is
201
the inducible form of the enzyme that plays a key role in the inflammatory response 
[Vane et a l, 1994], COX-2 is found predominantly in leucocytes, such as macrophages 
and monocytes, in which de novo synthesis o f the COX-2 gene occurs in response to EL- 
1 [Hla & Neulson, 1992]. NSAID-induced small bowel damage can therefore be 
prevented by administering a newer, COX-2 inhibitor, such as nabumetone, rather than 
an older style NSAID which is an inhibitor o f COX-1.
The initial damage caused by some NSAIDs is probably due to a direct topical effect of 
the drug as it enters the stomach and then, if not fully absorbed there, as it passes 
through into the small bowel. This topical damage within the stomach occurs as a result 
of'ion trapping' and is caused primarily with NSAIDs which have a low pKa value, such 
as diclofenac, naproxen and indomethacin. These drugs, which are predominantly un­
ionised within the acidic environment o f the gastric lumen, pass through the lipid bilayer 
of the cells which constitute the gastric epithelium. Once they enter the cytosol of a 
gastric epithelial cell, where the pH is maintained at about 7.4, they become ionised with 
the result that they become trapped within the cell. NSAIDs which have a higher pKa 
value, such as piroxicam and fenbufen, or are neutral like nabumetone do not become 
trapped within the gastric epithelial cells as they remain predominantly un-ionised even 
within the cytosol o f the epithelial cells As a result they are free to pass back and forth 
across the lipid bilayer without causing very much damage to the cell. To a lesser extent 
the process o f 'ion trapping' continues within the small bowel even though most of the 
drugs with the lower pKa values are ionised at pH 7.0. A proportion o f these drugs, 
however, will still be un-ionised and it is this portion that is able to pass through into the 
cells lining the intestinal epithelium where they become trapped. The drugs with the 
higher pKa values are still un-ionised and are thus able to pass freely back and forth 
across the lipid bilayer and consequently they cause little damage.
Once inside the cells o f the gastrointestinal epithelium the NSAIDs may cause damage 
through more than one mechanism. In the stomach, where the water soluble NSAIDs, 
such as diclofenac, can become highly concentrated, albeit temporarily, within the gastric 
epithelial cells, the high intracellular concentration of acidic NSAID may exert a direct 
acid damaging effect [Schoen & Vender, 1989], NSAIDs are also able to uncouple
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mitochondrial oxidative phosphorylation and it has been reported that the NSAIDs with 
the lower pKa values are the most effective uncouplers [Mahmud et a l, 1996a], Topical 
damage as a result of this process is more significant within the intestinal epithelium 
where the pH of the small bowel prevents high concentrations of drug accumulating 
through 'ion trapping'. In the presence of such uncouplers electron transport proceeds 
normally but ATP is not formed by the mitochondrial ATPase [Stryer, 1981], This 
depletion in ATP is believed to be responsible for the small bowel permeability, a 
characteristic of NSAID-induced damage, as ATP is necessary for the maintenance of 
the tight junctions within the intestinal epithelium [Meza et a l, 1980; Madara & 
Dharmsathaphom, 1985; Madara et a l, 1986, 1987], Additional damage within the cell 
could be due to NSAID inhibition o f various enzymes involved in glycolysis and/or the 
tricarboxylic acid cycle which also prevents the formation of ATP [Smith & Dawkins, 
1971],
This topical damage would appear to be exacerbated the more times the gastrointestinal 
epithelium is exposed to the drug. In the case of a single dose, the gastric epithelium can 
only be exposed to the drug once prior to absorption, but this is not the case with the 
intestinal epithelium. Therefore the enterohepatic circulation plays an important role in 
NSAID-induced ulceration within the small bowel and here it is only the drugs which are 
excreted in the bile that have ulcerogenic properties. Thus as a result o f enterohepatic 
recirculation the small bowel is exposed to the effects o f a single dose on more than one 
occasion with some NSAIDs. The NSAIDs with the lower molecular weights, such as 
naproxen, fenbufen and nabumetone, which do not undergo significant enterohepatic 
recirculation, only pass through the small bowel once. Thus any damage that the drug 
may cause via a direct topical effect can only occur once prior to absorption. The 
NSAIDs with the higher molecular weights, such as diclofenac, indomethacin and 
piroxicam, all undergo enterohepatic recirculation and as a result the small bowel is 
exposed to the effects o f a single dose on more than one occasion.
Although the phenomenon o f 'ion-trapping' occurs primarily within in the gastric lumen, 
a proportion of the drugs with the lower pKa values will still be un-ionised. The un­
ionised portion is therefore able to pass through the lipid bilayers of the intestinal
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epithelial cells where it becomes trapped within the cytosol of the cell. The damage 
caused as a result of 'ion-trapping' is relatively insignificant if the intestinal epithelium is 
only exposed to the drug once but if exposed continually this damage can become 
significant. This is probably why naproxen, which has a lower pKa value than 
indomethacin and is readily trapped within gastrointestinal epithelial cells, is less 
ulcerogenic than diclofenac and indomethacin. NSAIDs that undergo enterohepatic 
recirculation, such as piroxicam, which have a higher pKa value are less likely to be 
trapped within the cells o f the intestinal epithelium. Thus even if the small bowel is 
exposed to drugs such as these on numerous occasions the resultant topical damage will 
be very slight. This is probably why piroxicam is less ulcerogenic than diclofenac and 
indomethacin. During this project indomethacin and diclofenac were the only drugs 
which caused small bowel ulceration in the rat and this was probably due to a 
combination of their having low pKa values in addition to undergoing extensive 
enterohepatic circulation. Evidence supporting this proposal is provided by the fact that 
a chemical modification o f diclofenac, which does not undergo such extensive 
enterohepatic recirculation, is considerably less ulcerogenic [Reuter et a l, 1997], 
Diclofenac is less toxic to the intestinal epithelium in man than indomethacin, even 
though it has a lower pKa value, and in humans this can be explained by the fact that 
indomethacin undergoes more extensive enterohepatic recirculation in man than 
diclofenac. This does not explain the difference in ulcerogenesis observed within the rat 
where both drugs undergo enterohepatic recirculation to a similar extent [Hucker et a l, 
1966; Yesair et a l, 1970; Duggan et a l, 1975; Riess et a l, 1975], In this instance the 
difference is probably due to the fact that diclofenac sequesters arachidonic acid into lipid 
(largely triglyceride) pools [Day et a l, 1990] from where it can be re-incorporated into 
the inner membrane of the cell, thus limiting leukotriene formation.
In rats the role o f normal gastrointestinal bacteria is probably the major contributory 
factor in NSAID-induced ulceration. In the experimental rat small bowel tissue which 
had been taken from animals treated with indomethacin ID6o, the discrete ulcers and 
erosions were associated with Peyer's patches. Peyer's patches are areas of attraction for 
many bacteria [Garland et al.9 1979; Savage, 1979; Sonnenwirth, 1980; Wolf, 1988; 
O'Loughlin, 1995; Sansonetti et a l, 1996; Kuby, 1997] as they are able to adhere to the
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smooth surface of the M cells which cover the lymphoid follicles [Savage, 1969; Klaasen 
et a l ,  1992; Jepson et al., 1993, Sansonetti et a l, 1996]. However, the majority of the 
intestinal epithelium within the small bowel, o f both man and the rat, is devoid of bacteria 
as gut motility, a non-immunological defence mechanism [Sarker & Gyr, 1992], prevents 
bacteria from adhering to the epithelial cells which are covered in microvilli.
In the experimental ulcerated rat small bowel tissue, the areas of damage away from 
Peyer's patches had not elicited an inflammatory response. Thus it would appear that, in 
the absence of bacteria and their toxins, such damage would be repaired via epithelial cell 
turnover and would not result in an ulcer. Similarly, indomethacin-induced small bowel 
permeability on its own does not automatically result in an ulcer. It is probably the 
bacteria and/or their toxins entering the extracellular space of the intestinal epithelium 
which initiates the catastrophic inflammatory cytokine mediated response. Evidence 
supporting this proposal is provided by the fact that germ-free rats do not develop ulcers 
when given an ulcerogenic dose of indomethacin which would produce ulcers in 
conventional rats [Robert & Asano, 1977], The total removal o f these microorganisms 
from the gastrointestinal tract with a combination o f the antibiotics metronidazole and 
amoxycillin, prior to dosing with indomethacin, conferred complete protection against 
the ulcerogenic process mediated by the NSAID. The antibiotic treatment was still 
effective to some degree even when the animals were dosed up to two weeks before the 
indomethacin challenge. This protection has also been observed by other researchers in 
animals pretreated with antibiotics or given them concomitantly [Kent et a l, 1969; Fang 
et a l, 1977; Yamada et a l, 1993; Collins et a l, 1995], Antibiotics given after the 
ulcerative process has already been initiated, however, confers no significant protection 
at all and does not promote healing [Kent et a l, 1969; Robert & Asano, 1977; Satoh et 
a l, 1983; Benoni et a l, 1987; Bjamason et a l, 1988b]. It would seem from this that 
once the process o f ulcerogenesis has started, mechanisms other than those afforded by 
bacteria play a key role.
Neutrophils have been implicated as being the key contributors to the tissue damage seen 
in the small bowel as a result o f NSAID-induced ulceration [Del Soldato et a l, 1985; 
Pihan et a l, 1987; Vaananan et a l, 1991], Animals which are neutropaenic or have been
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made neutropaenic by treatment with an anti-neutrophil antiserum are resistant to 
NSAID-induced ulceration [Wallace et a l, 1990; Lee et al., 1992], The recruitment of 
these leucocytes to the area of infection is most probably triggered by bacterial toxins, 
such as lipopolysaccharide, diffusing into the gastrointestinal mucosa as a result of the 
NSAID-induced small bowel permeability where they initiate the inflammatory cytokine 
cascade. Once this inflammatory response has been initiated, however, it would appear 
to become self generating, especially in the presence o f NSAIDs which are inhibitors of 
COX-1 and as a result o f this property are responsible for the increased production of 
chemoattractant leukotrienes. The necrotic tissue within the area o f ulceration contains a 
mixture of potent chemoattractant debris made up of bacterial products and fragments of 
cells [Kuby, 1997a] which have been destroyed as a result of neutrophil degranulation 
[Grisham & Granger, 1988], Thus the eradication of bacteria from the area of 
ulceration, once this process has started, would not appear to be able to prevent the 
inflammatory response. This is probably why administration o f antibiotics after the 
ulcerative process has started does not heal the ulcers but there is a possibility that 
antibiotics may attenuate the process to a certain extent. (It is possible that antibiotics 
given to rats 12-24 hours after an acute dose o f indomethacin ID125 (12.5 mg/kg) may 
have prevented the longitudinal ulcers forming.)
Humans are less likely than rats to be exposed to large amounts o f bacteria within the 
small bowel as man does not practice coprophagy, however, bacteria here probably do 
have a similar role in ulcerogenesis. It has been reported that long-term use o f NSAIDs 
can result in diaphragm-like small bowel strictures [Bjamason et a l, 1988a; Levi et a l, 
1990], usually within the ileum [Lang et al, 1988; Levi et a l, 1990], which may narrow 
the lumen down to a pinhole [Bjamason et a l, 1993, Levi & Shaw-Smith, 1994] and 
these strictures are often associated with circumferential ulceration [Lang et a l, 1988], 
It may be that bacteria, which would otherwise pass through the small bowel harmlessly 
due to normal gut motility, become trapped in the area of these strictures enabling them 
to colonise a region usually sparsely populated by bacteria. (Under normal conditions 
the upper/mid regions o f the small bowel are usually free from Bacteroides spp. but these 
bacteria have been found in large numbers within areas of stasis in the ileum [Gorbach et 
a l, 1969; Rath et a l, 1996].) Thus bacteria within these small bowel strictures in
206
conjunction with small bowel permeability, due to NSAID ingestion, may be responsible 
for the formation of these circumferential ulcers.
In recent years it has become widely known that it is a bacterium which is responsible for 
80 per cent o f gastric ulcers and 95 per cent of ulcers in the duodenum [Peterson, 1991; 
Graham, 1991; Veldhuyzen van Zanten et al., 1994], The ulcerative process in the case 
of Helicobacter pylori is probably also dependent on mechanisms other than those 
exhibited by the bacterium itself, as illustrated by the fact that very few of the people 
infected with the more virulent strains go on to develop gastric or duodenal ulcers 
[Sipponen et a l , 1989]. Factors contributing to ulcer formation in this instance are many 
and people who are Helicobacter pylori-positive are more at risk from developing an 
ulcer if they are taking NSAIDs [Jones et a l, 1991] as a result of mechanisms previously 
discussed. Helicobacter pylori-yosiiwQ subjects are also at risk o f developing an ulcer 
and/or gastric cancer if they smoke, consume alcohol or have a stressful lifestyle and the 
mechanisms involved in these risk factors are described in the Introduction.
Thus it would appear that the development of an ulcer within the gastrointestinal tract 
does depend on a balance between protective and aggressive factors, as previously 
proposed [Shay, 1961] and when this balance is disturbed by outside deleterious 
influences, such as NSAIDs or Helicobacter pylori, ulceration occurs. The normal 
complement o f gastrointestinal microflora would in themselves appear to be 'potential 
pathogens' which are kept in check by defence mechanisms which have evolved within 
the gut to protect the host from serious infections [KagnofF, 1987b]. In the past it has 
been proposed that the normal microflora within the gastrointestinal tract is essential to 
life [Schottelius, 1902] and many scientists still believe this to be true. However, this 
hypothesis has long since been disproved by generations o f germ-free animals outliving 
their conventional laboratory counterparts [Reyniers et al., 1949; Gordon & Pesti, 1971; 
Mackowiak, 1982].
This project has investigated various mechanisms by which lesions o f the stomach and 
small bowel are produced in rat and man. Differences in ulcerogenic properties between 
the selected NSAIDs have been established and comparisons made between the two
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species. In the rat indomethacin and diclofenac are extremely ulcerogenic as 
enterohepatic recirculation o f these drugs is considerable within this species, however, in 
man the enterohepatic recirculation is less extensive. Consequently NSAID-induced 
ulceration does not occur as readily in man where ulcer formation in the stomach and 
small bowel may be mediated by exogenous agents or environmental factors such as 
smoking, ethanol and stress. Helicobacter pylori is specific for the stomach and the 
duodenum whereas NSAIDs cause damage throughout the gastrointestinal tract. Once 
diagnosed, ulcers associated with Helicobacter pylori are treated with antibiotics 
whereas NSAID-induced ulcers are treated either by withdrawal of the drug for six 
months or by substitution with another.
In comparison with man the rat displays many physiological differences, such as drug 
metabolism and inflammatory response, and behavioural differences such as coprophagy 
which results in there being a significant difference in the composition of small bowel 
microflora between the two species. Interestingly it has proved virtually impossible to 
infect the stomach of rats with Helicobacter pylori. In conclusion it would appear that 
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Appendix 1
Centre for Electron Optical Studies 
School o f  Materials Science  
Claverton Down  
Bath






Tissue Type (Also Human Duodenum)
CIA = Rat Small Bowel - Acetone treated to remove mucus 
Cl = Rat Small Bowel - Warm saline treated to remove mucus 
C3 = Rat Small Bowel - Lesion
Prefix Time Over Night
2% GDA in 0.05M Sorensens Buffer pH 7.4 Temp 4°C
Wash
0 .1M Sorensens Buffer + 




1% 0 s 0 4 in 0 .1M Sorensens Buffer + 





(Follow with OTOTO Method) 




( x 6 changes)
RT
Dehydrate
50, 60, 70, 85, 90, 95, 100, 100% dry
Time
Temp
10 mins each 
( x 3 changes) 
RT







Critical-Point Drying Method (Appendix 2)
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Appendix 2
CRITICAL-PO INT DRYING M ETHOD
1. Ensure that the pressure chamber temperature is between about 5 and 12°C by 
circulating cold water through the water jacket or setting and switching on the 
thermoelectric cooling/heating device.
2. Pressure-test the Viton™ seals around the windows and door of the pressure 
chamber by opening the chamber to the cylinder, thereby ensuring that the 
chamber is at the same pressure as the cylinder )approx 800 psi/5.5 MPa). This 
should be done prior to committing valuable specimens to the chamber and 
finding later that a seal is leaking and that the rum must be aborted.
3. Load the dehydrated specimens, soaked in intermediate fluid (100%) acetone), 
into the specimen-holders o f the critical-point dryer.
4. Insert the specimen-holder into the pressure chamber and seal the door.
5. Fill the chamber with liquid carbon dioxide. The intermediate fluid should sit as a 
reasonably discrete and separate layer in the bottom of the pressure chamber.
6. Withdraw intermediate fluid from the bottom of the pressure chamber via the 
liquid bleed valve until the level of the transitional fluid (the gas/liquid interface) 
is just above the specimen-holder.
7. Refill the chamber with liquid carbon dioxide, and repeat step 5 about fore times 
over a period o f about 10 min in order to flush out all residual intermediate fluid 
(acetone).
8. Leave the specimens soaking in carbon dioxide for 20-45 min, depending upon 
their hardness and size, so that the last traces of acetone may diffuse from them. 
Gentle rocking o f the critical-point dryer will cause turbulence in the liquid
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carbon dioxide and increase the diffusion rate, but this agitation should not be too 
violent; otherwise mechanical damage to the specimens could occur.
9. Seal the pressure chamber and gently open the liquid bleed valve until the 
chamber is only three-quarters full o f liquid carbon dioxide.
10. Close the liquid bleed valve.
11. At this stage the chamber will be at the same pressure as the carbon dioxide 
cylinder (approx 800 psi/5.5 MPa), gently warm the pressure chamber by either 
slowly increasing the temperature o f the water in the jacket surrounding the 
chamber or by altering the settings o f the thermoelectric cooling/heating device. 
The temperature should be raised to 38°C over a period of about 20 min. The 
pressure will also increase and should be maintained at about 1300-1400 psi(9.0- 
9.7 MPa) by gently opening and closing the gas bleed valve.
12. Once the critical point has been exceeded (38°C and 1300 psi/9.0 MPa), gently 
open the gas bleed valve and depressurise the bomb over a period o f about 10-15 
min. As far as possible, the gas should flow from the chamber at a constant rate.
13. Remove the specimen-holders and transfer them to a desiccator.
Ref: Lewis, E.R., Jackson, L. & Scott, T. (1975) Comparison o f miscibilities and 
critical-point drying properties o f various intermediate and transitional fluids. In 
Scanning Electron Microscopy. Pt II. eds. Johari, O & Corvin, I. pp. 392-317. 
Chicago: ITT Research Inst.
Source: Robards, A.W., Wilson, A.J. et a l, (1993) Basic biological preparation 
techniques for scanning electron microscopy. (Section 11). In Procedures In Electron 
Microscopy, eds. Robards, A.W. & Wilson, A.J. pp. 11:4.3-11:4.4. Chichester. John 
Wiley & Sons Ltd.
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Appendix 3.1
Centre for Electron Optical Studies 
School o f  Materials Science 
Claverton Down 
Bath
B A 2 7 AY
TEM PROCESSING
Name




Rat Small Bowel 
(Control and Experimental)
Prefix Time
2% GDA in 0.05M Sorensens Phosphate Buffer + 




0.01M Sorensens Phosphate Buffer
0.16M Sucrose pH 7.2 385 mOsm Temp
15 mins 
( x 3 Changes) 
On Ice
Postfix Time
1% 0 S0 4 in 0 .1M Sorensens Phosphate Buffer + 




0 .1M Sorensens Phosphate Buffer +




In Acetone 60, 80, 90, 95, 100, 100% dry
Temp
15 mins each 
( x 2 changes) 
60-90% on ice 
90-100% RT




In Spurr's Resin : Acetone 3:1 Time
100% Time
100% Time
Embed In Spurr's Resin 100% Time 1.0 hr
Polymerise At 70°C for 8 Hour
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Appendix 3.2ai
Centre for Electron Optical Studies 
School o f  Materials Science  
Claverton Down 
Bath
B A 2 7 AY
TEM PROCESSING
Name




Rat Small Bowel 
(Control)
Prefix (by perfusion)





Wash Time 15 mins
( x 3 changes)
RT
0 .1M Sorensens + 0.16 M Sucrose 
pH 7.2 384/385 mOsm Temp
Postfix Time 1 hour 
RT
1% OsCMn 0.1 M Sorensens + 0.16 M Sucrose 
pH 7.2 384/385 mOsm Temp
Wash Time 15 mins each 
( x 3 changes) 
RT
0 .1M Sorensens + 0 .16M Sucrose 
pH 7.2 384/385 mOsm Temp
Dehydrate Time 15 mins each 




100% dry x 2
Temp
Infiltrate in Spurr's 1:1 Time 1 hr x 4 changes 
1 hr x 4 changes 
ON.
Resin: Acetone 3:1 Time
100% Time
Time
Embed in Spurr's Resin
Polymerise 8 - 9 hrs 70°C
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Appendix 3.2a2
Centre for Electron Optical Studies 
School o f  Materials Science 
Claverton Down 
Bath
B A 2 7 AY
TEM PROCESSING
Name




Rat Small Bowel 
(Control)
Prefix (by perfusion) Time 2Vi hrs
2% GDA in 0.05M Sorensens Phosphate Buffer
0.02M Sucrose Temp RT
pH 7.2 371mOsm
Wash Time 15 mins
0 .1M Sorensens + 0.16 M Sucrose ( x 3 changes)
pH 7.2 384/385 mOsm Temp RT
Postfix Time 1 hour
1% OsCMn 0.1 M Sorensens + 0.16 M Sucrose
pH 7.2 384/385 mOsm Temp RT
Wash Time 15 mins each
0 .1M Sorensens + 0 .16M Sucrose ( x 3 changes)
pH 7.2 384/385 mOsm Temp 1 @ RT+2 @ RT
O N. 4°C
Dehydrate Time 15 mins each
In Acetone ( x 3 changes)
60,80,90,95,100% Temp RT
100% dry x 2
Infiltrate in Spurr's 1:1 Time 1 hr x 1 change
Resin:Acetone 3:1 Time 1 hr x 1 change
100% Time 1 hr
Time
Embed in Spurr’s Resin
Polymerise 8 - 9 hrs 70°C
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Appendix 3.2b
Centre for Electron Optical Studies 
School o f  Materials Science 
Claverton Down 
Bath
B A 2 7 AY
Name Date
Julia Reid - Method 7b 22/10/96
Tissue Type
Rat Small Bowel 
(Control)
Prefix (by perfusion) Time 2Vi hrs
2% GDA in 0.05M Sorensens Phosphate Buffer
0.02M Sucrose Temp RT
pH 7.2 371mOsm
Wash Time 15 mins
0 .1M Sorensens + 0.16 M Sucrose ( x 3 changes)
pH 7.2 384/385 mOsm Temp RT
Postfix Time 1 hour
1% OsC>4 in 0.1 M Sorensens + 0.16 M Sucrose
pH 7.2 384/385 mOsm Temp RT
Wash Time 15 mins each
0 .1M Sorensens + 0 .16M Sucrose ( x 3 changes)
pH 7.2 384/385 mOsm Temp R.T
Dehydrate In Quetol Time 15 mins each
( x 2 changes)
60,70,85,90,95,100% Temp RT
Infiltrate 3:1 Time 1.0 hr












Uranvl Acetate Solution 
0.6 g Uranyl Acetate
20 ml 30% Ethanol (in sterile distilled water)
In a fume cupboard, carefully add the 30% ethanol to the uranyl 
Filter the solution and then store in an amber glass bottle in the dark, 
keep for up to three weeks




Reynold's Lead Citrate Solution
1.33 g Lead Acetate
1.76 g Sodium Citrate 
30 ml Sterile Distilled Water
In a fume cupboard, place the lead acetate and the sodium acetate in a 50 ml 
volumetric flask and add the sterile distilled water. Shake vigorously for one minute 
(until the compounds are fully into solution) then leave to stand for 30 minutes 
(shaking once very five to ten minutes). Add 8.0 ml 1.0M sodium hydroxide solution 
(carbonate free) then make up to 50 ml with sterile distilled water. This solution will 
keep for up to four weeks.
acetate and mix. 
This solution will
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Reynold's Lead Citrate Staining Procedure
See below.
Uranyl Acetate / Reynold's Lead Citrate Staining Procedure
In a fume cupboard, aliquot drops o f boiled glass distilled water, uranyl acetate 
solution and lead citrate solution onto different pieces of dental wax. Place the grids, 
section side down, onto the droplets o f boiled glass distilled water (one grid per 
droplet). Dry grids carefully with a piece of filter paper and then place on the droplets 
o f uranyl acetate (one grid per droplet) and leave for 10 minutes. Dry grids carefully 
with a piece of filter paper and then place on the droplets o f lead citrate solution (one 
grid per droplet). Leave for one to five minutes. Place the grids, section side down, 
onto fresh droplets o f boiled glass distilled water (one grid per droplet). Rinse grids 
well with running sterile distilled water, dry with filter paper and store in a grid box.
N.B. Uranyl acetate must be kept away from light as much as possible so keep the 
droplets which are on the dental wax covered at all times (wrap aluminium foil around 
a small glass trough). The lead citrate must be maintained in an atmosphere free of 
carbon dioxide so keep the dental wax that the drops o f lead citrate solution are on in a 
covered glass petri dish with filter paper soaked in 10.0M sodium hydroxide.
Appendix 4c
Double Lead Stain Solution
0.25 g Lead Citrate
0.1-0.2 g One Sodium Hydroxide Pellet
In a fume cupboard, pour 40 ml of sterile distilled water into a 50 ml volumetric flask 
and then add the sodium hydroxide pellet and shake until dissolved. Add lead citrate 
and make up to 50 ml with sterile distilled water, shake until dissolved. This solution, 
which has a pH of about 12, will keep for several months in a sealed container at 4°C.
N.B. Filter or centrifuge before use.
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Uranyl Acetate / Double Lead Stain Staining Procedure
In a fume cupboard, aliquot drops of boiled glass distilled water, uranyl acetate 
solution and lead citrate solution onto different pieces of dental wax. Place the grids, 
section side down, onto the droplets of boiled glass distilled water (one grid per 
droplet). Dry grids carefully with a piece of filter paper and then place, section side 
down, on the droplets o f lead citrate solution (one grid per droplet) leave for one to 
five minutes. Rinse each grid several times in a beaker of sterile distilled water. Dry 
grids carefully with a piece o f filter paper and then place, section side down, on the 
droplets of uranyi acetate (one grid per droplet) and leave for 40 minutes. Rinse each 
grid several times in a beaker of sterile distilled water then dry carefully with filter 
paper. Place grids, section side down, on fresh droplets of lead citrate solution (one 
grid per droplet) and leave for 20 minutes. Rinse each grid several times in a beaker o f  
sterile distilled water, dry with filter paper and store in a grid box.
N.B. Uranyl acetate must be kept away from light as much as possible so keep the 
droplets which are on the dental wax covered at all times (wrap aluminium foil around 
a small glass trough). The lead citrate must be maintained in an atmosphere free of 
carbon dioxide so keep the dental wax that the drops o f lead citrate solution are on in a 
covered glass petri dish with filter paper soaked in 10.0M sodium hydroxide.
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Appendix 5
H AEM ATO XYLIN AND EOSIN STAINING
The method described here is typical o f the many H & E procedures.
1. De-wax and hydrate paraffin sections. Frozen sections should be dried onto slides.
2. 3% Acetic Acid in Absolute Alcohol (60 sec).
3. 95% Alcohol (60 sec).
4. Tap Water (60 sec).
5. Mayer's Haematoxylin (60 sec).
6. Water (60 sec).
7. Alkaline Water (60 sec).
8. Tap Water (60 sec).
9. Eosin (60 sec).
10. Tap Water (60 sec).
11. Absolute Alcohol (60 sec).
12. Absolute Alcohol (60 sec).
13. Citroclear (60 sec).
14. Mount in XAM.
Results
Nuclear chromatin stains blue to purple and cytoplasm, collagen, keratin, erythrocytes 
stain pink
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50.Og Aluminium Potassium Sulphate 12-Hydrate (Potassium Alum) 
l.Og Citric Acid 
50.0g Chloral Hydrate 
1000ml Distilled Water
In a fume cupboard, using a 2000ml glass beaker, dissolve the haematoxylin, 
aluminium potassium sulphate 12-hydrate and sodium iodate in the distilled water by 
leaving overnight or by stirring. Once these reagents have dissolved (warm if 
necessary) add the chloral hydrate and the citric acid then boil for 5 min. Once cooled, 
filter then store at room temperature.
This solution will keep for up to a year but some batches lose their potency after a few 
months. The solution may be used many times but if it fails to stain nuclei properly, it 
may be over-oxidised. Should this occur make up the solution as before but halve the 
concentration o f sodium iodate.
2. EOSIN
5.0g Eosin
Make up to 1000ml with distilled water.
This solution keeps indefinitely and may be used repeatedly. Moulds often grow in this 
solution and on such occasions the microorganisms need to be removed by filtration.
Ref. Kieman, J.A. (1981). Histological Staining in One or Two Colours. In 




AV IDIN-BIO TIN M ETHOD FOR PARAFFIN SECTIONS
USING MOUSE OR HAMSTER ANTISERA (MONOCLONALS)
1. Pick up sections onto glass slides, precoated with 'Sta-On', dry overnight at 37°C.
Before commencing dewaxing steps, put 300 ml of distilled water and 300 ml Tris 
Buffered HC1 (for trypsinisation step) into the oven to warm to 37°C.
2. Dewax sections 30 minutes take to alcohol.
a. Citroclear 1 for 10 mins.
b. Citroclear 2 for 10 mins.
c. Citroclear 3 for 10 mins.
d. Alcohol (industrial methylated spirits O.K.) for 10 mins.
(Usually only need one 10 min ‘dunk’ in Citroclear. Use three here to be particularly 
careful. Probably could make do with two. At the end of the week throw away the 
citroclear in the first pot. Move other two pots forward, so that final pot of citroclear is 
always fresh.)
After deparaffinisation can mark round section with a wax pen. However have to be 
careful not to do it too close to the section as the antibody will shrink away from the wax
mark. If you have a lot o f sections use this method for speed. However if only a few
best just to wipe carefully around the section with a clean dry tissue after adding 
solutions or washing. (Wipe under the slide first then carefully around section.) Both 
procedures prevent the antibody from spreading out all over the slide.
During these washes prepare blocking solution for Step 3. Also add chymotrypsin and 
calcium chloride to tris buffered HC1 which is at 37°C. Also need to begin preparing 
primary antibody dilutions i.e. work out concentrations required and label tubes. Do not 
add antibody to dilution buffer (TBS) too soon before use.
3. Block in 2.5% hydrogen peroxide in methanol for 10 min.
Put 300 mis o f highgrade methanol into a pot. To this add 7.5 ml o f 30% H2O2 (100 
vols), 2.5 ml at a time using a 3.0 ml plastic pasteur pipette. Stir solution with the 
pipette.
285
(This is the ‘blocking reagent’ which blocks the peroxidases which are usually present. 
This has to be done because we use the enzyme horse radish peroxidase to label the 
antigen/antibody complex. It is possible to use the enzyme alkaline phosphatase instead, 
but cannot store these sections long term as you can with ones that have been prepared 
using horseradish peroxidase.)
4. Wash in running tap water for 2 min followed by a quick dunk in a pot of distilled 
water.
5.a Place slides which are to be trypsinised into distilled water which is at 37°C and 
leave in the oven for 5 min.
5.b Place slides which are not to be trypsinised into glass pot filled with tris buffered 
saline (TBS).
6. Place slides with sections which need to be trypsinised in chymotrypsin solution, 
preheated to 37°C, for 15 min in the oven.
(When tissue is placed in formalin, bonds binding the tissue proteins together are formed. 
This is the preserving process as it prevents autolysis by immobilysing all tissue proteins 
such as enzymes etc. The trypsin cleaves these bonds so that those antigens which are 
locked inside can be exposed to the antibody. However some antigens do not survive 
trypsin so these sections by-pass this step.
7. Take sections which have been in chymotrypsin solution out of the oven and wash in 
running water for 2 min followed by a quick dunk in a pot of distilled water. Then place 
sections in pot o f TBS.
Trypsin can be used again if doing another run on the same day. However needs to be 
made up fresh each day.
8. Wipe carefully around each section then place in moist chamber, section covered with 
TBS. (Sections must not be allowed to dry out.)
9. Treat with 5% Normal Rabbit Serum for 5 min.
(Normal tissue contains other connective tissues such as collagen. These have an affinity 
for the antibody, non-specific binding. As a result these sites have to be blocked. To do 
this use whole serum from the appropriate animal i.e. use the serum from the species that
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the secondary antibody has been raised in. This blocks out interference which can occur 
by the secondary antibody binding to sites in the tissue and swamping the 
antigen/antibody effect. After this treatment the secondary antibody should only bind to 
the primary antibody.)
10. Tap off. DO NOT WASH.
Tip off excess serum
11. Incubate in Primary Antisera for I hour.
.Allow 100 pi per small section. With larger sections may need to increase volume 
containing amount of antibody required accordingly. Use a 1.0 ml plastic pasteur pipette 
to aliquot antibody (a couple of drops = 100 pi). Negative controls just get 100 pi TBS.
N.B. Put the sections into the slide tray/box before you add the primary antibody. Put 
on the lid and leave in a warm place (or in the incubator at 37°C depending on assay). 
Must ensure that the sections do not dry out. If using DAKO tray make sure the 
reservoir has TBS in it. If using a box (Shandon) put a tissue soaked in TBS along the 
bottom of the box at the top of the glass slides (white border at the bottom so can read 
what is written on the slides).
12. Gently rinse in TBS from wash bottle.
13. Incubate in secondary antibody for 40 min.
For monoclonals the secondary antibody is either Rabbit Anti-Mouse Biotinylated (Blue) 
or Rabbit Anti-Hamster Biotinylated (Yellow). This has to be diluted 1/400 in TBS. 
Make up sufficient quantity so that there is lOOpl per section. Use a 1.0ml plastic 
pasteur pipette to aliquot diluted antibody (a couple o f drops = lOOpl). Leave sections 
in a warm place or in the incubator at 37°C.
14. Prepare Avidin Biotin Complex (ABC).
ABC must be made up at least 30 min before use as it has to complex. Make up in the 
ratio 10:10:1000 A:B:TBS and store at 4°C until required. 1000 pi is sufficient for 5 
sections.
15. Gently rinse twice in TBS from wash bottle.
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16. Add ABC and leave at room temperature for 40 min.
Aliquot 200 pi ABC per section with plastic pasteur pipette (about 4 drops).
Make up DAB during this incubation time. (DAB is very nasty so take care and make up 
and use solution in a fumehood.)
17. Gently rinse twice in TBS from a wash bottle.
18. Aliquot 200-300 pi of DAB onto each section and leave for 10 min.
19. Remove DAB with a disposable pasteur pipette into waste bottle. Rinse sections 
with 200-300 pi distilled water and remove this with pasteur pipette into waste bottle.
20. Place sections in a rack which is standing in a pot of tap water, then wash in running 
tap water for 5 min.
21. Stain nuclei in Gills haematoxylin for 1.0 min.
Can re-use Gills solution many times. Only need to change once staining begins to get 
faint. However if there is a shiny film on the surface remove this before you immerse the 
slide rack by using a folded tissue to skim the surface. If the Gills has been used a lot or 
left over the weekend filter it (filter paper and funnel is sufficient).
22. Blue in tap water. (Do this by placing rack in a pot o f running tap water). 
In Bath, because the local water supply is alkaline, all you have to do is wash in running 
tap water for about 10 mins. This causes the haematoxylin stain to turn blue. If in an 
area where the water is more acidic, need to use a solution of bicarbonate.
N.B. Empty first lot o f water out immediately as otherwise the sections can effectively 
sit in haematoxylin longer if the concentration is greater at the bottom.
23. Dehydrate sections.
Dry off rack with a tissue. Dunk in industrial alcohol twice (a few seconds in each pot). 
Then put rack into another pot o f citroclear. (Don’t have to leave the sections in here 
too long. Just ensure that the citroclear on the sections runs clear before they are 
mounted.
24. Mount sections in XAM.
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Place cover slips of suitable sizes onto tissue. Put a blob of XAM on the cover slip, 
using a 3.0 ml plastic pasteur pipette, one blob/section. Put slide, still ‘runny’ with 
citroclear (ie take slide out of rack which is still in the citroclear, stand slide up on end on 
pile of green paper towels just to drain off excess citroclear) on top of the coverslip. 
Turn slide over and allow weight of cover slip to spread out the XAM and displace the 
air bubbles. Any persistent air bubbles can be forced out from under the coverslip with a 
slight amount o f pressure. Once all the coverslips are on can dry off with a cloth or 
tissue.
N.B. Make sure that you put the cover slips on the correct side o f the slide.
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IMMUNO PEROXIDASE SOLUTIONS
1. BLOCKING REAGENT (2.5% HYDROGEN PEROXIDE IN METHANOL)
7.5 ml 30% Hydrogen Peroxide (100 vol) [H2O2] FW> 34.01
300ml Methanol (HPLC) [CH3OH] FW> 32.04
Using a 3.0ml plastic pasteur pipette add 3 x 2.5 ml hydrogen peroxide to the methanol 
and mix by stirring with the pipette.
30% Hydrogen Peroxide 
Methanol
2. HYDROCHLORIC ACID 2.0M
172.0ml Hydrochloric Acid (S.G. 1.18) [HC1] FW:-36.46
Add concentrated hydrochloric acid to 750.0ml distilled water and make up to 1.0 litre 
with distilled water. Store at 27°C.
Hydrochloric Acid (S.G. 1.18) Fisons:- H/l 150/PB17
3. TRIS BUFFERED SALINE (TBS1:0.05M Tris/Hcl. 0.15M NaCh p H 7.6
30.285g Tris(hydroxymethyl)methylamine [NH2C(CH2OH)3] FW> 121.14
42.5g Sodium Chloride [NaCl] FW> 58.44
115.5ml 2.0M Hydrochloric Acid [HC1]




4. TRIS BUFFERED HC1:0.05M. p H  7.8 (for trypsin)
15.Og Tris(hydroxymethyl)methylamine [NH2C(CH2OH)3] FW> 121.14






Make up to 2.5 litres with distilled water. pH to 7.8 with Sodium Hydroxide.
T ris(hydroxymethyl)methylamine BDH:- 103156X
5. TRYPSIN SOLUTION
300ml Tris Buffered HCL pH 7.8
0.3g a-Chymotrypsin
0.3g Calcium Chloride [CaCl2.2H20 ] FW> 147.02
Warm 300 ml of tris buffered HCL to 37°C in an oven. Take glass pot containing warm 
tris buffered saline and place on a magnetic stirrer (heater on very low) with a flea. 
Weigh out calcium chloride and add to tris buffered HCL then weigh out trypsin (best to 
do this in a fume cupboard as some people can become sensitised to it very rapidly 
causing breathing problems!) and add to the tris buffered HCL, remove reagent adhering 
to the weighing boat by immersing it in the solution. Once reagents have dissolved 
adjust the pH to 7.8 with 3% sodium hydroxide Return to oven at 37°C.
a-Chymotrypsin (Type II: From Bovine Pancreas) Sigma:- C-4129
Calcium Chloride BDH:- 10070
6. NORMAL RABBIT SERUM 5% (Monoclonals)
200ml Tris Buffered Saline pH7.6
0.2g Sodium Azide 
10.0ml Normal Rabbit Serum
Weigh out Sodium Azide in a fume cupboard (POISON - WEAR GLOVES) and add to 
Tris Buffered Saline, mix. Add Normal Rabbit Serum to this solution and mix. Store at
4°C.
Sodium Azide BDH:- 10369
Normal Rabbit Serum Dako:- X0902
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7. NORMAL SWINE SERUM 5% (POLYCLONALS)
200ml Tris Buffered Saline pH 7.6
0.2g Sodium Azide [
10.0ml Normal Swine Serum
Weigh out Sodium Azide in a fume cupboard (POISON - WEAR GLOVES) and add to 





lOOOpl Tris Buffered Saline pH 7.6 
1 Ojj.1 Reagent A
lOpl Reagent B
Mix and leave in the fridge for 40 min before use. (1000pl is sufficient for 5 slides.) 
ABComplex Dako:- K355
9. DAB REAGENT
15.0ml Tris Buffered Saline pH 7.6
lOmg 3.3’-Diaminobenzidine Tetrahydrochloride [C12H14N4.4HCI] (1 tablet)
12.0|il 30% Hydrogen Peroxide (100 vol) [H2O2] FW> 34.01
In a fume cupboard add a DAB tablet to a universal containing Tris Buffered Saline, 









AVIDIN-BIO TIN M ETHOD FOR PARAFFIN SECTIONS
USING RABBIT ANTISERA (POLYCLONALS)
1. Pick up sections onto glass slides, precoated with 'Sta-On',dry at 37°C overnight.
Before commencing dewaxing steps, put 300ml of Tris Buffered HC1 (for 
trypsinisation step) into the oven to warm to 37°C.
2. Dewax sections 30 minutes take to alcohol.
a. Citroclear 1 for 10 mins.
b. Citroclear 2 for 10 mins.
c. Citroclear 3 for 10 mins.
d. Alcohol (industrial methylated spirits O.K.) for 10 mins.
(Usually only need one 10 min ‘dunk’ in Citroclear. Use three here to be particularly 
careful. Probably could make do with two. At the end of the week throw away the 
citroclear in the first pot. Move other two pots forward, so that final pot of citroclear 
is always fresh.)
After deparaffinisation can mark round section with a wax pen. However have to be 
careful not to do it too close to the section as the antibody will shrink away from the 
wax mark. If you have a lot o f sections use this method for speed. However if only a 
few best just to wipe carefully around the section with a clean dry tissue after adding 
solutions or washing. (Wipe under the slide first then carefully around section.) Both 
procedures prevent the antibody from spreading out all over the slide.
During these washes prepare blocking solution for Step 3. Also add chymotrypsin and 
calcium chloride to tris buffered HC1 which is at 37°C. Also need to begin preparing 
primary antibody dilutions i.e. work out concentrations required and label tubes. Do 
not add antibody to dilution buffer (TBS) too soon before use.
3. Block in 2.5% hydrogen peroxide in methanol for 10 min.
Put 300 mis o f highgrade methanol into a pot. To this add 7.5 ml of 30% H2C>2 (100 
vols), 2.5 ml at a time using a 3.0 ml plastic pasteur pipette. Stir solution with the 
pipette.
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(This is the ‘blocking reagent’ which blocks the peroxidases which are usually present. 
This has to be done because we use the enzyme horse radish peroxidase to label the 
antigen/antibody complex. It is possible to use the enzyme alkaline phosphatase 
instead, but cannot store these sections long term as you can with ones that have been 
prepared using horseradish peroxidase.)
4. Wash in running tap water for 2 min followed by a quick dunk in a pot of distilled 
water.
5.a Place slides which are to be trypsinised into distilled water which is at 37°C and 
leave in the oven for 5 min.
5.b Place slides which are not to be trypsinised into glass pot filled with tris buffered 
saline (TBS).
6. Place slides with sections which need to be trypsinised in chymotrypsin solution, 
preheated to 37°C, for 15 min in the oven.
(When tissue is placed in formalin, bonds binding the tissue proteins together are 
formed. This is the preserving process as it prevents autolysis by immobilysing all 
tissue proteins such as enzymes etc. The trypsin cleaves these bonds so that those 
antigens which are locked inside can be exposed to the antibody. However some 
antigens do not survive trypsin so these sections by-pass this step.
7. Take sections which have been in chymotrypsin solution out o f the oven and wash 
in running water for 2 min followed by a quick dunk in a pot o f distilled water. Then 
place sections in pot o f TBS.
Trypsin can be used again if doing another run on the same day. However needs to be 
made up fresh each day.
8. Wipe carefully around each section then place in moist chamber, section covered 
with TBS. (Sections must not be allowed to dry out.)
9. Treat with 5% Normal Swine Serum for 5 min.
(Normal tissue contains other connective tissues such as collagen. These have an 
affinity for the antibody, non-specific binding. As a result these sites have to be 
blocked. To do this use whole serum from the appropriate animal i.e. use the serum
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from the species that the secondary antibody has been raised in. This blocks out 
interference which can occur by the secondary antibody binding to sites in the tissue 
and swamping the antigen/antibody effect. After this treatment the secondary antibody 
should only bind to the primary antibody.)
10. Tap off. DO NOT WASH.
Tip off excess serum
11. Incubate in Primary Antisera for 1 hour at 37°C.
Allow 100 pi per small section. With larger sections may need to increase volume 
containing amount o f antibody required accordingly. Use a 1.0 ml plastic pasteur 
pipette to aliquot antibody (a couple o f drops = 100 pi). Negative controls just get 
lOOpl TBS.
N.B. Put the sections into the slide tray/box before you add the primary antibody. Put 
on the lid and leave in a warm place (or in the incubator at 37°C depending on assay). 
Must ensure that the sections do not dry out. If using DAKO tray make sure the 
reservoir has TBS in it. If using a box (Shandon) put a tissue soaked in TBS along the 
bottom of the box at the top of the glass slides (white border at the bottom so can read 
what is written on the slides).
12. Gently rinse in TBS from wash bottle.
13. Incubate in secondary antibody for 40 min at 37°C.
For polyclonals the secondary antibody is Swine Anti-Rabbit Biotinylated (Red). This 
has to be diluted 1/500 in TBS. Make up sufficient quantity so that there is 100 pi per 
section. Use a 1.0ml plastic pasteur pipette to aliquot diluted antibody (a couple of  
drops = lOOpl).
14. Prepare Avidin Biotin Complex (ABC).
ABC must be made up at least 30 min before use as it has to complex. Make up in the 
ratio 10:10:1000 A:B:TBS and store at 4°C until required. 1000 pi is sufficient for 5 
sections.
15. Gently rinse twice in TBS from wash bottle.
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16. Add ABC and leave at room temperature for 40 min.
Aliquot 200pl ABC per section with plastic pasteur pipette (about 4 drops).
Make up DAB during this incubation time. (DAB is very nasty so take care and make 
up and use solution in a fumehood.)
17. Gently rinse twice in TBS from a wash bottle.
18. Aliquot 200-300 pi of DAB onto each section and leave for 10 min.
19. Remove DAB with a disposable pasteur pipette into waste bottle. Rinse sections 
with 200-300 pi distilled water and remove this with pasteur pipette into waste bottle.
20. Place sections in a rack which is standing in a pot of tap water, then wash in 
running tap water for 5 min.
21. Stain nuclei in Gills haematoxylin for 1.0 min.
Can re-use Gills solution many times. Only need to change once staining begins to get 
faint. However if there is a shiny film on the surface remove this before you immerse 
the slide rack by using a folded tissue to skim the surface. If the Gills has been used a 
lot or left over the weekend filter it (filter paper and funnel is sufficient).
22. Blue in tap water. (Do this by placing rack in a pot of running tap water).
In Bath, because the local water supply is alkaline, all you have to do is wash in 
running tap water for about 10 mins. This causes the haematoxylin stain to turn blue. 
If in an area where the water is more acidic, need to use a solution of bicarbonate.
N.B. Empty first lot o f water out immediately as otherwise the sections can effectively 
sit in haematoxylin longer if the concentration is greater at the bottom.
23. Dehydrate sections.
Dry off rack with a tissue. Dunk in industrial alcohol twice (a few seconds in each 
pot). Then put rack into another pot o f citroclear. (Don’t have to leave the sections in 
here too long. Just ensure that the citroclear on the sections runs clear before they are 
mounted.
24. Mount sections in XAM.
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Place cover slips o f suitable sizes onto tissue. Put a blob of XAM on the cover slip, 
using a 3.0 ml plastic pasteur pipette, one blob/section. Put slide, still ‘runny’ with 
citroclear (ie take slide out o f rack which is still in the citroclear, stand slide up on end 
on pile of green paper towels just to drain off excess citroclear) on top of the coverslip. 
Turn slide over and allow weight of cover slip to spread out the XAM and displace the 
air bubbles. Any persistent air bubbles can be forced out from under the coverslip with 
a slight amount of pressure. Once all the coverslips are on can dry off with a cloth or 
tissue.






1. Wearing gloves to avoid protein contamination, cut out a piece of nitrocellulose 
membrane and activate with methanol. (Membrane is white, once activated in 
methanol it goes opaque. Proteins will not bind if not activated.)
2. Wash in distilled water and place on a piece of clean filter paper to dry off excess 
water.
3. Dot membrane with the required concentration o f the recombinant protein.
4. Cut off one comer of the membrane then make a small dot with a pencil on the 
membrane to mark where the protein is being dotted. (Need to dot the protein 
on in minute amounts. Once the dot is dry it is impossible to see where the 
protein is.) Make a note o f where each protein has been dotted.
5. Once dots are dry place membrane into blocking buffer and agitate on a shaker 
for one hour.
6 . Pour off blocking buffer and wash twice with NaCl/Tris, shaking for 10 min.
Wash for a third time in NaCl/Tris + Tween for 10 min.
7. Cover membrane with approximately 10 ml of diluted antibody in NaCl/Tris + 
Tween. Shake at room temperature for two hours.
8. Pour off diluted antibody and wash membrane three times in NaCl/Tris + Tween, 
shaking for 10 min.
9. Cover membrane with approximately 10 ml o f diluted alkaline phosphatase 
secondary in NaCl/Tris + Tween. Shake at room temperature for one hour.
10. Pour off diluted secondary antibody and wash membrane three times in NaCl/Tris 
+ Tween, shaking for 10 min.
11. Add detection solution to the membrane and allow brown stain to develop 
(rapidly). Stop the reaction by quenching with cold PBS. Wash membrane twice 
in PBS
12. Leave to dry on clean filter paper.
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PRO TEIN DOT BLOTTING SOLUTIONS
BLOTTING BUFFER (NaCl/Tris^
170mM NaCl (9.93 g/1)
1 OmM Tris (TRIZMA base) (1.211 g/1)
Make up to 1000 ml with distilled water. pH to 7.4 with concentrated HC1.
BLOCKING BUFFER
5% low fat milk powder (50 g/1) in NaCl/Tris (blotting buffer)
NACL/TRIS + TWEEN
0.05% Tween-20 (0.5 ML/1000 ml of NaCl/Tris
HIGH SALT WASH
100 ml NaCl/Tris + Tween + 1.93 g NaCl
DETECTION SOLUTION
33 pi Nitro blue tetrazolium (NBT)
33 pi 5-Bromo-4-chloro-3-indolyl phosphate (BCIP)
Make up to 10 ml with
0 .1M Tris ]
O.lMNaCl I- pH 9.5
50mM MgCl2 J
N.B. 5-Bromo-4-chloro-3-indolyl phosphate does not dissolve well so mix until in 
suspension.
NBT = 100 mg/ml in 70% dimethylformamide 
BCIP = 50 mg/ml in 100% dimethylformamide
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Appendix 9
SERUM  HAPTOG LO BIN
1. Melt a 7 .5(15.0) ml aliquot of agarose, which is in a glass universal, in a beaker of 
boiling water on a hot plate. Transfer to a 56°C water bath when melted.
2. Weigh 0.15 (0.30) g o f PEG 6000 into a plastic universal then add 7.5 (15.0) ml 
working buffer and place in the 56°C water bath.
3. Set up the levelling table and place a glass plate on it to insulate and support the 
plastic film (Gelbond).
4. Cut a piece o f Gelbond to the size required, 10 cm x 10 cm (10 cm x 20 cm), and 
attach it to the glass plate (hydrophobic side down) using a thin film of water, 
ensuring all the comers are down.
N.B. The longer lengths o f Gelbond tend to spring up away from the glass plate, 
overcoming the effect o f the film o f water. This also happens with the shorter 
lengths, towards the end o f the roll where the plastic film, close to the middle, has 
been rolled very tightly. To prevent this happening, cut the required length of 
Gelbond, at least 48 hours before required, and roll it tightly in the opposite direction 
either around a suitable cardboard inner from a roll o f paper or slip it inside a 100 ml 
measuring cylinder.
5. Quickly, but accurately, pipette 50 (100) pi o f the anti-human haptoglobin into the 
warmed buffer. Invert to mix, and pour the contents into the glass universal 
containing the agarose. Mix by rolling gently in the hands (so no air bubbles form).
N.B. Keep buffer and agarose at 56°C as antibody will be destroyed if temperature goes 
much above this. However, need to have agarose as hot as possible so it will not set 
too soon when you pour it (that is before it has covered the entire surface o f the 
plastic film).
300
6. Pour contents of glass universal into the middle of the Gelbond and touch the 
universal to the comers, if necessary, to produce an even layer.
7. Whilst the gel is setting, fill the buffer containers of electrophoresis tank to the 
maximum level, set up the cooling platen in the tank and prepare two wicks, using the 
glass plate as a template.
N.B. The wicks can either be made of Whatman filter paper, four pieces/wick, or as a 
cheaper alternative hospital lint can be used. Cut a single length o f lint/gel, long 
enough so that it can be folded in half and the straight, folded, edge is used to overlap 
the gel.
8. Into plastic LP3 tubes aliquot sufficient working buffer for dilution of standards (90 
|il), samples (990 pi) and control serum (990 pi) then add 10 pi o f each o f the sera to 
be assayed to the relevant tubes.
9. When the gel has set punch a row of wells, using a 5 pi well punch, one well every 0.5 
cm, positioning the row of wells 2.0 cm from the edge of the gel (using a piece o f  
graph paper within a polythene cover as a template).
Instead of a well punch a glass tip from an Oxford Pipette can be used, connected via 
tubes, o f varying diameters, to a Buchner flask which is itself connected to a venturi 
pump.
10.Place the glass plate with the gel onto the cooling platen, with the row of wells 
nearest the cathode, and carefully place the wicks on the gel so that they overlap by 
about 1.0 cm. (Make sure that the wicks are soaked in buffer and that the other ends 
are at least 5.0 cm below the level of the buffer.) Turn on the water to the cooling 
platen and power to 250 volts to equilibrate for 5 min.
11. Aliquot 5 pi o f standards, test samples and control serum into the wells, leaving the 
outer and any badly punched wells empty. (The larger gels need to have two sets of
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standards, one each side, whereas one set of standards in the middle is sufficient for 
the smaller gels.)
12.Electrophorese for 4 hours at 250 volts or for 1 hour at 250 volts followed by 18 
hours (overnight) at 110 volts. (The rockets are more distinct and have a better shape 
when the electrophoresis is conducted slowly.)
N.B. During high voltage electrophoresis the lid may need to be wiped clear of 
condensation every 30 min.
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STAINING SERUM HAPTOGLOBINS
Switch off at the end of the electrophoresis time. Remove the glass plate from the 
cooling platen and place it agarose up on a piece of dry Whatman filter paper. Fill the 
wells with distilled water and place a piece of wet filter paper on top of the gel taking 
care to exclude any air bubbles (carefully use a glass pipette as a 'rolling pin'). Add 4 
more layers of dry filter paper followed by some paper (green interlocked) hand towels 
and then place a large glass plate on the top. Place a heavy weight on top of the glass 
plate and leave to press for 15-20 min.
Remove layers of paper hand towel (the ones which are still dry can be re-used) and the 
pieces o f filter paper, taking care not to peel the thin film of gel off with the paper. Dry 
the gel with a hair dryer until it becomes transparent and glossy.
In a fiime hood, place gel in the stain until the rockets are clearly seen. Wash in de- 
staining solution (two or three times) until the de-stain solution is clear.
Blot with filter paper and then dry with a hair dryer.
Measure the rocket height from the top of the well to the tip o f the rocket. Plot a graph 
of rocket height against In haptoglobin concentration o f the standards using linear graph 
paper.
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SERUM  HAPTOGLOBIN SOLUTIONS
1. BARBITAL BUFFER 0.02M. p H 8.6
20.61 g Sodium Barbitone [(C2H5)2CCONHC(ONa):NCO] FW> 206.18
4.00 g Barbitone (5,5-Diethylbarbituric acid) [(C2H5)2CCONHCONCCO] FW> 184.20
Place a litre of distilled water in a glass beaker with a flea and set stirring on a 
heater/stirrer in a fume hood. Wearing a mask, weigh out the reagents in the fume hood, 
front well down but the fan off, and then add the fine powder to the distilled water. (If 
the reagents are not added while the water is stirring they form large clumps which take a 
long time to dissolve.) Switch on the fume hood and then heat the solution gently. Once 
the reagents have dissolved pour the contents of the beaker into a 5 litre volumetric flask 






Dissolve the agarose in 50 ml of the Barbital buffer 0.02M, pH 8.6, by boiling in a small 
glass beaker on a hot plate. Pour 7.5 (15.0) ml aliquots into glass universals and once 
cooled store at 4°C.
Agarose 15 'Electran' BDH:- 443023R
3. STAINS
Coomassie Blue Stain
0.4g Brilliant Blue R (Coomassie Brilliant Blue R-250) [C4sH44N3 0 7 S2Na] FW> 826.0
80 ml Methanol
20 ml Glacial Acetic Acid




Add the Coomassie Blue R to the distilled water and dissolve then add the solvents to 
this solution and mix.
Sigma:- B-0149 
BDH - U N I230 
Fisons: -A/0360/PB17
De-Staining Solution
As above but without the Coomassie blue.
Brilliant Blue R 
Methanol (HPLC Grade) 
Glacial Acetic Acid
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CHARACTERISTICS OF ULCERS OF THE SMALL BOWEL INDUCED 
BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS IN THE RAT: 
IMPLICATIONS FOR CLINICAL PRACTICE
A. J. COLLINS,*f J. REID,*t C. J. SOPER* and L. J. NOTARIANNI*
* School o f  Pharmacy and Pharmacology, University o f  Bath, Claverton Down, Bath BA2  7A Y and f  R oyal National 
Hospital fo r  Rheumatic Diseases, Upper Borough Walls, Bath
SUMMARY
Small bowel ulcers were created in the rat after the oral administration of non-steroidal anti-inflammatory drugs (NSAIDs). 
Of the six NSAIDs tested, indomethacin and diclofenac alone were associated with such damage which did not occur in a simple 
dose-related fashion. Bacteria were observed by electron microscopy in an active state of division in the base of the ulcers. When 
grown aerobically these were shown to be strains of Escherichia coli and Proteus mirabilis. Anatomically, NSAID-induced ulcers 
were found throughout the length of the bowel although more abundant in the proximal half. In vivo and in vitro sensitivity 
to antibiotics suggested that in addition to the bacteria identified, anaerobic /?-lactamase-producing organisms also have an 
important role in ulcer production in this model. This rat model of NSAID-induced gut toxicity is discussed in relation to the 
human situation, particularly for patients who take NSAIDs and who have an iron-deficiency anaemia and blood in their faeces, 
but no lesions in either the upper or lower bowel.
K e y  w o r d s :  Small bowel, Ulcers, Bacteria, Antibiotics.
T h e  effects of ingestion of non-steroidal anti­
inflammatory drugs (NSAIDs) in man and consequent 
damage to the upper gastrointestinal (GI) tract is well 
accepted and described [1]. Further, the toxicological 
mechanisms which lead to the breakdown of the gastric 
protective mechanisms is partially understood [2]. 
There is strong evidence to suggest that damage from 
NSAIDs is not apparently limited to the upper GI 
tract, but extends to the small bowel. Animal studies [3] 
predicted the finding of Bjarnason et al. [4, 5] who have 
described human experiments with NSAIDs, particu­
larly indomethacin, which caused inflammation of the 
small bowel (SB) with leakage of cells and protein into 
the lumen of the order of that found in Crohn’s disease. 
Visual evidence of this damage has been described by 
Morris et al. by enteroscopy [6, 7], and post-mortem 
studies have shown increased incidence of SB lesions 
after NSAID ingestion [8].
The rat model has been used to measure the dam­
age caused by individual NSAIDs in the small bowel, 
and to explain the mechanisms involved. Inhibition of 
prostaglandin protection [9, 10], bacterial infection [11] 
and biliary excretion of NSAIDs [12, 13] have been 
implicated, but the relevance of these findings to the 
situation in the human small bowel has not been 
demonstrated. We have attempted to clarify the 
characteristics of SB NSAID-induced lesions in the rat 
in respect to their association with particular drugs, 
their position in the SB, their anatomical association 
with bacteria, the bacteria involved, and the sensitivity 
of the associated bacteria and SB ulceration to treat-
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ment with antibiotics, in an attempt to see their 
relevance to the clinical situation, particularly that 
experienced by patients on long-term NSAIDs who 
become anaemic and who are suspected to harbour SB 
lesions.
MATERIALS AND METHODS
Animals and drugs 
Male Wistar rats (Bath University strain) of 
250-270 g body weight were used throughout. They 
were given free access to food and water at all times. 
Six NSAIDs were studied: indomethacin, diclofenac, 
naproxen, piroxicam, fenbufen and nabumatone. 
These were purchased from the Sigma Chemical Co. 
(Poole, Dorset), except for nabumetone which was a 
gift from SmithKline Beecham. The minimum dose 
(ID25) of each NSAID used was the amount required 
to inhibit carageenan-induced oedema in the rat by 
25% and the maximum was five times this dose. For 
oral dosing, the drugs were vortex mixed in Tween 
80/water 1:9 and sonicated for 30 min. These drugs 
were administered using an oral-dosing needle in a 
volume of not more than 1 ml.
Antibiotic prophylaxis
Groups of three or more animals (per treatment) 
were used to demonstrate the prophylactic effect of 
antibiotics on the creation of SB ulceration which was 
induced by indomethacin given orally at a dose of 
6 mg/kg on a single occasion. Three antibiotics were 
studied in vivo; metronidazole, amoxycillin and 
cloxacillin at doses of 50-100 mg/kg given either indi­
vidually or in combination by the oral route once a day 
for 3 days before an acute ulcerogenic dose of in­
domethacin (6 mg/kg). The SB was examined 2 days 
later and damage measured as described below.
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Acute SB ulceration
After acute N SA ID  administration, rats were killed 
after 48 h. The gut was opened along the anti- 
mesenteric side and divided into 15-cm lengths which 
were displayed in sequence. SB lesions were identified 
and copied onto an overlaid acetate sheet.
Scanning electron microscopy (SEM)
Individual ulcers were identified and excised with a 
margin o f  normal mucosa, under aseptic conditions. 
The tissue was fixed in a 2% gluteraldehyde/0.05 m 
phosphate buffer, pH 7.4, for 24 h and post-fixed with 
osmium tetroxide in 0.1 m  phosphate/0.15 m  sucrose 
buffer followed by the OTOTO method o f  staining 
[14,15].
Bacteriological culture
Ulcer bases were sampled asceptically and inoculates 
made into Tryptone broth or Thioglycolate medium  
USP, and incubated at 37°C for 48 h. Gram-negative 
bacteria were identified using an api 20e kit (bio 
Merieux). Isolation o f strictly anaerobic organisms was 
not attempted. Cultures o f  the bacteria obtained from 
ulcer bases were partially characterized and their 
growth tested against a range o f antibiotics active 
against aerobic and anaerobic organisms.
RESULTS
Toxicity o f  individual NSAIDs 
O f the six N SA ID s tested, only indomethacin and 
diclofenac caused SB lesions. The other four N SA ID s  
failed to produce SB lesions even when the highest
dose was administered chronically over a period o f  
28 days.
Characteristics and distribution o f SB damage
Both diclofenac and indomethacin caused similar 
types o f damage. An acute dose o f  indomethacin at a 
dose o f 7.5 m g/kg caused acute haemorrhage, oedema 
and perforation o f the SB in the area o f  the jejunum  
within 24 h o f  administration. At lower doses, indo­
methacin caused discrete ulcers throughout the small 
bowel and/or a thin longitudinal lesion o f up to 10 cm 
in length. D iclofenac caused lesions similar to those 
seen with indomethacin but only after four daily doses 
o f 10.35 mg/kg. These lesions were true ulcers (Fig. 1). 
Their distribution in the SB is shown in Fig. 2.
Characteristics o f SB ulcers by SEM
Characteristically ulcer bases showed the presence o f  
many bacteria in active division, while adjacent mucosa 
showed few if any organisms. The bacteria (Fig. 3) were 
shown to be a mixture o f  Escherichia coli and Proteus 
mirabilis, although strict anaerobes were not identified 
by the culture methods used.
Prophylactic effect o f antibiotics on NSAID-induced SB 
ulceration
M etronidazole (100 mg/kg) and amoxycillin 
(50 mg/kg) given orally for three days before the 
administration o f indomethacin (6 mg/kg) on day 
four, completely abolished its ulcerogenic effect. When 
the interval between the last antibiotic dose and indo­
methacin exceeded 7 days, the prophylactic protection 
was lost. Control animals dosed with saline in
F ig . 1.— The histo logical appearance o f  a rat small bow el ulcer 48 h after induction by an acute oral dose o f  indom ethacin (6 m g/kg). T he section  
show s the lesion penetrates the full thickness o f  the m ucosa, and is a true ulcer rather than an erosion.
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F ig . 2 .— The distribution o f  ulceration (in m m 2) along the small 
bow el o f  the rat given diclofenac (10.35 m g/kg orally, daily for 4 
days). T he figure show s the mean result from six anim als killed 48 h 
after the last dose. Bowel length is expressed as a percentage distance  
from the stom ach to ileocaecal junction to adjust for variation in 
individual bowel length.
place o f the antibiotics showed the expected pattern o f  
ulceration throughout the experiment. Animals treated 
prophylactically with amoxycillin, metronidazole and 
cloxacillin given individually all produced a reduction 
in ulcer frequency after an indomethacin challenge. 
M etronidazole and cloxacillin protected the terminal 
SB, amoxycillin tended to protect the proximal SB 
(Fig. 4).
Differential effects o f antibiotics on SB ulceration and on 
associated bacteria grown in vitro
When a number o f  antibiotics were tested against 
the in vitro growth o f organisms recovered from SB 
ulcer bases collected as described, differences in inhib­
itory effects were demonstrated (Table I). Amoxycillin  
was an effective inhibitor. M etronidazole (100 mg/kg) 
and cloxacillin (100 mg/kg) were ineffective in inhibit­
ing growth o f  mixed cultures o f  E. coli and P. mirabilis 
although they were active in preventing ulcers in vivo, 
suggesting that essential anaerobic bacteria had not 
been isolated by the m ethods described, and were 
probably the organisms necessary for ulcer formation.
D ISC U SSIO N  
If the rat model o f NSAID -induced SB damage is 
to be useful in understanding the clinical phenomenon  
o f anaemia associated with the ingestion o f  N SA ID s, 
suppositions must be made concerning the pathogen­
esis and pathology o f  the SB damage in the two 
situations. There are obvious differences.
The time course o f the damage appears to differ. 
In humans, Bjarnasson et al. have suggested a long 
exposure to N SA ID s is necessary for an enteropathy 
and blood loss to occur [4, 5]. The SB in the rat model 
ulcerates within hours or days o f  exposure to specific 
N SA ID s, with acute perforation o f  the jejunum at high 
doses. Enteroscopic determination o f  SB ulceration in 
man has been retrospective with no clear association o f  
the time course o f  action o f  these drugs and with no 
association with particular N SA ID s [6, 7]. Lesions in
F i g .  3.— Scanning electron m icrograph o f  a representative small bowel ulcer formed after the oral adm inistration o f  d iclofenac (10.35 m g/kg  
orally, daily for 4 days). The ulcer base was covered with a dense collection o f  actively dividing bacteria; m ost were short rods, m any with newly 
formed septa, som e with features suggesting L forms. Adjacent areas o f  non-ulcerated m ucosa show ed only  scant growth o f  bacteria. W hen 
grow n aerobically these bacteria were show n to be Escherichia coli and Proteus mirabilis spp.
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F ig . 4 .— The com parative action o f  a variety o f  antibiotics in 
inhibiting indom ethacin-induced small bow el ulcers in the rat. Bars 
represent the mean o f  six anim als per experim ent. (A ) Control: 
distribution and number o f  small bowel ulcers after a single oral dose  
o f  indom ethacin (6 m g/kg). (B) Prophylactic dose o f  am oxycillin  
(50 m g/kg) given once a day for 2 days before the indom ethacin  
challenge. (C) C loxacillin given as in (B) at a dose o f  100 m g/kg. 
(D ) M etronidazole given as in (B) at a dose o f  100 m g/kg.
the rat SB were always true ulcers whereas enteroscopic 
views o f the human SB often reported haemorrhagic 
lesions, probably erosions.
The creation o f ulcers in the rat SB depended 
absolutely on the presence o f  bacteria, probably anaer­
obes for their production. These bacteria were likely to 
be o f  faecal origin and their source was probably
ingested faeces, given the rat’s habit o f coprophagia, 
explaining the presence o f  viable coliform organisms in 
ulcer bases throughout the whole length o f the SB. This 
would not be expected in the human SB and thus 
ulcers, if present, may be caused by another mechan­
ism. Recent experiments carried out by us have not 
detected coliform organisms in the SB o f patients who 
take N SA ID s and who have anaemia, but have shown 
the presence o f  other organisms [16].
When patients with an enteropathy and blood loss 
ascribed to a N SA ID  were given metronidazole, the 
result was to reduce blood loss suggesting either an 
antimicrobial effect or a direct action o f the drug on the 
ulcerogenic process [17]. Our results suggest only pro­
phylactic treatment protects against N SA ID  ulcers. 
Antibiotics given following ulcer formation had no 
effect [18]. Our data from in vitro and in vivo effects o f  
antibiotics (Table I; Fig. 4) show that metronidazole 
and cloxacillin, which have no effect on the inhibition 
o f gut bacteria grown aerobically, nevertheless prophy- 
lactically protect against NSAID-induced ulcers in vivo. 
The organisms involved in ulceration are therefore 
likely to be strict anaerobes and there is no direct effect 
o f the antibiotic on the ulcerogenic process per se.
It has been suggested that N SA ID s that are excreted 
via the bile are particularly prone to cause SB damage 
[12 ,13 ,19 ,20 ], perhaps because o f the extra-enteric 
exposure this produces. In the rat however, other 
N SA ID s at high doses did not result in ulceration, 
suggesting not the primary N SA ID  but a metabolite 
may be the initiator o f  damage. To extrapolate these 
findings to man requires the hepatic metabolites o f  
N SA ID s to be quantitatively and qualitatively similar 
in both species.
The rat SB is sensitive to the effects o f N SA ID s, but 
peculiarly only indomethacin and diclofenac, and at 
relatively high therapeutic doses. Their effects appear 
to be completely dependent on a bacterial adjuvant 
before ulceration is manifest. It is unlikely that the 
human situation can be directly compared with this 
model in respect to either specific N SA ID s, their dose 
or therapeutic protective measures. The extrapolation
T A B L E  I
The com parative inhibition caused by a variety o f  antibiotics when 
applied to a mixed culture o f  organism s taken from an ulcer base 
represented by Fig. 4. The organism s grow n aerobically were E. coli 
and P. mirabilis. The com parative figures o f  inhibition were produced  
using oxoid antim icrobial susceptibility discs on oxoid antim icrobial 
test m edia cultured at 37°C
A ntibiotic O xoid code Zone (m m) o f  inhibition
Ciprofloxacin CIP 5 10.8
A m oxycillin A M L  25 7.3
Cefuroxim e C X M  30 5.8
N eom ycin N  30 5.5
N alidixic acid N a 30 4.8
Chloram phenicol CIO 4.3
G entam icin C N  10 3.5
Oxytetracycline O T 30 3.3
M etronidazole M TZ  50 0
C loxacillin OB 5 0
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o f  animal data to the clinical situation is therefore 
likely to be o f  limited value.
A c k n o w l e d g e m e n t s  
W e are grateful to Sm ithKline Beecham who sup­
ported this work, and Ursula Potter, Electron Optics 
U nit, University o f  Bath for electron m icroscopy.
R e f e r e n c e s
1. Aabakken L. Review article: non-steroidal, anti-inflam­
matory drugs— the extending scope o f gastrointestinal 
side effects. Aliment Pharmacol Ther 1992;6:143-62.
2. Robert A. Cytoprotection by prostaglandins. G astro­
enterology 1979;77:761-7.
3. Kent TH, Cardelli RM , Stamler FW. Small intestinal 
ulcers and intestinal flora in rats given indomethacin. 
Am J  Pathol 1969;54:237-45.
4. Bjarnason I, Zanelli G, Prouse P, Smethurst P, Smith T, 
Levi S, Gumpei MJ, Levi AJ. Blood and protein loss via 
small-intestinal inflammation induced by non-steroidal 
anti-inflammatory drugs. Lancet 1987;ii:711—14.
5. Bjarnason I, Zanelli G, Smith T, Prouse P, Williams P, 
Smethurst P, Delacey G, Gumpei MJ, Levi AJ. 
Nonsteroidal antiinflammatory drug-induced intestinal 
inflammation in humans. Gastroenterology 1987;93: 
480-9 .
6. Morris AJ, Madhok R, Sturrock RD, Capell HA, 
MacKenzie JF. Enteroscopic diagnosis o f small bowel 
ulceration in patients receiving non-steroidal anti­
inflammatory drugs. Lancet 1991;337:520.
7. Morris AJ, Wasson LA, MacKenzie JF. Small bowel 
enteroscopy in undiagnosed gastrointestinal blood loss. 
Gut 1992;33:887-9.
8. Allison MC, Howatson AG, Torrance CJ, Lee FD, 
Russell RI. Gastrointestinal damage associated with the 
use o f nonsteroidal antiinflammatory drugs. N Engl J  
M ed  1992;327:749-54.
9. Bjarnason I, Smethurst P, Fenn GC, Lee CF, Menzies IS, 
Levi AJ. Misoprostal reduces indomethacin induced 
changes in human small intestinal permeability. Dig Dis 
Sci 1989;34:407-11.
10. Morris AJ, Madhok RJ, Capell HA, Sturrock RD, 
MacKenzie JF. The effect o f misoprostal on enteroscopy- 
diagnosed N SA ID  small bowel enteropathy— a retro­
spective study. Gut 1992;33(suppl. 1):S9.
11. Bjarnason I, Hayllar J, MacPherson AJ, Russell AS. Side 
effects o f nonsteroidal anti-inflammatory drugs on the 
small and large intestine in humans. Gastroenterology 
1993;104:1832-47.
12. Yesair DW , Callahan M, Remington L, Kensler CJ. 
Biochem Pharmacol 1970;19:1579-90.
13. Duggan DE, Hooke KF, N oll RM, Kwan KC. 
Enterohepatic circulation o f indomethacin and its 
role in intestinal irritation. Biochem Pharmacol 1975; 
25:1749-54.
14. Seligman AM , Wasserkrug HL, Hanker JS. A new 
staining method (OTO) for enhancing contrast o f lipid- 
containing membranes and droplets in osmium tetroxide 
fixed tissue with osmiophilic thiocarbohydrazine (TCH). 
J  Cell Biol 1966;30:424-32.
15. Kelley RO, Dekker RAF, Bluemink JG. Ligand- 
mediated osmium binding— its application in coating 
biological specimens for scanning electron-microscopy. 
J  Ultra Res 1973;45:254-8.
16. Potter U, Collins AJ, Notarianni LJ, Morris AJ, 
Smith AW. Spirochaetes in small bowel. Lancet 1995; 
345:723.
17. Bjarnason I, Hayllar J, Smethurst P, Price A, Gumpei 
MJ. Metronidazole reduces intestinal inflammation 
and blood loss in non-steroidal anti-inflammatory drug 
induced enteropathy. Gut 1992;33:1204-8.
18. Bjarnason I, Smethurst P, Levi AJ, Price AB. Indo­
methacin induced chronic small intestinal ulceration 
in the rat. Gastroenterology 1988;94:A37.
19. Riess W, Stierlin H, Degen P, Faigle JW, Gerardin A, 
Moppert J, Sallmann A, Schmid K, Schweizer A, Sulc M, 
Theobald W, Wagner J. Pharmacokinetics and metab­
olism of the anti-inflammatory agent voltaren. Scand J  
Rheumatol 1978;22(suppl.): 17-29.
20. Brune K, Lanz R. Pharmacokinetics o f non-steroidal 
anti-inflammatory drugs. In: Bonta IL, Bray MA, 
Parnham MJ, eds. Handbook o f  inflammation, Vol. 5. 
Amsterdam: Elsevier Science, 1985:413—49.
